gene,snp,snippet
AANAT,Rs28936679,sleep disorder
AANAT,Rs28936679,sleep phase syndrome
ABCA1,Rs2066715,Apolipoprotein E levels in cerebrospinal fluid 
ABCA1,Rs2066715,effects of ABCA1 polymorphisms.
ABCA1,Rs2066715,HDL cholesterol level
ABCA1,Rs2066715,ABCA1 sequence variation confirms association with dementia.
ABCA1,Rs363717,dementia
ABCA1,Rs4149274,C allele
ABCA1,Rs4149274,HDL cholesterol
ABCA12,Rs726070,aka c.7093G>
ABCA12,Rs726070,p.Asp2365Asn
ABCA3,Rs149989682,ambiguous flip confusion
ABCA3,Rs149989682,death of a newborn
ABCA3,Rs149989682,type 3
ABCA3,Rs149989682,disorder involving severe neonatal distress
ABCA3,Rs149989682,surfactant metabolism dysfunction
ABCA3,Rs149989682,rare mutation
ABCA3,Rs149989682,pulmonary
ABCA7,Rs72973581,rs72973581(A)
ABCA7,Rs115550680,late-onset Alzheimer's disease
ABCA7,Rs115550680,could result in defective protein function
ABCA7,Rs4147929,late onset Alzheimer's disease
ABCA7,Rs72973581,Alzheimer's disease
ABCA7,Rs72973581,ABCA7
ABCA7,Rs72973581, p.G215S
ABCB1,Rs3789243,A Danish case-control study comprising 373 Crohn's disease
ABCB1,Rs4148739,depression
ABCB1,Rs2235015,major depression
ABCB1,Rs4148739,depression
ABCB1,Rs4148740,depression
ABCB1,Rs4148739,depression
ABCB1,Rs2235015,depression
ABCB1,Rs2235015,were more likely to remit
ABCB1,Rs2032583,antidepressant drugs
ABCB1,Rs2032583,relationships for selective serotonin reuptake inhibitors
ABCB1,Rs2032583,intracerebral concentrations of certain drugs
ABCB1,Rs11983225,depression 
ABCB1,Rs11983225,depression 
ABCB1,Rs11983225,depression 
ABCB1,Rs11983225,adverse side effects
ABCB4,Rs45575636,woman at between 2-fold to 16-fold
ABCB4,Rs45575636,intrahepatic cholestasis of pregnancy
ABCB4,Rs58238559,rs58238559(C) allele
ABCB4,Rs58238559,3.75-fold increase in the probability of developing atrial fibrillation/flutter
ABCC11,Rs17822931,Caucasian women
ABCC11,Rs17822931,risk of breast cancer
ABCC11,Rs17822931,genotypically nonodorous
ABCC11,Rs17822931,(T;T) for 
ABCC11,Rs17822931,East Asians and (C;C) for Europeans and Africans
ABCC11,Rs17822931,lipid secretion
ABCC11,Rs17822931,sweat production
ABCC11,Rs17822931,wet vs dry earwax
ABCC11,Rs17822931,lipid secretion
ABCC11,Rs17822931,sweat production
ABCC11,Rs17822931,wet vs dry earwax
ABCC2,Rs3740065,invasive breast cancer
ABCC2,Rs3740065,shorter recurrence-free survival
ABCC2,Rs3740065,higher risk of recurrence
ABCC2,Rs3740066,intrahepatic cholestasis of pregnancy (ICP)
ABCC2,Rs3740066,remature birth
ABCC2,Rs3740066,intrauterine death
ABCC2,Rs3740066,intrahepatic cholestasis of pregnancy (ICP)
ABCC2,Rs3740066,Argentinian
ABCC2,Rs3740066,premature birth
ABCC2,Rs3740066,intrauterine death
ABCC4,Rs11568658,multidrug resistance
ABCC4,Rs11568658,myocardial infarction
ABCC4,Rs11568658,myocardial infarction
ABCC4,Rs11568658,human multidrug resistance protein
ABCC6,Rs212077,familial combined hyperlipidemia
ABCC8,Rs137852676,chronic renal insufficiency
ABCC8,Rs137852676,focal or diffuse congenital hyperinsulinism
ABCC8,Rs137852676,neonatal diabetes
ABCC8,Rs137852676,"dominant, recessive, or compound heterozygous SUR1 mutations"
ABCC9,Rs11046205,rs11046205
ABCC9,Rs11046205,Drosophila
ABCD1,Rs398123113,ALD Mutation
ABCD1,Rs193922094,adrenoleukodystrophy
ABCD1,Rs1057518721,Chromosome Xq28 deletion syndrome
ABCD1,Rs193922094,mutation
ABCD1,Rs1057518721,dystonia
ABCD1,Rs1057518721,deafness
ABCD1,Rs1057518721,cerebral hypomyelination (DDCH)
ABCG2,Rs2199936,uric acid concentrations
ABCG2,Rs72552713,significantly associated with gout
ABCG2,Rs72552713,associated with the ROL gout subtype
ABCG2,Rs72552713,urinary urate excretion (UUE) is over 25.0 mg/h/1.73 m2
ABCG8,Rs6544713,dyslipidemia 
ABCG8,Rs6544713,carotid artery disease
ABO,Rs8176740,Influences ABO blood groupABO Blood Type
ABO,Rs8176741,blood group type
ABO,Rs8176741,genosets
ABO,Rs8176741,SNP
ABO,Rs8176740,ABO Blood Type
ABO,Rs8176740,Influences ABO blood group
ABO,Rs8176720,cystic fibrosis lung disease severity
ABO,Rs8176741,ABO gene
ABO,Rs56392308,ABO blood group
ABO,I4000505,ABO Blood Type
ABO,I4000505,Influences ABO blood group
ABO,I4000505,Influences ABO blood groupABO Blood Type
ABO,I4000504,ABO Blood Type
ABO,I4000504,Influences ABO blood group
ABO,I4000504,Influences ABO blood groupABO Blood Type
ABO,Rs8176720,infection
ABP1,Rs2071517,polymorphisms
ABP1,Rs2071514,polymorphisms
ABP1,Rs1049748,polymorphisms
ACADM,I5012755,Medium-Chain
ACADM,I5012755,Acyl-CoA
ACADM,I5012755,Dehydrogenase Deficiency
ACADM,I5012758,Acyl-CoA
ACADM,I5012758,Dehydrogenase
ACADM,I5012758,eficiencyrs
ACADM,I5012758,Medium-Chain Acyl-CoA Dehydrogenase Deficiency
ACADM,I5012759,Medium-Chain Acyl-CoA Dehydrogenase Deficiency
ACADM,I5012760,Dehydrogenase Deficiency
ACADVL,Rs113994167,c.848T>C (p.Val283Ala or V283A)
ACAT1,Rs779565865,pathogenic variant
ACAT1,Rs779565865,NM_000019
ACAT1,Rs779565865,ACAT1
ACAT1,Rs779565865,149delC 
ACAT1,Rs779565865,Thr50Asnfs
ACAT1,Rs779565865,OMIM
ACAT1,Rs779565865,pathogenic 
ACE,Rs4646994,extreme obesity with the highest carbohydrate intake
ACE,Rs4646994,morbidly obese
ACE,Rs4646994,carbohydrate intake
ACE,Rs4646994,higher risk for early-onset psoriasis
ACE,Rs4646994,erectile dysfunction
ACE,Rs4646994,obesity
ACE,Rs4646994,the highest carbohydrate intake
ACE,Rs4344,G12269A
ACE,Rs4343,diabetic nephropathy
ACE,Rs4646994,respond better to Viagra
ACKR1,Rs34599082,lower antigen expression
ACKR1,Rs34599082,chemokine binding ability
ACKR1,Rs34599082,lower amounts of DARC protein
ACKR1,Rs34599082,malaria
ACKR1,Rs34599082,Duffy blood group FY(bwk) phenotype
ACKR1,Rs34599082,infection by malaria
ACKR1,Rs34599082,Duffy blood group (antigen) on red blood cells
ACTN4,Rs121908415,Focal segmental glomerulosclerosis
ACTN4,Rs121908416,Focal segmental glomerulosclerosis
ADAD1,Rs17388568,type-1 diabetes
ADAM10,Rs61751103,Alzheimer's disease
ADAM33,Rs543749,COPD
ADAM33,Rs543749,chronic obstructive pulmonary disease
ADAM33,Rs528557, northeastern China
ADAM33,Rs528557,sthma in Indian children.
ADAM33,Rs2280090,bronchial hyperresponsiveness
ADAM33,Rs3918396,chronic obstructive pulmonary disease
ADAM33,Rs2280090,asthma
ADAM33,Rs528557,childhood asthma 
ADCY5,Rs9883204,birth weight in preterm neonates.
ADCY5,Rs11708067, glucose and insulin responses to an oral glucose challenge.
ADCY5,Rs11708067,glucose and insulin responses
ADCY5,Rs11708067,Genetic variation in GIPR 
ADCY5,Rs11708067,oral glucose challenge.
ADH1B,Rs2066702,PDTaverage
ADH1B,Rs2066702,alcoholism
ADH1B,Rs2066702,Arg369Cys in exon 9
ADH1B,Rs2066702,ADH1B 3
ADH1B,Rs2066702,Native American
ADH1B,Rs2066702,African American
ADH1B,Rs2066702,maternal and fetal alcohol syndromes
ADH1B,Rs2066702,ADH1B genotypes
ADH1B,Rs2066702,ADH1B 3
ADH1B,Rs2066702,low-risk allele
ADH1B,Rs2066702,ADH1B 1
ADH1B,Rs2066702,high-risk allele
ADH1B,Rs2066702,DSM-IV
ADH1B,Rs2066702,African American
ADH1B,Rs2066702,PDTsum
ADH1B,Rs2066702,PDTaverage
ADH1B,Rs2066702,high-risk allele
ADH1B,Rs2066702,low-risk allele
ADH1B,Rs2066702,maternal and fetal alcohol syndromes
ADH1B,Rs2066702,protection against alcoholism
ADH1B,Rs2066702,alcoholism
ADH1B,Rs2066702,ADH1B 3
ADH1B,Rs2066702,SNP
ADH1B,Rs2066702,ICD-10
ADH1B,Rs2066702,alcoholism
ADH1B,Rs2066702,rs2066702
ADH4,Rs1800759,Caucasians
ADH4,Rs1800759,(A;A) genotypes A/A 
ADH4,Rs1800759,alleles
ADH4,Rs1800759,rs1800759(A)
ADH4,Rs1800759,ADH4 SNP
ADH4,Rs1800759,healthy control subjects
ADH4,Rs1800759,African Americans
ADH4,Rs1800759,European Americans
ADH4,Rs1800759,substance dependence
ADH4,Rs1800759,five-factor model of personality traits
ADH4,Rs1800759,recessive manner
ADH4,Rs1800759,alcohol dehydrogenase 4 (ADH4) gene
ADH4,Rs1800759,rs1800759
ADH4,Rs1800759,drug dependence
ADH4,Rs1800759,alcohol dependence
ADH4,Rs1800759,alcohol dehydrogenase 4 (ADH4) gene
ADH4,Rs1800759,promoter (regulatory region)
ADH4,Rs1800759,SNP
ADH4,Rs1800759,rs1800759
ADH4,Rs1800759,associated with agreeableness scores.
ADH4,Rs1800759,rs1800759
ADH4,Rs1800759,ADH4 SNP
ADIPOQ,Rs266729,obesity
ADIPOQ,Rs2241766,lowest (perhaps 0.15x) risk
ADIPOQ,Rs2241766,high adiponectin signaler
ADIPOQ,Rs2241766,reduced risk of breast cancer
ADIPOQ,Rs2241766,high signaler
ADIPOQ,Rs2241766,average breast cancer risk
ADIPOQ,Rs2241766,low adiponectin signaler
ADIPOQ,Rs2241766,adiponectin signaling status
ADIPOQ,Rs266729,cancer
ADIPOQ,Rs2241766,high signaler
ADIPOQ,Rs2241766,intermediate adiponectin signaler
ADIPOQ,Rs266729,colorectal cancer
ADIPOQ,Rs822391,type 2 diabetes
ADIPOQ,Rs266729,colorectal cancer
ADIPOQ,Rs266729,obesity
ADIPOQ,Rs266729,colorectal cancer
ADIPOQ,Rs822391,diabetes-related quantitative traits
ADIPOQ,Rs822391,insulin sensitivity in a cohort of adolescents and their parents
ADIPOQ,Rs822391,risk of ischemic stroke
ADIPOQ,Rs822393,Caucasians
ADIPOQ,Rs822391,Korean population
ADIPOQ,Rs822391,type 2 diabetes
ADIPOQ,Rs822391,plasma adiponectin levels
ADIPOQ,Rs822391,ischemic stroke
ADIPOQ,Rs2241766,high signaler
ADIPOQ,Rs266729,colorectal cancer
ADIPOQ,Rs2241766,intermediate signaler
ADIPOQ,Rs17366743,diabetes
ADIPOQ,Rs2241766,intermediate signaler
ADIPOQ,Rs1501299,cancer
ADIPOQ,Rs2241766,intermediate signaler
ADIPOQ,Rs1501299,breast cancer
ADIPOQ,Rs1501299,breast cancer
ADIPOQ,Rs2241766,chromosome 3
ADIPOQ,Rs2241766,decreased cancer risk
ADIPOQ,Rs2241766,breast cancer
ADIPOQ,Rs2241766,adiponectin
ADIPOQ,Rs2241766,lipid metabolism
ADIPOQ,Rs2241766,you
ADIPOQ,Rs2241766,adiponectin signaler
ADIPOQ,Rs2241766,average breast cancer risk
ADIPOQ,Rs1501299,breast cancer
ADIPOQ,Rs2241766,breast cancer
ADIPOQ,Rs2241766,at reduced risk
ADIPOQ,Rs2241766,adiponectin signaling status
ADIPOQ,Rs2241766,low signalers
ADIPOQ,Rs2241766,intermediate signalers
ADIPOQ,Rs2241766,decrease in breast cancer risk
ADIPOQ,Rs2241766,high signalers
ADIPOQ,Rs2241766,lower breast cancer risk 
ADIPOQ,Rs2241766,Adiponectin signaling status
ADIPOQ,Rs2241766,low signaler
ADIPOQ,Rs2241766,low signaler
ADIPOQ,Rs2241766,low signaler
ADIPOQ,Rs2241766,decreased cancer risk
ADIPOR2,Rs1044471,smaller waist circumference
ADIPOR2,Rs1044471, g.33447T (rs1044471)
ADIPOR2,Rs1044471,lower insulin resistance
ADIPOR2,Rs1044471,g.-7309A
ADIPOR2,Rs1044471,rs75172865)
ADORA2A,Rs2298383,Variation at this SNP
ADORA2A,Rs2298383,levels (150mg) of caffeine
ADRA2A,Rs553668,Cystic Fibrosis severity
ADRA2A,Rs553668,polymorphism of the alpha 2-adrenergic recepto
ADRA2A,Rs553668,platelet aggregation
ADRA2A,Rs553668,baroreceptor sensitivity
ADRA2A,Rs553668,salt excretion
ADRA2A,Rs553668, C-1291G polymorphism
ADRA2A,Rs553668,cortisol escape
ADRA2A,Rs553668,satiation and gastric motor function in obesity.
ADRA2A,Rs553668,possible mediating effect of personality
ADRA2A,Rs553668,Variants of ADRA2A
ADRA2A,Rs553668,"fasting glucose, blood pressure, body mass index and type 2 diabetes risk"
ADRA2A,Rs553668,worsening of fasting glucose values
ADRA2A,Rs553668,cystic fibrosis
ADRA2A,Rs553668,ADRA2A
ADRA2A,Rs553668,ADRA2A
ADRA2A,Rs553668,type 2 diabetes
ADRA2A,Rs553668,adrenergic receptor alpha 2A
ADRA2A,Rs521674,Genetic determinants of target
ADRA2A,Rs521674,potentials
ADRA2A,Rs553668,increased platelet aggregation
ADRA2A,Rs553668,baroreceptor sensitivity
ADRA2A,Rs553668,salt excretion
ADRA2A,Rs553668,type 2 diabetes
ADRA2A,Rs553668,obesity and type 2 diabetes
ADRA2A,Rs553668,rs553668
ADRA2A,Rs553668,type 2 diabetes
ADRA2A,Rs553668,chromosome 10
ADRA2A,Rs553668,obesity
ADRA2A,Rs553668,ADRA2A
ADRA2A,Rs553668,polymorphism
ADRB2,Rs17334242,asthma
ADRB2,Rs1800888,myocardial infarction
ADRB2,Rs1800888,PCI
ADRB2,Rs1800888,coronary artery bypass graft
AFG3L2,Rs151344523,spinocerebellar ataxia-28
AFG3L2,Rs151344523,Considered in ClinVar to be a dominant mutation leading to spinocerebellar ataxia-28.
AGT,Rs5051,rs5051(C).
AGT,Rs5051,rs5051(T)
AGT,Rs5051,"""A"" allele"
AGT,Rs5051,essential hypertension
AGT,Rs5051,rs5051
AGT,Rs5051, rs5051(T) allele
AGT,Rs5051,rs699.rs5051(T;T) homozygotes
AGT,Rs5051,"""A-6G"""
AGT,Rs5051,Crohn's disease
AGT,Rs5051,haplotypes with left ventricular phenotypes
AGT,Rs5051,ngiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of Crohn's disease
AGT,Rs5051,angiotensinogen polymorphisms
AGT,Rs5051,plasma angiotensinogen levels
AGT,Rs5051,Alzheimer disease
AGT,Rs5051,heterogeneity and epistasis
AGT,Rs5051,Alzheimer disease
AGT,Rs5051,"ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3"
AGT,Rs5051,RNA structural
AGT,Rs5051,GenHAT
AGT,Rs5051,AGT SNP with Crohn's disease
AGT,Rs5051,rs5051(T)
AGT,Rs5051,dbSNP entry
AGT,Rs5051,homozygotes have been reported to be at increased risk for Crohn's disease
AGT,Rs5051,increased risk for hypertension
AGT,Rs5051,nd complications thereof.
AGT,Rs5051,higher plasma angiotensinogen levels
AGT,Rs5051,increased risk of essential hypertension
AGT,Rs5051,generally higher in African populations
AGT,Rs5051,compared to Caucasian populations
AGT,Rs5051,higher incidence of hypertension in African population
AGT,Rs5051,hypertension
AGT,Rs5051,350 Australian patients
AGT,Rs5051, rs699
AGT,Rs5051,treatment of Crohn's disease
AGT,Rs5051,Alzheimer disease
AGT,Rs5051,Alzheimer disease
AGT,Rs5051,ancestral risk
AGT,Rs5051,rs5051
AGT,Rs5051,SNP
AGT,Rs5051,promoter of the angiotensin AGT gene
AGT,Rs5051,rs5051(T) allele
AGT,Rs5051,Crohn's disease
AGTR1,Rs5186,Age
AGTR1,Rs5186,pregnancy-induced hypertension
AGTR1,Rs5186,Pregnant women
AGTR1,Rs5186,gender
AGTR1,Rs5186,coronary heart disease
AGTR1,Rs5186,Japanese population
AGTR1,Rs5186,hypertension
AGTR1,Rs5186,Chinese population
AGTR1,Rs5182,hypertensive subjects
AGTR1,Rs5186,SNP
AGTR1,Rs5182,reduced risk of heart attack
AGTR1,Rs5186,Caucasian populations
AGXT,Rs111996685,both are pathogenic according to ClinVar
AHCY,Rs13043752,minor allele
AHCY,Rs819134,regulation of biologic methylations
AHSG,Rs201849460,pathogenic variant
AHSG,Rs4918,snp Homozygosity
AHSG,Rs4918,leanness
AIP,Rs267606567,pathogenic variant
AIP,Rs267606555,pathogenic variant
AIP,Rs267606559,pathogenic variant
AKT1,Rs3803304,mechanism
AKT1,Rs3803304,area
AKT1,Rs3803304,boundary 
AKT1,Rs3803304,regulatory 
AKT1,Rs3803304,conserved 
AKT1,Rs3803304,proximity 
AKT1,Rs3803304,RNA 
AKT1,Rs3803304,gene
AKT1,Rs3803304,rs3803304 
AKT1,Rs3803304,rs3803304 
AKT1,Rs3803304,No significant association was seen in heterozygous subjects
AKT1,Rs3803304,An inverse association towards longevity was seen in those homozygous for the minor allele
AKT1,Rs3803304,significantly associated with longevity
AKT1,Rs3803304,disruptions 
AKT1,Rs3803304,underrepresented among long-lived
ALB,Rs76285851,Structural changes
ALB,Rs72552710,genetic variation on the thermal stability of human
ALB,Rs72552710,diazepam
ALB,Rs72552710,serum albumin
ALB,Rs77050410,Mutations in genetic variants of human serum albumin
ALB,Rs76285851,metal binding
ALB,Rs72552710,albumin reading identified by PCR analysis
ALB,Rs72552710,Binding of warfarin
ALB,Rs72552710,The molecular defect of albumin Tagliacozzo
ALB,Rs72552710,known mutations
ALB,Rs72552710,enetic variants of human serum albumin
ALB,Rs72552710,salicylate
ALB,Rs72552710,serum albumin
ALDH7A1,Rs864622558,i709034
ALDOB,Rs78340951,Lys
ALDOB,Rs76917243,ALDOB gene mutation
ALDOB,Rs387906225,aka c.360_363delCAAA (p.Asn120Lysfs)
ALDOB,Rs185972191,Mendelian disease
ALDOB,Rs185972191,biocurators
ALDOB,Rs185972191,Table S6
ALDOB,Rs185972191,Mendelian Disease
ALDOB,Rs185972191,Pathogenic Regulatory Variants
ALDOB,Rs185972191,Whole-Genome
ALDOB,Rs185972191,Mendelian disease
ALDOB,Rs185972191,SNP
ALOX5AP,Rs9579646,schemic stroke:
ALOX5AP,Rs17216473,ischemic 
ALOX5AP,Rs17216473,infarction 
ALOX5AP,Rs17216473,risk 
ALOX5AP,Rs17216473,haplotype 
ALOX5AP,Rs17216473,part 
ALOX5AP,Rs17216473,SNP 
ALOX5AP,Rs17216473,ALOX5AP 
ALOX5AP,Rs17216473,SG13S377
ALOX5AP,Rs17216473,myocardial infarction
ALOX5AP,Rs17216473,ischemic stroke
ALOX5AP,Rs17216473,is 
ALOX5AP,Rs17216473,also 
ALOX5AP,Rs17216473,rs17216473
ALPL,I6006926,hypophosphatasia.
ALPL,I6006925,p.R184W
ALPL,I6006925,c.550C>T
ALPL,I6006925,i6006925
ALPL,I6006895,odonto form of hypophosphatasia
ALPL,I6006895,"i6006895, also known as c.215T>C or p.I72T, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the odonto form of hypophosphatasia"
ALPL,I6006895,"i6006895, also known as c.215T>C or p.I72T, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the odonto form o"
ALPL,I6006890,"p.T371I,"
ALPL,I6006890,c.1112C>
ALPL,I6006890,i6006890
ALPL,I6006933,SNP
ALPL,I5900451,gene mutations
ALPL,I5900451,odonto form of hypophosphatasia
ALPL,I5900451,ALPL gene mutations database
ALPL,I5012686,SNP
ALPL,I5012686,hypophosphatasia
ALPL,I5012686,gene mutations
ALPL,I5012686,the rare/minor allele is considered pathogenic for the infantile form of hypophosphatasia
ALPL,I5012686,the ALPL gene on chromosome 1
ALPL,I6006888,perinatal form of hypophosphatasia
ALPL,I6006933,ALPL
ALPL,I6006933,rare/minor allele
ALPL,I6006933,ALPL gene mutations
ALPL,I6007018,the rare/minor allele is considered pathogenic for the perinatal form of hypophosphatasia
ALPL,I6007018,ALPL gene on chromosome 1
ALPL,I6007004,perinatal form of hypophosphatasia
ALPL,I6006962,rare/minor allele
ALPL,I6006962,pathogenic for the childhood form of hypophosphatasia.
ALPL,I6006962,chromosome 1
ALPL,I6006962,ALPL gene
ALPL,I6006962,SNP
ALPL,I6006962,p.V382I
ALPL,I6006962,c.1144G>A
ALPL,I6006962,i6006962
ALPL,I6006953,the rare/minor allele is considered pathogenic for the adult form of hypophosphatasia
ALPL,I6006953,ALPL gene on chromosome 1
ALPL,I6006948,hypophosphatasia
ALPL,I6006947,childhood form of hypophosphatasia
ALPL,I6006944,hypophosphatasia
ALPL,I6006933,p.E311K
ALPL,I6006933,c.931G>A
ALPL,I6006933,perinatal form of hypophosphatasia
ALPL,I6006933,pathogenic
ALPL,I5012684,SNP
ALPL,I6006933,chromosome 1
ALPL,I5012684,dbSNP name
ALPL,I5900451,hypophosphatasia
ALPL,I5012684,pathogenic for the infantile form of hypophosphatasia
ALPL,I5002773,ALPL gene mutations database
ALPL,I5002771,perinatal form of hypophosphatasia
ALPL,I5002771,pathogenic
ALPL,I5002771,rare/minor allele
ALPL,I5002771,chromosome 1
ALPL,I5002771,ALPL gene mutations
ALPL,I5002771,ALPL gene
ALPL,I5002771,SNP
ALPL,I5002771,p.Q207P
ALPL,I5002773,hypophosphatasia
ALPL,I5002771,c.620A>C
ALPL,I5012684,rs121918007
ALPL,I5002770,hypophosphatasia
ALPL,I5002769,considered pathogenic for the childhood form of hypophosphatasia
ALPL,I5002765,p.F327L
ALPL,I5002765,c.979T>C
ALPL,I5002765,i5002765
ALPL,I5002758,c.746G>T or p.G249V
ALPL,I5002758,i5002758
ALPL,I5002757,"Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the perinatal form of hypophosphatasia"
ALPL,I5002771,i5002771
ALPL,I5002774,i5002774
ALPL,I5002770,hypophosphatasia.
ALPL,I5002774,pathogenic for the infantile form of hypophosphatasia.
ALPL,I5012684,allele
ALPL,I5012684,ALPL gene mutations
ALPL,I5012684,chromosome 1
ALPL,I5012684,ALPL gene
ALPL,I5012684,SNP
ALPL,I5012684,p.E191K
ALPL,I5012684,c.571G>A
ALPL,I5012684,i5012684
ALPL,I5012684,dbSNP
ALPL,I5012684,hypophosphatasia
ALPL,I5012684,rs121918007 
ALPL,I5012684,database
ALPL,I5012684, ALPL 
ALPL,I5012684,Based 
ALPL,I5012684,ALPL 
ALPL,I5012684,is 
ALPL,I5012684,E191K
ALPL,I5012684,571G
ALPL,I5012684,also 
ALPL,I5012684,i5012684
ALPL,I5012684,considered 
ALPL,I5002774,SNP in the ALPL gene 
AMPD1,Rs17602729,muscle myalgia
AMPD1,Rs17602729,coronary artery disease seem to fare better than wild-type homozygotes
AMPD1,Rs17602729,"Heterozygotes, i.e. rs17602729(A;G) individuals, do not seem to suffer any exercise or fitness related deficit."
AMPD1,Rs17602729,"AMPD1 gene encodes the enzyme adenosine monophosphate deaminase, which is one of the key enzymes used to process the energy source ATP."
AMPD1,Rs17602729,"AMPD1 gene and also known as 'C34T', has at times been called the ""most prevalent genetic disease mutation"", at least in Caucasians."
AMPD1,Rs17602729,get muscle cramps and pains
AMPD1,Rs17602729,Some individuals - but by no means all or even a majority apparently - who are AMPD1 deficient get muscle cramps and pains when they exert themselves.
ANK2,Rs121912705,cardiac arrhythmia syndrome
ANK2,Rs121912705,loss of ankyrin-B function.
ANO5,Rs372221490,ka c.762
ANXA11,Rs2789679,sarcoidosis
ANXA11,Rs2789679,German individuals
ANXA11,Rs2789679,sarcoidosis
ANXA11,Rs2789679,sarcoidosis
ANXA11,Rs2789679,sarcoidosis
AOC1,Rs2071517,polymorphisms
AOC1,Rs1049748,polymorphisms
AOC1,Rs2071514,polymorphisms
AP4E1,Rs556450190,stuttering
APC,Rs1801155,no symptoms
APC,Rs587782557,Mormon
APC,Rs587782557,Mormons in Utah
APC,Rs587782557,dominantly inherited form of attentuated familial polyposis
APC,Rs1801155,Familial Adenomatous Polyposis
APC,Rs1801155,Colorectal Cancer
APC,Rs1801155,Colorectal Cancer
APC,Rs1801155,colorectal cancer
APC,Rs1801155,colorectal cancer
APC,Rs1801155,colorectal cancer
APC,Rs1801155,Muslim and Christian Palestinian Arabs
APC,Rs1801155,Sephardi and Mizrahi Jews
APC,Rs1801155,colorectal cancer.
APC,Rs1801155,gene mutation
APC,Rs1801155,Ashkenazi Jews 
APC,Rs1801155,Jews of Eastern European or Russian ancestry
APC,Rs1801155,Negev Bedouin
APC,Rs1801155,Ashkenazi Jewish heritage
APOA2,Rs3813627,high-density lipoprotein-cholesterol
APOA2,Rs3813627,coronary atherosclerosis
APOB,Rs5742904,Familial Hypercholesterolemia Type B
APOB,Rs5742904,familial hypercholesterolemia type B
APOB,Rs5742904,Caucasians
APOB,Rs5742904,familial hypercholesterolemia type B
APOB,Rs5742904,"alternative allele, c.10580G>T, which is also considered pathogenic"
APOB,Rs5742904,This variant is considered to the most frequent APOB gene FH mutation in Caucasians
APOC3,Rs5128,SNP
APOE,Rs1799724,cigarette smoking
APOE,Rs439401,rs4420638
APOE,Rs28931576,ancestral allele
APOE,Rs267606664,ApoE
APOE,Rs267606664,variant
APOE,Rs267606664,rise 
APOE,Rs267606664,APOE 
APOE,Rs267606664,variant 
APOE,Rs267606664,rs267606664 
APOE,Rs267606664,hypertriglyceridemia
APOE,Rs1799724,gastric cancer
APOE,Rs1799724,low bone mineral density
APOE,Rs769452,Subarachnoid hemorrhage
APOE,Rs1799724,Alzheimer's disease
APOE,Rs1799724,post-menopausal women
APOE,Rs121918394, familial dysbetalipoproteinemia
APOE,Rs121918394,dysbetalipoproteinemia
APOE,Rs121918394,type III hyperlipoproteinemia (i.e. familial dysbetalipoproteinemia)
APOE,Rs1799724,Caucasians
APOE,Rs121918394,type III hyperlipoproteinemia
APOE,Rs1799724,post-menopausal women
APOE,Rs1799724,low bone mineral density
APOE,Rs1799724,gastric cancer risk
APOE,Rs1799724,Caucasians
APOE,Rs1799724,Alzheimer's disease
APOM,Rs3117583,severe cutaneous adverse reactions
APP,Rs63749810,"""Iowa"" mutation"
APP,Rs63750973,"pathogenic for an aggressive, early-onset form of Alzheimer's disease"
APP,Rs63750851,early-onset Alzheimer's disease.
APP,Rs63750643,rare mutation
APP,Rs63749810, Alzheimer's disease
APP,Rs63749810,Alzheimer's disease or cerebral amyloid angiopathy.
APP,Rs532876832,Mendelian disease
APP,Rs63750643,Alzheimer
APP,Rs532876832,Table S6
APP,Rs532876832,SNP
APP,Rs532876832,Mendelian Disease
APP,Rs532876832,Pathogenic Regulatory Variants
APP,Rs532876832,Whole-Genome
APP,Rs532876832,Mendelian disease
APP,Rs193922916,Alzheimer's disease 
APP,Rs532876832,biocurators
APPL2,Rs139106853,Familial Bipolar Disorder
APPL2,Rs139106853,variants speculated
APPL2,Rs139106853,bipolar disorder
APPL2,Rs139106853,Bipolar Disorder
APPL2,Rs139106853,bipolar disorde
AR,Rs137852591,minor allele
ARL15,Rs1694089,regulatory genes
ARL15,Rs1694089,human microRNAs
ARSA,Rs28940893,aka c.1283C>T
ARSA,Rs28940893,rs80338815
ARSA,Rs28940893,metachromatic leukodystrophy
ARSA,Rs28940893,Caucasians.23andMe
ARSA,Rs28940893,metachromatic leukodystrophy
ARSA,Rs28940893,Caucasians
ARSDP1,I4000178,Haplogroup I1 (Y-DNA) subclade
ARSDP1,I4000178,i4000178(A;A) mutation
ARSDP1,I4000178,Haplogroup I (Y-DNA)
ARSDP1,I4000178,P30+.rs112707890
ARSDP1,I4000186,Haplogroup I (Y-DNA)
ASGR1,Rs186021206,lowered risk for myocardial infarction
ASGR1,Rs186021206,coronary artery disease
ASGR1,Rs186021206,myocardial infarction
ASGR1,Rs186021206,coronary artery disease
ASL,Rs869312976, 2T>
ASL,Rs138310841,argininosuccinate lyase deficiency
ASL,Rs767543051,argininosuccinate lyase deficiency
ASPA,Rs28940279,Ashkenazi Jewish population
ASPA,Rs28940279,Ashkenazi Jewish population
ASPA,Rs28940279,Ashkenazi Jews
ASPA,Rs28940279,utation originated in the Vilna area
ASPA,Rs28940279,European population
ASPA,Rs28940279,in Poland
ASPA,Rs28940279,Lithuania
ASPA,Rs28940279,Canavan disease
ASPA,Rs28940279,Canavan disease is a degenerative disease of the nervous system
ASPA,Rs28940279,childhood onset disease
ASPA,Rs28940279,disordered muscular behavior
ASPA,Rs28940279,"neurological symptoms, such as blindness, developmental and cognitive delays"
ASPA,Rs28940279,demyelination and leukodystrophy
ASPA,Rs28940279,spongy degeneration
ASPA,Rs28940279,strocytic swelling of normal neurons and abnormality of astrocyte mitochondria
ASPA,Rs28940279,ll and die on average at 18 months of age
ASPA,Rs28940279,European population
ASPA,Rs28940574,Canavan disease
ASPA,Rs28940279,amino acids
ASPA,Rs28940279,catalytic domain
ASPA,Rs28940279,common in Ashkenazi Jews
ASPA,Rs28940279,catalytic domain of aspartocyclase
ASPA,Rs28940279,missense mutation
ASPA,Rs12948217,Canavan disease
ASPA,Rs28940279,everal known causal SNPs of Canavan disease
ASPA,Rs28940279,Canavan disease is a degenerative disease of the nervous system
ASPA,Rs28940279,hildhood onset disease which begins in early infancy
ASPA,Rs28940279,"hypotonia, hyperextension"
ASPA,Rs28940279,neurological symptoms
ASPA,Rs28940279,blindness
ASPA,Rs28940279,developmental
ASPA,Rs28940279,haracterized by disordered muscular behavior
ASPA,Rs28940279,neurological findings appear to be due to demyelination and leukodystrophy
ASPA,Rs28940279,glutamate
ASPA,Rs28940279,cognitive delays
ASPA,Rs28940279,a hydrophobic
ASPA,Rs28940279,The A-C transversion results in a substitution of alanine
ASPA,Rs28940279,"small-chain amino acid,"
ASPA,Rs28940279,sufferers become extremely ill and die on average at 18 months of age
ASPA,Rs28940279,cytology confirms astrocytic swelling of normal neurons and abnormality of astrocyte mitochondria
ASPA,Rs28940279,spongy degeneration
ASPA,Rs28940279,aspartoacylase ASPA gene
ASS1,Rs121908641,1168G
ASS1,Rs121908641,Gly390Arg 
ASS1,Rs121908641,G390R
ATG16L1,Rs2241879,Crohn's disease
ATM,Rs664143,is associated with poorer overall survival for pancreatic cancer patients
ATM,Rs4986761,Breast Cancer Association Consortium
ATM,Rs664143,associated with poorer overall survival
ATM,Rs664143,American patients with potentially resectable pancreatic cancer
ATM,Rs664143,Korean lung cancer patients
ATM,Rs4986761,breast cancer
ATM,Rs4986761,breast cancer
ATM,Rs4986761,breast cancer
ATM,Rs3218707,breast cancer
ATM,Rs3218707,"breast cancer,"
ATM,Rs3218707,breast cancer.
ATM,Rs4986761,breast cancer
ATP13A2,Rs3738815,Parkinson disease
ATP13A2,Rs587776890,Phe851Cysfs
ATP1A2,Rs28933400,sodium transport related genes
ATP1A2,Rs28933400,essential hypertension.
ATP7B,Rs121907996,2906G
ATP7B,Rs121907996,Arg969Gln 
ATP7B,Rs121907996,R969Q
ATP8B4,Rs55687265,higher risk for systemic sclerosis
ATP8B4,Rs10519262,Alzheimer's disease
ATP8B4,Rs55687265,a rare variant in the ATP8B4 gene on chromosome 15
ATXN1,Rs179943,rs4420638
ATXN1,Rs179943,rs11159647
ATXN1,Rs179943,rs3826656
ATXN1,Rs179943,Alzheimer’s disease
AVPR1A,Rs11174811,AVPR1A
AVPR1A,Rs1042615,lower concentrations of triglycerides
AVPR1A,Rs1042615,nondiabetic subjects
AVPR1A,Rs1042615,higher fasting blood glucose
AVPR1A,Rs1042615,a tendency toward an increased prevalence of diabetes
AVPR1B,Rs35369693,child-onset mood disorders (primarily depression or bipolar disorder)
AVPR1B,Rs35369693,childhood aggression
AVPR1B,Rs35369693,childhood aggression
AVPR1B,Rs35369693,females
AVPR1B,Rs35369693,depression
AVPR1B,Rs35369693,bipolar disorder
AVPR1B,Rs35369693,Hungarian
AVPR1B,Rs35369693,associated with child-onset mood disorders
BAIAP2,Rs8079781,ADHD.
BAIAP2,Rs8079626,adult ADHD.
BAIAP2,Rs8079626,AC haploty
BAIAP2,Rs8079626,GC haplotype
BAIAP2,Rs8079626,ADHD 
BAIAP2,Rs8079781,Bonferroni correction
BAIAP2,Rs7210438,adult ADHD.
BAIAP2,Rs7210438,AC haploty
BAIAP2,Rs7210438,GC haplotype
BAIAP2,Rs7210438,ADHD 
BAIAP2,Rs7210438,Attention-deficit hyperactivity disorder
BAIAP2,Rs8079626,Attention-deficit hyperactivity disorder
BAK1,Rs210138,increase the odds
BAK1,Rs210138,testicular cancer
BANK1,Rs3733197,gene associated
BANK1,Rs3733197,systemic lupus erythematosus.
BARD1,Rs6435862,allelic odds ratio of 1.68 (p = 8.65 x 10(-18)) for risk of aggressive neuroblastoma
BARD1,Rs6435862,aggressive neuroblastoma
BARD1,Rs3768716,clinically aggressive neuroblastoma
BARD1,Rs3768716,increases the odds of aggressive neuroblastoma
BARD1,Rs3768716,clinically aggressive neuroblastoma
BARD1,Rs3768716,increases the odds of aggressive neuroblastoma
BARD1,Rs28997576,missense variant in the BRCA1
BARD1,Rs28997576,rs28997576
BARD1,Rs28997576,BARD1 Cys557Ser
BARD1,Rs28997576,risk is amplified in carriers of the BRCA2 999del5
BARD1,Rs28997576,In families with at least three BC and/or ovarian cancer cases
BARD1,Rs28997576,rs28997576(C;G) was associated with increased breast cancer risk 
BARD1,Rs28997576,"confers risk of single and multiple primary breast cancers, and this risk is amplified in carriers of the BRCA2 999del5 (codon 257, exon 9) mutation."
BARD1,Rs28997576,variant
BARD1,Rs28997576,rs28997576
BARD1,Rs28997576,BARD1 Cys557Ser (rs28997576)
BCAM,Rs3810141,p.Cys237Ter
BCAM,Rs3810141,c.711C>T
BCHE,Rs201820739,Bipolar Disorder
BCHE,Rs28933390,Pseudocholinesterase Deficiency
BCHE,Rs201820739,bipolar disorde
BCHE,Rs201820739,bipolar disorder
BCHE,Rs1799807,soldiers
BCHE,Rs201820739,Familial Bipolar Disorder
BCHE,Rs1799807,delayed return to spontaneous breathing
BCHE,Rs201820739,variants speculated
BCKDHB,Rs28934895,R183P
BCKDHB,Rs28934895,"Maple Syrup Urine Disease,"
BCKDHB,Rs28934895,homozygotes
BCL2,Rs1564483,breast cancer
BCL2,Rs1564483,clubfoot
BCL2,Rs1564483,clubfoot
BCL2,Rs1564483,breast cancer.
BCL2,Rs2279115,prostate cancer treatment response
BCL2,Rs7226979,excessive hairiness
BCL2,Rs1564483,MYBL2 interacting genes
BCR,Rs3313172,depression
BCR,Rs3761418,increased risk for depression
BCR,Rs3313172,1.28
BCR,Rs3313172,allele 
BCR,Rs3761418,increased risk for depression
BCR,Rs3313172,risk 
BCR,Rs3313172,increased risk for depression
BCR,Rs2267012,increased risk for depression
BCR,Rs2156921,depression
BCR,Rs3313172,rs3313172
BCS1L,Rs28937590,GRACILE syndrome
BDNF,Rs11030104,Alzheimer's disease
BDNF,Rs11030104,heterozygous 
BDNF,Rs11030104,diplotypes 
BDNF,Rs2049045,Alzheimer's disease
BDNF,Rs2049045,heterozygous 
BDNF,Rs2049045,diplotypes 
BDNF,Rs28722151,Brain-derived
BDNF,Rs988748,lacks any clear effects
BHLHE41,Rs121912617,short sleepers to stay awake longer
BHLHE41,Rs121912617,sleep disorder
BHLHE41,Rs121912617,more orexin production
BHLHE41,Rs121912617,Familial Natural Short Sleepers
BHLHE41,Rs121912617,sleep disorder
BHLHE41,Rs121912617,"sleep 6–6.5 hours per night (∼2 hours less than controls) on average, without reporting any sense of sleep deprivation"
BHLHE41,Rs121912617,Familial Natural Short Sleepers (FNSS)
BHLHE41,Rs121912617,does not appear to have any known negative medical consequence
BHMT,Rs3733890,neural tube defects
BLM,Rs113993962,deletion of 6 bases
BLM,Rs113993962,Bloom syndrome
BLM,Rs113993962,>95% of such cases in the Ashkenazi population.
BLM,Rs2380165,breast cancer
BLOC1S3,Rs281865115,pathogenic variant
BMP2,Rs15705,A polymorphism in a conserved posttranscriptional regulatory motif alters bone morphogenetic protein 2
BMP2,Rs15705,fat and muscle mass
BMP2,Rs15705,BMP2 gene
BNC2,Rs2153271,freckling
BRAF,Rs180177034,23andMe
BRAF,Rs180177034,p.Ala246Pro)
BRAF,Rs180177034,aka c.736G
BRCA1,Rs80357662,breast cancer
BRCA1,Rs80357662,pathogenic
BRCA1,Rs80357662,BRCA1
BRCA1,Rs80357635,breast cancer
BRCA1,Rs80357669,deletion variant
BRCA1,Rs80357635,breast cancer
BRCA1,Rs80357624,p.Arg1085_Leu1086?fs
BRCA1,Rs80357624,c.3255_3256insGA
BRCA1,Rs80357624,3374insGA
BRCA1,Rs80357624,rs80357624
BRCA1,Rs80357624,breast cancer
BRCA1,Rs80357624,BRCA1
BRCA1,Rs80357618,gene considered pathogenic for breast cancer
BRCA1,Rs80357607,breast cancer
BRCA1,Rs80357569,BRCA1 
BRCA1,Rs80357601,BRCA1
BRCA1,Rs80357569,variant in the BRCA1 gene
BRCA1,Rs80357569,pathogenic for breast cancer
BRCA1,Rs80357569,rs80357569
BRCA1,Rs80357569,also 
BRCA1,Rs80357569,1135insA
BRCA1,Rs80357569,1016_1017insA 
BRCA1,Rs80357601,p.Glu1001=fs
BRCA1,Rs80357569,Lys339
BRCA1,Rs80357669,BRCA1 gene
BRCA1,Rs80357569,pathogenic 
BRCA1,Rs80357569,cancer 
BRCA1,Rs80357600,breast cancer
BRCA1,Rs80357601,rs80357601
BRCA1,Rs80357601,3121delA
BRCA1,Rs80357569,variant 
BRCA1,Rs80357669,pathogenic mutation.
BRCA1,Rs80357787,variant in the BRCA1 gene
BRCA1,Rs80357711,breast cancer
BRCA1,Rs80357522,breast cancer
BRCA1,Rs80359876,breast cancer
BRCA1,Rs80359876,pathogenic for breast cancer in ClinVar.
BRCA1,Rs80359874,breast cancer
BRCA1,Rs80359872,breast cancer
BRCA1,Rs80358158,breast cancer
BRCA1,Rs80358047,breast cancer
BRCA1,Rs80357977,breast cancer
BRCA1,Rs80357975,breast cancer
BRCA1,Rs80357945,breast cancer
BRCA1,Rs80357945,considered pathogenic for breast cancer
BRCA1,Rs80357916,breast cancer
BRCA1,Rs80357916,breast cancer
BRCA1,Rs80357877,p.Glu1161_Ser1164?fs
BRCA1,Rs80357711,breast cancer
BRCA1,Rs80357877,BRCA1
BRCA1,Rs80357877,3600del11
BRCA1,Rs80357877,rs80357877
BRCA1,Rs80357862,breast cancer
BRCA1,Rs80357854,breast cancer
BRCA1,Rs80357853,pathogenic for breast cancer in ClinVar
BRCA1,Rs80357853,breast cancer
BRCA1,Rs80357848,breast cancer
BRCA1,Rs80357808,breast cancer
BRCA1,Rs80357787,pathogenic for breast cancer in ClinVar
BRCA1,Rs80357774,breast cancer in ClinVar
BRCA1,Rs80357747,breast cancer
BRCA1,Rs80357724,breast cancer
BRCA1,Rs80357724,p.Val266_Ser267ValLysfs
BRCA1,Rs80357724,rs80357724
BRCA1,Rs80357877,c.3481_3491delGAAGATACTAG
BRCA1,Rs80357463,i5010039
BRCA1,I5009493,breast cancer
BRCA1,Rs80357321,breast cancer
BRCA1,Rs28897696,founder mutation in the Columbian Hispanic population
BRCA1,Rs28897696,breast cancer
BRCA1,Rs28897696,clinical importance
BRCA1,Rs28897696,spurious association
BRCA1,Rs28897696,likely to lead to breast cancer
BRCA1,Rs273900730,breast cancer
BRCA1,Rs273900730,considered
BRCA1,Rs273897659,pathogenic for breast cancer
BRCA1,Rs273897659,BRCA1 gene
BRCA1,Rs16942,increased risk for breast cancer
BRCA1,Rs16942,1 of 25 SNPs
BRCA1,Rs16942,SNP
BRCA1,Rs16942,BRCA1
BRCA1,Rs16942,increased risk for breast cancer
BRCA1,I5009558,breast cancer
BRCA1,I5009558,causal/pathogenic BRCA1 mutations
BRCA1,I5009553,breast cancer
BRCA1,I5009553,causal/pathogenic BRCA1 mutations
BRCA1,I5009546,breast cancer
BRCA1,I5009546,causal/pathogenic BRCA1 mutations
BRCA1,I5009541,breast cancer
BRCA1,I5009541,causal/pathogenic BRCA1 mutations
BRCA1,I5009536,breast cancer
BRCA1,I5009536,causal/pathogenic BRCA1 mutations
BRCA1,I5009526,breast cancer
BRCA1,I5009526,causal/pathogenic BRCA1 mutations
BRCA1,I5009511,breast cancer
BRCA1,I5009511,causal/pathogenic BRCA1 mutations
BRCA1,I5009493,causal/pathogenic BRCA1 mutations
BRCA1,Rs28897696,breast cancer
BRCA1,Rs28897696,breast cancer
BRCA1,I5009624,breast cancer
BRCA1,Rs41293455,ovarian cancer
BRCA1,Rs80356898,pathogenic
BRCA1,Rs80356898,breast cancer
BRCA1,Rs80357018,breast cancer
BRCA1,Rs80357021,breast cancer
BRCA1,Rs80357021,breast cancer in ClinVar
BRCA1,Rs80357055,breast cancer
BRCA1,Rs4986852,ovarian cancer
BRCA1,Rs80357069,Gly
BRCA1,Rs80357162,variant
BRCA1,Rs80357162,BRCA1
BRCA1,Rs80357162,pathogenic for breast cancer
BRCA1,Rs80357254,gene considered pathogenic for breast cancer
BRCA1,Rs80357254,breast cancer
BRCA1,Rs41293455,breast cancer
BRCA1,Rs80357069,Val
BRCA1,Rs4986852,breast cancer
BRCA1,Rs80357382,pathogenic/likely pathogenic for breast cancer23andMe
BRCA1,Rs4986852,breast cancer
BRCA1,Rs41293455,breast cancer
BRCA1,Rs41293455,breast cancer
BRCA1,Rs41293463,breast cancer
BRCA1,Rs41293463,breast cancer.
BRCA1,Rs41293463,breast cancer
BRCA1,Rs41293463,breast cancer
BRCA1,Rs41293455,ovarian cancer susceptibility
BRCA1,Rs41293463,breast cancer mutations 
BRCA1,Rs41293463,Nigerian patients
BRCA1,Rs45553935,SNP is listed at pathogenic for breast cancer
BRCA1,Rs45553935,it does predispose carriers to breast cancer
BRCA1,Rs45553935,There are breast cancer patients harboring the BRCA1 V1736G mutation
BRCA1,Rs4986852,breast cancer
BRCA1,Rs41293463,African-American family
BRCA2,Rs1799944,increased risk for malignant melanoma
BRCA2,Rs1799944,malignant melanoma cases vs. 0.13% of controls
BRCA2,Rs1799944,histories of inherited breast cancer
BRCA2,Rs1799944,Risk of non-Hodgkin lymphoma
BRCA2,Rs766173,breast cancer
BRCA2,Rs1799944,familial breast cancer
BRCA2,Rs766173,breast cancer
BRCA2,Rs766173,breast cancer
BRCA2,Rs144848,increased risk for breast cancer
BRCA2,Rs1799944,risk of breast cancer
BRCA2,Rs144848,breast cancer
BRCA2,Rs144848,affects fetal survival in a sex-dependent manner
BRCA2,Rs144848,breast cancer
BRCA2,Rs144848,normal females of all ages
BRCA2,Rs144848,breast cancer greater risk
BRCA2,Rs144848,breast cancer
BRCA2,Rs144848,"overall risk estimates for breast cancer,"
BRCA2,Rs144848,increased risk for breast cancer
BRCA2,I4000379,SNP
BRCA2,I4000379,breast cancer
BRCA2,I4000379,odds of developing breast cancer
BRCA2,Rs144848,breast cancer
BRIP1,Rs587780240,cancer
BRIP1,Rs574552037,ovarian cancer
BRIP1,Rs34289250,ovarian cancer in Icelandic women
BRIP1,Rs2191249,breast cancer
BRIP1,Rs2191249,breast cancer
BRIP1,Rs34289250,ovarian cancer
BTBD9,Rs9394492,(T) minor allele.
BTBD9,Rs9394492,rs9394492
BTBD9,Rs9394492,restless legs syndrome
BTBD9,Rs9394492,sleep disorder
BTD,Rs34885143,minor allele
BTD,Rs146011150,minor allele
BTD,Rs119103232,biotinidase deficiency
BTK,Rs128620187,Brazilian patients
BTK,Rs128620187,human monocytes
BTK,Rs128620187,X-linked agammaglobulinemia
BTK,Rs128620187,Bruton's tyrosine kinase
BTK,Rs128620187,agammaglobulinemia
C3,Rs11569562,adult bronchial asthma
C3,Rs2250656,metabolic syndrome.
C5,Rs17611,overall stroke risk
CACNA1A,Rs121908236,episodic ataxia type 2
CACNA1A,Rs121908236,episodic ataxia type 2.
CACNA1C,Rs216013,warfarin dose
CACNA1S,Rs2281845,reduced mature dentition
CACNA1S,Rs2281845,reduction in permanent teeth erupted
CACNA1S,Rs2281845,mature teeth
CACNA1S,Rs2281845,"skeletal maturation, Tanner score and growth spurt"
CACNA1S,Rs80338778,hypokalemic periodic paralysis
CACNA1S,Rs80338778,Hypokalaemic periodic paralysis type 2
CACNA1S,Rs80338778,autosomal dominant hypokalemic periodic paralysis
CACNB2,Rs7069923,systolic blood pressure
CADM2,Rs2875907,life time cannabis use
CALR3,Rs142951029,rs142951029
CALR3,Rs142951029,0 homozygotes
CALR3,Rs142951029,ExAC
CALR3,Rs142951029,121142 alleles
CALR3,Rs142951029,chromosome 19
CALR3,Rs142951029,"Familial hypertrophic cardiomyopathy, type 19"
CALR3,Rs142951029,K82R
CALR3,Rs142951029,p.Lys82Arg
CALR3,Rs142951029,CALR3 gene
CALR3,Rs142951029,c.245A>G
CARD14,Rs387907240,pityriasis rubra pilaris
CARD14,Rs587777763,autosomal dominantly inherited psoriasis
CASP8,Rs13113,marginal zone lymphoma
CASP8,Rs3769827,endometrial cancer
CAV3,Rs116840802,A CAV3 microdeletion
CAV3,Rs116840802,A CAV3 microdeletion
CAV3,Rs116840802,A CAV3 microdeletion
CAV3,Rs28936685,rippling muscle disease
CBLB,Rs3772534,increased risk for developing type 1 diabetes
CBS,Rs234706,Ehlers-Danlos syndrome
CBS,Rs234706,overproduction of ammonia
CBS,Rs2298758,Ehlers-Danlos syndrome
CBS,Rs234706,decrease in glutathione
CBS,Rs1801181,Ehlers-Danlos syndrome
CBS,Rs2298758,Ehlers-Danlos syndrome
CBS,Rs121964972,Homocystinuria
CBS,Rs1801181,Ehlers-Danlos syndrome
CBS,Rs121964972,unresponsive to pyridoxine (vitamin B6) treatment
CBS,Rs121964972,severe form of Homocystinuria
CBS,Rs117687681,minor allele
CBX5,Rs1920045,Heterogeneous nuclear ribonucleoprotein A1
CBX5,Rs1920045,plasma cholesterol
CBX5,Rs1920045,lowering total plasma cholesterol
CCDC122,Rs3088362,leprosy
CCDC122,Rs3088362,CCDC122
CCDC122,Rs3088362,leprosy
CCL11,Rs1129844,delayed AD onset
CCL11,Rs1129844,AD
CCL11,Rs1129844,are certain to develop dementia
CCL11,Rs1129844,delayed Alzheimer disease onset by 10 years.
CCL11,Rs1129844,Alzheimer's
CCL11,Rs1129844,Alzheimer
CCL11,Rs1129844,delayed Alzheimer disease onset by up to 10 years
CCL11,Rs1129844,AD
CCL11,Rs1129844,delayed onset of Alzheimer's disease
CCL11,Rs1129844,decreased neurogenesis
CCL11,Rs1129844,dementia
CCL11,Rs1129844,Alzheimer's disease
CCL11,Rs1129844,decreased neurogenesis
CCL11,Rs1129844,rs1129844
CCL11,Rs1129844,'''early-onset''' Alzheimer's
CCL2,Rs1024611,conotruncal heart defects.
CCL2,Rs1024611,Crohn's disease
CCL2,Rs1024611,extrapulmonary tuberculosis.
CCL2,Rs1024611,exercise-induced skeletal muscle damage
CCL2,Rs1024611,depression
CCL2,Rs1024611,type 2 diabetes
CCL2,Rs1024611,pulmonary tuberculosis
CCL2,Rs1024611,HIV-associated dementia
CCL2,Rs1024611,non-small cell lung cancer
CCL2,Rs1024611,ischemic stroke
CCL2,Rs1024611,carotid atherosclerosis
CCL2,Rs1024611,pulmonary tuberculosis
CCL2,Rs1024611,atherosclerosis
CCL2,Rs1024611,knee osteoarthritis
CCL2,Rs1024611,colorectal cancer
CCL2,Rs1024611,systemic lupus erythematosus
CCL2,Rs1024611,celiac disease
CCL2,Rs1024611,systemic sclerosis
CCL2,Rs1024611,heart disease
CCL2,Rs1024611,exercise induced ischemia
CCL2,Rs1024611,premature heart disease
CCL2,Rs1024611,schizophrenia
CCL2,Rs1024611,retinal vein occlusion
CCM2,Rs797044623,c.30+5_30+6delGCinsTT
CCR5,I3003626,AIDS
CCR5,I3003626,HIV infection
CD244,Rs3766379,Japanese
CD244,Rs3766379,the CD244 gene
CD244,Rs3766379,rheumatoid arthritis
CD274,Rs2282055,may be biomarkers for the efficacy of nivolumab.
CD274,Rs2282055,rs2282055
CD274,Rs2282055,rs4143815
CD274,Rs2282055,biomarkers
CD274,Rs4143815,may be biomarkers for the efficacy of nivolumab.
CD274,Rs4143815,rs2282055
CD274,Rs4143815,rs4143815
CD274,Rs4143815,biomarkers
CD320,Rs150384171,pathogenic variant
CD33,Rs3826656,s3826656
CD33,Rs3826656, Alzheimer's disease
CD33,Rs3826656,rs4420638
CD33,Rs3826656,rs11159647
CD44,Rs187116,gastric cancer
CD44,Rs187116,gastric cancer
CD44,Rs1467558,dbSNP
CD44,Rs1467558,SNP
CD44,Rs1467558,ALT
CD44,Rs1467558,SNPedia
CD44,Rs1467558,(G;G) homozygotes
CD44,Rs1467558,alanine aminotransferase (ALT)
CD44,Rs1467558,rs1467558(A;G)
CD44,Rs1467558,Acetaminophen (Tylenol®)
CD44,Rs353644,vaccine-induced immunity to HBV
CD44,Rs1467558,ALT
CD44,Rs353644,Host genetic factors
CD58,Rs12044852,multiple sclerosis
CD58,Rs12044852,multiple sclerosis
CD59,Rs397514767,hemolytic anemia
CD59,Rs397514767,immune-mediated polyneuropathy
CDH1,Rs876658261,CDH1 gene
CDH1,Rs864622655,hereditary diffuse gastric cancer
CDH1,Rs587781276,gastric cancer
CDH1,Rs786203752,hereditary diffuse gastric cancer
CDH1,Rs786203576,"A, p.Trp20Ter i W20X"
CDH1,Rs786203576,aka c.60G
CDH1,Rs786202033,hereditary diffuse gastric cancer
CDH1,Rs587783048,hereditary diffuse gastric cancer
CDH1,Rs587781276,hereditary
CDH1,Rs587781276,gastric cancer
CDH1,Rs587781276,hereditary diffuse
CDH1,Rs587781276,pathogenic rare mutation
CDH1,I5004972,gastric cancer
CDH1,Rs587780113,pathogenic rare mutation
CDH1,Rs587776398,hereditary diffuse gastric cancer
CDH1,Rs267606712,pathogenic rare mutation
CDH1,Rs267606712,cancer
CDH1,Rs121964878,hereditary diffuse gastric cancer
CDH1,Rs121964878,hereditary diffuse gastric cancer
CDH1,Rs121964878,pathogenic rare mutation
CDH1,Rs121964877,hereditary diffuse gastric cancer
CDH1,I5994973,gastric cancer
CDH1,I5004972,gastric cancer
CDH1,Rs587780113,hereditary diffuse gastric cancer
CDH13,Rs11649622,substance abuse
CDH13,Rs11649622,bipolar disorder
CDH13,Rs11649622,autism
CDH13,Rs11649622,schizophrenia
CDH13,Rs11149566,rs4660646
CDH13,Rs11149566,rs4458717
CDH13,Rs11149566,rs11149566 
CDH13,Rs11649622,ADHD
CDKAL1,Rs7756992,Polycystic Kidney disease
CDKAL1,Rs7756992,This SNP was confirmed to be associated with type-2 diabetes
CDKAL1,Rs7756992,normal glucose tolerant (NGT) individuals
CDKAL1,Rs7756992,type-2 diabetes
CDKAL1,Rs7756992,type-2 diabetes risk
CDKAL1,Rs7756992,Polycystic Kidney disease
CDKAL1,Rs7756992,type 2 diabetes patients
CDKN1A,Rs762624,rs762624(A;A)
CDKN1A,Rs762624,increased susceptibility to SLE and lupus nephritis
CDKN2A,Rs587776716,p16-Leiden
CDKN2A,Rs587776716,increased risk for pancreatic cancer in addition to malignant melanoma
CDKN2A,Rs587776716,rs587776716
CDKN2A,Rs587776716,deletion
CDKN2A,Rs587776716,atypical multiple-mole melanoma
CDKN2A,Rs587776716,both moles and pancreatic cancer
CDKN2A,Rs587776716,rare mutation
CDKN2A,Rs587776716,significantly increased risk for pancreatic cancer in addition to malignant melanoma
CDKN2A,Rs587776716,atypical multiple-mole melanoma
CDKN2A,Rs104894097,malignant melanoma
CDKN2A,Rs587776716,CDKN2A
CDKN2B-AS1,Rs2383206,diabetes
CDKN2B-AS1,Rs2383206,increased risk for coronary artery disease
CDKN2B-AS1,Rs2383206,myocardial infarction
CDKN2B-AS1,Rs6475606,Coronary artery disease 
CDKN2B-AS1,Rs2383206,early-onset angiographic coronary artery disease (CAD)
CDKN2B-AS1,Rs2383206,myocardial infarction
CDKN2B-AS1,Rs2383207,coronary heart disease
CDKN2B-AS1,Rs2383207,myocardial infarction
CDKN2B-AS1,Rs2383207,coronary heart disease
CDKN2B-AS1,Rs2383207,overweight
CDKN2B-AS1,Rs4977756,open-angle glaucoma (OAG) blindness
CDKN2B-AS1,Rs6475606,increases susceptibility to Coronary artery disease 1.30 times for heterozygotes
CDKN2B-AS1,Rs6475606,1.54 times for homozygotes
CDKN2B-AS1,Rs2383206,risk of coronary heart disease is increased
CDKN2B-AS1,Rs2383207,coronary artery disease
CDKN2B-AS1,Rs2383206,significantly increase the risk of heart disease
CDKN2B-AS1,Rs2383206,diabetes
CDKN2B-AS1,Rs2383206,associated with an adjusted odds ratio of 1.39 (CI: 1.05-1.85) for (A;G) heterozygotes and 1.73 (CI: 1.26-2.37)
CDKN2B-AS1,Rs10116277,abdominal aortic aneurysm
CDKN2B-AS1,Rs10116277,myocardial infarction
CDKN2B-AS1,Rs10116277,risk of myocardial infarction
CDKN2B-AS1,Rs2383206,myocardial infarction risk
CDKN2B-AS1,Rs10757272,Coronary artery disease
CDKN2B-AS1,Rs17756311,childhood acute lymphoblastic leukemia in ethnically diverse populations
CDKN2B-AS1,Rs10116277,lower risk of abdominal aortic aneurysm
CDKN2B-AS1,Rs2151280,Basal Cell Carcinoma
CDKN2B-AS1,Rs2383206,increase the risk of heart disease.
CDKN2B-AS1,Rs2383206,risk of coronary heart disease is increased by 30 to 40%.
CDKN2B-AS1,Rs2383206,increased risk for coronary artery disease
CDKN2B-AS1,Rs2383206,myocardial infarction patients
CDKN2B-AS1,Rs2383206,early-onset angiographic coronary artery disease (CAD)
CDKN2B-AS1,Rs17756311,lymphoblastic leukemia
CEP152,Rs141600901,pathogenic variant
CETP,Rs7499892,decreased HDL cholesterol levels
CETP,Rs1800775,recurrent venous thromboembolism
CETP,Rs7499892,HDL cholesterol
CETP,Rs7499892,A allele
CFAP43,Rs147356105,pathogenic variant
CFAP44,Rs780798708,NM_018338.3(CFAP44):c.2005_2006delAT
CFH,Rs380390,blindness
CFH,Rs3766404,polypoidal choroidal vasculopathy.
CFH,Rs3766404,dvanced age-related macular degeneration
CFH,Rs3766404,drusen
CFH,Rs3766404,Haplotypes in the complement factor H (CFH) gene
CFH,Rs11200638,neovascular AMD
CFH,Rs11200638,wet age related macular degeneration
CFH,Rs11200638,Chinese AMD patients
CFH,Rs11200638,ncreases the risk of wet AMD in all populations
CFH,Rs1065489,36% lower odds of meningococcal disease
CFH,Rs11200638,increased risk of wet age related macular degeneration in Japanese and Caucasian populations
CFH,Rs11200638,Japanese and Caucasian populations
CFH,Rs11200638,smoking almost doubles the risk
CFH,Rs11200638,risk of developing AMD
CFTR,I4000300,Cystic Fibrosis
CFTR,I4000302,Fibrosisrs121909005
CFTR,I4000307,Cystic
CFTR,I4000309,Cystic
CFTR,I4000309,Fibrosisrs
CFTR,I4000309,Cystic Fibrosis
CFTR,I4000319,predictive of Cystic Fibrosis
CFTR,I4000323,predictive of Cystic Fibrosis
CHAMP1,Rs863225078,mental retardation
CHAMP1,Rs879255261,pathogenic
CHAMP1,Rs863225077,autosomal dominant mental retardation
CHAMP1,Rs863225077,pathogenic in ClinVar
CHAMP1,Rs863225074,"based on similar mutations also in the CHAMP1 gene, likely to be a form of autosomal dominant mental retardation"
CHAMP1,Rs782397980,mental retardation
CHAMP1,Rs797044963,autosomal dominant mental retardation
CHAMP1,Rs797044962,autosomal dominant mental retardation
CHAMP1,Rs797044961,a form of autosomal dominant mental retardation
CHAMP1,Rs879255261,autosomal dominant mental retardation
CHAMP1,Rs797044963,autosomal dominant mental retardation.
CHEK1,Rs521102,potentially resectable pancreatic cancer
CHEK1,Rs521102,pancreatic cancer patients
CHEK1,Rs521102,19 American patients with potentially resectable pancreatic cancer
CHEK1,Rs521102,pancreatic cancer
CHEK2,Rs555607708,hereditary breast cancer
CHEK2,Rs555607708,sarcoma
CHEK2,Rs555607708,Polish
CHEK2,Rs555607708,Prostate cancer
CHEK2,Rs555607708,woman
CHEK2,Rs555607708,Breast Cancer
CHEK2,Rs555607708,women
CHEK2,Rs555607708,men
CHEK2,Rs555607708,Breast cancer
CHEK2,Rs555607708,women
CHEK2,Rs555607708,increased cancer risk
CHEK2,Rs555607708,histiocytoma
CHEK2,Rs141568342,cancer
CHEK2,Rs555607708,breast cancer
CHEK2,Rs555607708,Li-Fraumeni syndrome-2
CHEK2,Rs555607708,Prostate cancer
CHEK2,Rs555607708,Breast cancer
CHEK2,Rs555607708,increased cancer risk
CHEK2,Rs555607708,"breast cancer, glioma, histiocytoma, and sarcoma."
CHEK2,Rs28909982,breast cancer
CHEK2,Rs28909982,breast cancer 
CHEK2,Rs2236142,breast tumour characteristics and survival
CHEK2,Rs142763740,cancer
CHEK2,Rs555607708,glioma
CHI3L1,Rs2275351,schizophrenia
CHRM2,Rs324650,Uncovering genes for cognitive (dys)function and predisposition for alcoholism spectrum disorders
CHRM2,Rs324650,functional role of the CHRM2 gene in human cognition
CHRM2,Rs324650,nfluenced intelligence and alcohol dependence
CHRM2,Rs324650,"gene predisposes to alcohol dependence, drug dependence and affective disorders"
CHRNA3,Rs8192482,as a risk factor for age-dependent nicotine addiction
CHRNA3,Rs8192482,A candidate gene
CHRNA3,Rs8042374,lung cancer
CHRNA3,Rs8042374,lung cancer
CHRNA3,Rs12910984,lung cancer
CHRNA3,Rs12910984,nicotine dependence
CHRNA3,Rs8192482,Nicotine Addiction
CHRNA3,Rs12910984,systolic blood pressure
CHRNA3,Rs12910984,hypertension
CHRNA3,Rs12910984,nicotine dependence
CHRNA3,Rs12910984,hypertension
CHRNA3,Rs12910984,lung cancer
CHRNA3,Rs12910984,Mexican-Americans
CHRNA3,Rs12910984,Mexican-Americans
CHRNA5,Rs8192482,as a risk factor for age-dependent nicotine addiction
CHRNA5,Rs8192482,A candidate gene
CHRNA5,Rs8192482,Nicotine Addiction
CHRNB3,Rs4950,Leadership Role Occupancy
CHRNB3,Rs4950,leadership role occupancy
CHRNB3,Rs4950,acetylcholine receptor
CHRNB3,Rs4950,are statistically more likely (odds ratio ~1.5) to occupy leadership positions
CLCN1,Rs121912805,myotonia congenita
CLCN1,Rs121912805,autosomal dominant or recessive manner
CLCN1,I6056364,Myotonia congenita
CLCN1,I5003258,Myotonia congenita
CLCN1,I5003264,80356700
CLCN1,I5003255,Myotonia congenita
CLCN1,I5003254,Myotonia congenitars
CLCN1,I5003254,Myotonia
CLCN1,I5003257,Myotonia
CLDN14,Rs74315438,deafness;
CLDN14,Rs786200885,deafness
CLEC16A,Rs6498169,14 
CLEC16A,Rs6498169,dbSNP
CLEC16A,Rs6498169,risk 
CLEC16A,Rs6498169,rs6498169 
CLEC16A,Rs6498169,multiple sclerosis
CLEC16A,Rs6498169,sclerosis
CLEC16A,Rs2903692,significant risk factors for the cooccurrence of AITD
CLEC16A,Rs2903692,associated with type 1 diabetes odds ratio 1.37 and 1.28.
CLEC16A,Rs17806056,Common variable immunodeficiency disorder (CVID)
CLEC16A,Rs12599402,NP is tagging the same functional variant as previously reported in European populations
CLEC16A,Rs12599402,systemic lupus erythematosus
CLEC16A,Rs6498169,rs6498169
CLN5,Rs386833969,p.Tyr392Terfs)
CLN5,Rs386833967,recessively inherited condition
CLN5,Rs386833967,"pathogenic for ceroid lipofuscinosis neuronal 5,"
CLN5,Rs386833967,CLN5 gene on chromosome 13.The variant
CLN5,Rs386833967,rs386833967
CLN5,Rs386833967,epresents a very rare deletion mutation
CLOCK,Rs1801260,to fertility and seasonality
CLOCK,Rs1801260,obesity
CLOCK,Rs1801260,sleep disorders
CLOCK,Rs1801260,evening preference
CLOCK,Rs1801260,weight loss resistance
CLOCK,Rs1801260,might have adverse effects on the regulation of gastric motility
CLOCK,Rs1801260,bipolar disorder
CLOCK,Rs1801260,produces a manic-like phenotype
CLOCK,Rs1801260,more obese and lose less weight ina dietary and behavioral treatment for obesity
CLOCK,Rs1801260,moreevening-type subjects
CLOCK,Rs1801260,Attention-Deficit Hyperactivity Disorder
CLOCK,Rs1801260,associate with comorbid alcohol use and depressive disorders.
CLOCK,Rs1801260,cardiometabolic disorders
CLOCK,Rs1801260,dysfunctional circadian rhythm
CLOCK,Rs1801260,schizophrenics and controls
CLOCK,Rs1801260,the metabolic syndrome
CLOCK,Rs1801260,depression
CLOCK,Rs1801260,higher activity levels in the evening
CLOCK,Rs1801260,delayed sleep onset
CLOCK,Rs1801260,bipolar disorder susceptibility
CLOCK,Rs1801260,ADHD
CLOCK,Rs1801260,Schizophrenics
CLOCK,Rs1801260,reduced amount of sleep during the night
CLOCK,Rs1801260,greater difficulty in losing weight than non-carriers
CLOCK,Rs1801260,influence sleep and activity patterns in patients affected by bipolar depression
CLOCK,Rs1801260,activity levels in the second part of the day
CLOCK,Rs1801260,neuropsychological performance
CLOCK,Rs1801260,obesity
CLOCK,Rs1801260,weight loss
CLRN1,I4990151,Usher syndrome
CLRN1,I4990151,Usher syndrome
CLTCL1,Rs1061325,insulin resistance
CLTCL1,Rs1061325,farmers
CLTCL1,Rs1061325,hunter-gatherers
CLTCL1,Rs1061325,insulin resistance
CNGB3,Rs3735972,other SNPs in this same gene which are known to lead to various forms of color-blindness.
CNGB3,Rs3735972,it is not known to have medical consequences
CNGB3,Rs3735972,"is not known to have medical consequences,"
CNGB3,Rs3735972,amino acid substitution
CNGB3,Rs3735972,various forms of color-blindness.
CNR1,Rs1049353,G1359A polymorphism of the cannabinoid receptor gene
CNR1,Rs1049353,insulin resistance
CNR1,Rs1049353,diabetes mellitus type 2
CNR1,Rs12720071,post-traumatic stress disorder.
CNR1,Rs12720071,Cannabinoid type-1 receptor gene polymorphisms are associated with central obesity in a Southern Brazilian population
CNR1,Rs12720071,Evidence for association between polymorphisms in the cannabinoid receptor 1 (CNR1) gene and cannabis dependence.
CNR1,Rs12720071,"Genetic variation in cannabinoid receptor 1 (CNR1) is associated with derangements in lipid homeostasis, independent of body mass index"
CNR1,Rs12720071,Role of genetic variation in the cannabinoid type 1 receptor gene (CNR1) in the pathophysiology of human obesity.
CNR1,Rs806368,comorbid drug dependence (DD) and alcohol dependence (AD)
CNR1,Rs806368,Alcoholic patients
CNR1,Rs806368,"risk of the development of substance dependence significantly increased with the number of ""G"" alleles at rs6454674 and SNP8 (rs806368);T/T"
CNR1,Rs806368,Alcoholic patients with TGT haplotype (corresponding to rs6454674-rs1049353-rs806368 polymorphisms in this order) were less prone to have AD (p = 0.017)
CNR1,Rs806368,These studies provide data to suggest that the CNR1 receptor gene may be significantly associated with impulsivity in SWC Indians.
CNR1,Rs806380,cannabis dependence
CNR1,Rs806380,gaze duration for happy faces.
CNR1,Rs806380,cannabis dependence
CNR1,Rs12720071,A common variation in the cannabinoid 1 receptor (CNR1) gene is associated with pre-eclampsia in the Central European population.
CNR1,Rs1049353,anorexia nervosa and bulimia nervosa
CNR1,Rs806379,childhood anxiety disorders
CNR1,Rs1049353,CNR1 and FAAH
CNR1,Rs1049353,polymorphisms
CNR1,Rs1049353,rs1049353
CNR1,Rs1049353,minor A allele
CNR1,Rs1049353,greater antidepressant responsiveness
CNR1,Rs1049353,"males, the result was opposite"
CNR1,Rs1049353,G allele associated with greater antidepressant responsiveness
CNR1,Rs1049353,rs806368(C) together with rs1049353(A) or rs1049353(G)
CNR1,Rs1049353,PTSD
CNR1,Rs1049353,protection against depression in response to stress
CNR1,Rs1049353,higher risk of PTSD
CNR1,Rs1049353,C-G haplotype
CNR1,Rs1049353,lower risk of PTSD
CNR1,Rs1049353,CNR1
CNR1,Rs1049353,abdominal adiposity in obese men
CNR1,Rs1049353,derangements in lipid homeostasis
CNR1,Rs1049353,Cannabinoid receptor 1 gene association with nicotine dependence
CNR1,Rs1049353,central obesity in a Southern Brazilian
CNR1,Rs1049353,C-A haplotype
CNTN5,Rs952700,frontal brain volume
CNTNAP2,Rs2710102,rs2710102
CNTNAP2,Rs2710102,SNP
CNTNAP2,Rs2710102,delayed onset of speech
CNTNAP2,Rs2710102,autism
CNTNAP2,Rs2710117,rs4431523
CNTNAP2,Rs851715,rs4431523
CNTNAP2,Rs2710117,"rs851715, rs10246256, rs2710102, rs759178, rs1922892, rs2538991, rs17236239, rs2538976, and rs2710117"
CNTNAP2,Rs759178,autism
CNTNAP2,Rs759178,autism
CNTNAP2,Rs851715,rs17236239
CNTNAP2,Rs2710102,delayed onset of speech
CNTNAP2,Rs851715,"rs851715, rs10246256, rs2710102, rs759178, rs1922892, rs2538991, rs17236239, rs2538976, and rs2710117"
CNTNAP2,Rs2710117,rs17236239
CNTNAP2,Rs2538991,nonsense-word repetition
CNTNAP2,Rs2710102,CNTNAP2
CNTNAP2,Rs2538991,associated with autism
CNTNAP2,Rs2538991,Speech development
CNTNAP2,Rs10246256,rs4431523
CNTNAP2,Rs10246256,rs17236239
CNTNAP2,Rs10246256,"rs851715, rs10246256, rs2710102, rs759178, rs1922892, rs2538991, rs17236239, rs2538976, and rs2710117"
CNTNAP2,Rs17236239,snp nejm CNTNAP2 variants affect early language development in the general population
CNTNAP2,Rs1922892,potentially associated with autism
CNTNAP2,Rs149032771,pathogenic variant
CNTNAP2,Rs1922892,autism-susceptibility gene
CNTNAP2,Rs201076428,pathogenic variant
CNTNAP2,Rs2538976,rs4431523
CNTNAP2,Rs2538976,rs17236239
CNTNAP2,Rs2538976,"rs851715, rs10246256, rs2710102, rs759178, rs1922892, rs2538991, rs17236239, rs2538976, and rs2710117"
CNTNAP2,Rs1922892,Speech development 
COL17A1,Rs121912771,mild junctional epidermolysis bullosa (JEB)
COL17A1,Rs121912771,blistering and thinning skin
COL1A1,Rs2075555,Accelerated Bone Mineral Density Loss
COL1A2,Rs42524,familial intracranial aneurysms
COL4A3,Rs121912825,autosomal recessive Alport syndrome
COL4A3,Rs121912825,Alport syndrome
COL4A3,Rs121912825,Mutations in the type IV collagen alpha 3 (COL4A3) gene
COL7A1,Rs121912838,Gly
COL7A1,Rs121912838,Ser
COL7A1,Rs121912840,Toenail dystrophy
COL7A1,Rs121912840,dystrophic epidermolysis bullosa.
COL9A2,Rs137853213,intervertebral disc disease
COL9A3,Rs61734651,linked the rs61734651(T) allele to somewhat higher risk (odds ratio of ~3) to lumbar disc disease
COMT,Rs737865,non-Hodgkin lymphoma
COMT,Rs737865,nxiety-related personality traits
COMT,Rs737865,smoking cessation
COMT,Rs737865,bupropion treatment
COMT,Rs737865,schizophrenia
CPS1,Rs1392559810,aka
CPS1,Rs1392559810,c.3265C
CPT1A,Rs80356791,hypoketotic hypoglycaemia
CPT1A,Rs80356790,hypoketotic hypoglycaemia
CPT1A,Rs80356790,carnitine palmitoyltransferase 1A deficiency
CPT1A,Rs80356791,carnitine palmitoyltransferase 1A deficiency
CREB1,Rs4675690,increased chance of suicide
CREB1,Rs4675690,CREB1 gene on treatment resistance in major depression.
CREB1,Rs4675690,"showed less disgust, but not happiness, desire or fear"
CREB1,Rs4675690,rs4675690 
CREB1,Rs4675690,rs4675690
CREB1,Rs4675690,"CREB1,"
CREB1,Rs4675690,CREB1
CRP,Rs2808630,systemic inflammation
CRP,Rs2808630,COPD
CRP,Rs2808630,coronary heart disease
CRP,Rs2808630,cause-specific mortality
CRP,Rs2808630,longevity
CRP,Rs1205,obese and nonobese elderly subjects
CRP,Rs1205,central obesity and lung function in taiwan asthmatics
CRP,Rs1205,coronary heart disease
CRP,Rs1205,adolescent emotional problems and metabolic syndrome
CRP,Rs1205,"central obesity, low high-density lipoprotein cholesterol"
CRP,Rs1205,wheezing and lower respiratory tract infections in the offspring
CRP,Rs1205,emerging cardiovascular risk markers in adult women
CRP,Rs1205,healthy male twins
CRP,Rs1205,adiposity
CRP,Rs1205,coronary heart disease
CRP,Rs2808630,complex human diseases
CRP,Rs2808630,cortisol awakening response
CRP,Rs2808630,obesity
CRP,Rs2808630,low high-density lipoprotein cholesterol
CRP,Rs3093058,cardiovascular risk markers in adult women
CRP,Rs3093058,coronary artery bypass surgery
CRP,Rs3093058,African Americans
CRP,Rs3093058,Filipino systemic lupus erythematosus families
CRP,Rs3093058,plasma CRP levels
CRP,Rs3093058,coronary artery bypass surgery
CRP,Rs3093058,prostate cancer
CRP,Rs1205,metastatic prostate cancer
CRP,Rs3093058,lupus erythematosus
CRP,Rs2808630,entral obesity
CRP,Rs2808630,associated with the cortisol awakening response in basal conditions
CRP,Rs2808630,prostate cancer risk in men aged 65 years and older
CRP,Rs2808630,Filipino systemic lupus erythematosus families
CRP,Rs2808630,risk of incident coronary heart disease
CRP,Rs2808630,lung cancer
CRP,Rs2808630,C-reactive protein polymorphisms
CRP,Rs2808630,lung cancer
CRP,Rs1205,hypertension in Turkish adults
CRP,Rs2808630,prostate cancer
CRP,Rs1205,COPD
CRP,Rs1205,"SLE, systemic lupus erythematosus"
CRP,Rs1205,"central obesity,"
CRP,Rs1205,lower respiratory tract infections
CRP,Rs1205,metastatic prostate cancer
CRP,Rs1205,cancer 
CRP,Rs1205,hemorrhagic stroke
CRP,Rs1205,ischemic stroke
CRP,Rs1205,higher CRP levels
CRP,Rs1205,atherosclerosis
CRP,Rs1205,myocardial infarction
CRP,Rs1205,type 2 diabetes mellitus
CRP,Rs1205,myocardial infarction
CRP,Rs1205,myocardial infarction
CRP,Rs1205,ischemic stroke
CRP,Rs1205,heart disease
CRP,Rs1205,systemic inflammation
CRP,Rs1205,coronary heart disease
CRP,Rs1205,type 1 diabetes
CRP,Rs1205,"autoimmune disorder SLE, systemic lupus erythematosus."
CRP,Rs1205,ischemic stroke in Japanese subjects
CRP,Rs1205,age-related macular degeneration
CRP,Rs1205,prostate cancer risk in men aged 65 years and older.
CRP,Rs1205,susceptibility to ischemic stroke and hemorrhagic stroke in the Chinese Han population
CRP,Rs1205,systemic lupus erythematosus
CRP,Rs1205,coronary heart disease
CRP,Rs1205,atherosclerosis
CRP,Rs1205,metabolic-syndrome
CRP,Rs1205,lung function
CRP,Rs1205,African Americans
CRP,Rs1205,Systemic inflammation
CRP,Rs1205,Filipino systemic lupus erythematosus families
CRP,Rs1205,incident coronary heart disease
CRP,Rs1205,myocardial infarction survivors
CRP,Rs1205,type 2 diabetes mellitus
CRP,Rs1205,arterial pulse wave velocity in healthy elderly Japanese
CRP,Rs1205,postoperative myocardial infarction after cardiac surgery
CRP,Rs1205,genetic susceptibility
CSF2RB,Rs1801117,schizophrenia
CST3,Rs28939068,young normotensive adults
CST3,Rs28939068,brain hemorrhages in young normotensive adults
CST3,Rs28939068,autosomal dominant disease with high penetrance
CST3,Rs28939068,brain hemorrhages
CST3,Rs28939068,Icelandic hereditary cystatin C amyloid angiopathy
CST3,Rs28939068,Icelandic
CST3,Rs1064039,no increased risk was seen in Asians
CST3,Rs1064039,1.5x increased odds ratio for developing Alzheimer's disease in Caucasians
CST3,Rs1064039,3 fold increase in risk for exudative age-related macular degeneration
CST3,Rs28939068,hereditary cystatin C amyloid angiopathy (HCCAA)
CTLA4,Rs231775,patients with other autoimmune diseases
CTLA4,Rs231775,vitiligo
CTLA4,Rs231775,Portuguese patients
CTLA4,Rs231775,type-1 diabetes
CTLA4,Rs231775,women
CTLA4,Rs231775,preeclampsia
CTLA4,Rs231775,reproductive and breast cancer
CTLA4,Rs231775,Graves' disease
CTLA4,Rs231775,Asians
CTLA4,Rs231775,race
CTLA4,Rs231775,patients with both T1D and AITD
CTLA4,Rs231775,Caucasians
CTLA4,Rs231775,cancer risk
CTLA4,Rs231775,Asian
CTLA4,Rs231775, risk of cancer
CTLA4,Rs231775,Asian populations
CTLA4,Rs231775,cancer
CTLA4,Rs231775,skin cancer
CTLA4,Rs231775,hematopoietic malignancy
CTLA4,Rs231775,digestive system cancer
CTLA4,Rs231775,malignant bone tumor
CTLA4,Rs231775,"autoimmune thyroiditis,"
CTLA4,Rs231775,Asians)
CTLA4,Rs231775,Graves’ disease
CTLA4,Rs231775,placental abruption
CTLA4,Rs231775,India.
CTLA4,Rs231775,respiratory system cancer
CTLA4,Rs733618,individuals
CTLA4,Rs733618,healthy
CTLA4,Rs733618,disease 
CTLA4,Rs733618,87 
CTLA4,Rs733618,heterozygotes 
CTLA4,Rs733618,rs733618
CTLA4,Rs733618,CD152 
CTLA4,Rs733618,encodes 
CTLA4,Rs733618,CTLA4 
CTLA4,Rs733618,cytotoxic 
CTLA4,Rs231775,Han Chinese
CTLA4,Rs733618,activator 
CTLA4,Rs733618,is 
CTLA4,Rs733618,rs733618
CTLA4,Rs733618,rs733618(A;G)
CTLA4,Rs733618,myasthenia gravis
CTLA4,Rs733618,T/C-1772
CTLA4,Rs733618,rs733618
CTLA4,Rs3772534,increased risk for developing type 1 diabetes
CTLA4,Rs231778,genotyping
CTLA4,Rs231778,genotyping
CTLA4,Rs231775,autoimmune diseases
CTLA4,Rs231775,Asian
CTLA4,Rs733618,SNP 
CTLA4,Rs231775,epithelial tumor
CTLA4,Rs231775,Adults
CTLA4,Rs231775,lung cancer
CTLA4,Rs231775,"Gujarat, India."
CTLA4,Rs231775,hypothyroidism patients
CTLA4,Rs231775,Autoimmune Hypothyroidism
CTLA4,Rs231775,children
CTLA4,Rs231775,adults 
CTLA4,Rs231775,GD (Graves' disease)
CTLA4,Rs231775,children
CTLA4,Rs231775,adults
CTLA4,Rs231775,GD (Graves' disease)
CTLA4,Rs231775,Han Chinese population
CTLA4,Rs231775,Children and Adults
CTLA4,Rs231775,Autoimmune Thyroid Disease
CTLA4,Rs231775,GD
CTLA4,Rs231775,GO
CTLA4,Rs231775,Graves' Orbitopathy (GO)
CTLA4,Rs231775,Autoimmune thyroiditis
CTLA4,Rs231775,Graves' disease
CTLA4,Rs231775,Graves’ disease
CTLA4,Rs231775,autoimmune thyroiditis
CTLA4,Rs231775,autoimmune diseases
CTLA4,Rs12992492,candidate genes
CTLA4,Rs12992492,generalized vitiligo
CTLA4,Rs12992492,vitiligo
CTLA4,Rs231775,autoimmune hypothyroidism
CTLA4,Rs231775,patients
CTLA4,Rs231775,family burden of GD
CTLA4,Rs231775,patients
CTLA4,Rs231775,controls
CTLA4,Rs231775,breast cancer
CTLA4,Rs231775,cancer types
CTLA4,Rs231775,cancer risk
CTLA4,Rs231775,protective factor for cancer
CTLA4,Rs231775,cancer
CTLA4,Rs231775,controls
CTLA4,Rs231775, control group
CTLA4,Rs231775,liver cancer
CTLA4,Rs231775,hepatocellular carcinoma
CTLA4,Rs231775,patients
CTLA4,Rs231775,classic type 2 diabetes patients
CTLA4,Rs231775,diabetes
CTLA4,Rs231775,individuals
CTLA4,Rs231775,LADA (latent autoimmune diabetes in adults)
CTLA4,Rs231775,cancers
CTLA4,Rs231775,Latent Autoimmune Diabetes
CTLA4,Rs231775,patients vs. controls
CTLA4,Rs231775,controls
CTLA4,Rs231775,patients
CTLA4,Rs231775,controls
CTLA4,Rs231775,patients
CTLA4,Rs231775,controls
CTLA4,Rs231775,insulin dependence in LADA patients
CTSZ,Rs34069356,UTR 
CTSZ,Rs34069356,tuberculosis 
CTSZ,Rs34069356,and 
CTSZ,Rs34069356,associated 
CTSZ,Rs34069356,Polymorphisms 
CTSZ,Rs34069356,associated with tuberculosis susceptibility
CTSZ,Rs34069356,Polymorphisms
CTSZ,Rs34069356,MC3R 
CUBN,Rs10904849,enhanced colorectal cancer risk
CUBN,Rs138083522,CUBN
CUBN,Rs138083522,minor allele reported as pathogenic
CYP17A1,Rs2486758,cancer 
CYP17A1,Rs2486758,resistant 
CYP17A1,Rs2486758,castration
CYP17A1,Rs2486758,metastatic
CYP17A1,Rs2486758,cancer
CYP17A1,Rs2486758,risk 
CYP17A1,Rs2486758,"), "
CYP17A1,Rs2486758,rs2486758
CYP17A1,Rs2486758,allele
CYP17A1,Rs2486758,CYP17A1 
CYP17A1,Rs2486758,rs2486758 
CYP17A1,Rs2486758,variant 
CYP17A1,Rs104894141,Trp17Ter
CYP17A1,Rs104894141,23andMe 
CYP17A1,Rs104894141,i5001490
CYP17A1,Rs104894141,51G
CYP17A1,Rs104894153,Arg96Gln
CYP17A1,Rs104894153,i5001478
CYP17A1,Rs2486758,prostate cancer
CYP17A1,Rs104894153,287G
CYP19A1,Rs700518,hypertension
CYP19A1,Rs749292,ovarian cancer risk
CYP19A1,Rs700518,hypertension
CYP19A1,Rs700518,specific 
CYP19A1,Rs700518,gender
CYP19A1,Rs700518,SNP 
CYP19A1,Rs700518,rs700518 
CYP19A1,Rs2414096,androgen excess in girls and young women
CYP19A1,Rs2414096,variation at the aromatase gene
CYP19A1,Rs2414096,young women
CYP19A1,Rs2414096,hyperandrogenism
CYP19A1,Rs2414096,aromatase (CYP 19) gene variation
CYP19A1,Rs1062033,evere large-joint osteoarthritis
CYP19A1,Rs1062033,variations in estrogen-related gene
CYP19A1,Rs1062033,carriers of the G allele
CYP19A1,Rs1062033,postmenopausa
CYP19A1,Rs1062033,Osteoporosis
CYP1A1,Rs4646903,estrogen-metabolizing genes
CYP1A1,Rs4646903,breast cancer survival.
CYP1A1,Rs4646903,Cytochrome P450 1A1 
CYP1A1,Rs4646903,Polycystic ovary syndrome and ovarian response
CYP1A1,Rs4646903,breast cancer
CYP1A1,Rs4646903,CYP1A1
CYP1A1,Rs4646903,childhood leukemia risk
CYP1A1,Rs4646903,CYP1A1 and CYP1B1
CYP1A1,Rs4646903,colorectal cancer
CYP1A1,Rs4646903,endometriosis
CYP1A1,Rs4646903,epithelial ovarian cancer
CYP1A1,Rs4646903,colorectal cancer risk.
CYP1A1,Rs4646903,ovarian cancer
CYP1A1,Rs4646903,cell lung cancer in women
CYP1A1,Rs4646903,"FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome"
CYP1A1,Rs4646903,CYP1A1 genotype modifies the impact of smoking on effectiveness of HAART among women
CYP1A1,Rs4646903,nasopharyngeal carcinoma risk with cytochrome P450 CYP1A1 gene polymorphisms.
CYP1A1,Rs4646903,uterine leiomyoma risk
CYP1A1,Rs4646903,premenopausal and perimenopausal.
CYP1A1,Rs1048943,Japanese population
CYP1A1,Rs4646903,CYP1B1
CYP1A1,Rs1048943,ovarian cancer
CYP1A1,Rs1048943,non-small cell lung cancer in women
CYP1A1,Rs1048943,workers exposed to vinyl chloride monomer
CYP1A1,Rs1048943,heterogeneity and multidimensionality 
CYP1A1,Rs1048943,systolic blood pressure in Mexican-Americans
CYP1A1,Rs1048943,risk of non-Hodgkin lymphoma
CYP1A1,Rs1048943,risk of lung cancer
CYP1A1,Rs1048943,among women
CYP1A1,Rs1048943,pre- and early perimenopausal women
CYP1A1,Rs1048943,nasopharyngeal carcinoma risk
CYP1A1,Rs1048943,breast cancer risk in Mexican women
CYP1A1,Rs1048943,human sperm concentrations and motility
CYP1A1,Rs1048943,gallbladder cancer
CYP1A1,Rs1048943,metastatic breast cancer
CYP1A1,Rs1048943,lung cancer risk
CYP1A1,Rs4646903,CYP1A1 and COMT genotypes on breast cancer risk in Mexican women
CYP1A1,Rs4646903,CYP1A1
CYP1A1,Rs4646903,estradiol and estrogen metabolites
CYP1A1,Rs4646903,Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk
CYP1A1,Rs4646903,colorectal cancer risk
CYP1A1,Rs4646903,premenopausal
CYP1A1,Rs4646903,polycystic ovary syndrome
CYP1A1,Rs4646903,lung cancer:
CYP1A1,Rs4646903,smoking
CYP1A1,Rs4646903,Sex
CYP1A1,Rs4646903,women
CYP1A1,Rs4646903,pre- and early perimenopausal women
CYP1A1,Rs4646903,African American
CYP1A1,Rs4646903,breast cancer
CYP1A1,Rs4646903,nasopharyngeal carcinoma
CYP1A1,Rs4646903,breast cancer
CYP1A1,Rs4646903,Mexican women
CYP1A1,Rs4646903,human sperm concentrations and motility.
CYP1A1,Rs4646903,al precancer and cancer risk
CYP1A1,Rs4646903,cervical dysplasia
CYP1A1,Rs4646903,cancer
CYP1A1,Rs4646903,Maternal smoking during pregnancy
CYP1A1,Rs4646903,ung cancer risk
CYP1A1,Rs4646903,adolescent girls
CYP1A1,Rs4646903,women.
CYP1A1,Rs4646903,non-small cell lung cancer
CYP1A1,Rs4646903,ovarian cancer
CYP1A1,Rs4646903,perimenopausal.
CYP1A1,Rs1048943,Colon tumor mutations
CYP1A1,Rs4646903,breast cancer survival.
CYP1A1,Rs4646903,Korean women
CYP1A1,Rs4646903,African American
CYP1A1,Rs4646903,Dominican
CYP1A1,Rs4646903,Caucasian mothers and newborns
CYP1A1,Rs4646903,female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Polymorphi
CYP1A1,Rs4646903,women
CYP1A1,Rs4646903,Paternal smoking
CYP1A1,Rs4646903,Chinese women
CYP1A1,Rs4646903,uterine leiomyoma risk
CYP1A1,Rs4646903,Japanese
CYP1A1,Rs4646903,Coffee intake
CYP1A1,Rs4646903,epithelial ovarian cancer
CYP1A1,Rs4646903,Red meat intake
CYP1A1,Rs4646903,"doneness,"
CYP1A1,Rs4646903,colorectal cancer
CYP1A1,Rs4646903,childhood leukemia risk.
CYP1A1,Rs1048943,colorectal cancer risk
CYP1A1,Rs4646903,female reproductive disorders
CYP1A1,Rs1048943,osteoporotic fractures
CYP1A1,Rs1048943,Paternal smoking
CYP1A1,Rs1048943,genetic polymorphism
CYP1A1,Rs1048943,childhood leukemia risk.
CYP1A1,Rs1048943,genetic polymorphisms
CYP1A1,Rs1048943,uterine leiomyoma risk in Chinese women.
CYP1A1,Rs1048943,Genetic variation
CYP1A1,Rs1048943,"candidate osteoporosis genes, bone mineral density, and fracture risk: the study of osteoporotic fractures"
CYP1A1,Rs1048943,genetic polymorphisms 
CYP1A1,Rs1048943,Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect
CYP1A1,Rs1048943,Red meat
CYP1A1,Rs1048943,doneness
CYP1A1,Rs1048943,polymorphisms
CYP1A1,Rs1048943,genes that encode carcinogen-metabolizing enzymes
CYP1A1,Rs1048943,colorectal cancer risk
CYP1A1,Rs1048943,Colon tumor mutations and epigenetic changes associated with genetic polymorphism
CYP1A1,Rs1048943,disease pathways.
CYP1A1,Rs1048943,genetic risk 
CYP1A1,Rs1048943,metabolizing genes.
CYP1A1,Rs1048943,Bladder cancer risk and genetic variation
CYP1A1,Rs1048943,"Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer"
CYP1A1,Rs1048943,Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population
CYP1A1,Rs1048943,female reproductive disorders: part II--endometriosis
CYP1A1,Rs1048943,Genome amplification of single sperm using multiple displacement amplification
CYP1A1,Rs1048943,Decision forest analysis of 61 single nucleotide polymorphisms in a case-control study of esophageal cancer; a novel method
CYP1A1,Rs1048943,Multilocus analysis of SNP and metabolic data within a given pathway
CYP1A1,Rs1048943,polymorphisms
CYP1A1,Rs1048943,estradiol
CYP1A1,Rs1048943,premenopausal
CYP1A1,Rs1048943,perimenopausal
CYP1A1,Rs1048943,ovarian cancer through the international Ovarian Cancer Association Consortium
CYP1A1,Rs1048943,Dietary phytoestrogen intake is associated with reduced colorectal cancer risk
CYP1A1,Rs1048943,polymorphisms in polycyclic aromatic hydrocarbon 
CYP1A1,Rs1048943,metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race
CYP1A1,Rs1048943,Cytochrome
CYP1A1,Rs1048943,polymorphisms and breast cancer risk in Korean women.
CYP1A1,Rs1048943,lung cancer
CYP1A1,Rs1048943,case-control
CYP1A1,Rs1048943,bioinformatic tools
CYP1A1,Rs1048943,genetic factors protect for early onset lung cancer
CYP1A1,Rs1048943,smoking
CYP1A1,Rs1048943,Tobacco 
CYP1A1,Rs1048943,estrogen metabolites
CYP1A1,Rs1048943,polymorphisms and risk of non-small cell lung cancer in women
CYP1A1,Rs1048943,Candidate gene studies in gallbladder cancer:
CYP1A1,Rs1048943,Pharmacogenetic assessment of clinical outcome in patients with metastatic breast cancer treated with docetaxel plus capecitabine
CYP1A1,Rs1048943,Genetic polymorphisms involved in carcinogen metabolism and DNA repair and lung cancer risk in a Japanese population
CYP1A1,Rs1048943,esophageal cancer
CYP1A1,Rs1048943,women who are premenopausal and perimenopausal
CYP1A1,Rs1048943,reduced colorectal cancer risk
CYP1A1,Rs1048943,breast cancer risk in Korean women
CYP1A1,Rs1048943,lung cancer
CYP1A1,Rs1048943,early onset lung cancer
CYP1A1,Rs1048943,the development of papillary thyroid cancer susceptibility
CYP1A1,Rs1048943,Chinese women
CYP1A1,Rs1048943,Middle Eastern population
CYP1A1,Rs1048943,risk of postmenopausal breast cancer
CYP1A1,Rs1048943,Bladder cancer risk
CYP1A1,Rs1048943,childhood leukemia risk
CYP1A1,Rs1048943,uterine leiomyoma risk
CYP1A1,Rs1048943,estrogen metabolic
CYP1A1,Rs1048943,Quantitative trait analysis suggests polymorphisms of estrogen-related genes regulate human sperm concentrations and motility.
CYP1A1,Rs1048943,clubfoot.
CYP1A1,Rs1048943,meta-analysis
CYP1A1,Rs1048943,Smoking
CYP1A1,Rs1048943,Relationship between genetic polymorphisms of phase I and phase II metabolizing enzymes and DNA damage of workers exposed to vinyl chloride monomer
CYP1A1,Rs1048943,Clique-finding for heterogeneit
CYP1A1,Rs1048943,multidimensionality in biomarker epidemiology research
CYP1A1,Rs1048943,Gene by smoking interaction in hypertension
CYP1A1,Rs1048943,quantitative trait locus on chromosome
CYP1A1,Rs1048943,xenobiotic pathway
CYP1A1,Rs1048943,Genetic polymorphisms in glutathione S-transferases and cytochrome
CYP1A1,Rs1048943,tobacco
CYP1A1,Rs1048943,smoking
CYP1A1,Rs1048943,systolic blood pressure in Mexican-American
CYP1A1,Rs1048943,Phase I metabolic genes and risk of lung cancer
CYP1A1,Rs1048943,multiple polymorphisms and mRNA expression
CYP1A1,Rs1048943,genotype modifies the impact of smoking on effectiveness of HAART among women
CYP1A1,Rs1048943,Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women
CYP1A1,Rs1048943,Polymorphisms of drug-metabolizing genes and risk of non-Hodgkin lymphoma
CYP1A1,Rs1048943,nasopharyngeal carcinoma risk with cytochrome
CYP1A1,Rs1048943,gene polymorphisms
CYP1A1,Rs1048943,risk of non-Hodgkin lymphoma
CYP1A1,Rs1048943,enotypes on breast cancer risk in Mexican women:
CYP1A2,Rs72547515,SNP
CYP1A2,Rs72547515,rs72547515
CYP1A2,Rs72547515,SNP 
CYP1A2,Rs72547515,variant
CYP1A2,Rs72547515,defines 
CYP1A2,Rs72547515,CYP1A2 
CYP1A2,Rs55889066, CYP1A2 5
CYP1A2,Rs72547515,rs72547515
CYP1A2,Rs55889066,rs55889066(A)
CYP1A2,Rs72547515,CYP1A2 
CYP1A2,Rs55889066,C406Y
CYP1A2,Rs12720461,rs12720461
CYP1A2,Rs12720461,SNP
CYP1A2,Rs12720461,CYP1A2
CYP1A2,Rs55889066,CYP1A2
CYP1A2,Rs12720461,CYP1A2 1K_-729C>T
CYP1A2,Rs55889066,rs55889066
CYP1A2,Rs55889066,3497G>A
CYP1A2,Rs12720461,s12720461(T)
CYP1B1,Rs9282671,Finnish European populations
CYP1B1,Rs9282671,recessively inherited
CYP1B1,Rs9282671,adult-onset primary open angle glaucoma
CYP1B1,Rs9282671,Finnish European populations 
CYP1B1,Rs9282671,disorder that is recessively inherited
CYP1B1,Rs9282671,POAG
CYP1B1,Rs9282671,adult-onset primary open angle glaucoma (POAG)
CYP1B1,Rs1056836,never smoked
CYP1B1,Rs1056836,lung cancer 
CYP1B1,Rs1056836,br
CYP1B1,Rs1056836,br
CYP1B1,Rs1056836,prostate cancer
CYP1B1,Rs1056836,hormonal carcinogenesis
CYP1B1,Rs1056836,lung cancer
CYP1B1,Rs1056836,experience a longer progression-free survival
CYP1B1,Rs1056836,high-risk stage III and IV breast cancer
CYP1B1,Rs1056836,prostate cancer
CYP1B1,Rs1056836,patients
CYP1B1,Rs1056836,Hispanic Caucasians
CYP21A2,Rs6471,associated with non-classic 21-OH CAH
CYP21A2,Rs9378251,non-classic 21-OH
CYP21A2,I5005436,Congenital adrenal hyperplasia
CYP21A2,I5005431,Congenital adrenal hyperplasia
CYP21A2,I5005432,Congenital adrenal hyperplasia
CYP2A6,Rs1801272,slow metaboliser
CYP2A6,Rs1801272,slow metaboliser 
CYP2A6,Rs28399433,HIV-infected patients
CYP2B6,Rs8192719,Correlated genotypes in friendship networks
CYP2B6,Rs8192719,simulation of heritable longitudinal cardiovascular phenotypes based on actual genome-wide single-nucleotide polymorphisms in the Framingham Heart Study
CYP2B6,Rs8192719,The Genetic Analysis Workshop
CYP2B6,Rs8192719,genome-wide
CYP2B6,Rs8192719, comparative study of three methods for detecting association of quantitative traits in samples of related subjects
CYP2B6,Rs8192719,Family-based bivariate association tests for quantitative traits
CYP2B6,Rs8192719,"variants and plasma efavirenz concentrations during antiretroviral therapy in Port-au-Prince, Haiti."
CYP2B6,Rs8192719,single dose of nevirapine or efavirenz in African americans
CYP2B6,Rs8192719,Univariate/multivariate genome-wide association scans using data from families and unrelated samples
CYP2B6,Rs8192719,polymorphisms
CYP2B6,Rs35303484,bipolar disorde
CYP2B6,Rs35303484,Bipolar Disorder
CYP2B6,Rs35303484,bipolar disorder
CYP2B6,Rs35303484,variants speculated
CYP2B6,Rs35303484,Familial Bipolar Disorder
CYP2B6,Rs2279345,methadone S-enantiomer
CYP2B6,Rs8192719,pharmacokinetics
CYP2C19,Rs72558186,splice donor mutation that leads to a poor metabolizer phenotype
CYP2C19,Rs57081121,poor metabolizer of several commonly prescribed drugs
CYP2C19,Rs3758581,spectrometry
CYP2C19,Rs57081121,cytochrome p450
CYP2C19,Rs41291556,reduction in the metabolism of S-mephenytoin and tolbutamide in vitro.Clopidogrel Efficacy
CYP2C19,Rs3758581,population
CYP2C19,Rs3758581,Chinese
CYP2C19,Rs3758581,allele
CYP2C19,Rs28399504,rs28399504
CYP2C19,Rs28399504,esomeprazole
CYP2C19,Rs28399504,omeprazole
CYP2C19,Rs28399504,poor metabolizer of several commonly prescribed drugs
CYP2C19,Rs28399504,mephenytoin
CYP2C19,Rs28399504,CYP2C19 gene
CYP2C19,Rs17884712,metabolism of S-mephenytoin
CYP2C19,Rs28399504,lansoprazole 
CYP2C8,Rs1934980,osteonecrosis
CYP2C8,Rs1113129,genetic polymorphisms
CYP2C8,Rs10509681,a determinant of NSAID-induced gastrointestinal bleeding.
CYP2C8,Rs10509681,risk increased if carriers drank more than 20g alcohol/day to an OR=1.99
CYP2C8,Rs1113129,calcineurin inhibitor-induced chronic kidney disease
CYP2C8,Rs10509681,risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding
CYP2C8,Rs10509681,increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs
CYP2C8,Rs10509681,NSAID metabolism as a risk factor for gastrointestinal bleeding
CYP2C8,Rs10509681,GI bleeding event risk OR=1.81
CYP2C9,Rs1799853,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans."
CYP2C9,Rs1799853,the study discovered that carriers of CYP2C8 3 (a minor allele of both rs10509681 and rs11572080) had a GI bleeding event risk OR=1.81 (95% CI=0.95–3.46; P=0.071) and risk increased if carriers drank more than 20g alcohol/day
CYP2C9,Rs1799853,"""Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding,"""
CYP2C9,Rs1799853,"In addition, carriers of the risk allele for CYP2C9 2 rs1799853 have decreased metabolism of Ibuprofen, Flurbiprofen, Piroxicam, and Tenoxicam."
CYP2C9,Rs1799853,"Individuals carrying minor alleles of this both CYP2C9 2 rs1799853 AND CYP2C8 3 (a minor allele of both rs10509681 and rs11572080) have increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib."
CYP2C9,Rs1799853,The CYP2C9 2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin
CYP2C9,Rs1799853,rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism and risk of GI bleeding with some NSAID drugs.
CYP2C9,Rs1799853,Moroccan patients
CYP2C9,Rs1799853,very preterm infants
CYP2C9,Rs1799853,children
CYP2C9,Rs1799853,"Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Low-penetrance alleles predisposing to sporadic colorectal cancers:"
CYP2C9,Rs1799853,The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9 3
CYP2C9,Rs28371686,decreased activity
CYP2C9,Rs7089580,18786
CYP2C9,Rs28371686,CYP2C9
CYP2C9,Rs28371686,CYP2C9 5
CYP2C9,Rs67807361,SNP
CYP2C9,Rs7089580,VKORC1-8191
CYP2C9,Rs7089580,rs61162043
CYP2C9,Rs7089580,P = 0.0041
CYP2C9,Rs1799853,ode-positive breast cancer
CYP2C9,Rs7089580,CYP2C9
CYP2C9,Rs7089580,rs7089580
CYP2C9,Rs72558188,gene
CYP2C9,Rs72558189,rs72558189(A) allele
CYP2C9,Rs7900194,decreased activity
CYP2C9,Rs28371686,SNP
CYP2C9,Rs1799853,Chilean women
CYP2C9,Rs72558189,which may have decreased activity.
CYP2C9,Rs1799853,capsaicin metabolism
CYP2C9,Rs1799853,gallbladder cancer 
CYP2C9,Rs1799853,poor warfarin metabolism
CYP2C9,Rs1799853,GI bleeding
CYP2C9,Rs1799853,poor metabolism of warfarin
CYP2C9,Rs1799853,Stevens-Johnson syndrome
CYP2C9,Rs1799853,gastrointestinal bleeding
CYP2C9,Rs1799853,increased risk of developing acute gastrointestinal bleeding
CYP2C9,Rs1799853,decreased metabolism
CYP2C9,Rs1799853,gastrointestinal bleeding
CYP2C9,Rs1799853,GI bleeding
CYP2C9,Rs1799853,NSAID-induced gastrointestinal bleeding
CYP2C9,Rs1799853,European-Americans
CYP2C9,Rs1799853,African-Americans
CYP2C9,Rs1799853,Individuals carrying minor alleles of this both CYP2C9 2 rs1799853 AND CYP2C8 3
CYP2C9,Rs1799853,orthopedic patients
CYP2C9,Rs1799853,gallstone 
CYP2C9,Rs1799853,cancer
CYP2C9,Rs1799853,Sao Miguel's healthy population
CYP2C9,Rs1799853,Hodgkin lymphoma
CYP2C9,Rs1799853,French
CYP2C9,Rs1799853,sporadic colorectal cancers
CYP2C9,Rs1799853,Colon tumor
CYP2C9,Rs1799853,colorectal cancer
CYP2C9,Rs1799853,Han Chinese
CYP2C9,Rs1799853,Genetic factors
CYP2C9,Rs1799853,African Americans
CYP2C9,Rs1799853,Caucasians
CYP2D6,Rs71328651,a variation in
CYP2D6,Rs71667834,a variation in
CYP2D6,Rs71328653,a variation in
CYP2D6,Rs71328652,a variation in
CYP2D6,Rs71710351,a variation in
CYP2D6,Rs71328650,a variation in
CYP2D6,Rs61737947,a variation in
CYP2D6,Rs67780109,a variation in
CYP2D6,Rs67497403,a variation in
CYP2D6,Rs62625688,a variation in
CYP2D6,Rs61745683,a variation in
CYP2D6,Rs61737946,a variation in
CYP2D6,Rs71754064,a variation in
CYP2D6,Rs71184866,a variation in
CYP2D6,Rs71800336,a variation in
CYP2D6,Rs72549356,a variation in
CYP2D6,Rs72454628,a variation in
CYP2D6,Rs72549359,a variation in
CYP2D6,Rs72549358,a variation in
CYP2D6,Rs72549357,a variation in
CYP2D6,Rs61736911,a variation in
CYP2D6,Rs72549355,a variation in
CYP2D6,Rs72549353,a variation in
CYP2D6,Rs72233016,a variation in
CYP2D6,Rs72549352,a variation in
CYP2D6,Rs72549350,a variation in
CYP2D6,Rs72549349,a variation in
CYP2D6,Rs72549348,a variation in
CYP2D6,Rs72549347,a variation in
CYP2D6,Rs72549346,a variation in
CYP2D6,Rs72549345,a variation in
CYP2D6,Rs72549351,a variation in
CYP2D6,Rs61736517,a variation in
CYP2D6,Rs58331414,a variation in
CYP2D6,Rs61736514,a variation in
CYP2D6,Rs5030866,a variation in
CYP2D6,Rs5030863,inactive
CYP2D6,Rs4996603,a variation in
CYP2D6,Rs4996602,a variation in
CYP2D6,Rs4996601,a variation in
CYP2D6,Rs4987144,a variation in
CYP2D6,Rs56011157,a variation in
CYP2D6,Rs4078249,a variation in
CYP2D6,Rs3915951,a variation in
CYP2D6,Rs3831704,a variation in
CYP2D6,Rs35970455,a variation in
CYP2D6,Rs35888064,a variation in
CYP2D6,Rs35534760,a variation in
CYP2D6,Rs72552262,a variation in
CYP2D6,Rs4078248,a variation in
CYP2D6,Rs61736515,a variation in
CYP2D6,Rs56358138,a variation in
CYP2D6,Rs5758597,a variation in
CYP2D6,Rs61736507,a variation in
CYP2D6,Rs61731586,a variation in
CYP2D6,Rs61731577,a variation in
CYP2D6,Rs60979881,a variation in
CYP2D6,Rs6002635,a variation in
CYP2D6,Rs59360719,a variation in
CYP2D6,Rs5758596,a variation in
CYP2D6,Rs59099247,a variation in
CYP2D6,Rs5845524,a variation in
CYP2D6,Rs58440431,a variation in
CYP2D6,Rs58405804,a variation in
CYP2D6,Rs58188898,a variation in
CYP2D6,Rs5758599,a variation in
CYP2D6,Rs5758598,a variation in
CYP2D6,Rs5845525,a variation in
CYP2D6,Rs72552268,a variation in
CYP2D6,Rs35481113,a variation in
CYP2D6,Rs7285233,a variation in
CYP2D6,Rs79102241,a variation in
CYP2D6,Rs78854695,a variation in
CYP2D6,Rs78762568,a variation in
CYP2D6,Rs78482768,a variation in
CYP2D6,Rs78459009,a variation in
CYP2D6,Rs78340630,a variation in
CYP2D6,Rs79125935,a variation in
CYP2D6,Rs78209835,a variation in
CYP2D6,Rs78047908,a variation in
CYP2D6,Rs77952980,a variation in
CYP2D6,Rs77913725,a variation in
CYP2D6,Rs77867647,a variation in
CYP2D6,Rs77845838,a variation in
CYP2D6,Rs77827855,a variation in
CYP2D6,Rs78139609,a variation in
CYP2D6,Rs77593160,a variation in
CYP2D6,Rs79292917,a variation in
CYP2D6,Rs79347391,a variation in
CYP2D6,Rs9623532,a variation in
CYP2D6,Rs9611741,a variation in
CYP2D6,Rs915947,a variation in
CYP2D6,Rs80262685,a variation in
CYP2D6,Rs80018788,a variation in
CYP2D6,Rs79931073,a variation in
CYP2D6,Rs79331140,a variation in
CYP2D6,Rs79802111,a variation in
CYP2D6,Rs79712708,a variation in
CYP2D6,Rs79650744,a variation in
CYP2D6,Rs79596243,a variation in
CYP2D6,Rs79489631,a variation in
CYP2D6,Rs79441454,a variation in
CYP2D6,Rs79392742,a variation in
CYP2D6,Rs79738337,a variation in
CYP2D6,Rs72552269,a variation in
CYP2D6,Rs77578877,a variation in
CYP2D6,Rs77449786,a variation in
CYP2D6,Rs75467367,a variation in
CYP2D6,Rs75386357,a variation in
CYP2D6,Rs75324300,a variation in
CYP2D6,Rs75276289,a variation in
CYP2D6,Rs75203276,a variation in
CYP2D6,Rs75112600,a variation in
CYP2D6,Rs75471486,a variation in
CYP2D6,Rs75085559,a variation in
CYP2D6,Rs74962936,a variation in
CYP2D6,Rs74951492,a variation in
CYP2D6,Rs74802369,a variation in
CYP2D6,Rs74644586,a variation in
CYP2D6,Rs74516776,a variation in
CYP2D6,Rs74478221,a variation in
CYP2D6,Rs74966855,a variation in
CYP2D6,Rs77562994,a variation in
CYP2D6,Rs75614915,a variation in
CYP2D6,Rs76015180,a variation in
CYP2D6,Rs77312092,a variation in
CYP2D6,Rs77185887,a variation in
CYP2D6,Rs769259,a variation in
CYP2D6,Rs769258,a variation in
CYP2D6,Rs769257,a variation in
CYP2D6,Rs76802407,a variation in
CYP2D6,Rs75824064,a variation in
CYP2D6,Rs76527171,a variation in
CYP2D6,Rs76326664,a variation in
CYP2D6,Rs76312385,a variation in
CYP2D6,Rs76210340,a variation in
CYP2D6,Rs76187628,a variation in
CYP2D6,Rs76088846,a variation in
CYP2D6,Rs76060075,a variation in
CYP2D6,Rs76327133,a variation in
CYP2D6,Rs35183748,a variation in
CYP2D6,I4001480,a variation in
CYP2D6,Rs35029149,a variation in
CYP2D6,I4001472,a variation in
CYP2D6,I4001474,a variation in
CYP2D6,I4001476,a variation in
CYP2D6,Rs35046171,a variation in
CYP2D6,I4001488,a variation in
CYP2D6,I4001489,a variation in
CYP2D6,I4001490,a variation in
CYP2D6,I4001494,a variation in
CYP2D6,I4001497,a variation in
CYP2D6,I4001499,a variation in
CYP2D6,Rs1058164,Involved in a number of decreased and non-functioning CYP2D6 variants
CYP2D6,Rs1058170,a variation in
CYP2D6,Rs1075944,a variation in
CYP2D6,Rs1080984,a variation in
CYP2D6,Rs1080986,a variation in
CYP2D6,Rs1080988,a variation in
CYP2D6,Rs1080989,a variation in
CYP2D6,Rs1135829,a variation in
CYP2D6,Rs1135828,a variation in
CYP2D6,Rs1135827,a variation in
CYP2D6,Rs1135825,a variation in
CYP2D6,Rs1135822,a variation in
CYP2D6,Rs1135821,a variation in
CYP2D6,I4001471,a variation in
CYP2D6,Rs1081000,a variation in
CYP2D6,Rs1080997,a variation in
CYP2D6,Rs1080996,a variation in
CYP2D6,Rs1080995,a variation in
CYP2D6,Rs1080993,a variation in
CYP2D6,Rs1080992,a variation in
CYP2D6,Rs1080990,a variation in
CYP2D6,Rs1080999,a variation in
CYP2D6,I4001469,a variation in
CYP2D6,I4001468,a variation in
CYP2D6,I4001466,a variation in
CYP2D6,I4001414,a variation in
CYP2D6,I4001413,a variation in
CYP2D6,I4001411,a variation in
CYP2D6,I4001409,a variation in
CYP2D6,I4001404,a variation in
CYP2D6,I4001403,a variation in
CYP2D6,I4001416,a variation in
CYP2D6,I4001400,a variation in
CYP2D6,I4001391,a variation in
CYP2D6,I4001388,a variation in
CYP2D6,I4001387,a variation in
CYP2D6,I4000487,a variation in
CYP2D6,I4000452,a variation in
CYP2D6,I3003610,a variation in
CYP2D6,I4001392,a variation in
CYP2D6,Rs1135830,a variation in
CYP2D6,I4001419,a variation in
CYP2D6,I4001421,a variation in
CYP2D6,I4001464,a variation in
CYP2D6,I4001459,a variation in
CYP2D6,I4001456,non-functioning variant.
CYP2D6,I4001456,CYP2D6
CYP2D6,I4001456,the (A) allele
CYP2D6,I4001454,a variation in
CYP2D6,I4001420,a variation in
CYP2D6,I4001452,a variation in
CYP2D6,I4001444,a variation in
CYP2D6,I4001442,a variation in
CYP2D6,I4001436,a variation in
CYP2D6,I4001435,a variation in
CYP2D6,I4001434,a variation in
CYP2D6,I4001423,a variation in
CYP2D6,I4001451,a variation in
CYP2D6,Rs1135831,a variation in
CYP2D6,I4001438,a variation in
CYP2D6,Rs1135833,a variation in
CYP2D6,Rs28448769,a variation in
CYP2D6,Rs28439297,a variation in
CYP2D6,Rs28439001,a variation in
CYP2D6,Rs28371738,a variation in
CYP2D6,Rs28371737,a variation in
CYP2D6,Rs28371736,a variation in
CYP2D6,Rs28578778,a variation in
CYP2D6,Rs28371735,a variation in
CYP2D6,Rs28371730,a variation in
CYP2D6,Rs1135832,a variation in
CYP2D6,Rs28371728,a variation in
CYP2D6,Rs28371726,a variation in
CYP2D6,Rs28371724,a variation in
CYP2D6,Rs28371723,a variation in
CYP2D6,Rs28371732,a variation in
CYP2D6,Rs28371722,a variation in
CYP2D6,Rs28588594,a variation in
CYP2D6,Rs28633410,a variation in
CYP2D6,Rs35028622,a variation in
CYP2D6,Rs35023634,a variation in
CYP2D6,Rs34898711,a variation in
CYP2D6,Rs34894147,a variation in
CYP2D6,Rs34291018,a variation in
CYP2D6,Rs3045547,a variation in
CYP2D6,Rs28624811,a variation in
CYP2D6,Rs3021084,a variation in
CYP2D6,Rs29001678,a variation in
CYP2D6,Rs29001518,a variation in
CYP2D6,Rs2899353,a variation in
CYP2D6,Rs28735595,a variation in
CYP2D6,Rs28695233,a variation in
CYP2D6,Rs28680494,a variation in
CYP2D6,Rs2982055,a variation in
CYP2D6,Rs28371721,a variation in
CYP2D6,Rs28371729,a variation in
CYP2D6,Rs28371718,a variation in
CYP2D6,Rs1985842,a variation in
CYP2D6,Rs1807314,a variation in
CYP2D6,Rs1807313,a variation in
CYP2D6,Rs28371719,a variation in
CYP2D6,Rs17002853,a variation in
CYP2D6,Rs17002852,a variation in
CYP2D6,Rs2004511,a variation in
CYP2D6,Rs16947,ultrafast metabolizer phenotype
CYP2D6,Rs13056401,a variation in
CYP2D6,Rs12169962,a variation in
CYP2D6,Rs1135840,human target tissues
CYP2D6,Rs1135837,a variation in
CYP2D6,Rs1135836,a variation in
CYP2D6,Rs1135835,a variation in
CYP2D6,Rs16947,non-wild type CYP2D6 variant
CYP2D6,Rs2267447,a variation in
CYP2D6,Rs1800716,a variation in
CYP2D6,Rs28371694,a variation in
CYP2D6,Rs28371717,a variation in
CYP2D6,Rs2267448,a variation in
CYP2D6,Rs28371713,a variation in
CYP2D6,Rs28371712,a variation in
CYP2D6,Rs28371710,a variation in
CYP2D6,Rs28371705,a variation in
CYP2D6,Rs28371704,a variation in
CYP2D6,Rs28371715,a variation in
CYP2D6,Rs28371702,a variation in
CYP2D6,Rs28371701,a variation in
CYP2D6,Rs28371700,a variation in
CYP2D6,Rs28371699,a variation in
CYP2D6,Rs28371696,a variation in
CYP2D6,Rs28371695,a variation in
CYP2D6,Rs28371703,a variation in
CYP2E1,Rs55897648,10023G>A
CYP2E1,Rs55897648,V389I
CYP2E1,Rs55897648,SNP
CYP2E1,Rs55897648,CYP2E1
CYP2E1,Rs55897648,rs55897648(A)
CYP2E1,Rs55897648,CYP2E1 3
CYP2E1,Rs6413432,"Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes"
CYP2E1,Rs6413432,cancer
CYP2E1,Rs6413432,colorectal cancer risk.
CYP2E1,Rs6413432,gallstone formation
CYP2E1,Rs6413432,capsaicin metabolism
CYP2E1,Rs6413432,risk of gallbladder cancer
CYP2E1,Rs6413432,Dietary phytoestrogen intake is associated with reduced colorectal cancer risk
CYP2E1,Rs55897648,rs55897648
CYP2E1,Rs4646976,haplotypes world-wide.
CYP2E1,Rs4646976,allele defines
CYP2E1,Rs2031920,rs2031920
CYP2E1,Rs2031920,SNP
CYP2E1,Rs2031920,CYP2E1 gene
CYP2E1,Rs2031920,CYP2E1_-1055C>T variant
CYP2E1,Rs2031920,rs2031920(T)
CYP2E1,Rs55897648,SNP in the CYP2E1 gene
CYP2E1,Rs3813867,SNP
CYP2E1,Rs3813867,c2 allele
CYP2E1,Rs3813867,CYP2E1
CYP2E1,Rs3813867,rs3813867(C)
CYP2E1,Rs3813867,CYP2E1_-1295G>C
CYP2E1,Rs3813867,CYP2E1_-1295G>C
CYP2R1,Rs2060793,circulating vitamin D levels
CYP2R1,Rs2060793,SNP
CYP2R1,Rs2060793,CYP2R1
CYP2R1,Rs2060793,key C-25 hydroxylase 
CYP2R1,Rs2060793,vitamin D3
CYP2R1,Rs2060793,rs2282679
CYP2R1,Rs2060793,SNP
CYP2R1,Rs2060793,rs3829251
CYP2R1,Rs2060793,rs6599638
CYP2R1,Rs2060793,circulating vitamin D levels
CYP2R1,Rs2060793,Genome
CYP2R1,Rs2060793,active vitamin D receptor ligand
CYP2R1,Rs2060793,frequency of the allelic variation in the CYP2R1 gene
CYP2R1,Rs2060793,vitamin D levels
CYP2R1,Rs2060793,familial longevity
CYP2R1,Rs117913124,p.Aps120Asp
CYP2R1,Rs117913124,CYP2R1 gene
CYP2R1,Rs117913124,chromosome 11
CYP2R1,Rs117913124,rs117913124(A)
CYP2R1,Rs117913124,Vitamin D insufficiency
CYP2R1,Rs117913124,rs117913124
CYP2R1,Rs117913124,rs117913124(A)
CYP2R1,Rs117913124,multiple sclerosis
CYP2R1,Rs2060793,25-hydroxyvitamin D
CYP2R1,Rs2060793,familial longevity
CYP2R1,Rs117913124,25OHD levels
CYP3A4,Rs4987161,15615T>C
CYP3A4,Rs4987161,F189S
CYP3A4,Rs4987161,SNP
CYP3A4,Rs4987161,CYP3A4
CYP3A4,Rs4987161,rs4987161(C)
CYP3A4,Rs55901263,rs55901263
CYP3A4,Rs55901263,653C> 
CYP3A4,Rs55901263, rs55901263 
CYP3A4,Rs55901263,15702C
CYP3A4,Rs4987161,566T>C
CYP3A4,Rs4987161,CYP3A4 17
CYP3A4,Rs4987161,rs498716
CYP3A4,Rs2242480,SNP 
CYP3A4,Rs4986913,CYP3A4
CYP3A4,Rs4986913,CYP3A4
CYP3A4,Rs2242480,CYP3A4 
CYP3A4,Rs2242480,rs2242480
CYP3A4,Rs2242480,CYP3A4 
CYP3A4,Rs2242480,rs2242480 
CYP3A4,Rs28371759,CYP3A4
CYP3A4,Rs28371759,CYP3A4
CYP3A4,Rs4986907,CYP3A4
CYP3A4,Rs4986907,CYP3A4
CYP3A4,Rs2242480,variant
CYP3A5,Rs776746,cancer
CYP3A5,Rs776746,prostate cancer
CYP3A5,Rs776746,Caucasians
CYP3A5,Rs776746,African descent
CYP3A5,Rs776746,testicular germ cell cancer
CYP3A5,Rs776746,colorectal cancer
CYP3A5,Rs776746,Asian Indians
CYP3A5,Rs776746,prostate cancer
CYP3A5,Rs776746,Gilbert's syndrome
CYP3A5,Rs776746,African Americans
CYP3A5,Rs776746,myeloid leukemia
CYP3A5,Rs776746,hyperbilirubinemia
CYP3A5,Rs776746,breast cancer
CYP3A5,Rs776746,genomic ancestry of individuals from different geographical regions of Brazil
CYP3A5,Rs776746,nephrotoxicity
CYP3A5,Rs776746,testicular germ cell cancer
CYP3A5,Rs776746,HIV
CYP3A5,Rs45593941,SNP
CYP3A5,Rs45593941,rs28365085
CYP3A5,Rs45593941,rs45593941(T) allele
CYP3A5,Rs10264272,rs10264272
CYP3A5,Rs10264272,14690G>A
CYP3A5,Rs10264272,SNP 
CYP3A5,Rs10264272,CYP3A5
CYP3A5,Rs10264272,CYP3A5
CYP3A5,Rs10264272,CYP3A5 6
CYP3A5,Rs10264272,14690G>A
CYP3A5,Rs10264272,dbSNP
CYP3A5,Rs10264272,624G-A
CYP3A5,Rs45593941,CYP3A5 3F variant
CYP3A5,Rs10264272,AAA (Lysine)
CYP3A5,Rs28383479,nonfunctional
CYP3A5,Rs41303343,those of African descent
CYP3A5,Rs45593941,rs45593941
CYP3A5,Rs45593941,L82R
CYP3A5,Rs45593941,SNP
CYP3A5,Rs45593941,CYP3A5 gene
CYP3A5,Rs10264272,AAG (Lysine)
CYP3A7,Rs45446698,CYP3A7 1C
CYP3A7,Rs45446698,"increased risk of breast cancer, lung cancer, and CLL"
CYP4F2,Rs2108622,weekly warfarin dose variance is explained by CYP4F2 genotype.
CYP4F2,Rs2108622,of mean
CYP4F2,Rs2108622,7%
CYP4F2,Rs2108622,of warfarin versus 2.93 mg/day for (C;C)
CYP4F2,Rs2108622,require 5.49 mg/day
CYP4F2,Rs2108622,SNP
CYP4F2,Rs2108622,significantly higher
CYP4F2,Rs2108622,In the males
CYP4F2,Rs2108622,cytochrome P450
CYP4F2,Rs2108622,rs2108622
CYP4F2,Rs2108622,study of Italian patients
CYP4V2,Rs13146272,gene variants associated with deep vein thrombosis.
CYP4V2,Rs13146272,associated with deep vein thrombosis
CYP4V2,Rs13146272,New gene variants associated with venous thrombosis:
CYP4V2,Rs13146272,vein thrombosis
CYP4V2,Rs13146272,venous thrombosis
CYP7A1,Rs3808607,polymorphism
CYP7A1,Rs3808607,gallstone disease patients
CYP7A1,Rs3808607,polymorphisms
CYP7A1,Rs3808607,gallbladder cancer
CYP7A1,Rs3808607,North Indian population
CYP7A1,Rs3808607,holesterol 7alpha-hydroxylase gene
CYP7A1,Rs3808607,plant sterols in humans and increased transcriptional activity
DBH,Rs77905,cessation
DBH,Rs77905,smoking
DBH,Rs4531,Cholinergic nicotinic receptor 
DBH,Rs3025382,Cholinergic nicotinic receptor 
DBH,Rs2283123,Croatians
DBH,Rs2283123,schizophrenia
DBH,Rs2007153,The G allele was associated with an increased risk of schizophrenia.
DBH,Rs1611115,aggressive hostility
DBH,Rs1611115,aggression
DBH,Rs1611115,impulsiveness
DBH,Rs1611115,impulsiveness
DBH,Rs1611115,neuroticism
DBH,Rs1611115,ADHD
DBH,Rs1611115,lower DBH expression in plasma
DBH,Rs2007153,schizophrenia
DCDC2,Rs807701, DCDC2 gene
DCDC2,Rs807701,The risk allele in the Caucasian populations studied is (C)
DCDC2,Rs9467076,dyslexia
DCDC2,Rs807701,dyslexic individuals
DCDC2,Rs807701,in several independent studies as likely to associated with dyslexia.
DCDC2,Rs807701,Caucasian populations
DCDC2,Rs807701,more severely dyslexic individuals as compared to more heterogenous
DCDC2,Rs807701,dyslexia
DCDC2,Rs2027584,dyslexia
DDC,Rs6592961,attention-deficit/hyperactivity disorder
DDC,Rs6592961,ADHD
DDC,Rs6592961,adults and children with attention-deficit/hyperactivity disorder
DDC,Rs6592961, associated with ADHD in adults and children.
DDX3Y,Rs9341301,Haplogroup I (Y-DNA)
DFNB31,Rs10982256,bipolar disorder
DGKH,Rs1012053,Bipolar disorder
DGKH,Rs1012053,Bipolar disorder
DGKH,Rs1170191,bipolar disorder
DGKH,Rs1170191,SNP
DGKH,Rs1170191,bipolar disorder
DHDDS,Rs147394623,considered pathogenic for a form of retinitis pigmentosa
DHDDS,Rs147394623,rare mutation in the DHDDS gene on chromosome
DHDDS,Rs147394623,mutation
DHDDS,Rs147394623,rare mutation in the DHDDS gene
DHDDS,Rs147394623,retinitis pigmentosa
DHDDS,Rs147394623,retinitis pigmentosa
DHFR,Rs70991108,lymphoblastic leukemia (ALL)
DHFR,Rs70991108,rs70991108 deletion allele
DHFR,Rs70991108, hepatic toxicity
DHFR,Rs70991108,methotrexate treatment
DHFR,Rs70991108,heterozygous
DHFR,Rs70991108,homozygous rs70991108 deletion genotypes
DHFR,Rs70991108,rs70991108 deletion allele
DHFR,Rs70991108,dihydrofolate reductase DHFR gene
DHFR,Rs70991108,hepatic toxicity
DHFR,Rs70991108,SNP
DHFR,Rs70991108,spina bifida
DHFR,Rs70991108,PMID 14735580
DHFR,Rs70991108,PMID 15755837
DHFR,Rs70991108,spina bifida
DHFR,Rs70991108,non-deletion genotype
DHFR,Rs70991108,"arrier of a rs1801133(T) allele,"
DHFR,Rs70991108,RBC folate
DHFR,Rs70991108,polymorphism consisting of a 19-bp deletion
DHFR,Rs70991108,folic acid
DHFR,Rs70991108,deletion genotype
DHFR,Rs70991108,homozygous
DHFR,Rs70991108,folic acid
DHFR,Rs70991108,folic acid levels
DHFR,Rs70991108, rs70991108
DHFR,Rs70991108,folic acid (and folate) metabolism
DHFR,Rs70991108,SNP
DHFR,Rs70991108,homozygotes
DHFR,Rs70991108,rs70991108
DHFR,Rs70991108,baby born with spina bifida
DHFR,Rs70991108,risk for hepatic toxicity
DHFR,Rs70991108,alterations in folic acid (and folate) metabolism
DHFR,Rs70991108,polymorphism
DHFR,Rs1677693,prostate cancer
DHFR,Rs1677693,single nucleotide polymorphisms
DIO1,Rs11206244,Polymorphisms 
DIO1,Rs11206244,hypothyroid patients
DIO1,Rs11206244,polymorphism 
DIO1,Rs11206244,Polymorphism 
DIO2,Rs225014,Type 2 Diabetes
DIO2,Rs225014,Patients carrying D2 Ala/Ala genotype had a higher fasting plasma insulin and HOMA(IR) index as compared to patients carrying Thr/Ala or Thr/Thr genotypes
DIO2,Rs225014, testing for and treating polymorphisms
DIO2,Rs225014,risk factor for neurodegenerative disease
DIO2,Rs225014,variants have shown that thyroid hormones contribute to osteoarthritis and these variants influence Intelligence quotient alterations associated with iodine deficiency.
DIO2,Rs225014,lower brain thyroid levels (not reflected in their serum levels)
DIO2,Rs225014,Thyroid hormone metabolism and treatment for hypothyroidism
DIO2,Rs225014,Both SNPs were significantly higher in the BPAD (Bipolar disorder) patients
DIO2,Rs225014,frequently detected in patients with depression.
DIO2,Rs225014,recurrent depressive disorder.
DIO2,Rs225014,"patients with depression,"
DIO2,Rs225014,in female cases with advanced/symptomatic hip osteoarthritis
DIO2,Rs225014,additional osteoarthritis studies
DIO2,Rs225014,Psychological disorders
DIO2,Rs225014,higher risk of osteoarthritis
DIO2,Rs12885300,symptomatic osteoarthritis
DIO2,Rs12885300,BPAD
DIO2,Rs12885300,Bipolar disorder
DIO2,Rs12885300,symptomatic osteoarthritis
DIO2,Rs225014,a new susceptibility locus for symptomatic osteoarthritis
DIO2,Rs12885300,osteoarthritis
DIO2,Rs12885300,hip osteoarthritis
DIO2,Rs12885300,OA
DIO2,Rs225014,Polymorphisms in this SNP
DIO2,Rs225014,"osteoarthritis, psychological disorders, reduced thyroid hormone metabolism, Type 2 diabetes, and various other conditions."
DIO2,Rs225014,Osteoarthritis
DIO2,Rs12885300,OA
DISC1,Rs821616,rs821616(T)
DISC1,Rs821616,13 single-nucleotide polymorphisms
DISC1,Rs821616,rs821616
DISC1,Rs821616,Bipolar disorder
DISC1,Rs821616,rapid cognitive decline
DISC1,Rs821597,"association with schizophrenia, schizoaffective disorder, and bipolar disorder."
DISC1,Rs821597,bipolar affective case-control
DISC1,Rs821597,depression case-control
DISC1,Rs821597,increases risk for schizophrenia
DISC1,Rs821597,affects hippocampal structure and function
DISC1,Rs821597,Psychosis
DLD,I5003700,Dehydrogenase Deficiency
DLG2,Rs10501570,genotype patterns
DMRT1,Rs755383,Test
DMRT1,Rs755383,ce
DMRT1,Rs755383,Testicular Cancer
DMRT1,Rs755383,Can
DNAH1,Rs140883175,pathogenic variant
DNAH1,Rs779490893,p.Pro3909Argfs
DNAI1,Rs200669099,c.1644G>A
DNAI1,Rs200669099,p.Trp548Ter
DNAI1,Rs397515363,primary ciliary dyskinesia.
DNAI1,Rs397515363,gene mutation
DNAI1,Rs397515363,primary ciliary dyskinesia
DNMT3A,Rs13420827,primary epithelial ovarian cancer
DNMT3A,Rs13420827,risk among multivitamin supplement users
DNMT3A,Rs11887120,primary epithelial ovarian cancer
DNMT3A,Rs13420827,primary epithelial ovarian cancer
DNMT3A,Rs13420827,Caucasian cases
DNMT3A,Rs11887120,Caucasian cases
DNMT3A,Rs11695471,Caucasian cases
DNMT3A,Rs11887120,primary epithelial ovarian cancer
DNMT3A,Rs11695471,primary epithelial ovarian cancer
DNMT3A,Rs11887120,risk among multivitamin supplement users
DNMT3A,Rs11695471,risk among multivitamin supplement users
DNMT3A,Rs11695471,primary epithelial ovarian cancer
DNMT3L,Rs2276248,ovarian endometriosis
DOCK7,Rs10889353,"lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides"
DOCK7,Rs10889353,coronary heart disease
DOCK7,Rs10889353,disease susceptibility
DOCK7,Rs10889353,coronary heart disease
DPP6,Rs10260404,homozygotes
DPP6,Rs10260404,Bonferroni significance
DPP6,Rs10260404,ALS (Lou Gehrig's disease)
DPP6,Rs10260404,SNP
DPP6,Rs3807218,familial idiopathic ventricular fibrillation.
DPP6,Rs3807218,ventricular fibrillation
DPYD,Rs1801265,ovarian carcinoma
DPYD,Rs67376798,the gene is in reverse orientation to the chromosome strand on the reference genome.
DPYD,Rs1801265,Ovarian Cancer
DPYD,Rs1801265,cancer
DPYD,Rs1801160,5-fluorouracil regimen
DPYD,Rs1801160,neutropenia
DPYD,Rs1801160,2-fold higher risk for an adverse effect
DPYD,Rs1801160,patients with a rs1801160(A) allele
DPYD,Rs1801265,ovarian cancer risk
DRD1,Rs686,Heroin addiction in African Americans
DRD1,Rs686,attention-deficit/hyperactivity disorder (ADHD)
DRD1,Rs686,DRD1
DRD1,Rs686,haplotype
DRD1,Rs686,alcohol dependence
DRD1,Rs686,autism spectrum disorders
DRD1,Rs686,haplotype of the dopamine D1 receptor DRD1
DRD1,Rs686,risk of schizophrenia
DRD1,Rs686,children with attention-deficit/hyperactivity disorder (ADHD)
DRD1,Rs5326,schizophrenia.
DRD1,Rs686,impulsive behavioral aggression
DRD1,Rs686,DRD1 gene is associated with alcohol dependence. 
DRD1,Rs686,association of DRD1 with nicotine dependence.
DRD1,Rs686,autism spectrum disorders in families having only affected males.
DRD1,Rs5326,(early onset) schizophrenia
DRD1,Rs5326,dopamine D1 receptor gene
DRD1,Rs5326,No genetic association
DRD1,Rs686,cognitive impulsivity
DRD2,Rs1799978,Pharmacogenetics and antipsychotics
DRD2,Rs1799732,Alcoholism
DRD2,Rs1799732,alcoholism
DRD2,Rs1799732,alcoholism
DRD2,Rs1799978,caffeine-induced anxiety
DRD2,Rs1799978,brain activity in schizophrenia
DRD2,Rs1799978,healthy participants
DRD2,Rs6275,disease risk among schizophrenia patients
DRD2,Rs1799732,adenoma
DRD2,Rs6277,schizophrenia
DRD2,Rs6277,higher risk
DRD2,Rs6277,older adults
DRD2,Rs6277,exhibit better episodic memory
DRD2,Rs6277,post-traumatic stress
DRD2,Rs6277,127 war veterans
DRD2,Rs6277,decrease in mRNA levels
DRD2,Rs6277,300+ Russian patients
DRD2,Rs1799732,adenoma
DRD2,Rs1799978,d-amphetamine
DRD2,Rs1799732,colorectal adenoma
DRD2,Rs1076560,rs1076560
DRD2,Rs1076560,rs1076560(A) alleles 
DRD2,Rs1076560,Alcoholism
DRD2,Rs1076560,rs1076560
DRD2,Rs1076560,located in intron 6 of the dopamine receptor D2 gene
DRD2,Rs1076560,rs1076560(A) alleles were 1.3 fold more associated with Alcoholism than the rs1076560(C) alleles
DRD2,Rs11214606,schizophrenia
DRD2,Rs11214606,haplotypic association with schizophrenia.
DRD2,Rs1076560,rs1076560 as a potentially important variable in the development of alcoholism.
DRD2,Rs1799732,adenoma
DRD2,Rs1799732,adenoma
DRD2,Rs1799732,adenoma
DRD2,Rs1799732,adenoma
DRD2,Rs1799732,colorectal cancer
DRD2,Rs1799732,severe alcoholism
DRD2,Rs1799732,severe alcoholism
DRD2,Rs1799732,colorectal adenoma
DRD3,Rs6280,"individuals with a history of depression, from a clinical sample"
DRD3,Rs6280,in patients with major depression
DRD3,Rs6280,association between a dopamine D3 receptor gene variant and obsessive-compulsive personality disorder
DRD3,Rs6280,"88 patients being treated for schizophrenia with olanzapine, those who were rs6280(C;C) homozygotes had greater positive symptom remission"
DRD3,Rs6280,Male gender was also found to be a significant predictor of OCPD
DRD3,Rs6280,"Associated in a family association study and pooled sample of 2,037 with nicotine dependence in Americans of European descent"
DRD3,Rs6280,nicotine dependence in Americans of European descent
DRD3,Rs6280,88 patients being treated for schizophrenia with olanzapine
DRD3,Rs167771,associated with increased extra-pyramidal symptom risk
DRD3,Rs167771,associated with autism spectrum disorder
DRD3,Rs6280,obsessive-compulsive personality disorder in patients with major depression
DRD4,Rs4331145,schizophrenia
DRD4,Rs4331145,schizophrenia
DRD4,Rs554375713,rs554375713
DRD4,Rs916457,Japanese schizophrenics
DSPP,Rs36094464,DSPP
DTNA,Rs104894654,leads to left ventricular noncompaction
DTNBP1,Rs2619539,intelligence
DYSF,Rs11903223,Mendelian disease
DYSF,Rs11903223,biocurators
DYSF,Rs11903223,Table S6
DYSF,Rs11903223,SNP
DYSF,Rs11903223,Pathogenic Regulatory Variants
DYSF,Rs11903223,Whole-Genome
DYSF,Rs11903223,Mendelian disease
DYSF,Rs11903223,Mendelian Disease
EDAR,Rs260643,SNP
EDAR,Rs260643,straight/curly hair
EDN1,Rs2071942,endothelin-1 gene polymorphisms
EDN1,Rs2071942,susceptibility to vitiligo in a Korean population
EIF2AK4,Rs587777207,"rare forms of pulmonary hypertension, specifically, pulmonary capillary hemangiomatosis (PCH) and pulmonary venoocclusive disease (PVOD)"
EIF2B5,Rs28939717,leukoencephalopathy with vanishing white matter
EIF2B5,Rs28939717,Leukoencephalopathy with vanishing white matter
ELANE,Rs137854448,neutropenia
ELANE,Rs137854450,c.377C>T
ELANE,Rs137854448,Promethease
ELANE,Rs137854448,ELANE
ELANE,Rs137854448,neutropenia
ELANE,Rs137854448,mutation leading to severe congenital neutropenia
ELN,Rs3757587,Subarachnoid hemorrhage
ELN,Rs3757587,chronic obstructive pulmonary disease
ELN,Rs3757587,Subarachnoid hemorrhage
ELN,Rs3757587,chronic obstructive pulmonary
ELN,Rs7787362,elastic microfibrils
ELN,Rs7787362,striae distensae
ELP4,Rs986527,rolandic epilepsy
ELP4,Rs11031434,rolandic epilepsy
ELP4,Rs11031434,Centrotemporal sharp wave EEG trait
ELP4,Rs11031434,rolandic epilepsy
ENG,Rs756994701,Mendelian disease
ENG,Rs756994701,Table S6
ENG,Rs756994701,SNP
ENG,Rs756994701,Mendelian Disease
ENG,Rs756994701,Pathogenic Regulatory Variants
ENG,Rs756994701,Whole-Genome
ENG,Rs756994701,Mendelian disease
ENG,Rs756994701,biocurators
ENG,Rs368423516,biocurators
ENG,Rs368423516,Table S6
ENG,Rs368423516,SNP
ENG,Rs368423516,Mendelian Disease
ENG,Rs368423516,Pathogenic Regulatory Variants
ENG,Rs368423516,Whole-Genome
ENG,Rs368423516,Mendelian disease
ENG,Rs368423516,Mendelian disease
ENPP1,Rs1044498,diabetes 
ENPP1,Rs1044498,patients with type 2 diabetes
ENPP1,Rs1044498,decreased kidney function
ENPP1,Rs1044498,Turkish population
ENPP1,Rs1044498,Polycystic ovary syndrome
ENPP1,Rs1044498,type 2 diabetes
ENPP1,Rs1044498,type 2 diabetes
ENPP1,Rs1044498,female reproductive disorders
ENPP1,Rs1044498,obesity status:
ENPP1,Rs1044498,Gender 
ENPP1,Rs1044498,Arabic population from Tunisia
ENPP1,Rs1044498,obesity
ENPP1,Rs1044498,type 2 diabetes
ENPP1,Rs1044498,African-American patients with schizophrenia or schizoaffective disorder.
ENPP1,Rs1044498,Chinese Han population. 
ENPP1,Rs1044498,tumor
ENPP1,Rs1044498,Europeans
ENPP1,Rs1044498,Chinese Han population
ENPP1,Rs1044498,type 2 diabetes
ENPP1,Rs1800949,adult-onset morbid obesity
ENPP1,Rs753851892,pathogenic
ENPP1,Rs943003,adult-onset morbid obesity
ENPP1,Rs1044498,type 2 diabetes
ENPP1,Rs1044498,African-American male birth weight
ENPP1,Rs1044498,enriched for nephropathy
ENPP1,Rs1044498,type 2 diabetes 
ENPP1,Rs1044498,2 diabetes
ENPP1,Rs1044498,Danish white
ENPP1,Rs1044498,African-American
ENPP1,Rs1044498,African-American
ENPP1,Rs1044498,obesity
ENPP1,Rs1044498,type II diabetes
ENPP1,Rs1044498,non-Africans
ENPP1,Rs1044498,Africans
ENPP1,Rs1044498,insulin resistance
ENPP1,Rs1044498,whites
ENPP1,Rs1044498,increased fasting plasma glucose (FPG)
ENPP1,Rs1044498,fasting insulin
ENPP1,Rs1044498,hyperglycemia
ENPP1,Rs1044498,Chuvasha population
ENPP1,Rs1044498,type 2 diabetes
ENPP1,Rs1044498,hand osteoarthritis
ENPP1,Rs1044498,"obesity,"
ENPP1,Rs1044498,obesity.
ENPP1,Rs1044498,diabetes
ENPP1,Rs1044498,hyperglycaemia
ENPP1,Rs1044498,Danish white subjects
ENPP1,Rs1044498,obesity
ENPP1,Rs1044498,type 2 diabetes
ENPP1,Rs1044498,insulin resistance
ENPP1,Rs1044498,an African-American population
EPAS1,Rs141965374,Familial Bipolar Disorder
EPAS1,Rs141965374,variants speculated
EPAS1,Rs141965374,bipolar disorder
EPAS1,Rs141965374,Bipolar Disorder
EPAS1,Rs141965374,bipolar disorde
EPAS1,Rs7579899,heterozygotes
EPAS1,Rs7579899,renal cell carcinoma
ERAP1,Rs30187,ankylosing spondylitis
ERAP1,Rs17482078,ankylosing spondylitis
ERCC2,Rs50872,esophageal squamous cell carcinoma
ERCC2,Rs50872,DNA polymorphism
ERCC2,Rs50872,DNA polymorphism and risk of esophageal squamous cell carcinoma
ESCO2,Rs144288263,Familial Bipolar Disorder
ESCO2,Rs144288263,variants speculated
ESCO2,Rs144288263,bipolar disorder
ESCO2,Rs144288263,Bipolar Disorder
ESCO2,Rs144288263,bipolar disorde
ESR1,Rs2273206,schizophrenia
ESR1,Rs2273207,schizophrenia
ESR1,Rs2228480,schizophrenia
ESR1,Rs2152750,susceptibility to Bone mineral density variations
ESR1,Rs1709183,EDV
ESR1,Rs1709183,endothelium-dependent vasodilation
ESR1,Rs1709183,rs1709183
ESR1,Rs1569788,African American
ESR1,Rs1709183,"EDV endothelium-dependent vasodilation in resistance, but not conduit arteries"
EXO1,Rs1635498,risk of breast cancer
EXO1,Rs1635517,risk of breast cancer
EYA1,Rs3779748,kidney disease
F11,I4000397,Factor XI
F11,Rs121965064,most common factor XI-deficiency causing mutations
F11,Rs373297713,Ashkenazi Jews
F11,Rs375422404,Arg
F11,Rs375422404,Ter
F12,Rs187018744,SNP
F12,Rs187018744,Table S6
F12,Rs187018744,biocurators
F12,Rs187018744,Mendelian disease
F12,Rs41309132,Mendelian disease
F12,Rs41309132,Mendelian disease
F12,Rs41309132,Pathogenic Regulatory Variants
F12,Rs41309132,Mendelian Disease
F12,Rs41309132,SNP
F12,Rs41309132,Table S6
F12,Rs41309132,biocurators
F12,Rs41309132,Whole-Genome
F12,Rs187018744,Mendelian Disease
F12,Rs187018744,Whole-Genome
F12,Rs187018744,Mendelian disease
F12,Rs187018744,Pathogenic Regulatory Variants
F12,Rs1801020,heart disease
F12,Rs1801020,very weak association with myocardial infarction
F12,Rs1801020,heart disease
F12,Rs1801020,men
F12,Rs1801020,venous thromboembolism and myocardial infarction was weak.
F12,Rs1801020,Finnish population
F12,Rs1801020,myocardial infarction
F12,Rs1801020,venous thromboembolism
F12,Rs1801020,myocardial infarction
F12,Rs1801020,women
F5,Rs1800595,individuals who are heterozygous for both factor V Leiden and the R2 polymorphism
F5,Rs6022,non-smoking mothers
F5,Rs6022,maternal smoking
F5,Rs1800595,Coinheritance of Factor V Mutation (Leiden)
F5,Rs1800595,patients who are carriers of Factor V Mutation (Leiden)
F5,Rs1800595,increases risk of venous thrombosis in individuals who are heterozygous for the factor V Leiden mutation
F5,Rs1800595,venous thrombosis
F5,Rs1800595,"""Factor V Leiden"" mutation"
F5,Rs1800595,polymorphism
F5,Rs1800595,Venous Thromboembolism
F5,Rs1800595,thrombotic event
F5,Rs1800595,venous thrombosis
F5,Rs1800595,Factor V Leiden
F9,I5007022,Hemophilia B
FAAH,Rs873978,anorexia nervosa
FABP2,Rs1799883,Japanese individuals
FABP2,Rs5861422,GATA factors
FABP2,Rs1799883,type 2 diabetes mellitus
FABP2,Rs1799883,hypercholesterolaemic patients
FABP2,Rs5861422,haplotypes
FABP2,Rs5861422,Type 2 diabetes-associated fatty acid binding protein 2 promoter haplotypes are differentially regulated by GATA factors.
FABP2,Rs5861422,Type 2 diabetes-associated 
FABP2,Rs1799883,chronic kidney disease
FABP2,Rs1799883,type 2 diabetes-associated
FABP2,Rs1799883,metabolic syndrome
FABP2,Rs1799883,type 2 diabetes
FABP2,Rs1799883,atherothrombotic cerebral infarction
FABP2,Rs1799883,myocardial infarction
FABP2,Rs1799883,"reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure"
FABP2,Rs1799883,hypercholesterolaemic patients
FABP2,Rs1799883,type 2 diabetes mellitus
FABP2,Rs1799883,chronic kidney disease
FABP2,Rs1799883,metabolic syndrome
FABP2,Rs1799883,atherothrombotic cerebral infarction
FABP2,Rs1799883,myocardial infarction
FABP2,Rs1799883,Japanese individuals
FABP7,Rs2279381,No particular negative consequences
FABP7,Rs2279381,10% carrying a variant rs2279381(A) allele exhibited more fragmented sleep than non-carriers
FABP7,Rs2279381, were associated with the difference in sleep fragmentation.
FABP7,Rs2279381,No particular negative consequences
FABP7,Rs2279381,~300 Japanese adult males
FADS1,Rs174546,alpha
FADS1,Rs174550,"high concentrations of very large and large HDL particles, particle diameter, and nominally associated with low concentrations of all VLDL particles."
FADS1,Rs174546,linolenic 
FADS1,Rs174546,intake 
FADS1,Rs174546,non
FADS1,Rs174546,HDL
FADS1,Rs174546,cholesterol 
FADS1,Rs174546,modulate 
FADS1,Rs174546,effect 
FADS1,Rs174546,allergic 
FADS1,Rs174546,children
FADS1,Rs174550,glucose-increasing T allele
FADS1,Rs174546,FADS1 
FADS1,Rs174546,FADS
FADS1,Rs174546,erythrocyte 
FADS1,Rs174546,by 
FADS1,Rs174546,FADS1 
FADS1,Rs174546,PUFA 
FADS1,Rs174546,European populations
FADS1,Rs174546,European
FADS1,Rs174546,Cancer
FADS1,Rs174546,European adolescents
FADS1,Rs174546,allergic diseases in children
FADS1,Rs174546,homogeneous island population
FADS1,Rs174546,FADS 
FADS1,Rs174546,delta
FADS1,Rs174546,5 
FADS1,Rs174546,activities 
FADS1,Rs174546,fatty 
FADS1,Rs174546,ratios
FADS1,Rs174546,polymorphisms 
FADS2,Rs482548,lipid desaturases
FADS2,Rs1535,IQ
FADS2,Rs1535,Breast feeding
FAH,I5012862,Tyrosinemia
FAH,I5012865,Tyrosinemia
FAH,I5012865,Tyrosinemia Type
FAM13A,Rs7671167,Individual and cumulative effects of GWAS susceptibility loci in lung cancer
FAM13A,Rs7671167,lung cancer
FAM13A,Rs7671167,GWAS susceptibility loci
FAM98B,Rs11073328,mitochondrial protein
FAM98B,Rs11073328,protein-protein interaction
FAM98B,Rs11073328,a gene
FANCC,Rs121917783,Arg
FANCC,Rs121917783,Ter
FBXL3,Rs386833967,rs386833967
FBXL3,Rs386833967,epresents a very rare deletion mutation
FBXL3,Rs386833967,CLN5 gene on chromosome 13.The variant
FBXL3,Rs386833967,"pathogenic for ceroid lipofuscinosis neuronal 5,"
FBXL3,Rs386833967,recessively inherited condition
FBXL3,Rs386833969,p.Tyr392Terfs)
FCER1A,Rs2427837,chromosome 1q23
FCER1A,Rs2427837,serum IgE
FCER1A,Rs2427837,allergies
FCER1A,Rs2427837,mediators
FCER1A,Rs2427837,(A) alleles
FCER1A,Rs2427837,rs2427837
FCER1A,Rs2427837,FCER1A SNP
FCER1A,Rs2427837,homozygous
FCER1A,Rs2427837,serum IgE
FCER1A,Rs2427837,(G) allele
FCER1A,Rs2427837,higher serum IgE
FCER1A,Rs2427837,FCER1A
FCER1A,Rs2427837,rs2251746(G;G)
FCER1A,Rs2427837,atopic eczema
FCER1A,Rs2427837,asthma
FCER1A,Rs2427837,rs2251746
FCER1A,Rs2427837,high affinity receptor 
FCER1A,Rs2427837,autoimmune diseases
FCER1A,Rs2427837,gene
FCER1A,Rs2427837,alpha chain
FCER1A,Rs2427827,polymorphisms
FCER1A,Rs2427827,dermatitis
FCER1A,Rs2427827,promoter polymorphisms and total serum IgE levels in Japanese atopic dermatitis patients.
FCER1A,Rs2427837,chromosome
FCER1A,Rs2427837,High levels of serum
FCER1A,Rs2427837,allergies
FCER1A,Rs2427837,mediators of autoimmune diseases
FCER1A,Rs2427837,SNP in the gene encoding the alpha chain of the high affinity receptor
FCER1A,Rs2427837,The more common (G) allele was associated with higher serum
FCER1A,Rs2427837,additive
FCER1A,Rs2427837,"Therefore, homozygous"
FCER1A,Rs2427837,topic eczema
FCER1A,Rs2427837,asthma than carriers of one or two (A) alleles.
FCER1A,Rs2427837,rs2427837
FCER1A,Rs2427837,high levels of serum
FCER1A,Rs2427837,SNP
FCGR2A,Rs1801274,malaria
FCGR2A,Rs1801274,Systemic lupus erythematosus (SLE)
FCGR2A,Rs1801274,SLE
FCGR2A,Rs1801274,neuroblastoma
FCGR2A,Rs1801274,diffuse large B-cell lymphoma
FCGR2A,Rs1801274,Malaria
FCGR2A,Rs1801274,Malaria 
FCGR2A,Rs1801274,rheumatoid arthritis
FCGR2A,Rs1801274,Hemophilia
FCGR2A,Rs1801274,metastatic colorectal cancer
FCGR2A,Rs1801274,lymphoma
FCGR2A,Rs1801274,higher risk of follicular and small lymphocytic lymphomas
FCGR2A,Rs1801274,rheumatoid arthritis (RA)
FCGR2A,Rs1801274,systemic lupus erythematosus (SLE)
FCGR2A,Rs1801274,AIDS
FCGR2A,Rs1801274,autoimmune diseases
FCGR2A,Rs1801274,pneumonia
FCGR2A,Rs1801274,AIDS-defining illness
FCGR2A,Rs1801274,Lymphoma
FCGR2A,Rs1801274,AIDS
FCGR2B,Rs3219018,systemic lupus erythematosus
FCGR2B,Rs3219018,hemolytic anemia
FECH,Rs3848519,erythropoietic protoporphyria
FECH,Rs3848519,benign or likely benign
FERMT1,Rs869312722,Mendelian disease
FERMT1,Rs869312722,biocurators
FERMT1,Rs869312722,SNP
FERMT1,Rs869312722,Table S6
FERMT1,Rs869312722,Pathogenic Regulatory Variants
FERMT1,Rs869312722,Whole-Genome
FERMT1,Rs869312722,Mendelian disease
FERMT1,Rs869312722,Mendelian Disease
FGF21,Rs838133,total intake of all types of sweet-tasting foods
FGF21,Rs838133,intake of all types of sweet-tasting foods
FGF21,Rs838133,intake of cake
FGF21,Rs838133,candy intake
FGF23,Rs193922702,reduces expression of type IIa Na+/Pi co-transporter
FGF23,Rs193922702,Physiological regulation of renal sodium-dependent phosphate cotransporters.
FGF23,Rs193922702,Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.
FGF23,Rs193922702,inhibits renal tubular phosphate transport
FGF23,Rs104894344,p.Ser129Phe
FGF23,Rs104894344,S129F
FGFR2,Rs11200014,breast cancer
FGFR3,Rs121913114,achondroplasia
FGFR3,Rs121913114,autosomal dominant manner
FGFR3,Rs121913114,SNP
FGFR3,Rs121913114,i5001264
FGFR3,Rs121913114,OMIM 134934
FGFR3,Rs121913114,rs121913114(T) allele
FGFR3,Rs121913114,achondroplasia
FGFR3,Rs121913114,chromosome 4.Acting
FGFR3,Rs121913114,FGFR3 gene
FGFR3,Rs121913114,S279C
FGFR3,Rs121913114,Ser279Cys
FGFR3,Rs121913114,rs121913114
FGFR3,Rs121913114,autosomal dominant manner
FGG,Rs2066865,deep venous thrombosis
FGG,Rs2066865,venous thrombosis
FGG,Rs2066865,colorectal cancer risk
FKBP5,Rs7757037,bipolar disorder
FKBP5,Rs1360780,linked with the severity of child abuse to predict level of adult PTSD symptoms
FKBP5,Rs1360780,rs1360780(T;T) homozgyotes tend to report more depressive episodes
FKBP5,Rs1360780,may influence how patients respond to antidepressants including citalopram
FKBP5,Rs1360780,predict level of adult PTSD symptoms
FKBP5,Rs1360780,Caucasian non-Hispanics
FKBP5,Rs1360780,"In Caucasian non-Hispanics, the rs1360780(T) allele is associated with increased risk for depression"
FKBP5,Rs1360780,increased risk for depression
FKRP,Rs200990647,minor allele
FKRP,Rs28937900,Limb-girdle muscular dystrophy-dystroglycanopathy
FLG,Rs754812742,ichythosis vulgaris
FLG,Rs754812742,pathogenic for ichythosis vulgaris
FLG,Rs41370446,individuals of European and African American ancestry
FLG,Rs144419479,loss of normal protein function through protein truncation
FLG,Rs144419479,loss of normal protein function
FLG,Rs41370446,loss of normal protein function through protein truncation
FLNB,Rs9834312,rs9834312
FLNB,Rs9834312,rs939882
FMO3,Rs72549325,associated with trimethylaminuria
FMO3,Rs72549321,reported in a single patient with trimethylaminuria
FMO3,Rs72549322,trimethylaminuria.
FMO3,Rs72549325,ow FMO3 activity
FMO3,Rs72549325,low conversion rates of caffeine to theobromine
FMO3,Rs72549325,heterozygous
FMO3,Rs72549325,trimethylaminuria
FMO3,Rs72549330,rs72549330
FMO3,Rs72549330,trimethylaminuria
FMO3,Rs72549332,trimethylaminuria
FMO3,Rs72549332,SNP in the FMO3 gene
FOXO3,Rs2802292,shorter lifespan
FOXO3,Rs2802292,longer lifespan
FOXO3,Rs2802292,linked to longevity
FOXO3,Rs1935949,demonstrated a significant association with longevity
FOXO3,Rs2802288,increased the odds of living
FOXO3,Rs2802288,increased the odds of living to 100 by 1.5x
FOXO3,Rs2802292,some of whom lived significantly longer than average
FOXP2,Rs121908377,developmental verbal dyspraxia
FOXP2,Rs121908377,Speech-language disorder-1
FOXP2,Rs121908377,SPCH1
FOXP2,Rs121908378,verbal dyspraxia
FOXP2,Rs121908378,Speech-language disorder-1
FOXP2,Rs121908378,SPCH1.
FSHR,Rs6166,Ser/Ser homozygotes
FSHR,Rs6166,follicle stimulating hormone receptor FSHR gene
FTL,Rs398124637,Mendelian Disease
FTL,Rs398124636,Mendelian Disease
FTL,Rs398124636,SNP
FTL,Rs398124636,Table S6
FTL,Rs398124636,biocurators
FTL,Rs398124636,Mendelian disease
FTL,Rs398124637,Mendelian disease
FTL,Rs398124636,Pathogenic Regulatory Variants
FTL,Rs398124637,Whole-Genome
FTL,Rs398124637,Pathogenic Regulatory Variants
FTL,Rs398124637,SNP
FTL,Rs398124638,Mendelian disease
FTL,Rs398124637,biocurators
FTL,Rs398124637,Mendelian disease
FTL,Rs398124638,Mendelian disease
FTL,Rs398124638,Whole-Genome
FTL,Rs398124638,Pathogenic Regulatory Variants
FTL,Rs398124638,Mendelian Disease
FTL,Rs398124638,SNP
FTL,Rs398124638,Table S6
FTL,Rs398124638,biocurators
FTL,Rs398124636,Whole-Genome
FTL,Rs398124637,Table S6
FTL,Rs398124636,Mendelian disease
FTL,Rs398124633,Mendelian disease
FTL,Rs398124635,biocurators
FTL,Rs398124635,Mendelian disease
FTL,Rs398124633,Whole-Genome
FTL,Rs398124633,Pathogenic Regulatory Variants
FTL,Rs398124633,Mendelian Disease
FTL,Rs398124633,SNP
FTL,Rs398124633,Table S6
FTL,Rs398124633,biocurators
FTL,Rs398124634,Mendelian disease
FTL,Rs398124634,Whole-Genome
FTL,Rs398124634,Pathogenic Regulatory Variants
FTL,Rs398124633,Mendelian disease
FTL,Rs398124634,SNP
FTL,Rs398124634,Mendelian Disease
FTL,Rs398124635,SNP
FTL,Rs398124635,Mendelian Disease
FTL,Rs398124635,Pathogenic Regulatory Variants
FTL,Rs398124635,Table S6
FTL,Rs398124635,Mendelian disease
FTL,Rs398124634,Mendelian disease
FTL,Rs398124634,biocurators
FTL,Rs398124634,Table S6
FTL,Rs398124635,Whole-Genome
FTO,Rs9937053,FTO gene region
FTO,Rs9937053,SNP
FTO,Rs9939609,increase in BMI (95% confidence interval (CI): 0.16-0.74; P = 0.004) and 0.97 cm increase in waist circumference
FTO,Rs9937053,BMI
FTO,Rs9937053,body mass index
FTO,Rs9937053,rs9937053
FTO,Rs9937053,SNP
FTO,Rs9937053,co-inherited SNPs
FTO,Rs9937053,FTO gene
FTO,Rs9939609,risk allele for obesity is likely to influence appetite
FTO,Rs9939609,"rs9939609 is a SNP in the fat mass and obesity associated FTO gene, aka the ""Fat Gene"""
FTO,Rs9939609,identified 10 different FTO SNPs in the first intron of the gene that associated with both BMI and type-2 diabetes
FTO,Rs9939609,associated with type-2 diabetes
FTO,Rs9939609,"study of 3,000+ UK children indicated that (A;A) genotypes were less satieted"
FTO,Rs9939609,associated with (severe) obesity in a study of 927 Japanese patients
FTO,Rs9939609,associated with adult obesity in Mexicans
FTO,Rs9939609,the A-allele of the FTO SNP appears to increase mortality of a magnitude similar to smoking
FTO,Rs9939609,without a particular underlying disease pattern barring an increase in the risk of diseases of the nervous system
FTO,Rs9937053,FTO gene
FTO,Rs9937053,"FTO SNPs, rs9930506."
FTO,Rs9937053,co-inherited
FTO,Rs8047395,multiethnic Insulin Resistance Atherosclerosis Study cohort
FTO,Rs9922619,body weight
FTO,Rs9923233,association with body weight
FTO,Rs1861868,obesity in subjects with low physical activity scores
FTO,Rs1861868,no effect on those with above-average physical activity scores
FTO,Rs1861868,obesity
FTO,Rs1861868,morbid obesity
FTO,Rs1861868,low physical activity
FTO,Rs1861868,above-average physical activity
FTO,Rs1861868,body mass index
FTO,Rs1861868,obesity
FTO,Rs1861868,body mass index and obesity
FTO,Rs1861868,Portuguese Children
FTO,Rs8043757,body weight
FTO,Rs8043757,"body mass index, BMI"
FTO,Rs8047395,obesity
FTO,Rs8047395,glucose homeostasis
FTO,Rs8047395,obesity
FTO,Rs8047395,glucose homeostasis
FTO,Rs9922619,"body weight (i.e. body mass index, BMI)"
FTO,Rs1861868,morbid obesity
FUS,Rs559575844,biocurators
FUS,Rs559575844,Mendelian disease
FUS,Rs780606789,Mendelian disease
FUS,Rs780606789,Whole-Genome
FUS,Rs780606789,Pathogenic Regulatory Variants
FUS,Rs780606789,biocurators
FUS,Rs780606789,SNP
FUS,Rs780606789,Table S6
FUS,Rs780606789,Mendelian disease
FUS,Rs559575844,Table S6
FUS,Rs780606789,Mendelian Disease
FUS,Rs559575844,SNP
FUS,Rs559575844,Whole-Genome
FUS,Rs559575844,Pathogenic Regulatory Variants
FUS,Rs559575844,Mendelian disease
FUS,Rs376510148,Mendelian disease
FUS,Rs376510148,biocurators
FUS,Rs376510148,Table S6
FUS,Rs376510148,SNP
FUS,Rs376510148,Mendelian Disease
FUS,Rs376510148,Pathogenic Regulatory Variants
FUS,Rs376510148,Whole-Genome
FUS,Rs376510148,Mendelian disease
FUS,Rs559575844,Mendelian Disease
FUT1,Rs838133,candy intake
FUT1,Rs838133,intake of cake
FUT1,Rs838133,intake of all types of sweet-tasting foods
FUT1,Rs838133,total intake of all types of sweet-tasting foods
FUT1,Rs150074056,deleterious phenotype
FUT1,Rs150074056,H-deficient
FUT1,Rs150074056,Bombay and para-Bombay
FUT1,Rs150074056,Para-Bombay
FUT1,Rs150074056,H-deficient Reunion variant
FUT2,Rs601338,bacteria
FUT2,Rs601338,Norovirus
FUT2,Rs601338,cystic fibrosis lung disease severity
FUT2,Rs601338,women
FUT2,Rs601338,Japanese
FUT2,Rs601338,non-Caucasian populations
FUT2,Rs601338,influenza viruses
FUT2,Rs601338,adults
FUT2,Rs601338,acute gastroenteritis
FUT2,Rs601338,Norwalk norovirus
FUT2,Rs601338,Swedish adults
FUT2,Rs492602,nonsecretor variant encoding
FUT2,Rs492602,n strong linkage disequilibrium
FUT2,Rs601338,cruise ship gastroenteritis
FXN,Rs145045861,Friedreich's ataxia
FXN,Rs146948377,Friedreich's ataxia
FXN,Rs146948377,Friedreich's ataxia
FXN,Rs146948377,compound heterozygote
FXN,Rs147211454,rs147211454
FXN,Rs147211454,c.340_352
FXN,Rs147211454,associated with Friedreich's ataxia
FXN,Rs148698100,Friedreich's ataxia
FXN,Rs149229839,Friedreich's ataxia
FXN,Rs149335881,Friedreich's ataxia
FXN,Rs149335881,The minor allele of this SNP
FXN,Rs149335881,compound heterozygote
FXN,Rs149724959,rs149724959
FXN,Rs149724959,Friedreich's ataxia
FXN,Rs149724959,heterozygote
FXN,Rs149724959,associated with Friedreich's ataxia
FXN,Rs150676454,Friedreich's ataxia
FXN,Rs149335881,a mutation in the FXN gene on chromosome
FXN,Rs144610605,Friedreich's ataxia
FXN,Rs145045861,Friedreich's ataxia
FXN,Rs138837292,Friedreich's ataxia
FXN,Rs104894105,mutation in the FXN gene on chromosome 9
FXN,Rs104894105,Friedreich's ataxia
FXN,Rs104894105,2 known minor alleles
FXN,Rs138471431,Friedreich's ataxia
FXN,Rs138837292,Friedreich's ataxia
FXN,Rs143340609,Friedreich's ataxia
FXN,Rs140510894,associated with Friedreich's ataxia
FXN,Rs140510894,inherited in two copies or as a compound heterozygote
FXN,Rs139616452,Friedreich's ataxia
FXN,Rs142133355,Friedreich's ataxia
FXN,Rs143340609,Friedreich's ataxia
FXN,Rs143340609,rs143340609
FXN,Rs143340609,c.467
FXN,Rs143340609,p.L156P
FXN,Rs143340609,FXN
FXN,Rs143340609,chromosome 9
FXN,Rs143340609,SNP
FXN,Rs142133355,compound heterozygote
FYCO1,Rs7652331,prostate cancer
FYCO1,Rs1545985,increased risk for prostate cancer
FYCO1,Rs1545985,The risk allele for this SNP is (G)
FYCO1,Rs1545985,additive model of risk.
FYCO1,Rs1545985,the probability of false significance (not permuted though)
FYCO1,Rs1545985,increased risk for prostate cancer
FYCO1,Rs7652331,increased risk for prostate cancer
FZD8,Rs1352,gene FZD8
FZD8,Rs1352,Neocortex
G6PC,Rs80356488,glycogen storage disease type 1a
G6PC,Rs80356488,glycogen storage disease type 1a
G6PC,Rs80356488,glycogen storage disease type 1a
G6PC,I3002486,Glycogen Storage Disease Type 1
G6PC,I3002486,Glycogen Storage Disease
G6PD,Rs5030868,fava beans
G6PD,Rs5030868,dapsone
G6PD,Rs5030868,"primaquine,"
G6PD,Rs5030868,glibenclamide
G6PD,Rs5030868,Aspirin
G6PD,Rs5030868,acute hemolytic anemia
G6PD,Rs5030868, (G6PD) deficiency
G6PD,Rs398123546,(p.Arg484Cys or R484C)
G6PD,Rs398123546,c.1450C>T
G6PD,Rs398123546,c.1360C>T
G6PD,Rs137852346,i6010663
G6PD,Rs137852346,23
G6PD,Rs137852340,biochemical characterization
G6PD,Rs137852336,i5008448
G6PD,Rs137852336,23and
G6PD,Rs137852327,ndMe nazwa: i5008436
G6PD,Rs137852323,23andMe 
G6PD,Rs137852323,i6010641
G6PD,Rs137852321,i5008429
G6PD,Rs137852320,name
G6PD,Rs137852320,Me
G6PD,Rs137852320,and
G6PD,Rs5030868,Hemizygous males and homozygous females
G6PD,Rs5030868,malaria
GAA,Rs121907936,OMIM as pathogenic but as a variant of uncertain significance in ClinVar; the latter is annotated as of uncertain significance in ClinVar.
GABRA2,Rs279858,Alcoholism
GABRA2,Rs279858,prone to alcoholism
GABRA2,Rs279858,blocking effect
GADL1,Rs17026688,bipolar patients
GADL1,Rs17026688,carriers of at least one (T) allele
GADL1,Rs17026688,lithium treatment
GADL1,Rs17026688,rs17026688(C;C)
GADL1,Rs17026688,major depressive disorder
GADL1,Rs17026688,NPV
GADL1,Rs17026688,DNA
GADL1,Rs17026688,bipolar
GADL1,Rs17026688,lithium treatment
GADL1,Rs17026688,lithium
GADL1,Rs17026688,response allele
GADL1,Rs17026688,lithium
GADL1,Rs17026688,response allele
GADL1,Rs17026688,response allele
GADL1,Rs17026688,SNPs
GADL1,Rs17026688,biomarkers
GADL1,Rs17026688,bipolar disorder
GADL1,Rs17026688,lithium treatment
GADL1,Rs17026688,GADL1 gene variants
GADL1,Rs17026688,non-Asian populations
GADL1,Rs17026688,Asian population
GADL1,Rs17026688,lithium treatment
GADL1,Rs17026688,response allele
GADL1,Rs17026688,rs17026688(T)
GADL1,Rs17026688,PPV
GADL1,Rs17026688,proxies
GADL1,Rs17026688,Han Chinese descent with bipolar disorder
GADL1,Rs17026688,Asian patients
GADL1,Rs17026688,bipolar patients
GADL1,Rs17026688,bipolar patient 
GADL1,Rs17026688,patients with bipolar disorder 
GADL1,Rs17026688,non-Asian populations
GADL1,Rs17026688,high linkage disequilibrium
GADL1,Rs17026688,major depressive disorder.
GADL1,Rs17026688,rs17026688
GADL1,Rs17026688,SNP
GADL1,Rs17026688,intron
GADL1,Rs17026688,"Asian population,"
GADL1,Rs17026688,rs17026651
GADL1,Rs17026688,glutamate decarboxylase-like 1 GADL1 gene
GADL1,Rs17026688,rs17026651
GADL1,Rs17026688,SNPs
GADL1,Rs17026688,IVS8+48delG GADL1 allele
GADL1,Rs17026688,rs17026688
GADL1,Rs17026688,bipolar disorder
GADL1,Rs17026688,rs201973599
GADL1,Rs17026688,GADL1 IVS8+48delG
GADL1,Rs17026688,1 base deletion
GADL1,Rs17026688,lithium treatment
GALC,Rs200378205,Krabbe disease
GALC,Rs200378205,Krabbe disease
GALC,Rs387906953,Krabbe disease
GALC,Rs387906953,Krabbe disease
GALT,Rs111033690,pathogenic mutation associated with galactosemia
GATA2,Rs3803,familial early-onset coronary artery disease
GATA2,Rs3803,familial early-onset coronary artery disease
GATA2,Rs3803,GATA2
GATA2,Rs3803,reduces the risk of heart disease
GATA2,Rs3803,reduces the risk of heart disease
GATA2,Rs2713604,Having a C at this position
GATA2,Rs2713604,snp as playing a role
GATA2,Rs2713604,Having a T at this position
GATA2,Rs2713604,heart disease
GATA2,Rs2713604,heart disease
GATA2,Rs3803,playing a role in heart disease
GATA3,Rs4143094,pro-tumorigenic inflammatory or immunological response
GATA3,Rs4143094,colorectal cancer
GATA3,Rs4143094,colorectal cancer
GATA3,Rs4143094,colorectal cancer
GATA3,Rs4143094,colorectal cancer
GATA3,Rs4143094,Colorectal Cancer
GATA3,Rs4143094,Colon Cancer
GATA3,Rs4143094,colorectal cancer
GATA3,Rs4143094,cancers
GATA3,Rs4143094,"breast cancer, prostate cancer"
GATA3,Rs4143094,"breast, colorectal, and lung cancers"
GATA3,Rs4143094,colorectal cancer
GATA3,Rs4143094,colorectal cancer
GATA3,Rs4143094,ulcerative colitis
GATA3,Rs4143094,Colorectal cancer
GATA3,Rs4143094,colorectal cancer
GATA3,Rs4143094,Colorectal Cancer
GATA3,Rs4143094,colon cancer
GATA3,Rs4143094,colorectal cancer
GATA4,Rs769262495,Whole-Genome
GATA4,Rs769262495,Mendelian disease
GATA4,Rs769262495,biocurators
GATA4,Rs769262495,Table S6
GATA4,Rs769262495,Mendelian Disease
GATA4,Rs769262495,Pathogenic Regulatory Variants
GATA4,Rs769262495,Mendelian disease
GATA4,Rs769262495,SNP
GATA4,Rs372004083,biocurators
GATA4,Rs372004083,Table S6
GATA4,Rs372004083,SNP
GATA4,Rs372004083,Mendelian Disease
GATA4,Rs372004083,Mendelian disease
GATA4,Rs372004083,Pathogenic Regulatory Variants
GATA4,Rs372004083,Whole-Genome
GATA4,Rs372004083,Mendelian disease
GBA,Rs1064651,valvular heart disease
GBA,Rs1064651,Gaucher disease
GBA,Rs1064651,Gaucher's disease
GBA,Rs1064651,rs1064651
GBA,Rs1064651,Gaucher's disease
GC,Rs4588,migraine
GC,Rs4588,nonhypertensive
GC,Rs4588,recurrent venous thromboembolism
GC,Rs4588,blood pressure progression
GC,Rs4588,incident hypertension
GC,Rs4588,inflammation
GC,Rs705117,rs705117
GC,Rs4588,venous thromboembolism
GC,Rs4588,vitamin D concentration
GC,Rs4588,serum 25-hydroxyvitamin D concentrations
GC,Rs705117,rs7041
GC,Rs705117,vitamin D binding protein
GC,Rs4588,ischemic stroke
GC,Rs4588,thrombosis
GC,Rs4588,plasma concentrations of 25-hydroxyvitamin D
GC,Rs4588,lymphotoxin-alpha
GC,Rs4588,decreased postmenopausal breast cancer risk
GC,Rs4588,"25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels"
GC,Rs17467825,20 osteoporosis candidate
GC,Rs17467825,obesity-related traits in Caucasian nuclear families
GC,Rs17467825,high-density single-nucleotide polymorphism
GC,Rs17467825,gene-gene interaction
GC,Rs17467825,polymorphisms with variations of obesity-related traits
GC,Rs4588,decreased postmenopausal breast cancer risk
GC,Rs4588,lymphotoxin-alpha in nonhypertensive patients
GC,Rs4588,inflammation and thrombosis in relation to the risk of venous thromboembolism
GC,Rs4588,the development of immune responses in the 1st year of life
GC,Rs4588,chronic obstructive pulmonary disease.
GC,Rs4588,Vitamin D pathway
GC,Rs4588,diet
GC,Rs4588,risk of postmenopausal breast cancer
GC,Rs4588,Genetic risk factors in recurrent venous thromboembolism:
GCDH,Rs121434367,Amish 
GCDH,Rs1273164833,c.301G>A
GCDH,Rs121434367,mutation
GCDH,Rs121434367,as
GCDH,Rs121434367,1262C
GCDH,Rs121434367,A421V
GCDH,Rs121434367,Ala421Val 
GCDH,Rs121434367,may be referred to as the Amish GA1 mutation
GCDH,Rs121434367,referred 
GCH1,Rs41298442,Dystonia
GCH1,Rs998259,Triphosphate Cyclohydrolase
GCH1,Rs998259,Polymorphic Variation of the Guanosine Triphosphate Cyclohydrolase
GCH1,Rs998259,Lumbar Degenerative Disc Disease
GCH1,Rs886039379,autosomal dominant dopa-responsive dystonia
GCH1,Rs8007267,coronary artery disease
GCH1,Rs41298442,dopa-responsive myoclonus-dystonia syndrome
GCH1,Rs41298442,Dopa-responsive dystonia
GCH1,Rs41298442,British patients
GCH1,Rs41298442,Dopa-Responsive Dystonia
GCH1,Rs10483639,higher pain tolerance
GCH1,Rs3783641,Polymorphisms
GCH1,Rs10483639,associate
GCH1,Rs10483639,coronary artery disease
GCH1,Rs3783641,coronary artery disease
GCH1,Rs3783641,cyclohydrolase
GCH1,Rs3783641,sensitivity
GCH1,Rs3783641,persistence
GCH1,Rs3783641,pain
GCH1,Rs3783641,cyclohydrolase and tetrahydrobiopterin
GCK,Rs193922264,MODY
GCK,Rs1799884,gestational diabetes
GCK,Rs1799884,type-2 diabetes
GCK,Rs1799884,hyperglycaemia
GCK,Rs104894006,late-onset noninsulin-dependent diabetes
GCK,Rs1799884,rs1799884
GCK,Rs144723656,lucokinase mutations
GHR,Rs121909363,p.Arg235Ter
GHR,Rs121909363,R235X
GHRL,Rs35682,obesity/BMI
GHRL,Rs35682,associated with obesity/BMI
GHRL,Rs35682,New York European Americans
GIT1,Rs550818,ADHD-like behaviors
GIT1,Rs550818,ADHD
GIT1,Rs550818,ADHD GIT1 is associated with ADHD in humans and ADHD-like behaviors
GJB2,I6011464,deafness
GJB2,I6011481,rs786204597
GJB2,I6011481,GJB2 
GJB2,I6011481,deafness
GJB2,I6011485,see 
GJB2,Rs104894404,nonsyndromic hearing loss and deafness
GJB2,Rs104894404,keratoderma palmoplantar deafness
GJB2,Rs111033204,connexin 26 gene (GJB2) mutations in Japanese. Connexin26 mutations
GJB2,Rs111033204,nonsyndromic hearing loss
GJB2,Rs111033204,non-syndromic hearing loss among the German population
GJB2,Rs111033204,Mutations of Cx26 gene (GJB2) for prelingual deafness in Taiwan.
GJB2,Rs80338947,hearing loss
GJB2,Rs730880338,deafness
GJB2,Rs730880338,pathogenic/likely pathogenic for deafness
GJB2,Rs767178508,deafness
GJB2,Rs80338939,autosomal recessive nonsyndromic hearing loss
GJB2,Rs80338939,SNP
GJB2,Rs80338939,autosomal recessive nonsyndromic hearing loss
GJB2,Rs80338942,deafness-associated SNP
GJB2,Rs80338942,nonsyndromic recessive deafness-associated SNP in Ashkenazi Jewish
GJB2,Rs72474224,deafness
GJB2,I6011417,gene variant associated with deafness
GJB2,Rs72474224,Deafness
GJB2,I6011417,rs111033451
GJB2,I6011417, GJB2 
GJB2,I4000435,Hearing loss
GJB2,I4000435,Nonsyndromic Sensorineural Hearing Loss
GJB2,I5001996,deafness
GJB2,I5001996,deafness
GJB2,I5002001,gene variant associated with deafness
GJB2,I5012707,gene variant associated with deafness
GJB2,I6011303,gene variant associated with deafness
GJB2,I6011303,recessive GJB2 gene variant associated with deafness
GJB2,I6011314,recessive
GJB2,I5001998,associated with deafness
GJB2,I6011314,associated with deafness
GJB2,I6011325,associated with deafness
GJB2,I6011363,associated with deafness
GJB2,I6011412,rs111033293recessive
GJB2,I6011412,deafness
GJB2,I6011412,rs111033293recessive 
GJB2,I6011412,gene 
GJB2,I6011412,associated 
GJB2,I6011412,deafness
GJB2,I6011314,gene
GJC2,Rs587776888,Mendelian disease
GJC2,Rs587776888,biocurators
GJC2,Rs587776888,Table S6
GJC2,Rs587776888,SNP
GJC2,Rs587776888,Mendelian disease
GJC2,Rs587776888,Pathogenic Regulatory Variants
GJC2,Rs587776888,Whole-Genome
GJC2,Rs587776888,Mendelian Disease
GLA,Rs104894845,reduced alpha-galactosidase enzyme activity.
GLA,Rs28935485,note X-linkage
GLA,Rs104894845,milder Fabry disease phenotype
GLA,Rs104894845,asymptomatic adult
GLA,Rs104894845,amilial hypertrophic cardiomyopathy
GLA,Rs104894827,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
GLA,Rs104894845,hypertrophic cardiomyopathy (HCM)
GLB1,Rs72555362,Human beta-galactosidase gene mutations
GLB1,Rs72555362,morquio B disease
GLB1,Rs72555363,Human beta-galactosidase gene mutations
GLB1,Rs72555363,morquio B disease
GNB3,Rs5443,gastroesophageal reflux disease
GNB3,Rs5443,schizophrenia
GNB3,Rs5443,ventricular hypertrophy
GNB3,Rs5443,hypertension
GNB3,Rs5443,hypertension
GNB3,Rs5443,hypertrophy
GNB3,Rs5443,insulin resistance
GNB3,Rs5443,metabolic conditions
GNB3,Rs5443,therefore diabetes
GNB3,Rs5443,genotypes are more prevalent in gastroesophageal reflux disease
GNB3,Rs5443,Caucasian patients
GNB3,Rs5443,treatment of migraines or cluster headaches
GNB3,Rs5443,more weight
GNB3,Rs5443,for the treatment of schizophrenia
GNB3,Rs5443,"carriers are clearly at higher risk for hypertension, but this review indicates that whether they are also at increased risk for stroke and left ventricular hypertrophy remains controversial"
GNB3,Rs5443,"obese in Caucasian, Chinese, and African American populations"
GNB3,Rs5443,"a number of metabolic conditions including obesity, coronary artery disease, insulin resistance and therefore diabetes, left ventricular hypertrophy, and hypertension"
GNB3,Rs5443,131 obese Taiwanese patients
GNE,Rs28937594,rs28937594(C) allele
GNE,Rs28937594,M712T
GNE,Rs28937594,M743T
GNE,Rs28937594,c.2228T>C
GNE,Rs28937594,rs28937594
GNE,Rs28937594,p.Met743Thr
GNPTAB,Rs137853825,mutations
GNPTAB,Rs137853825,stutterers
GNPTAB,Rs137853825,stuttering
GNPTAB,Rs137853825,GNPTAB
GNPTAB,Rs137853825,GNPTAB
GNPTAB,Rs137853825,significantly longer pauses in their spontaneous vocalizations
GNPTAB,Rs137853822,stutterers
GNPTAB,Rs137853825,increased the risk of stuttering
GNPTAB,Rs137853822,stuttering
GNPTAB,Rs137853822,stuttering
GNPTAB,Rs137853825,associated with stuttering
GNPTAB,Rs137853822,additive genetic effect
GNPTAB,Rs137853822,Female 
GNPTG,Rs137853827,stuttering
GNPTG,Rs193302853,dystrophy
GNPTG,Rs193302853,609
GNPTG,Rs193302853,28_610
GNPTG,Rs193302853,16del 
GNPTG,Rs193302853,part 
GNPTG,Rs193302853,Blueprint 
GNPTG,Rs193302853,Retinal 
GOLM1,Rs11141235,bacteria and fungi
GPHN,Rs761543313,OMIM pathogenic variant
GPX1,Rs1800668,oxidative stress
GPX1,Rs1800668,risk of adult brain tumors
GPX4,Rs713041,rs713041
GPX4,Rs713041,rs757229
GPX4,Rs713041,mortality in breast cancer
GPX4,Rs713041,rs713041(T)
GPX4,Rs713041,increased risk of death
GPX4,Rs757228,SNPs
GPX4,Rs757229,all-cause mortality
GPX4,Rs757229,breast cancer
GRHPR,I5012629,Primary hyperoxaluria type 2
GRHPR,I5012629,Promethease
GRIK1,Rs726002,breast cancer
GRIN1,Rs11146020,schizophrenia
GRIN1,Rs200777850,pathogenic variant
GRIN2B,Rs1806201,Association between NMDA receptor subunit 2b gene polymorphism and Alzheimer's disease
GRIN2B,Rs1806201,Alzheimer's disease
GRIN2B,Rs1806201,subunit 2B are not associated with alcohol dependence and alcohol withdrawal-induced seizures and delirium tremens
GRM3,Rs2228595,schizophrenia 
GRM3,Rs2228595,GRM3 splicing
GRM3,Rs2228595,contribute to risk for schizophrenia
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,Parkinson's disease
GRN,Rs5848,Parkinson's disease
GRN,Rs5848,Reduced serum progranulin level
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,amnesic syndrome
GRN,Rs5848,FTLD
GRN,Rs794729670,frontotemporal dementia.
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,behavioral and/or language dysfunction
GRN,Rs5848,progranulin levels
GRN,Rs5848,Parkinson's disease
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,Parkinson's disease
GRN,Rs5848,eurodegenerative disorders
GRN,Rs5848,reduces plasma and brain levels of granulin
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,influences GRN mRNA levels in brain and peripheral mononuclear cells
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,serum progranulin level
GRN,Rs5848,progranulin level
GRN,Rs5848,dementia
GRN,Rs5848,Progranulin Insufficiency
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,progranulin levels
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,Alzheimer's disease
GRN,Rs193026789,a very rare mutation in the GRN gene
GRN,Rs193026789,frontotemporal dementia
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,progressive neurodegenerative disease
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,behavioral and/or language dysfunction
GRN,Rs5848,amnesic syndrome
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,Reduced serum progranulin level
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,Parkinson's disease
GRN,Rs5848,early-onset dementia
GRN,Rs5848,Parkinson's disease
GRN,Rs5848,frontotemporal dementia
GRN,Rs5848,inflammation
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,reduces plasma and brain levels of granulin in Alzheimer's disease patients
GRN,Rs5848,progressive neurodegenerative disease
GRN,Rs5848,Parkinson's disease
GRN,Rs5848,Parkinson's disease
GRN,Rs5848,Alzheimer's disease
GRN,Rs5848,reduces progranulin levels
GRN,Rs5848,neurodegenerative disorders
GSK3B,Rs334558,ipolar disorder
GSK3B,Rs334558,ithium treatment respons
GSK3B,Rs334558,protective effect in that individuals who have a (G) allele develop bipolar disorder at a later age than those with the more common
GSK3B,Rs334558,gene.may effect lithium treatment response
GSK3B,Rs334558,C allele carriers showed considerably greater response with lithium treatment
GSK3B,Rs7624540,schizophrenia
GSK3B,Rs7624540,polycystic ovary syndrome
GUCY2D,Rs61749670,GUCY2D c.389delC
GYPA,Rs7687256,the MNS blood group
GYPA,Rs7687256,SNP
GYPA,Rs7682260,define the MNS blood group
GYPA,Rs7682260,MNS blood group
GYPA,Rs7658293,MN blood group
GYPA,Rs7682260,rs7682260
GYPB,Rs7683365,rs7683365
GYPB,Rs7683365,MNS blood group
GYPB,Rs7683365,GYPB s/s individuals are less susceptible to infection.
GYPB,Rs7683365,GYPB S/S and GYPB S/s individuals have average susceptibility to being infected with malaria
HBA2,Rs63751269,Mendelian Disease
HBA2,Rs63751269,Mendelian disease
HBA2,Rs63751269,biocurators
HBA2,Rs63751269,Table S6
HBA2,Rs63751269,SNP
HBA2,Rs63751269,Pathogenic Regulatory Variants
HBA2,Rs63751269,Whole-Genome
HBA2,Rs63751269,Mendelian disease
HBA2,Rs63750067,Mendelian disease
HBA2,Rs63750067,biocurators
HBA2,Rs63750067,Table S6
HBA2,Rs63750067,SNP
HBA2,Rs63750067,Mendelian Disease
HBA2,Rs63750067,Pathogenic Regulatory Variants
HBA2,Rs63750067,Whole-Genome
HBA2,Rs63750067,Mendelian disease
HBA2,Rs281864828,pathogenic variant
HBB,Rs33930165,reduction in risk of clinical malaria
HBB,Rs33930165,reduction
HBB,Rs33950507,malarial resistance
HBB,Rs33974936,i6012428
HBB,Rs34451549,Beta Thalassemia
HBB,Rs34451549,er
HBB,Rs34451549,beta zero-thalassemia mutation
HBB,Rs33930165,"increased malarial resistance, yet without giving rise to sickle cell anemia"
HBB,Rs34451549,beta-thalassemia mutations
HBB,Rs34451549,beta-thalassemia genes
HBB,Rs34451549,beta-Thalassemia
HBB,Rs34451549,vivo RNA
HBB,Rs34451549,oligonucleotide hybridization
HBB,Rs34451549,haematological characterization of beta-thalassaemia
HBB,Rs34451549,(codons 27-28
HBB,Rs33930165,hemoglobin C
HBB,Rs334,sickle cell anemia
HBB,Rs33930165,malarial resistance
HBB,I3003137,Sickle Cell
HBB,I3003137,Anemia
HBB,I3003137,Malaria Resistance
HBB,Rs1141387,Modeling effects
HBB,Rs1141387,human single
HBB,Rs33930165,Hb C
HBB,Rs1141387,polymorphisms
HBB,Rs334,"same ancestor 7,300 years ago"
HBB,Rs334,life-threatening forms of malaria
HBB,Rs334,heterozygotes
HBB,Rs334,sickle cell anemia
HBB,Rs334,The (T) allele
HBB,Rs334,higher resistance to life-threatening forms of malaria
HBB,Rs334,mutation
HBG1,Rs7482144,sickle cell disease
HBG1,Rs7482144,Sickle Cell Disease
HBG1,Rs7482144,thalassemia
HBG1,Rs7482144,African descent
HBG1,Rs7482144,sickle cell disease
HBG1,Rs7482144, fetal hemoglobin levels and pain crises in sickle cell disease
HBG1,Rs7482144,Sickle Cell Disease
HBG1,Rs7482144,sickle cell patients
HBG1,Rs7482144,F cell levels in healthy individuals
HBG1,Rs7482144, sickle cell disease
HBG1,Rs7482144, Monogenic Disease with a Polygenic Phenotype
HCN1,Rs981782,invasive ovarian cancer susceptibility
HCN1,Rs981782,breast cancer
HCN1,Rs981782,major complex human diseases
HCN1,Rs981782,breast cancer risk
HCN1,Rs981782,breast cancer
HCN1,Rs981782,mammographic density
HCN1,Rs981782,Breast cancer susceptibility
HCN1,Rs981782,Breast cancer risk
HCN1,Rs981782,mammographic density
HCN1,Rs981782,a breast cancer risk
HCN1,Rs981782,breast cancer risk locus
HCN1,Rs981782,breast cancer susceptibility
HCRTR2,Rs2653349,homozygotes 
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,genotypes
HCRTR2,Rs2653349,rs2653349(G;G) genotype
HCRTR2,Rs2653349,Northern Europeans
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,rs2653349 genotype
HCRTR2,Rs2653349,Caucasian
HCRTR2,Rs2653349,rs2653349(G) allele
HCRTR2,Rs2653349,triptans
HCRTR2,Rs2653349,oxygen
HCRTR2,Rs2653349,verapamil
HCRTR2,Rs2653349,corticosteroids 
HCRTR2,Rs2653349,rs2653349 
HCRTR2,Rs2653349,migraine
HCRTR2,Rs2653349,rs2653349 
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,(G;G)
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,German 
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,(A;A)
HCRTR2,Rs2653349,genotypes
HCRTR2,Rs2653349,cluster headache
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,cluster headaches 
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,migraine
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,rs2653349
HCRTR2,Rs2653349,G1246A
HCRTR2,Rs2653349,SNP
HCRTR2,Rs2653349,HCRTR2 
HCRTR2,Rs2653349,hypocretin-orexin gene
HCRTR2,Rs2653349,cluster headaches
HCRTR2,Rs2653349,allele (G)
HCRTR2,Rs2653349,(A) allele
HCRTR2,Rs2653349,cluster headache
HCRTR2,Rs2653349,Italian
HCRTR2,Rs2653349,genotypes
HCRTR2,Rs2653349,(A;G)
HDC,Rs17740607,han chinese.
HDC,Rs17740607,chronic heart failure
HDC,Rs267606861,Tourette syndrome
HDC,Rs17740607,histidine decarboxylase
HDC,Rs17740607,polymorphism
HDC,Rs17740607,gene
HERC2,Rs916977,blue eye color
HERC2,Rs7183877,Caucasians
HERC2,Rs7183877,blue eye color
HERC2,Rs7183877,166kB
HERC2,Rs7183877,hromosome 15
HERC2,Rs7183877,13 SNPs
HERC2,Rs7183877,Caucasians
HERC2,Rs7183877,rs1129038 
HERC2,Rs7183877,rs12913832
HERC2,Rs7183877,rs4778241(C)
HERC2,Rs7183877,rs1129038(A)
HERC2,Rs7183877,rs12913832(G)
HERC2,Rs7183877,rs7183877(C)
HERC2,Rs7183877,rs3935591(G)
HERC2,Rs7183877,rs7170852(A)
HERC2,Rs7183877,rs2238289(T)
HERC2,Rs7183877,rs3940272(C)
HERC2,Rs7183877,rs8028689(T)
HERC2,Rs7183877,rs2240203(A)
HERC2,Rs7183877,rs11631797(G)
HERC2,Rs7183877,rs916977(G)
HERC2,Rs916977,blue eyes
HERC2,Rs7183877,blue eyes
HERC2,Rs7183877,"rs12593929(A)
"
HERC2,Rs7183877,Caucasians
HERC2,Rs7170852,Caucasians with blue eyes
HERC2,Rs7170852,rare among other ethnic groups
HERC2,Rs1129038,blue eyes
HERC2,Rs7170852,ndividuals with blue eye color
HERC2,Rs12913832,blue or brown eye color
HERC2,Rs12913832,lowering of promoter activity of the OCA2 gene
HERC2,Rs12913832,Blue eye color is associated
HERC2,Rs12913832,genotype
HERC2,Rs12913832,green versus blue eye color
HERC2,Rs12913832,allelic
HERC2,Rs12913832,chromosome 15
HERC2,Rs12913832,Caucasians with blue eyes
HERC2,Rs12913832,are relatively common in Caucasians though rare among other racial groups
HERC2,Rs1129038,blue eye color
HERC2,Rs12913832,brown eye
HERC2,Rs12913832,blue eye
HERC2,Rs12913832,"correlations with skin, eye, and hair color variation"
HERC2,Rs12913832,homozygous
HERC2,Rs12913832,blue eye color is composed as follows
HERC2,Rs12913832,A genome-wide association scan in admixed Latin Americans identifies loci influencing facial and scalp hair features
HERC2,Rs12913832,that may be functionally linked to blue or brown eye color
HERC2,Rs12913832,Blue eye color is associated with the rs12913832(G;G) genotype
HERC2,Rs12913832,"defined by 13 SNPs listed below, that is found in 97% of all Caucasians with blue eyes."
HERC2,Rs12913832,"correlations with skin, eye, and hair color variation."
HERC2,Rs7170852,relatively common in Caucasians
HERC2,Rs12913832,homozygotes
HEXA,I4000442,"""true"" Tay Sachs"
HEXA,I4000442,carrier for Tay Sachs disease
HEXA,I4000442,false positive blood test for Tay-Sachs Disease
HEXA,I4000442,Tay-Sachs Disease
HEXA,I4000393,Tay-Sachs Disease
HEXA,I4000442,Tay Sachs disease
HFE,Rs1799945,northern European
HFE,Rs1799945,Liver- hepatomegaly
HFE,Rs1799945,splenomegaly
HFE,Rs1799945,liver failure Joints- arthritis
HFE,Rs1799945,swelling
HFE,Rs1799945,chondrocalcinosis Heart- dilated cardiomyopathy
HFE,Rs1799945,hypogonadism
HFE,Rs1799945,Hypothyroidism
HFE,Rs1799945,Asian
HFE,Rs1799945,African
HFE,Rs1799945,European
HFE,Rs1799945,congestive heart failure
HFE,Rs1799945,CHF Skin- increased pigmentation Endocrine- testicular atrophy
HFE,Rs1799945,diabetes
HFE,Rs1799945,arthritis
HFE,Rs1799945,cancer
HFE,Rs1799945,cirrhosis of the liver
HFE,Rs1799945,weight loss
HFE,Rs1799945,abdominal pain
HFE,Rs1799945,fatigue
HFE,Rs1799945,stiffness
HFE,Rs1799945,joint pain
HFE,Rs1799945,ages of 40 and 60
HFE,Rs1799945,mutation as well as their sex and die
HFE,Rs1799945,Symptoms of Hereditary Hemochromatosis
HFE,Rs1799945,genetic disorder
HFE,Rs1799945,hereditary hemochromatosis
HFE,Rs1799945,iron overload condition
HFE,Rs1799945,mild form of hereditary hemochromatosis (HH)
HFE,Rs1799945,liver failure
HGF,Rs2286194,Noncoding mutations of HGF
HGF,Rs2286194,nonsyndromic hearing loss
HHEX,Rs7923837,rs7923837(G)
HHEX,Rs7923837,type-2 diabetes
HHEX,Rs7923837,Heterozygous
HHEX,Rs7923837,homozygous 
HHEX,Rs7923837,risk allele
HHEX,Rs7923837,rs7923837 
HHEX,Rs7923837,type-2 diabetes
HHEX,Rs7923837,Japanese 
HHEX,Rs7923837,SNP 
HHEX,Rs7923837,Japanese 
HHEX,Rs7923837,rs7923837 
HHEX,Rs7923837,rs1111875 
HHEX,Rs7923837,decreased insulin secretion
HHEX,Rs7923837,lower insulinogenic index
HHEX,Rs7923837,Germans 
HHEX,Rs7923837,type-2 diabetes
HHEX,Rs7923837,T2D
HHEX,Rs7923837,rs7923837
HHEX,Rs7923837,type-2 diabetes (T2D)
HHEX,Rs7756992,Polycystic Kidney disease
HHEX,Rs7756992,type-2 diabetes
HHEX,Rs7756992,type-2 diabetes risk
HHEX,Rs7923837,Caucasian 
HHEX,Rs7756992,normal glucose tolerant (NGT) individuals
HHEX,Rs7756992,This SNP was confirmed to be associated with type-2 diabetes
HHEX,Rs7756992,Polycystic Kidney disease
HHEX,Rs7756992,type 2 diabetes patients
HHEX,Rs7923837,type-2 diabetes
HHEX,Rs7923837,type-2 diabetes
HHEX,Rs7923837,type-2 diabetes
HHEX,Rs7923837,decreased insulin secretion and lower insulinogenic index
HHEX,Rs7923837,SNP
HHEX,Rs7923837,HHEX homeobox gene
HHEX,Rs7923837,type-2 diabetes
HLA-B,Rs4349859,familial ankylosing spondylitis
HLA-DPA1,Rs2856830,pppulmonary arterial hypertension
HLA-DPA1,Rs2856830,strongly associated with survival
HLA-DPA1,Rs2856830,pulmonary arterial hypertension
HLA-DPA1,Rs9277378,Chinese patients as roughly doubling risk for the nasal type of extranodal natural killer T-cell lymphoma
HLA-DPA1,Rs9277378,aggressive malignancy occurs predominantly in Asian and Latin American populations
HLA-DPA1,Rs9277378,extranodal natural killer T-cell lymphoma
HLA-DPB1,Rs9277378,extranodal natural killer T-cell lymphoma
HLA-DPB1,Rs9277378,Chinese patients as roughly doubling risk for the nasal type of extranodal natural killer T-cell lymphoma
HLA-DPB1,Rs9277378,aggressive malignancy occurs predominantly in Asian and Latin American populations
HLA-DPB1,Rs2856830,strongly associated with survival
HLA-DPB1,Rs2856830,pppulmonary arterial hypertension
HLA-DPB1,Rs2856830,pulmonary arterial hypertension
HLA-DQA1,Rs17612858,podoconiosis
HLA-DQA1,Rs9272346,quantitative trait loci
HLA-DQA1,Rs9272346,trait-associated polymorphisms
HLA-DQA1,Rs9272346,genome-wide significance
HLA-DQA1,Rs9272346,type-1 diabetes
HLA-DQA1,Rs9272346,common diseases
HLA-DQA1,Rs9272346,"Pakistani patients,"" among 191 Pakistani cases"
HLA-DQA1,Rs9272346,type 1 diabetes
HLA-DQA1,Rs9272346,type-1 diabetes.
HLA-DQA1,Rs2187668,Kidney Disease
HLA-DQA1,Rs2187668,nondiabetic adults
HLA-DQA1,Rs2187668,autoantibodies and insulin secretion
HLA-DQA1,Rs2187668,celiac disease
HLA-DQA1,Rs2187668,rheumatoid arthritis
HLA-DQA1,Rs2187668,systemic lupus erythematosus
HLA-DQA1,Rs2187668,7 immune-mediated diseases
HLA-DQA1,Rs2187668,1 diabetes
HLA-DQA1,Rs2187668,type 2 diabetes loci
HLA-DQA1,Rs2187668,immune response
HLA-DQA1,Rs2187668,Europeans
HLA-DQA1,Rs2187668,celiac disease
HLA-DQA1,Rs2187668,dominant manner
HLA-DQA1,Rs2187668,lupus
HLA-DQA1,Rs2187668,highest risk
HLA-DQA1,Rs17612858,"increases risk for podoconiosis, a tropical lymphedema"
HLA-DQA1,Rs2187668,clinical subphenotypes
HLA-DQB1,Rs4988889,Celiac disease
HLA-DQB1,Rs1049225,CVID 
HLA-DQB1,Rs1049225,rs1049225(T)
HLA-DQB1,Rs1049225,chromosome 6p21
HLA-DQB1,Rs1049225,immunodeficiency disorder (CVID)
HLA-DQB1,Rs1049225,human leukocyte antigen (HLA)
HLA-DRA,Rs7192,rheumatoid arthritis
HLA-DRA,Rs7192,food allergies
HLA-DRA,Rs3135388,seen in 269 Serbian patients
HLA-DRA,Rs3135388,Northern European ancestry
HLA-DRA,Rs3135388,narcolepsy
HLA-DRA,Rs3135388,systemic lupus erythematosis (SLE
HLA-DRA,Rs3135388,associated with other autoimmune diseases
HLA-DRA,Rs7192,peanut allergy
HLA-DRA,Rs3135388,systemic lupus erythematosis 
HLA-DRA,Rs3135388,autoimmune diseases
HLA-DRA,Rs3135388,multiple 
HLA-DRA,Rs3135388,sclerosis
HLA-DRA,Rs3129878,male infertility
HLA-DRA,Rs3129878,azoospermia
HLA-DRA,Rs3135388,higher risk for developing multiple sclerosis
HLA-DRB1,Rs3135388,sclerosis
HLA-DRB1,Rs3135388,multiple 
HLA-DRB1,Rs9270986,higher risk of liver injury in patients taking the nonsteroidal anti-inflammatory drug lumiracoxib
HLA-DRB1,Rs3135388,autoimmune diseases
HLA-DRB1,Rs3135388,systemic lupus erythematosis 
HLA-DRB1,Rs3135388,higher risk for developing multiple sclerosis
HLA-DRB1,Rs3135388,narcolepsy
HLA-DRB1,Rs3135388,systemic lupus erythematosis (SLE
HLA-DRB1,Rs3135388,Northern European ancestry
HLA-DRB1,Rs3135388,seen in 269 Serbian patients
HLA-DRB1,Rs9270986,higher risk of liver injury
HLA-DRB1,Rs2187668,Kidney Disease
HLA-DRB1,Rs3135388,associated with other autoimmune diseases
HLA-DRB1,Rs2187668,nondiabetic adults
HLA-DRB1,Rs2187668,systemic lupus erythematosus
HLA-DRB1,Rs2187668,rheumatoid arthritis
HLA-DRB1,Rs2187668,highest risk
HLA-DRB1,Rs2187668,lupus
HLA-DRB1,Rs2187668,dominant manner
HLA-DRB1,Rs2187668,celiac disease
HLA-DRB1,Rs2187668,Europeans
HLA-DRB1,Rs2187668,autoantibodies and insulin secretion
HLA-DRB1,Rs2187668,type 2 diabetes loci
HLA-DRB1,Rs2187668,1 diabetes
HLA-DRB1,Rs2187668,7 immune-mediated diseases
HLA-DRB1,Rs2187668,clinical subphenotypes
HLA-DRB1,Rs2187668,celiac disease
HLA-DRB1,Rs2187668,immune response
HLA-DRB9,Rs9268839,heumatoid arthritis
HLA-DRB9,Rs9268858,Risk alleles for multiple sclerosis
HMBS,Rs1057518886,acute intermittent porphyria
HMBS,Rs1057518806,gene associated with acute intermittent porphyria
HMBS,Rs1057518806,ClinVar
HMBS,Rs1057518806,Ala320Leufs
HMBS,Rs1057518806,c.958delG
HMGA2,Rs17179670,Rs17179670
HMGA2,Rs17179670,SNP
HMGCR,Rs12916,higher body weight
HMGCR,Rs12916,waist circumference 
HMGCR,Rs17238484,higher body weight
HMGCR,Rs17238484,waist circumference 
HNF1B,Rs11649743,rs11649743
HNF1B,Rs11649743,rs4430796
HNF1B,Rs11649743,prostate cancer
HNF1B,Rs11649743,prostate cancer
HNF1B,Rs11649743,HNF1B gene SNPs
HNF1B,Rs11649743,rs11649743
HNMT,Rs1801105,asthma
HOGA1,Rs138207257,860G
HOGA1,Rs138207257,Gly287Val 
HOGA1,Rs138207257,G287V
HP,Rs137853233,Glu amino acid
HP,Rs137853233,rs137853233(G)
HP,Rs137853233,haptoglobin alpha-1 fast allele
HP,Rs137853233,rs137853233(A)
HP,Rs137853233,slow allele
HP,Rs137853233,Lys-53-Glu
HP,Rs137853233,Lys54Glu
HP,Rs137853233,c.214A>G
HP,Rs137853233,Lys amino acid
HP,Rs137853233,ClinVar
HP,Rs137853233,p.Lys72Glu
HPCA,Rs550921485,Ala190Thr
HPCA,Rs550921485,A190T
HPCA,Rs775863165,mutation leading to dystonia 2
HPD,Rs1154510,leading to hawkinsinuria
HPS5,Rs200449378,pathogenic variant
HPS5,Rs766602179,Leu
HSD3B2,Rs767167623,rare mutation in the HSD3B2 gene on chromosome 1
HSD3B2,I5003813,HSD3B2 mutation
HSD3B2,I5003813,recessively inherited
HSD3B2,I5003813,deficiency 
HSD3B2,I5003813,congenital adrenal hyperplasia
HSD3B2,I5003810,congenital adrenal hyperplasia
HSD3B2,I5003810,deficiency based on HSD3B2 mutation
HSD3B2,I5003810,recessively inherited
HSD3B2,I5003810,congenital adrenal hyperplasia
HSD3B2,I5003810,HSD3B2 mutation
HSD3B2,I5003810,recessively inherited
HSPA1A,Rs1043618,association with noise-induced hearing loss
HSPA1A,Rs1043618,association with noise-induced hearing loss
HSPA1A,Rs1061581,noise-induced hearing loss
HSPA1L,Rs1043618,association with noise-induced hearing loss
HSPA1L,Rs1043618,association with noise-induced hearing loss
HSPA1L,Rs1061581,noise-induced hearing loss
HSPG2,Rs886041667,c.2039_2040delCG (p.Ala680Glyfs)
HSPG2,Rs137853248,this mutation as leading to (recessively inherited) Schwartz Jampel syndrome type 1
HSPG2,Rs137853248,Schwartz
HSPG2,Rs137853248,syndrome 
HSPG2,Rs137853248,C1532YOMIM 
HSPG2,Rs137853248,Cys1532Tyr 
HSPG2,Rs137853248,mutation 
HTR2A,Rs643627,rs6311: T
HTR2A,Rs643627,protective against suicidal behavior
HTR2A,Rs7997012,depression
HTR2A,Rs643627,(rs594242-rs6311: G-C and rs6311: C
HTR2A,Rs643627,increased risk for non-violent and impulsive suicidal behavior
HTR2A,Rs643627,SNP rs6311
HTR2A,Rs643627,rs655888
HTR2A,Rs643627,chronic fatigue syndrome
HTR2A,Rs643627,suicidal behavior
HTR2A,Rs643627,non-violent and impulsive suicidal behavior
HTR2A,Rs643627,anger- and aggression-related behavior
HTR2A,Rs659734,schizophrenia
HTR2A,Rs643627,anger- and aggression-related behavior
HTR2A,Rs643627,rs594242-rs6311: C-T
HTR2A,Rs3125,bipolar disorder
HTR2A,Rs3742278,are associated with quantitative traits in panic disorder.
HTR2A,Rs1328674,rheumatoid arthritis
HTR2A,Rs643627,rs643627-rs594242-rs6311: A-C-T
HTR2A,Rs1328674,European patients
HTR2A,Rs1745837,schizophrenia
HTR2A,Rs1928042,schizophrenia
HTR2A,Rs2070037,schizophrenia
HTR2A,Rs1328674,rheumatoid arthritis
HTR2A,Rs2296972,are associated with quantitative traits in panic disorder.
HTR2A,Rs2770292,Polymorphisms in the serotonin receptor gene HTR2A
HTR2A,Rs2770292,are associated with quantitative traits in panic disorder.
HTR2A,Rs3125,high-density schizophrenia
HTR2A,Rs3742278,Polymorphisms in the serotonin receptor gene HTR2A
HTR2A,Rs2296972,Polymorphisms in the serotonin receptor gene HTR2A
HTR2C,Rs3813929,metabolic syndrome
HTR2C,Rs3813929,Caucasians
HTR2C,Rs3813929,metabolic syndrome
HTR2C,Rs3813929,metabolic syndrome
HTR2C,Rs3813929,schizophrenia
HTR2C,Rs3813929,Cancer
HTR2C,Rs3813929,schizophrenia
HTR2C,Rs3813929,weight gain
HTR2C,Rs3813929,schizophrenia
HTR2C,Rs3813929,disorders
HTR2C,Rs3813929,psychopathology
HTR2C,Rs3813929,schizophrenia
HTR2C,Rs3813929,metabolic syndrome
HTR2C,Rs3813929,depression
HTR2C,Rs3813929,schizophrenia
HTR2C,Rs3813928,metabolic syndrome in patients with schizophrenia
HTR2C,Rs3813928,obesity
HTR2C,Rs3813928,autistic patients taking risperidone for up to one year
HTR2C,Rs1414334,risperidone
HTR2C,Rs1414334,patients using clozapine
HTR2C,Rs1414334,metabolic syndrome
HTR3C,Rs6766410,autism
HTRA1,Rs932275,nature age related macular degeneration
HTRA1,Rs11200638,wet age related macular degeneration
HTRA1,Rs11200638,Japanese and Caucasian populations
HTRA1,Rs11200638,ncreases the risk of wet AMD in all populations
HTRA1,Rs11200638,neovascular AMD
HTRA1,Rs11200638,Chinese AMD patients
HTRA1,Rs11200638,risk of developing AMD
HTRA1,Rs11200638,smoking almost doubles the risk
HTRA1,Rs11200638,increased risk of wet age related macular degeneration in Japanese and Caucasian populations
HTT,Rs362307,Huntington's disease
HTT,Rs362307,Huntington disease
IDH1,Rs121913499,somatic mutations
IDH1,Rs121913499,glioblastomas
IDS,Rs781997631,pathogenic for MPS type II.
IDS,Rs781997631,MPS type II
IDS,Rs1141608,No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans.
IFIH1,Rs1990760,multiple sclerosis risk.
IFIH1,Rs35667974,multiple sclerosis patients
IFIH1,Rs35667974,type-1 diabetes
IFIH1,Rs1990760,type 1 diabetes
IFIH1,Rs1990760,hereditary prostate cancer families
IFIH1,Rs1990760,multiple sclerosis and type I diabetes
IFIH1,Rs1990760,type 1 diabetes and celiac disease
IFIH1,Rs1990760,type 1 diabetes 
IFIH1,Rs1990760,type 1 diabetes and autoimmune thyroiditis:
IFIH1,Rs1990760,pre-diabetes to diabetes
IFIH1,Rs1990760,type 1 diabetes
IFIH1,Rs1990760,"PRDM1,"
IFIH1,Rs1990760,French Caucasian multiple sclerosis trio families 
IFIH1,Rs1990760,Graves' disease
IFIH1,Rs1990760,"JAZF1,"
IFIH1,Rs1990760,UHRF1BP1
IFIH1,Rs1990760,IL10
IFIH1,Rs1990760,"TNIP1,"
IFIH1,Rs1990760,autoimmune disorders
IFIH1,Rs1990760,Chinese patients
IFIH1,Rs1990760,Graves' disease
IFIH1,Rs1990760,"type-1 diabetes, organ-specific autoimmune diseases, including Graves' disease"
IFITM3,Rs12252,H1N1 influenza
IFITM3,Rs12252,interferon-inducible transmembrane protein
IFITM5,Rs587776916,"This IFITM5 gene mutation, c.-14C>T, is located in the 5' UTR region of the gene and appears to account for most cases of dominantly inherited osteogenesis imperfecta, type V"
IGF1,Rs70961704,Mendelian Disease
IGF1,Rs70961704,Mendelian disease
IGF1,Rs70961704,biocurators
IGF1,Rs70961704,Table S6
IGF1,Rs70961704,SNP
IGF1,Rs70961704,Pathogenic Regulatory Variants
IGF1,Rs12423791,prostate cancer risk
IGF1,Rs70961704,Mendelian disease
IGF1,Rs5742629,Bladder cancer
IGF1,Rs5742629,Bladder cancer
IGF1,Rs12423791,prostate cancer risk in African-American men
IGF1,Rs70961704,Whole-Genome
IGF1R,Rs2229765,ischemic stroke
IKBKAP,Rs137853022,rs137853022
IKBKAP,Rs137853022,R696P
IKBKAP,Rs137853022,"Arg696Pro,"
IKBKAP,Rs137853022,i4000400
IKZF3,Rs907092,autoimmune disease
IKZF3,Rs907092,ZPBP2/GSDMB/ORMDL3
IKZF3,Rs907092,asthma
IKZF3,Rs907092,Allele-specific chromatin remodeling
IKZF3,Rs907092,risk of asthma and autoimmune disease.
IL10,Rs1800872,AIDS-related non-Hodgkin lymphoma
IL10,Rs1800872,extrapulmonary tuberculosis.
IL10,Rs1800872,knee osteoarthritis
IL10,Rs1800872,pro-inflammatory responses 
IL10,Rs1800872,graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor
IL10,Rs1800872,Ghanaian population
IL10,Rs1800872,Asthma 
IL10,Rs1800872,Irish multiple sclerosis patients.
IL10,Rs1800872,migraine.
IL10,Rs1800872,prostate cancer mortality
IL10,Rs1800872,cutaneous melanoma
IL10,Rs1800872,pulmonary TB
IL10,Rs1800872,AIDS 
IL10,Rs1800872,hildhood Crohn's disease location.
IL10,Rs1800872,tuberculosis:
IL10,Rs1800872,Caucasians. 
IL10,Rs1800872,HIV-associated dementia.
IL10,Rs1800872,breast cancer 
IL10,Rs1800872,radiation-induced toxicity
IL10,Rs1800872,non-small cell lung cancer.
IL10,Rs1800872,breast cancer
IL10,Rs1800872, Crohn's disease
IL10,Rs1800872,New Zealand population
IL10,Rs1800872,Graves' diseas
IL10,Rs1800872, Chinese populations
IL10,Rs1800872,heparin-induced thrombocytopenia.
IL10,Rs1800872,acute coronary syndrome.
IL10,Rs1800872,cancer risk: 
IL10,Rs2222202,pediatric onset Crohn's disease.
IL10,Rs1800872,branch retinal vein occlusion. 
IL10,Rs1800872,depression
IL10,Rs1800872,incident hypertension:
IL10,Rs1800872,neonatal sepsis.
IL10,Rs1800872,nonhypertensive patients
IL10,Rs1800872,Aggressive Non-Hodgkin's Lymphoma
IL10,Rs1800872,pregnancies terminate early
IL10,Rs1800872,Asthma families
IL10,Rs1800872,non-Hodgkin lymphoma
IL10,Rs1800872,severe acute respiratory syndrome
IL10,Rs1800872,postoperative myocardial infarction after cardiac surgery.
IL10,Rs1800872,Lemierre's syndrome 
IL10,Rs1800872,systemic juvenile idiopathic arthritis.
IL10,Rs1800872,follicular lymphoma 
IL10,Rs1800872,susceptibility to giant cell arteritis in Northwestern Spain.
IL10,Rs1800872,infection following esophagectomy
IL10,Rs1800872,radiographic damage
IL10,Rs1800872,rheumatoid arthritis
IL10,Rs1800872,hay-fever
IL10,Rs1800872,rheumatoid arthritis patients
IL10,Rs1800872,non-Hodgkin's lymphoma.
IL10,Rs1800872,normal subjects in Malaysia
IL10,Rs1800872,asthma 
IL10,Rs1800872,major depressive disorder.
IL10,Rs1800872,non-Hodgkin lymphoma
IL10,Rs1800872,endometriosis.
IL10,Rs1800872,female reproductive disorders:
IL10,Rs1800872,melanoma. 
IL10,Rs1800872,Polish population.
IL10,Rs1800872,ischemic stroke 
IL10,Rs1800872,biliary tract cancers and stones
IL10,Rs1800872,diffuse large B-cell lymphoma patients
IL10,Rs1800872,patients with aggressive non-Hodgkin's lymphoma
IL10,Rs1800872,chronic hepatitis B infection 
IL10,Rs1800872,oral cancer
IL10,Rs1800872,gastric cancer
IL12A,Rs568408,significantly increased risk of cervical cancer
IL12A,Rs568408,increased risk of cervical cancer
IL12A-AS1,Rs568408,increased risk of cervical cancer
IL12A-AS1,Rs574808,Replicated association of 17q12-21
IL12A-AS1,Rs574808,primary biliary cirrhosis
IL12A-AS1,Rs485497,Primary biliary cirrhosis
IL12A-AS1,Rs568408,significantly increased risk of cervical cancer
IL12A-AS1,Rs574808,susceptibility of primary biliary cirrhosis in a Japanese cohort.
IL16,Rs4505265,chronic lymphocytic leukemia
IL17A,Rs8193036,stem cell transplantation
IL17A,Rs8193036,pediatric asthma
IL18,Rs1946518,may influence cervical cancer
IL18,Rs1834481,invasive epithelial ovarian cancer.
IL18,Rs1946519,may influence cervical cancer
IL18,Rs1834481,inflammation after cardiac surgery
IL18,Rs1834481,greater inflammation after cardiac surgery
IL18,Rs1834481,invasive epithelial ovarian cancer
IL18,Rs1834481,seasonal influenza vaccine response
IL18,Rs1834481,epithelial ovarian cancer in non-Hispanic white women
IL18,Rs1834481,epithelial ovarian cancer
IL18RAP,Rs3771150,amyotrophic lateral sclerosis (ALS)
IL18RAP,Rs3771150,SNP
IL18RAP,Rs917997,celiac disease
IL18RAP,Rs917997,Crohn's disease
IL18RAP,Rs917997,gut disease
IL18RAP,Rs917997,ulcerative colitis
IL1B,Rs419598,rs419598
IL1B,Rs419598,rs419598
IL1B,Rs419598,rs419598
IL1RN,Rs419598,rs419598
IL1RN,Rs419598,rs419598
IL1RN,Rs315952,knee osteoarthritis
IL1RN,Rs419598,rs419598
IL2,Rs2069772,Cervical and vulvar cancer
IL23R,Rs11209026,European ancestry
IL23R,Rs11209026,CD susceptibility
IL23R,Rs11209026,ankylosing spondylitis
IL23R,Rs11209026,Celiac Disease
IL23R,Rs11209026,Caucasian patients
IL23R,Rs11209026,psoriasis
IL23R,Rs11209026,CD
IL23R,Rs11209026,ulcerative colitis
IL23R,Rs11209026,Italian patients
IL23R,Rs11805303,rs11805303
IL23R,Rs2201841,overrepresented in Graves' disease patients with Graves ophthalmopathy
IL23R,Rs17375018,Polymorphisms of IL23R
IL23R,Rs17375018,Vogt-Koyanagi-Harada syndrome
IL23R,Rs17375018,IL10
IL23R,Rs17375018,IL23R-IL12RB2
IL23R,Rs17375018,Behcet's disease
IL23R,Rs2201841,increased risk for Crohn's disease
IL23R,Rs2201841,Crohn's disease
IL23R,Rs2201841,psoriasis
IL23R,Rs2201841,rs2201841
IL23R,Rs11209026,nflammatory Bowel Diseases
IL23R,Rs11805303,Crohn's disease
IL23R,Rs11209026,non-Jewish
IL23R,Rs1004819,rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients
IL23R,Rs11209026,Crohn's disease
IL23R,Rs11209026,Jewish
IL23R,Rs1004819,"SNP rs1004819, in the IL23R gene"
IL23R,Rs1004819,increased risk for Crohn's disease in both Jewish and non-Jewish populations
IL23R,Rs1004819,increase the risk for developing ankylosing spondylitis
IL23R,Rs1004819,CARD15 and IL23R influences Crohn's disease susceptibility but not disease phenotype in a Brazilian population
IL23R,Rs1004819,Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy
IL23R,Rs1004819,Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study.
IL23R,Rs1004819,"IL23R in the Swedish, Finnish, Hungarian and Italian populations: association with IBD and psoriasis, and linkage to celiac disease"
IL23R,Rs1004819,Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples.
IL23R,Rs1004819,Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients
IL23R,Rs1004819,Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RA
IL23R,Rs1004819,Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients
IL23R,Rs1004819,The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease
IL23R,Rs1004819,"NOD2/CARD15, ATG16L1"
IL23R,Rs1004819,IL23R gene
IL23R,Rs1004819,Crohn's disease
IL23R,Rs1004819,STAT4 
IL23R,Rs1004819,colonic Crohn's disease and early disease onset
IL23R,Rs11209026,ankylosing spondylitis
IL23R,Rs11209026,psoriasis
IL23R,Rs1004819,Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis
IL23R,Rs11209026,ulcerative colitis
IL2RA,Rs2104286,juvenile idiopathic arthritis
IL2RA,Rs2104286,multiple sclerosis
IL2RA,Rs2104286,risk of developing multiple sclerosis
IL2RA,Rs2104286,type-1 diabetes
IL2RA,Rs12722561,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489, intermediate uveitis
IL2RA,Rs12722489,single nucleotide polymorphisms
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs2104286,those positive for antinuclear antibodies
IL2RA,Rs12722489,rallel pathways?
IL2RA,Rs2104286,"oligoarthritis, the most common subtype of JIA"
IL2RA,Rs7072398,European-ancestry and African American families with schizophrenia
IL2RA,Rs2104286,influence multiple sclerosis and type-1 diabetes
IL2RA,Rs2104286,type-1 diabetes
IL2RA,Rs2104286,multiple sclerosis
IL2RA,Rs2104286,UK cases of juvenile idiopathic arthritis (JIA)
IL2RA,Rs2104286,oligoarthritis
IL2RA,Rs2104286,female
IL2RA,Rs2104286,positive for antinuclear antibodies
IL2RA,Rs2228149,strong association with late-onset Alzheimer disease
IL2RA,Rs2228149,"cytokine/cytokine receptor single nucleotide polymorphisms and humoral immunity to measles, mumps and rubella in a Somali population"
IL2RA,Rs7900744,Graves' disease
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs2104286,JIA
IL2RA,Rs12722489,soluble interleukin-2 receptor production
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,two independent European populations
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,type 1 diabetes
IL2RA,Rs12722489,soluble interleukin-2 receptor production
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,type 1 diabetes
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,type-1 diabetes 
IL2RA,Rs12722489,KIF21B and TMEM39A as susceptibility loci
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,type 1 diabetes susceptibility
IL2RA,Rs12722489,intermediate uveitis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,IL2RA gene polymorphism
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,single nucleotide polymorphisms
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RA,Rs12722489,multiple sclerosis
IL2RB,Rs1003694,the cytokine signaling sub-pathway
IL2RB,Rs1003694,This SNP is involved
IL4,Rs2243250,myocardial infarction
IL6,Rs2069830,stroke
IL6,Rs2069830,stroke
IL6,Rs2066992,coronary artery disease
IL6,Rs2066992,rs2066992
IL6R,Rs2228145,Crohn disease
IL6R,Rs4845618,heterozygous
IL6R,Rs4845618,melanoma risk
IL6R,Rs4845618,melanoma patients
IL6R,Rs2228145,coronary heart disease
IL6R,Rs2228145,breast cancer
IL6R,Rs2228145,non-small cell lung cancer
IL6R,Rs2228145,rheumatoid arthritis
IL6R,Rs2228145,rheumatoid arthritis
IL6R,Rs2228145,sporadic Alzheimer's disease
IL6R,Rs2228145,metabolic syndrome: GBCS-CVD
IL6R,Rs2228145,"Crohn disease, psoriasis, and inflammation"
IL6R,Rs2228145,inflammation
IL6R,Rs2228145,psoriasis
IL6R,Rs2228145,Schizophrenia
IL6R,Rs4845622,melanoma
IL6R,Rs2228145,RA susceptibility
IL6R,Rs2228145,rheumatoid arthritis
IL6R,Rs2228145,amyotrophic lateral sclerosis (ALS)
IL6R,Rs2228145,more severe disease symptoms
IL6R,Rs2228145,faster progression
IL6R,Rs2228145,type 2 diabetes
IL6R,Rs2228145,melanoma
IL6R,Rs2228145,inflammation
IL6R,Rs2228145,diabetes risk
IL6R,Rs2228145,type 2 diabetes
IL6R,Rs2228145,multiple myeloma
IL6R,Rs2228145,celiac disease susceptibility
IL6R,Rs2228145,asthma
IL6R,Rs2228145,risk of coronary heart disease
IL6R,Rs2228145,neuroblastoma
IL6R,Rs2228145,predisposing to autoimmune and inflammatory diseases
IMMP2L,Rs12531640,intra-extra dimensional set shift
IMMP2L,Rs12531640,ambridge Neuropsychological Test Automated Battery
IMPDH1,Rs2288549,pediatric heart transplant 
IMPDH1,Rs2288549,Genetic polymorphisms
IMPDH1,Rs2228075,pediatric heart transplant 
IMPDH1,Rs2228075,Genetic polymorphisms
INSL6,Rs4495487,had nearly four times higher odds of developing V617F-positive MPN compared to people without the variant.
INSL6,Rs4495487,23andMe blogAt rs12340895(G)
INSL6,Rs3780378,insulin sensitivity and lipid profile.
INSL6,Rs4495487,about two times the odds of developing V617F-positive MPN compared to people without the disease.
INSL6,Rs10974944,mutation
INSL6,Rs10974944,V617F-positive neoplasms
INSL6,Rs10974944,haplotype
INSL6,Rs3780378,body fat
INSR,Rs2059806,Polycystic ovary syndrome
IRAK1,Rs3027898,atherothrombotic cerebral infarction
IRAK1,Rs3027898,Japanese
IRAK1,Rs3027898,Diabetes
IRAK1,Rs3027898,reduced cortical surface area in humans in two independent populations
IRAK3,Rs1882200,asthma
IRF5,Rs77571059,Lupus
IRF7,Rs3758650,gallstone disease
IRF7,Rs3758650,Taiwanese
IRF8,Rs144424711,pathogenic variant
IRS2,Rs1805097,ong-lived (i.e. over 85 years old)
IRS2,Rs1805097,not (less than 85)
IRS2,Rs1805097,twice as likely to reach extreme old age
ITGA2B,Rs5911,gene on chromosome
ITGA2B,Rs5911,plus strand nomenclature
ITGA2B,Rs5911,encodes the Ile
ITGA2B,Rs5911,allele gives rise to the platelet-specific alloantigen
ITGA2B,Rs5911,platelet transfusion
ITGA2B,Rs5911,homozygotes
ITGA2B,Rs5911,decreased ex vivo antiplatelet activity of ticagrelor.
ITGAV,Rs9333289,human ceramide kinase gene
ITGAV,Rs9333289,autosomal recessive retinitis pigmentosa
ITGB3,Rs3809865,autism
ITGB3,Rs3809865,gene expression in the human term placenta
ITPR3,Rs3748079,lupus erythematosus
ITPR3,Rs3748079,SLE
JAK1,Rs11208534,individuals seropositive for dengue virus
JAK1,Rs11208534,Dengue hemorrhagic fever
JAK1,Rs11208534,susceptibility to dengue virus infection
JAK1,Rs11208534,DHF
JAK1,Rs11208534,symptoms of DF
JAK1,Rs11208534,patients with DHF-like symptoms
JAK1,Rs11208534,"high fever, major hemorrhaging, circulatory failure, and extremely low blood platelet counts"
JAK1,Rs11208534,Symptoms of dengue infection
JAK1,Rs11208534,"dengue fever (DF), dengue hemorrhagic fever (DHF) and severe hypovolemic shock, or dengue shock syndrome (DSS)"
JAK1,Rs11208534,undifferentiated fever
JAK1,Rs11208534,infection
JAK1,Rs11208534,antiviral responses
JAK1,Rs11208534,immune responses to pathogens
JAK1,Rs11208534,"high fever, general flu-like symptoms, and sometimes severe bleeding."
JAK2,Rs10974944,haplotype
JAK2,Rs10974944,V617F-positive neoplasms
JAK2,Rs10974944,mutation
JAK2,Rs3780378,body fat
JAK2,Rs3780378,insulin sensitivity and lipid profile.
JAK2,Rs4495487,23andMe blogAt rs12340895(G)
JAK2,Rs4495487,had nearly four times higher odds of developing V617F-positive MPN compared to people without the variant.
JAK2,Rs4495487,about two times the odds of developing V617F-positive MPN compared to people without the disease.
JARID2,Rs7766973,autism
JARID2,Rs7766973,this SNP
JARID2,Rs7766973,rs7766973 is a SNP
JARID2,Rs7766973,associated with autism
JUP,Rs113994176,ominant mutation in plakoglobin
JUP,Rs113994176,arrhythmogenic right ventricular cardiomyopathy
KCNB1,Rs756529,LV hypertrophy
KCNE1,Rs28933384,long QT syndromes
KCNJ11,Rs193929339,Relapsing diabetes
KCNJ11,Rs5219,type-1 diabetes
KCNJ11,Rs5219,type-2 diabetes
KCNJ11,Rs5219,each risk allele increased type-2 diabetes risk
KCNJ11,Rs5219,was associated with type-2 diabetes
KCNJ11,Rs80356613,Relapsing diabetes
KCNQ1,Rs120074177,mutations
KCNQ1,Rs120074177,cardiac arrhythmias
KCNQ1,Rs120074192,amilial atrial fibrillation
KCNQ1,Rs120074192,atrioventricular blocks
KCNQ4,Rs80358276,autosomal dominant hearing loss
KCNQ4,Rs80358276,KCNQ4 K+ channel gene
KCNQ4,Rs80358273,novel mutations
KCNQ4,Rs80358276,Mutations
KEL,Rs369569464,Kell null phenotype
KEL,Rs8176058,The K antigen is more potent at triggering an immune reaction than the k antigen.
KIAA0319,Rs761100,dyslexia
KIAA0319,Rs4504469,dyslexia
KIAA0319,Rs4504469,dyslexia
KIAA0319,Rs4504469,dyslexia
KIAA0319,Rs4504469,dyslexia
KIF1A,Rs116297894,paraplegia
KIRREL3,Rs1939992,Autosomal recessive ichthyosis with hypotrichosis
KITLG,Rs3782181,testicular germ cell cancer
KITLG,Rs4474514,tumors.
KITLG,Rs995030,testicular cancer
KL,Rs9536314,KL-VS heterozygotes had poorer cognitive function than noncarrier
KL,Rs9536314,"At the protein level, older adults with higher plasma klotho concentrations tend to show lower less decline with age on standardized cognitive tests , adults with higher stress tend to have lower plasma klotho levels , and transgenic mice bred to have excess human amyloid precursor protein (to simulate Alzheimer's disease) score better on some tests when their klotho levels are increased"
KL,Rs9536314,Variation in longevity gene KLOTHO is associated with greater cortical volumes
KL,Rs9536314,"The klotho protein is a hormone found primarily in the kidney and choroid plexus of the brain. At the genetic level, the Klotho gene is reported to affect longevity in mice and perhaps humans , and KL-VS heterozygosity (but not homozygosity) has been associated with greater brain cortical volume"
KL,Rs564481,Klotho locus
KL,Rs564481,older patients
KL,Rs564481,serum hemoglobin
KL,Rs564481,metabolic traits
KL,Rs9536314,increase klotho secretion and may alter its functions
KLC1,Rs8702,protective effect against the occurrence of multiple sclerosis
KLC1,Rs8702,Variability in the kinesin light chain 1 gene may influence risk of age-related cataract
KLF6,Rs3750861,lung cancer
KLF6,Rs3750861,prostate cancer
KLF6,Rs3750861,reduced lung cancer risk
KLF6,Rs3750861,lung cancer risk
KLF6,Rs3750861,prostate cancer
KLF6,Rs3750861,reduced lung cancer risk
KRAS,Rs17388587,endometriosis
KRAS,Rs1137282,Functional genetic polymorphisms
KRAS,Rs112445441,drug response to cetuximab and panitumumab
KRAS,Rs104894365,Val14Ile
KRIT1,Rs886043300,T (p.Gln239Ter)
KRIT1,Rs267607203,dominantly inherited
KRIT1,Rs267607203,founder mutation in Mexican-American/Hispanic families
KRIT1,Rs267607203,cerebral cavernous malformations
KRIT1,Rs267607203,cavernous angiomas
KRIT1,Rs267607203,Common Hispanic Mutation
KRIT1,Rs267607203,"dominantly inherited, founder mutation in Mexican-American/Hispanic families for cerebral cavernous malformations, also known as cavernous angiomas."
KRIT1,Rs267607203,"known as the ""Common Hispanic Mutation"""
KRIT1,Rs886039572,p.His603Metfs
KRIT1,Rs886043300,aka c.715C
KRT5,Rs11170164,Basal Cell Carcinoma
KRT5,Rs11170164,Basal Cell Carcinoma
KSR2,Rs10444502,C allele associated with decreased total cholesterol levels
KSR2,Rs4767631,A allele associated with lower LDL cholesterol
LACC1,Rs3764147,leprosy
LACC1,Rs3764147,Crohn's disease
LACC1,Rs3764147,Leprosy
LACC1,Rs3764147,leprosy
LACC1,Rs3764147,leprosy
LACC1,Rs3764147,Crohn's disease
LACC1,Rs3764147,leprosy
LAMA2,Rs12193446,risk of nearsightedness
LAMA2,Rs12205363,LAMA2 (Laminin alpha-2) gene
LAMB3,Rs747916314,p.Arg972Ter
LAMB3,Rs747916314,c.2914C>T
LAMC2,Rs141679163,Familial Bipolar Disorder
LAMC2,Rs141679163,variants speculated
LAMC2,Rs141679163,bipolar disorder
LAMC2,Rs141679163,Bipolar Disorder
LAMC2,Rs141679163,bipolar disorde
LARS2,Rs17637703,type 2 diabetes
LARS2,Rs71645922,type 2 diabetes
LARS2,Rs952621,type 2 diabetes
LBP,Rs2232596,hematopoietic 
LBP,Rs2232596,mortality 
LBP,Rs2232596,negative 
LBP,Rs2232596,transplantation
LBP,Rs2232596,risk 
LBP,Rs2232596,influence 
LBP,Rs2232596,Lipopolysaccharide 
LBP,Rs2232596,Gram
LDB3,Rs121908338,left ventricular noncompaction
LDB3,Rs121908338,nign polymorphism
LDB3,Rs45514002,rare mutation
LDB3,Rs45514002,gene on chromosome
LDB3,Rs45514002,autosomal dominant
LDB3,Rs45514002,form of left ventricular noncompaction
LDB3,Rs45514002, it reportedly leads to a form of left ventricular noncompaction.
LDLR,I4000356,Familial hypercholesterolemia
LDLR,I4000356,FH mutation
LDLRAP1,Rs753151497,pathogenic variant
LEP,Rs12706832,hypertension
LEP,Rs12706832,pressure
LEP,Rs12706832,associated
LIPC,Rs12593008,high-density lipoprotein cholesterol
LIPC,Rs8023503,hyperalphalipoproteinemia
LIPC,Rs8028759,high-density lipoprotein cholesterol
LIPT1,Rs137891647,rare mutation
LIPT1,Rs137891647,rare mutation
LIPT1,Rs137891647,LIPT1
LIPT1,Rs137891647,chromosome 2
LIPT1,Rs137891647,Recessively inherited
LIPT1,Rs137891647,mutations in the LIPT1
LIPT1,Rs137891647,lipoyltransferase 1 deficiency
LIPT1,Rs767568897,Recessively inherited
LIPT1,Rs767568897,lipoyltransferase 1 deficiency
LIPT1,Rs767568897,severe metabolic disorder often leading to death soon after birth
LOC105377329,Rs356219,patients from northern Spain
LOC105377329,Rs356219,European populations
LOC105377329,Rs356219,Parkinson's disease
LOC105377329,Rs356219,multiple system atrophy
LOC105377329,Rs356219,Japanese
LOC105377329,Rs356219,Swedish
LOC105377329,Rs356219,Parkinson's disease
LOC105377329,Rs356219,Parkinson disease.
LOC105377329,Rs356219,Parkinson's disease
LOC105377329,Rs356219,Parkinson disease
LOC105377329,Rs356219,Cerebellar alpha-synuclein levels are decreased in Parkinson's disease
LOC105377329,Rs356219,influences alpha-synuclein levels in the blood and brain
LOC105377329,Rs356219,Parkinson's disease
LOC105377329,Rs356219,late-onset Parkinson's disease
LOC105377329,Rs356219,Parkinson's disease
LOC105377329,Rs356219,multiple system atrophy.
LOC107987344,I4000178,P30+.rs112707890
LOC107987344,Rs112707890,name
LOC107987344,Rs112707890,Me
LOC107987344,Rs112707890,and
LOC107987344,I4000178,Haplogroup I1 (Y-DNA) subclade
LOC107987344,I4000178,Haplogroup I (Y-DNA)
LOC107987344,I4000178,i4000178(A;A) mutation
LOXHD1,Rs988213,amyotrophic lateral sclerosis (ALS)
LOXHD1,Rs988213,SNP
LOXL1,Rs1048661,blindness
LOXL1,Rs1048661,exfoliation ''syndrome'
LOXL1,Rs1048661,pseudoexfoliation glaucoma (PEXG)
LOXL1,Rs1048661,exfoliation glaucoma
LOXL1,Rs1048661,pseudoexfoliation (PEX)
LOXL1,Rs1048661,"The estimate for glaucoma incidence worldwide is 10-20% only for individuals over 60 years of age; in Iceland, where glaucoma incidence is high, 40% of individuals 80 or older show signs of exfoliation ''syndrome'', which has been seen to convert to exfolation ''glaucoma'' at a rate of 60% - over a 15 year period."
LOXL1,Rs1048661,the haplotypes identified as being of highest risk
LOXL1,Rs1048661,"The (T;T) haplotype is presumed to be at even lower risk than the (G;T) haplotype, but due at least in part to the high frequency of the rs1048661(G) allele"
LOXL1,Rs1048661,Approximately 25% of the general population is homozygous for the highest risk haplotype and their risk of suffering XFG (exfoliation glaucoma) is over 100 times that of those only carrying low-risk haplotypes
LOXL1,Rs1048661,linked to exfoliation glaucoma
LOXL1,Rs1048661,amino acid change in the lysyl oxidase
LOXL1,Rs1048661,glaucoma risk only becomes high in older individuals.
LPA,Rs3798220,benefited more from taking aspirin.
LPA,Rs3798220,adjusted odds ratio for severe CAD of 3.14
LPA,Rs3798220,had 5-fold higher median plasma lipoprotein(a) levels
LPA,Rs3798220,associated with severe CAD and plasma lipoprotein(a) levels
LPA,Rs3798220,risk for Coronary Heart Disease
LPA,Rs3798220,"LPA gene that has been reported to be associated with elevated plasma lipoprotein(a) Lp(a) and increased cardiovascular risk, and in particular, coronary artery disease."
LPA,Rs3798220,"In summary, rs3798220(C) carriers had higher plasma lipoprotein(a) and had double the risk of cardiovascular events, but also benefited more from taking aspirin."
LPA,Rs3798220,LPA I4399M SNP is associated with severe CAD and plasma lipoprotein(a) levels.
LPA,Rs3798220,is an independent predictor of risk for Coronary Heart Disease in men and women
LPA,Rs3798220,had double the risk of cardiovascular events
LPA,Rs3798220,higher levels of plasma Lp(a).
LPA,Rs3798220,higher plasma lipoprotein(a)
LPA,Rs10455872,associated with about 1.5-fold increased risk of Coronary Heart Disease
LPA,Rs3798220,risk was reduced more than twofold by aspirin
LPA,Rs3798220,2x higher risk of major cardiovascular events
LPA,Rs3798220,coronary artery disease
LPA,Rs3798220,increased cardiovascular risk
LPA,Rs3798220,associated with elevated plasma lipoprotein(a)
LPA,Rs10455872,explain most of the ancestry-specific variation in Lp(a) levels in African Americans
LPA,Rs10455872,"Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk."
LPA,Rs10455872,peripheral vascular disease
LPA,Rs10455872,Coronary Heart Disease
LPA,Rs10455872,rs10455872
LPA,Rs3798220,risk was not significantly reduced among non-carriers
LPL,Rs268,T2DM
LPL,Rs268,Type-2 diabetes
LPL,Rs268,"SNP in the lipoprotein lipase LPL gene, has been linked to increased susceptibility to hypertriglyceridemia"
LPL,Rs268,heart disease
LPL,Rs268,idiopathic venous thromboembolism
LPL,Rs268,CHD (Coronary Heart Disease
LPL,Rs268,Heterozygous N291S carriers are less insulin sensitive
LPL,Rs268,have increased plasma levels of nonesterified fatty acids and triglycerides
LPL,Rs268,"Significant interactions between the LPL Asn291Ser variant and fasting glucose, Type-2 diabetes|T2DM, and Heart disease|CHD (Coronary Heart Disease)"
LPL,Rs268,increasing age and weight gain
LPL,Rs268,the association of the Asn291Ser variant with plasma TG increased with increasing age and weight gain
LPL,Rs268,diopathic venous thromboembolism
LPL,Rs1800590,biocurators
LPL,Rs268,heart disease
LPL,Rs1800590,Whole-Genome
LPL,Rs1800590,Pathogenic Regulatory Variants
LPL,Rs1800590,Mendelian Disease
LPL,Rs1800590,SNP
LPL,Rs1800590,Table S6
LPL,Rs268,Type-2 diabetes
LPL,Rs1800590,Mendelian disease
LPL,Rs2197089,lipid profile
LPL,Rs268,hypertriglyceridemia
LPL,Rs1800590,Mendelian disease
LRP1,Rs11172113,rs11172113
LRP1,Rs11172113,migraines
LRP4,Rs4752946,Osteoporotic fractures
LRP4,Rs4752946,polymorphism
LRP4,Rs4752946,increases susceptibility
LRP4,Rs2306033,usceptibility to Osteoporotic fractures
LRP4,Rs2306033,Osteoporotic fractures
LRP5,Rs724159827,pathogenic variant
LRP5,Rs141178995,pathogenic variant
LRP5,Rs373910016,OMIM pathogenic variant
LRP5,Rs61889560,Familial Bipolar Disorder
LRP5,Rs61889560,variants speculated
LRP5,Rs61889560,bipolar disorder
LRP5,Rs61889560,Bipolar Disorder
LRP5,Rs61889560,bipolar disorde
LRPPRC,Rs119466000,Leigh syndrome known as the French-Canadian type
LRPPRC,Rs119466000,inherited recessively
LRPPRC,Rs119466000,pathogenic 
LRRK2,Rs34995376,p.Arg1441His
LRRK2,Rs74163686,utosomal dominant Parkinson disease (type 8)
LRRK2,Rs7308720,risk of Parkinson disease
LRRK2,Rs35801418,autosomal dominant Parkinson disorder (type 8)
LRRK2,Rs35801418,"Considered ""definitely pathogenic"""
LRRK2,Rs34594498,"Note that this 2006 study concluded that Ala419Val was a ""disease-unrelated polymorphism""."
LRRK2,Rs34594498,Finding no association:
LRRK2,Rs34594498,Reporting an association
LRRK2,Rs34594498,"Ala419Val was a ""disease-unrelated polymorphism"""
LRRK2,Rs34594498,"study of ~1,500 Chinese PD patients reported no association"
LRRK2,Rs34594498,study of ~600 Taiwenese PD patients reported no association
LRRK2,Rs34594498,"study of ~400 Chinese, Malays and Indians finds no association"
LRRK2,Rs34594498,~2x higher risk for PD in Asian patients (but not Caucasians)
LRRK2,Rs34594498,~2x higher risk for PD in Chinese patients
LRRK2,Rs34594498,"increase risk (by about 2x) for Parkinson's disease, primarily in studies of Asians"
LRRK2,Rs34594498,"The minor allele of this variant has been reported in some studies - and not others - to increase risk (by about 2x) for Parkinson's disease, primarily in studies of Asians. "
LTA,Rs909253,inflammatory and innate immune responses
LTA,Rs928815,lymphotoxin-alpha tag polymorphisms
LTA,Rs909253,Five SNPs in two cytokine genes
LTA,Rs909253,lymphoma
LTA,Rs909253,large B cell lymphoma
LTA,Rs928815,tumor necrosis
LTA,Rs928815,type 1 diabetes 
LTA,Rs909253,non-Hodgkin lymphoma
LTA,Rs1799724,gastric cancer
LTA,Rs909253,tumor necrosis
LTA,Rs1799724,low bone mineral density
LTA,Rs1799724,post-menopausal women
LTA,Rs1799724,Alzheimer's disease
LTA,Rs1799724,Caucasians
LTA,Rs1799724,gastric cancer risk
LTA,Rs1799724,low bone mineral density
LTA,Rs1799724,post-menopausal women
LTA,Rs1799724,Alzheimer's disease
LTA,Rs1799724,Caucasians
LTA,Rs1799724,cigarette smoking
MACROD2,Rs4141463,autism
MACROD2,Rs4141463,autism
MAGI2,Rs757863,SNP
MAGI2,Rs757863,amyotrophic lateral sclerosis (ALS)
MAOA,Rs6323,lower magnitude of placebo response.
MAOA,Rs909525,affecting white matter volume
MAOA,Rs2072743,increased incidence of migraine without aura
MAOA,Rs6323,major depressive disorder
MAP2K1,Rs121908594,Phe
MAP2K1,Rs121908594,Ser
MAP2K1,Rs727504317,c.199G>A
MAP2K1,Rs727504317,(p.Asp67Asn)
MAP2K2,Rs727504382,Glu207Lys
MAP2K5,Rs6494696,"sleep disorder,"
MAP2K5,Rs6494696,restless legs syndrome
MAP2K5,Rs4489954,sleep disorder
MAP2K5,Rs4489954,restless legs syndrome
MAP2K5,Rs3784709,sleep disorder
MAP2K5,Rs3784709,restless legs syndrome
MAP2K5,Rs6494696, European populations
MAP2K5,Rs3784709,restless legs syndrome
MAP2K5,Rs3784709,linked to
MAP2K5,Rs1026732,common sleep disorder
MAP2K5,Rs1026732,restless legs syndrome
MAP2K5,Rs1026732,chromosome 15q
MAP2K5,Rs3784709,common sleep disorder
MAP3K1,Rs143853590,pathogenic variant
MAPK1,Rs743409,epistasis single-nucleotide polymorphism
MAPK1,Rs743409,anti-cyclic citrullinated peptide
MAPK1,Rs743409,rheumatoid arthritis
MAPT,Rs242557,Alzheimer's
MAPT,Rs242557,increased risk
MAPT,Rs17650991,Baldness
MAPT,Rs242557,Alzheimer's disease
MAT1A,Rs2993763,SNP in the MAT1A gene
MBL2,Rs1800450,pulmonary morbidity in preterm infants.related to non-Hodgkin's lymphoma
MBL2,Rs1800450,DNA sequence variation and regulation of genes involved in pathogenesis of pulmonary tuberculosis.
MBL2,Rs1800450,Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatin
MBL2,Rs1800450,Polymorphisms in IL-1beta
MBL2,Rs1800450,extrapulmonary tuberculosis.
MBL2,Rs1800450,underrepresented among individuals suffering from noninfectious systemic inflammatory response syndrome.
MBL2,Rs1800450,Haplotype specific-sequencing reveals MBL2 association with asymptomatic Plasmodium falciparum infection.
MBL2,Rs1800450,Genetic variation
MBL2,Rs1800450,innate immunity genes in eastern India
MBL2,Rs1800450,cluster of acute lymphoblastic leukemia cases in Churchill County
MBL2,Rs1800450,pulmonary tuberculosis
MBL2,Rs1800450,hepatitis C virus infection
MBL2,Rs1800450,coronary artery disease treated with pravastatin
MBL2,Rs1800450,coronary atherosclerosis
MBL2,Rs1800450,extrapulmonary tuberculosis
MBL2,Rs1800450,noninfectious systemic inflammatory response syndrome
MBL2,Rs1800450,asymptomatic Plasmodium falciparum infection
MBL2,Rs1800450,type 1 diabetes or diabetic nephropathy
MBL2,Rs1800450,systemic lupus erythematosus
MBL2,Rs1800450,acute lymphoblastic leukemia
MBL2,Rs1800450,non-Hodgkin's lymphoma
MBL2,Rs1800450,pulmonary morbidity in preterm infants
MC1R,Rs201326893,pathogenicity of the minor allele
MC1R,Rs201326893,MC1R gene
MC4R,Rs2229616,Melanocortin-4 receptor
MC4R,Rs2229616,schizophrenic patients
MC4R,Rs2229616,antipsychotic-induced weight gain
MC4R,Rs2229616,metabolic-related traits
MC4R,Rs2229616,Turkish pediatric obese patients
MC4R,Rs2229616,polycystic ovary syndrome
MC4R,Rs2229616,insulin resistance
MC4R,Rs2229616,risk of obesity
MC4R,Rs2229616,weight
MC4R,Rs2229616,fat mass
MC4R,Rs2229616,cancer cachexia
MC4R,Rs2229616,no change in blood pressure
MC4R,Rs2229616,obesity:
MC4R,Rs2229616,decreased glycosylated hemoglobin
MC4R,Rs2229616,Caucasians with a significantly decreased waist circumference
MC4R,Rs2229616,metabolic syndrome
MC4R,Rs2229616,obesity
MC4R,Rs2229616,body mass index
MC4R,Rs2229616,appetite regulation
MC4R,Rs2229616,antipsychotic-induced weight gain and the melanocortin-4 receptor gene.
MC4R,Rs2229616,body mass index and insulin resistance
MC4R,Rs2229616,cancer cachexia
MC4R,Rs2229616,metabolic syndrome
MC4R,Rs2229616,increased HDL-cholesterol
MCOLN1,Rs104886461,SNP
MCOLN1,Rs104886461,SN
MCOLN1,Rs104886461,heterozygous
MCOLN1,Rs104886461,Mucolipidosis type IV
MCOLN1,Rs104886461,mucolipin-1 MCOLN1
MCOLN1,Rs104886461,autosomal recessive neurodegenerative lysosomal storage disorder
MDM2,Rs2279744,risk of breast cancer
MDM2,Rs2279744,rs2279744(G;G)
MDM2,Rs2279744,moles on the arms for (G;T) and (G;G) genotypes
MDM2,Rs2279744, SNP 
MDM2,Rs2279744,T;T) genotype
MDM2,Rs2279744,melanoma 
MDM2,Rs2279744,rs2279744
MDM2,Rs2279744,SNP
MDM2,Rs2279744,squamous cell carcinoma 
MDM2,Rs2279744,basal cell carcinom
MDM2,Rs2279744,melanom
MDM2,Rs2279744,cancer diagnosis
MDM2,Rs2279744,(G;T)
MDM2,Rs2279744,rs2279744(G;G) genotype
MDM2,Rs2279744,rs2279744(T;T) genotyp
MDM2,Rs2279744,multivariate analysis
MDM2,Rs2279744,irinotecan plus cisplatin regimen
MDM2,Rs2279744,chemotherapy
MDM2,Rs2279744,cell lung cancer (NSCLC)
MDM2,Rs2279744,(T;T)
MDM2,Rs2279744,endometrial cancer
MDM2,Rs2279744,rs2279744(G;G)
MDM2,Rs2279744,cancers
MDM2,Rs2279744,SNP
MDM2,Rs2279744,rs2279744(G)
MDM2,Rs2279744,high grade breast cancer tumors
MDM2,Rs2279744,melanoma
MDM2,Rs2279744,stomach and kidney cancer
MDM2,Rs2279744,breast cancer
MDM2,Rs2279744,cell lung cancer
MDM2,Rs937283,hereditary retinoblastoma
MDM2,Rs2279744,rs1625895
MDM2,Rs2279744,rs17878362
MDM2,Rs2279744,rs1042522
MDM2,Rs2279744,rs2279744
MDM2,Rs2279744,SLE 
MDM2,Rs2279744, rs2279744
MDM2,Rs2279744,melanoma
MDM2,Rs2279744,SNP rs2279744
MDM2,Rs2279744,MDM2
MDM2,Rs2279744,SNP
MDM2,Rs2279744,melanoma
MDM2,Rs2279744,stomach and kidney cancer
MDM2,Rs2279744,ovarian cancer
MDM2,Rs2279744,colorectal cancer
MDM2,Rs2279744,B-cell lymphoma
MDM2,Rs2279744,"tissue sarcoma,"
MDM2,Rs2279744,rs2279744(G)
MDM2,Rs2279744,SNP
MDM2,Rs2279744,SNP309G
MDM2,Rs2279744,SNP309G
MDM2,Rs2279744,breast cancer
MDM2,Rs2279744,SNP305G allele
MDM2,Rs2279744,MDM2 SNP
MDM2,Rs2279744,SNP285C
MDM2,Rs2279744,cell lung cancer
MDM2,Rs2279744,(G;G) homozygotes
MDM2,Rs2279744,Caucasians
MDM2,Rs2279744,rs2279744
MDM2,Rs2279744,Taiwanese
MDM2,Rs2279744,men
MDM2,Rs2279744,melanoma
MDM2,Rs2279744,women
MDM2,Rs2279744,skin cancer
MDM2,Rs2279744,squamous cell carcinoma
MDM2,Rs2279744,basal cell carcinoma
MDM2,Rs2279744,melanoma
MDM2,Rs2279744,Scottish Caucasian
MDM2,Rs2279744,high grade breast cancer tumors
MDM2,Rs2279744,individuals with advanced nonsmall cell lung cancer (NSCLC)
MDM2,Rs2279744,endometrial cancer
MDM2,Rs2279744,females
MDM2,Rs2279744,tumor
MDM2,Rs2279744,common cancers
MDM2,Rs2279744,Chinese leukemia patients
MDM2,Rs2279744,Caucasian patients
MDM2,Rs2279744,nonsmall cell lung cancer
MDM2,Rs2279744,breast cancer
MDM2,Rs2279744,young age
MDM2,Rs2279744,soft tissue sarcomas
MDM2,Rs2279744,12 years earlier
MDM2,Rs2279744,individuals with cancer
MDM2,Rs2279744,cancer
MDM2,Rs2279744,cell lung cancer risk
MDM2,Rs2279744,ovarian and breast cancer
MDM2,Rs2279744,soft tissue sarcoma
MDM2,Rs2279744,nonsmoking
MDM2,Rs2279744,colorectal cancer
MDM2,Rs2279744,rs2279744(G;G)
MDM2,Rs2279744,diffuse large B-cell lymphoma
MDM2,Rs2279744,rs2279744(G;T)
MDM2,Rs2279744,breast cancer
MDM2,Rs2279744,p53 
MDM2,Rs2279744,rs2279744(T;T)
MDM2,Rs2279744,p53 SNP
MDM2,Rs2279744,rs2279744(T;T) homozygotes
MDM2,Rs2279744,SNP
MDM2,Rs2279744,TP53 rs1042522(C)
MDM2,Rs2279744,rs2279744(G) alleles
MDM2,Rs2279744,s2279744(G)
MDM2,Rs2279744,rs2279744(G) 
MDM2,Rs2279744,mutant p53 
MDM2,Rs2279744,p53
MDM2,Rs2279744,tumor suppressor protein
MDM2,Rs2279744, MDM2 protein
MDM2,Rs2279744,ovarian cancer
MDM2,Rs2279744,cancer origin and treatment
MDM2,Rs2279744,MDM2
MDM2,Rs2279744,rs2279744
MDM2,Rs2279744,high grade endometrial cancer
MDM2,Rs2279744,rs2279744
MDM2,Rs2279744,Asian children and adults
MDM2,Rs2279744,African-Americans
MDM2,Rs2279744,non-small cell lung cancer in women
MECP2,Rs1734791,lupus is a predominantly female disease.
MECP2,Rs1734791,increased susceptibility to lupus and differential gene expression
MECP2,Rs1734791,reduced cortical surface area in humans
MECP2,Rs17435,systemic lupus erythromatosis
MECR,Rs145192716,MECR
MEFV,Rs3743930,symptoms of familial Mediterranean fever are caused by the person's own inflammatory response
MEFV,Rs3743930,gene are associated with fibromyalgia syndrome and correlate with elevated
MEFV,Rs3743930,not an infectious disease
MEFV,Rs3743930,"more common among Turks, Sephardic Jews"
MEFV,Rs3743930,people of Arab and Armenian ancestry
MEFV,Rs3743930,risk for Crohn's disease and ulcerative colitis
MEFV,Rs3743930,Missense mutations
MEFV,Rs3743930,Behcet's disease
MEFV,Rs3743930,weak diagnostic value for recurrent fevers in Western European Caucasian patients
MEFV,Rs3743930,associated with fibromyalgia syndrom
MEFV,Rs3743930,elevated IL-1beta plasma levels
MEFV,Rs61732874,familial Mediterranean fever
MEFV,Rs61732874,"Turks, Sephardic Jews, and people of Arab and Armenian ancestry."
MEFV,Rs61732874,inflammatory response
MEFV,Rs61732874,rs61732874
MEFV,Rs61732874,SNP 
MEFV,Rs61732874,Jews
MEFV,Rs61732874,23andMe 
MEFV,Rs61732874,Armenian 
MEFV,Rs3743930,plasma levels.
MEFV,Rs61732874,Arab 
MEFV,Rs61732874,Turks
MEFV,Rs61732874,common 
MEFV,Rs61732874,infectious 
MEFV,Rs61732874,not 
MEFV,Rs61732874,response
MEFV,Rs61732874,person
MEFV,Rs61732874,caused 
MEFV,Rs61732874,fever 
MEFV,Rs61732874,familial 
MEFV,Rs61732874,symptoms 
MEFV,Rs61732874,i4000409
MEFV,Rs61732874,equivalent 
MEFV,Rs61732874,MEFV 
MEFV,Rs3743930,Western European Caucasian patients
MEFV,Rs3743930,associated with fibromyalgia syndrome
MEFV,Rs3743930,fevers
MEFV,Rs28940578,ulcerative colitis
MEFV,Rs28940578,Crohn's disease
MEFV,Rs28940578,familial Mediterranean fever
MEFV,Rs11466023,Mediterranean fever
MEFV,Rs104895094,Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF)
MEFV,Rs104895094,"common among Turks, Sephardic Jews, and people of Arab and Armenian ancestry"
MEFV,Rs28940578,choline kinase
MEFV,Rs104895094,The symptoms of familial Mediterranean fever are caused by the person's own inflammatory response; it is not an infectious disease
MEFV,Rs104895093,infectious disease.
MEFV,Rs104895083,cause of familial Mediterranean fever
MEFV,Rs104895083,infectious disease
MEFV,Rs104895083,person's own inflammatory response
MEFV,Rs104895083,familial Mediterranean fever
MEFV,I4000403,Mediterranean
MEFV,Rs104895094,infectious disease
MEFV,Rs28940578,Familial Mediterranean fever
MEFV,Rs104895093, familial Mediterranean fever
MEFV,Rs3743930,SNP in the MEFV gene
MEFV,Rs28940578,fibromyalgia syndrome
MEFV,Rs3743930,mutations in 412 patients with familial Mediterranean fever
MEFV,Rs3743930,mutant alleles to the clinical profile of familial Mediterranean fever
MEFV,Rs3743930,mutations
MEFV,Rs3743930,Behcet's disease
MEFV,Rs3743930,ontophoretic application of acetylcholine or carbachol.
MEFV,Rs3743930,smooth muscle
MEFV,Rs3743930,form of the membrane
MEFV,Rs3743930,diagnostic
MEFV,Rs3743930,plasma levels
MEFV,Rs3743930,latency
MEFV,Rs3743930,correlate with elevated
MEFV,Rs3743930,gene are associated with fibromyalgia syndrome
MEFV,Rs3743930,Missense mutations
MEFV,Rs3743930,Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis
MEFV,Rs3743930,"The condition is more common among Turks, Sephardic Jews, and people of Arab and Armenian ancestry"
MEFV,Rs3743930,The symptoms of familial Mediterranean fever are caused by the person's own inflammatory response; it is not an infectious disease
MET,Rs38855,refractive error and ocular biometrics
MET,Rs38850,MET
MET,Rs38850,Monogenic Disease
MET,Rs38850,autism susceptibility
MET,Rs38850,Sickle Cell Disease
MFN2,Rs772701127,Charcot-Marie-Tooth disease
MFN2,Rs772701127,relatively mild and late-onset form of Charcot-Marie-Tooth disease
MGMT,Rs12269324,significant associations
MICA,Rs4349859,familial ankylosing spondylitis
MICA,Rs4418214,protection of developing AIDS
MICA,Rs4418214,play a particular important role in the protection of developing AIDS
MIR96,Rs587776523,biocurators
MIR96,Rs587776523,Mendelian disease
MIR96,Rs587776523,SNP
MIR96,Rs587776523,Mendelian Disease
MIR96,Rs587776523,Pathogenic Regulatory Variants
MIR96,Rs587776523,Whole-Genome
MIR96,Rs587776523,Mendelian disease
MIR96,Rs587776522,Mendelian disease
MIR96,Rs587776522,biocurators
MIR96,Rs587776522,Table S6
MIR96,Rs587776522,SNP
MIR96,Rs587776523,Table S6
MIR96,Rs587776522,Mendelian Disease
MIR96,Rs587776522,Whole-Genome
MIR96,Rs587776522,Mendelian disease
MIR96,Rs546098287,Mendelian disease
MIR96,Rs546098287,biocurators
MIR96,Rs546098287,Table S6
MIR96,Rs546098287,SNP
MIR96,Rs546098287,Mendelian Disease
MIR96,Rs546098287,Pathogenic Regulatory Variants
MIR96,Rs546098287,Whole-Genome
MIR96,Rs546098287,Mendelian disease
MIR96,Rs587776522,Pathogenic Regulatory Variants
MKLN1,Rs3847109,young-onset type 2 diabetes
MLLT10,Rs142554860,bipolar disorde
MLLT10,Rs142554860,Bipolar Disorder
MLLT10,Rs142554860,Familial Bipolar Disorder
MLLT10,Rs142554860,variants speculated
MLLT10,Rs142554860,bipolar disorder
MMAB,Rs369296618,Gln
MMAB,Rs369296618,Ter
MMACHC,Rs398124292,aka 
MMACHC,Rs398124292,271dupA
MME,Rs1836915,Alzheimer's disease
MME,Rs1836915,Alzheimer's disease
MME,Rs1836915,Caucasian patients
MMP1,Rs1799750,lymph node metastasis
MMP1,Rs1799750,breast cancer
MMP1,Rs1799750,cancer
MMP1,Rs1144393,chronic kidney disease
MMP1,Rs1144393,genetic variants
MMP2,Rs243847,breast cancer susceptibility
MMP2,Rs243847,polymorphisms and breast cancer susceptibility.
MMP3,Rs35068180,polymorphism
MMP7,Rs11568818,significantly worse prognosis
MMP7,Rs11568818,breast cancer
MMP9,Rs3918242,mixed ethnicities 
MMP9,Rs3918242,urther progression of breast cancer
MMP9,Rs3918242,"increased risk for myocardial infarction, but not coronary artery disease"
MMP9,Rs3918242,Caucasians only
MMP9,Rs3918242,heart disease
MMP9,Rs3918242, coronary artery disease
MMP9,Rs3918242,myocardial infarction
MMP9,Rs3918242,breast cancer
MPO,Rs56378716,752T
MPO,Rs56378716,Met251Thr 
MPO,Rs56378716,M251T
MRE11A,Rs11020790,human microRNAs
MRE11A,Rs11020790,regulatory genes
MSH2,Rs193922376,Hereditary nonpolyposis colorectal cancer
MSH2,Rs193922376,genetic alterations
MSH2,Rs193922376,microsatellite instability
MSH2,Rs193922376,tumors 
MSH2,Rs193922376,SNP 
MSH2,Rs193922376,saline soil
MSH2,Rs193922376,i5008753
MSH2,Rs193922376,mismatch-repair-gene mutations
MSH2,Rs193922376,El Salitre
MSH2,Rs193922376,Mutational germline analysis
MSH2,Rs193922376,OMIM 609309.0011A
MSH2,Rs193922376,hMLH1
MSH2,Rs193922376,colorectal cancer
MSH2,Rs193922376,hereditary nonpolyposis colorectal cancer
MSH2,Rs193922376,high mutation detection rate
MSH2,Rs193922376,MSH2 gene
MSH2,Rs193922376,Muir-Torre syndrome
MSH2,Rs193922376,Lynch syndrome
MSH2,Rs267607694,Lynch syndrome
MSH2,Rs267607920,c.264dupT 
MSH2,Rs267607920,c.263_264delTT
MSH2,Rs193922376,hMSH2
MSH2,Rs193922376,ynch syndrome mutation
MSH2,Rs193922376,hMSH2
MSH2,Rs193922376,Lynch syndrome
MSH2,I5900861,Lynch syndrome
MSH2,I5900861,Lynch syndrome
MSH2,Rs138068023,Mendelian disease
MSH2,Rs138068023,Pathogenic Regulatory Variants
MSH2,Rs138068023,Mendelian Disease
MSH2,Rs138068023,SNP
MSH2,Rs138068023,Table S6
MSH2,Rs138068023,biocurators
MSH2,Rs138068023,Mendelian disease
MSH2,Rs193922376,pathogenic 
MSH2,Rs138068023,Whole-Genome
MSH2,Rs193922376,Muir-Torre syndrome among Lynch syndrome families.
MSH2,Rs193922376,ClinVar for Lynch syndrome
MSH2,Rs193922376,pathogenic
MSH2,Rs193922376,rs193922376(T) allele
MSH2,Rs193922376,chromosome 2
MSH2,Rs193922376,autosomal dominant manner
MSH2,Rs193922376,MSH2 gene
MSH2,Rs193922376,mutation
MSH2,Rs193922376,c.943+3A>T
MSH2,Rs193922376,c.942+3A>T
MSH2,Rs193922376,colon cancer
MSH3,Rs70991108,lymphoblastic leukemia (ALL)
MSH3,Rs70991108,homozygous rs70991108 deletion genotypes
MSH3,Rs70991108,rs70991108 deletion allele
MSH3,Rs70991108, hepatic toxicity
MSH3,Rs70991108,methotrexate treatment
MSH3,Rs70991108,heterozygous
MSH3,Rs70991108,rs70991108 deletion allele
MSH3,Rs70991108,PMID 14735580
MSH3,Rs70991108,hepatic toxicity
MSH3,Rs70991108,SNP
MSH3,Rs70991108,spina bifida
MSH3,Rs70991108,PMID 15755837
MSH3,Rs70991108,spina bifida
MSH3,Rs70991108,non-deletion genotype
MSH3,Rs70991108,"arrier of a rs1801133(T) allele,"
MSH3,Rs70991108,RBC folate
MSH3,Rs70991108,SNP
MSH3,Rs70991108,folic acid
MSH3,Rs70991108,polymorphism
MSH3,Rs70991108,alterations in folic acid (and folate) metabolism
MSH3,Rs70991108,risk for hepatic toxicity
MSH3,Rs70991108,baby born with spina bifida
MSH3,Rs70991108,homozygotes
MSH3,Rs70991108,polymorphism consisting of a 19-bp deletion
MSH3,Rs70991108,dihydrofolate reductase DHFR gene
MSH3,Rs70991108,rs70991108
MSH3,Rs70991108,folic acid (and folate) metabolism
MSH3,Rs70991108, rs70991108
MSH3,Rs70991108,folic acid levels
MSH3,Rs70991108,folic acid
MSH3,Rs70991108,homozygous
MSH3,Rs70991108,deletion genotype
MSH6,I5037859,prone to miscalls
MT-CO1,Rs41464546,derived_allele
MT-CO1,Rs41464546,ancestral_allele
MT-CO1,Rs41464546,derived_haplogroup
MT-CO1,Rs41464546,ancestral_haplogroup
MT-CO1,Rs41464546,PhyloTree
MT-CO1,Rs41464546,haplogroups
MT-CO1,I3000564,derived_allele
MT-CO1,Rs41464546,haplogroups
MT-CO1,I3000564,ancestral_haplogroup
MT-CO1,I3000564,derived_haplogroup
MT-CO1,Rs41464546,haplogroup
MT-CO1,I3000564,ancestral_allele
MT-CO1,I3000564,PhyloTree
MT-ND1,Rs41524046,Mitochondrial_Haplogroup
MT-ND1,Rs41524046,mtDNA
MT-ND1,Rs41524046,mitochondrial haplogroup
MT-ND1,Rs199476118,males
MT-ND1,Rs199476118,Leber's optic atrophy
MT-ND1,Rs199476118,Leber's optic atrophy
MT-ND4,I5000099,Leber's Hereditary Optic Neuropathy (LHON)
MTHFD1,Rs141210410,pathogenic variant
MTHFD1,Rs2236224,single nucleotide polymorphisms
MTHFD1,Rs2236224,prostate cancer
MTHFD1,Rs370444838,aka NM_005956.3(MTHFD1):c.146C>T or (p.Ser49Phe)OMIM pathogenic variant
MTHFD1,Rs8003379,abdominal aortic aneurysm
MTHFR,Rs3737964,Caucasians
MTHFR,Rs4846048,Caucasians
MTHFR,Rs59514310,rs1801133
MTHFR,Rs4846048,lean body mass
MTHFR,Rs3737964,not fat body mass
MTHFR,Rs4846048,not fat body mass
MTHFR,Rs2066470,Caucasians
MTHFR,Rs2066470,not fat body mass
MTHFR,Rs2066470,lean body mass
MTHFR,Rs2066462,strategy based
MTHFR,Rs2066462,matrix-assisted
MTHFR,Rs3737964,lean body mass
MTNR1B,Rs10830963,an increased risk of type-2 diabetes
MTNR1B,Rs10830963,increased fasting plasma glucose
MTNR1B,Rs10830963,higher fasting plasma glucose concentrations
MTNR1B,Rs10830963,lower fasting plasma glucose levels and increased OGTT-induced insulin release 
MTNR1B,Rs10830963,the risk for type-2 diabetes
MTNR1B,Rs10830963,of isolated impaired fasting glycemia
MTNR1B,Rs10830963,but not isolated impaired glucose tolerance
MTNR1B,Rs10830963,patients with gestational diabetes
MTNR1B,Rs10830963,Europeans
MTR,Rs2853523,ovarian cancer
MTRR,Rs326118,risk factor for abdominal aortic aneurysm (AAA)
MTRR,Rs326118,abdominal aortic aneurysm
MTRR,Rs1801394,Polish population.
MTRR,Rs1801394,ovarian cancer risk 
MTRR,Rs1801394,celiac disease.
MTRR,Rs1801394,uterine cervical carcinoma.
MTRR,Rs1801394,men with localized prostate cancer
MTRR,Rs1801394,colon cancer risk.
MTRR,Rs1801394,unexplained reduced sperm counts.
MTRR,Rs1801394,breast cancer:
MTRR,Rs1801394,prostate cancer risk.
MTRR,Rs1801394,sporadic colorectal cancers:
MTRR,Rs1801394,colorectal adenomas
MTRR,Rs1801394, women with breast cancer. 
MTRR,Rs1801394,women with breast cancer. 
MTRR,Rs1801394,prostate cancer
MTRR,Rs1801394,oral facial clefts. 
MTRR,Rs162049,Pancreatic cancer
MTRR,Rs162049,rs162049
MTRR,Rs162049,His595Tyr
MTRR,Rs1801394,neural tube defects
MTRR,Rs1801394,Down syndrome 
MTRR,Rs1801394,British patients with primary brain tumors
MTRR,Rs1801394,glioma
MTRR,Rs1801394,ncreased mortality
MTRR,Rs1801394,meningioma
MTRR,Rs1801394,brain cancer.
MTRR,Rs1801394,Neural tube defects and folate pathway genes:
MTRR,Rs1801394,lung cancer
MTRR,Rs1801394,colorectal cancer.
MTRR,Rs1801394,meningioma
MTTP,Rs146064714,abetalipoproteinemia
MTTP,Rs17029215,high-density lipoprotein-cholesterol
MTTP,Rs17029215,coronary atherosclerosis
MUC5B,Rs375954692,variants speculated
MUC5B,Rs375954692,Familial Bipolar Disorder
MUC5B,Rs375954692,bipolar disorder
MUC5B,Rs375954692,Bipolar Disorder
MUC5B,Rs375954692,bipolar disorde
MUT,Rs535411418,recurrent pathogenic mutation in African-Americans
MUT,Rs727504022,Gly94Arg
MUT,Rs758008398,p.Val227fs
MUT,Rs758008398,c.678_679insAATTTATG
MUT,Rs190834116,284C
MUT,Rs727504022,G94R;
MUT,Rs190834116,as 
MUT,Rs727504022,"lias c.280G> A,"
MUT,Rs190834116,uncertain significance according to ClinVar.
MUT,Rs121918258,G215S
MUT,Rs121918258,Gly215Ser
MUT,Rs121918256,N219Y
MUT,Rs121918256,i5000071
MUT,Rs121918256,aka c.655A>
MUT,Rs190834116,Pathogenic 
MUTYH,Rs200165598,non-Lynch syndrome polyps
MUTYH,Rs200165598,mimicking Lynch syndrome
MUTYH,Rs200165598,MYH-associated polyposis
MUTYH,Rs200165598,MUTYH rs200165598 is pathogenic
MUTYH,Rs200165598,bi-allelic
MUTYH,Rs200165598,recurrent polyp illness
MUTYH,Rs200165598,non-Lynch syndrome polyps 
MUTYH,Rs200165598,recurrent polyp illness
MUTYH,Rs200165598,colon surgery
MUTYH,Rs200165598,Lynch syndrome
MUTYH,Rs200165598,MYH-associated polyposis
MUTYH,Rs200165598,mono-allelic MUTYH variants
MYBPC3,Rs121909377,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYBPC3,Rs121909374,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYBPC3,Rs111729952,hypertrophic cardiomyopathy
MYBPC3,Rs112738974,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYBPC3,Rs111729952,hypertrophic cardiomyopathy
MYBPC3,Rs111729952, hypertrophic cardiomyopathy.
MYBPC3,Rs111729952,familial hypertrophic cardiomyopathy
MYBPC3,Rs111729952,trabeculae 
MYH6,MYH6 c.2161,sick sinus syndrome
MYH6,MYH6 c.2161,atrial tissue
MYH6,MYH6 c.2161,No homozygotes
MYH6,MYH6 c.2161,tryptophan amino acid alteration at amino acid 721
MYH6,MYH6 c.2161,exon 18 of the MYH6 gene
MYH6,MYH6 c.2161,minor allele frequency
MYH6,MYH6 c.2161,heart rhythm
MYH6,MYH6 c.2161,sinus node dysfunction
MYH6,MYH6 c.2161,myosin
MYH6,MYH6 c.2161,MYH6 gene
MYH6,MYH6 c.2161,Icelanders
MYH6,MYH6 c.2161,sick sinus syndrome (SSS)
MYH6,MYH6 c.2161,sinus node dysfunction
MYH6,MYH6 c.2161,affect heart rhythm
MYH6,MYH6 c.2161,T allele
MYH6,MYH6 c.2161,decrease in heart rate
MYH6,MYH6 c.2161,atrial tissue
MYH6,MYH6 c.2161,sick sinus syndrome
MYH7,Rs121913641,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913638,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913637,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913632,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913630,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913629,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913631,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913628,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913626,mutation
MYH7,Rs121913626,hypertrophic cardiomyopathy
MYH7,Rs121913626,autosomal dominant
MYH7,Rs121913626,the MYH7 gene
MYH7,Rs121913625,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913624,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYH7,Rs121913626,fourth most common pathogenic variant
MYL2,Rs397516399,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYL2,Rs28932774,polymorphism
MYL2,Rs28932774,Familial hypertrophic cardiomyopathy
MYL2,Rs397516406,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYL2,Rs143139258,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYL2,Rs104894369,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYL2,Rs199474809,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYL2,Rs104894368,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYL3,Rs199474703,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYL3,Rs139794067,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
MYL3,Rs104893748,myopathy in human heart and skeletal muscle.
MYLK,Rs820336,lung injury
MYLK,Rs820336,ommunity-acquired pneumonia
MYLK,Rs936170,Polymorphisms 
MYLK,Rs936170,asthma
MYO18B,Rs869312740,p.Glu2166Ter
MYO3A,Rs747952173,aka c.3126T>G
MYO7A,Rs111033174,gene mutations in an Usher syndrome
MYO7A,Rs111033174,Usher syndrome type I
MYO7A,Rs111033415,c.1344-2A>G
MYOC,Rs766501882,Mendelian Disease
MYOC,Rs766501882,SNP
MYOC,Rs34928744,Table S6
MYOC,Rs766501882,biocurators
MYOC,Rs766501882,Mendelian disease
MYOC,Rs766501882,Pathogenic Regulatory Variants
MYOC,Rs766501882,Table S6
MYOC,Rs766501882,Whole-Genome
MYOC,Rs34928744,SNP
MYOC,Rs34928744,Mendelian disease
MYOC,Rs34928744,biocurators
MYOC,Rs34928744,Mendelian Disease
MYOC,Rs34928744,Pathogenic Regulatory Variants
MYOC,Rs34928744,Whole-Genome
MYOC,Rs34928744,Mendelian disease
MYOC,Rs766501882,Mendelian disease
NADSYN1,Rs12785878,lower vitamin D
NADSYN1,Rs12785878,average have lower vitamin D levels 
NADSYN1,Rs12785878,have lower vitamin D than carriers
NALCN,Rs9518307,Tardive Dyskinesia
NAT1,Rs56379106,slow metaboliser
NAT1,Rs4986782,non-Hodgkin lymphoma
NAT1,Rs56379106,slow metaboliser
NAT1,Rs4986782,risk of bladder cancer
NAT1,Rs4986782,Spanish Bladder Cancer Study
NAT2,Rs1799931,rs1799931(A)
NAT2,Rs1799931,SNP
NAT2,Rs1799931,risk allele
NAT2,Rs1799931,NAT2 gene
NAT2,Rs1799931,NAT2 SNPs
NAT2,Rs1799931,NAT2
NAT2,Rs1799931,protein
NAT2,Rs1799931,N-acetyltransferase
NAT2,Rs1799931,SNP
NAT2,Rs1799931,rs1799931
NAT2,Rs1799929,cervical cancer
NAT2,Rs1495741,NAT2 acetylation phenotypes
NAT2,Rs1495741,the NAT2 phenotype of an individual
NAT2,Rs1495741,rs1495741 is
NAT2,Rs1041983,slow NAT2 metabolization
NAT2,Rs1799931,NAT2 gene
NBN,Rs587776650,"a mutation in the NBN gene on chromosome 8. Carriers of one rs587776650(-) allele are at increased risk for several types of cancer, including breast cancer"
NBN,Rs587776650,Double mutations (i.e. recessive or compound heterozygote) in the NBN gene cause Nijmegen breakage syndrome
NBN,Rs587776650,Non-Hodgkin Lymphoma
NBN,Rs587776650,prostate cancer
NBN,Rs587776650,lymphoma
NBN,Rs587776650,Nijmegen breakage syndrome
NBN,Rs587776650,significantly increase risk for melanoma
NBN,Rs587776650,Nijmegen breakage syndrome
NBN,Rs587776650,significantly increase risk for melanoma and Non-Hodgkin Lymphoma
NBN,Rs587776650,prostate cancer
NBN,Rs587776650,lymphoma
NBN,Rs587776650,increased breast cancer risk
NBN,Rs587776650,including breast cancer
NBN,Rs587776650,"increased risk for several types of cancer,"
NBPF3,Rs4654748,human aging
NBPF3,Rs4654748,SNPs 
NCAN,Rs2228603,lower triglycerides and plasma LDL-Cholesterol in this study .
NCAN,Rs2228603,risk of insulin resistance and diabetes
NCAN,Rs2228603,NAFLD is associated with higher LDL-C and lower LDL-C levels
NCAN,Rs2228603,associated with nonalcoholic fatty liver disease
NCAN,Rs2228603,"In a large GWAS of individuals of European descent published in March, 2011"
NCAN,Rs1064395,The risk A-allele
NCAN,Rs1064395,patients with European ancestry
NCAN,Rs1064395,X-chromosomal SNPS
NCAN,Rs1064395,autosomal SNPs
NCAN,Rs1064395,fluctuation between manic episodes and severe depression
NCAN,Rs1064395,bipolar disorder (BD) and schizophrenia
NCAN,Rs1064395,schizophrenia
NCAN,Rs1064395,"hallucinations, both visual and auditory, paranoia, disorganized thinking and lack of normal social skills"
NCAN,Rs1064395,Schizophrenia
NCAN,Rs1064395,manic episodes and severe depression
NCAN,Rs1064395,schizophrenia
NCAN,Rs1064395,bipolar disorder (BD)
NCAN,Rs1064395,"hallucinations, both visual and auditory, paranoia, disorganized thinking and lack of normal social skills"
NDRG1,Rs119483085,Charcot-Marie-Tooth disease
NDST3,Rs11098403,SNP
NDST3,Rs11098403,schizophrenia
NDST3,Rs11098403,"be associated with increased risk for schizophrenia (odds ratio of 1.4, at least in Ashkenazi Jews),"
NDST3,Rs11098403,"associated with decreased risk (odds ratio 0.6, in Han Chinese)."
NF1,Rs199474747,c.2540T>G
NF1,Rs199474747,p.Leu847Pro
NF1,Rs199474747,Leu847Arg
NF1,Rs1060500254,p.Cys845Arg
NF1,Rs1060500254,c.2533T>C
NF1,Rs199474747,c.2540T>C
NFKB1,Rs28362491,-94 ATTG insertion/deletion polymorphism
NFKB1,Rs28362491,differences between men and women for this SNP
NFKB1,Rs28362491,differences between Asians and Caucasians
NFKB1,Rs4648127,21% reduced risk of lung cancer
NGF,Rs11102930,multiple sclerosis
NGF,Rs11102930,childhood IgA nephropathy.
NGF,Rs11102930,Genomic NGFB variation
NLRP12,Rs147080557,pathogenic variant
NLRP12,Rs199881207,pathogenic variant
NLRP3,Rs200154873,pathogenic variant
NOD2,Rs1077861,Crohn disease in Ashkenazi Jews
NOD2,Rs2066843,increases susceptibility to Crohn's disease
NOD2,Rs1077861,CARD15 genetic variation
NOS1,Rs73208120,enhanced colorectal cancer risk
NOS1AP,Rs16856785,QT interval
NOS2,Rs1060822,recurrent aphthous stomatitis
NOS2,Rs1060822,inheritance of a single-nucleotide polymorphism of the NOS2 gene
NOS2,Rs8072199,Parkinson's disease
NOS2,Rs8072199,adult brain tumors
NOS2,Rs8072199,tuberculosis
NOS3,Rs4496877,rs4496877
NOS3,Rs3918188,bone density/ultrasound and geometry in humans
NOS3,Rs3918188,Habitual energy expenditure
NOS3,Rs3918188,blood pressure
NOS3,Rs3918188,glaucoma
NOS3,Rs3918188,hypoxic-ischemic encephalopathy
NOS3,Rs4496877,Type-1 diabetes
NOS3,Rs4496877,nephropathy
NPHS1,Rs137853042,R1109X
NPHS1,Rs137853042,Arg1109Ter
NPPA,Rs5065,heart attack
NPPA,Rs5065,hypertensive
NPPA,Rs5065,diuretics
NPPA,Rs5065,cardiovascular disease
NPPA,Rs5065,hypertensive participants 55 or older
NPPA,Rs5065,diuretic
NPPA,Rs5065,calcium antagonis
NPPA,Rs5065,angiotensin-converting enzyme inhibitor
NPPA,Rs5065,alpha-blocker
NPPA,Rs5065, fatal heart disease
NPPA,Rs5065,cardiovascular disease
NPPA,Rs5065,chlorthalidone
NPPA,Rs5065,amlodipine
NPPB,Rs198389,co-dominant effect
NPPB,Rs198389,chronic heart failure (CHF)
NR1H3,Rs12221497,cardiovascular outcomes
NR1H3,Rs12221497,insulin secretion
NR1H3,Rs12221497,patients treated with antihypertensive therapy
NR1H3,Rs12221497,adolescents
NR1H3,Rs12221497,subjects at increased risk for type 2 diabetes
NR1H3,Rs12221497,type 2 diabetes
NR1H3,Rs12221497,liver X receptor alpha gene polymorphisms
NR1H3,Rs12221497,metabolic syndrome
NR1H3,Rs12221497,type 2 diabetes
NR1H3,Rs12221497,antihypertensive therapy
NR1H3,Rs12221497,type 2 diabetes
NR1H3,Rs12221497,metabolic syndrome
NR1H3,Rs2167079,supranuclear palsy
NR1H3,Rs12221497,French populations
NR1H3,Rs7120118,supranuclear
NR1I2,Rs2276707,Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease
NR1I2,Rs2276707,inflammatory bowel diseases
NR1I2,Rs2276707,chronic periodontitis
NR1I2,Rs1464603,ciclosporin
NR1I2,Rs1464603,kidney transplant recipients.
NR3C1,Rs6196,lithium response in bipolar patients
NR3C1,Rs6198,Glucocorticoid receptor gene polymorphisms
NR3C1,Rs6198,rheumatoid arthritis
NR3C1,Rs6198,major depression
NR3C1,Rs6198,bipolar disorder
NR3C1,Rs6198,depression
NR3C1,Rs6198,anovulatory polycystic ovary syndrome
NR3C1,Rs6198,Glucocorticoid receptor polymorphism
NR3C1,Rs6198,bipolar patients
NR3C1,Rs6198,a haplotype responsible for both regulation of glucocorticoid expression and mRNA stability
NR3C1,Rs6198,theorized to be associated with major depression
NR3C1,Rs6198,Glucocorticoid receptor gene polymorphisms and susceptibility to rheumatoid arthritis
NR3C1,Rs6198,Glucocorticoid receptor gene variant in the 3' untranslated region is associated with multiple measures of blood pressure
NR3C1,Rs6198,Glucocorticoid receptor-9beta polymorphism is associated with systolic blood pressure and heart growth during early childhood
NR3C1,Rs6198,Glucocorticoid receptor gene polymorphism and juvenile idiopathic arthritis
NR3C1,Rs6198,Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease
NR3C1,Rs6198,Glucocorticoid receptor polymorphism is associated with major depression
NR3C1,Rs6198,predominance of depression in the course of bipolar disorder
NR3C1,Rs6198,Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome
NR3C1,Rs6198,Glucocorticoid receptor polymorphism is associated with lithium response in bipolar patients
NR3C1,Rs6198,interaction of glucocorticoid receptor and dopaminergic genes
NR3C1,Rs6196,Glucocorticoid receptor polymorphism
NR3C1,Rs6196,Glucocorticoid receptor gene haplotype
NR3C1,Rs6198,Glucocorticoid receptor gene polymorphisms
NR3C1,Rs6196,Glucocorticoid receptor gene variant
NR3C1,Rs10482682,Glucocorticoid receptor gene
NR3C1,Rs17100498,492K SNP
NR3C1,Rs1866388,osteoporosis
NR3C1,Rs1866388,bone mineral density
NR3C1,Rs1866388,Chronic Fatigue Syndrome
NR3C1,Rs6196,multiple measures of blood pressure
NR3C1,Rs2918419,insulin resistance in men
NR3C1,Rs2918419,bone mineral density and thus osteoporosis in a Chinese population
NR3C1,Rs2918419,Chronic Fatigue Syndrome
NR3C1,Rs6190,glucocorticoid
NR3C1,Rs6190,Glucocorticoid
NR3C1,Rs1866388,neural response
NR3C1,Rs6190,IBD
NR3C1,Rs6190,nflammatory bowel disease
NR3C1,Rs6190,polymorphisms
NR3C1,Rs6190,anovulatory polycystic ovary syndrome
NR3C1,Rs6196,Polymorphisms
NR3C1,Rs6196,gene transcription
NR3C1,Rs6196,mRNA processing
NR3C1,Rs6196,pharmacogenetic candidate genes
NR3C1,Rs6196,uman target tissues
NR3C1,Rs6190,anovulatory polycystic ovary syndrome.
NRG1,Rs6994992,significantly associated with lateral ventricle volume
NRG1,Rs6994992,''not''' associated with neurocognition or chronic schizophrenia
NRG1,Rs6994992,schizophrenia
NRG1,Rs6994992,schizophrenia
NRG1,Rs6994992,effects white matter density and integrity
NRXN1,Rs1045881,nicotine dependence in European- and African-American
NRXN1,Rs1045881,nicotine dependence
NRXN3,Rs7147705,"35AA 58,12 ± 0,27Aa 57,15 ± 0,31aa 55,26 ± 0,65"
NRXN3,Rs7147705,ALS
NTRK1,Rs926103,Danish
NTRK1,Rs926103,Swedish
NTRK1,Rs926103,associated with multiple sclerosis in Norwegian
NTRK1,Rs926103,genetic susceptibility of multiple sclerosis
NTRK1,Rs926103,Multiple sclerosis
NTRK1,Rs926103,Promethease
NTRK1,Rs926103,multiple sclerosis 
NUTF2,Rs2271293,decreased LDL cholesterol
NUTF2,Rs2271293,increased HDL
NUTF2,Rs2271293,and decreased triglycerides
NUTF2,Rs2271293,decreased LDL cholesterol
NUTF2,Rs2271293,increased HDL
NUTF2,Rs2271293,decreased triglycerides
OAS1,Rs1051042,Genetic variation
OAS1,Rs1051042,risk factor for initial infection with West Nile virus in man.
OAS1,Rs1051042,single-nucleotide polymorphism
OAS1,Rs1051042,initial infection
OBSCN,Rs79023478,rs79023478(A)
OBSCN,Rs79023478,cardiovascular disease 
OBSCN,Rs79023478,R4344Q
OBSCN,Rs79023478,R4344Q
OBSCN,Rs79023478,hypertrophic cardiomyopathy
OBSCN,Rs79023478,the presence of certain environmental or biological stressors.
OBSCN,Rs79023478,cardiac remodeling and dilation
OBSCN,Rs79023478,pathological stress
OBSCN,Rs79023478,spontaneous arrhythmia
OBSCN,Rs79023478,Ca2+ deregulation
OBSCN,Rs79023478, R4344Q mutation
OBSCN,Rs79023478,hypertrophic cardiomyopathy
OBSCN,Rs79023478,rs79023478(A
OBSCN,Rs79023478,chromosome 1.A
OBSCN,Rs79023478,rs79023478(A)
OBSCN,Rs182714476,Familial Bipolar Disorder
OBSCN,Rs182714476,variants speculated
OBSCN,Rs182714476,bipolar disorder
OBSCN,Rs182714476,bipolar disorde
OBSCN,Rs182714476,Bipolar Disorder
OBSCN,Rs79023478,cardiovascular disease
OBSCN,Rs79023478,rs79023478
OBSCN,Rs79023478,c.13031G>A
OBSCN,Rs79023478,p.Arg4344Gln
OBSCN,Rs79023478,R4344Q
OBSCN,Rs79023478,arrhythmia
OCA2,Rs12913832,that may be functionally linked to blue or brown eye color
OCA2,Rs12913832,homozygous
OCA2,Rs12913832,blue eye color is composed as follows
OCA2,Rs12913832,A genome-wide association scan in admixed Latin Americans identifies loci influencing facial and scalp hair features
OCA2,Rs12913832,Blue eye color is associated with the rs12913832(G;G) genotype
OCA2,Rs7495174,blue or green eye color
OCA2,Rs12913832,"correlations with skin, eye, and hair color variation."
OCA2,Rs4778137,eye-color
OCA2,Rs4778137,color gene
OCA2,Rs6497268,Influences appearance
OCA2,Rs12913832,"correlations with skin, eye, and hair color variation"
OCA2,Rs12913832,"defined by 13 SNPs listed below, that is found in 97% of all Caucasians with blue eyes."
OCA2,Rs12913832,blue eye
OCA2,Rs12913832,green versus blue eye color
OCA2,Rs12913832,homozygotes
OCA2,Rs12913832,are relatively common in Caucasians though rare among other racial groups
OCA2,Rs12913832,Caucasians with blue eyes
OCA2,Rs12913832,chromosome 15
OCA2,Rs12913832,allelic
OCA2,Rs12913832,genotype
OCA2,Rs12913832,Blue eye color is associated
OCA2,Rs12913832,lowering of promoter activity of the OCA2 gene
OCA2,Rs12913832,blue or brown eye color
OCA2,Rs11855019,Influences appearance
OCA2,Rs1129038,blue eye color
OCA2,Rs1129038,blue eyes
OCA2,Rs7495174,association with eye color
OCA2,Rs12913832,brown eye
OCA2,Rs7495174,eye color
OPN1LW,I5005856,colorblindness
OPN1LW,I5005855,colorblindness
OPN1MW,Rs35104847,colorblindness
OPRD1,Rs1042114,increases susceptibility to Substance dependence
OPRD1,Rs12749204,"increases susceptibility to Substance dependence, Cocaine"
OPRM1,Rs540825,MOR1
OPRM1,Rs540825,expressed 
OPRM1,Rs540825,isoform
OPRM1,Rs540825,MOR1X 
OPRM1,Rs540825,only 
OPRM1,Rs540825,OPRM1 
OPRM1,Rs540825,exon 
OPRM1,Rs540825,alternatively 
OPRM1,Rs2281617,associated with less euphoria and energy in response to a given dose of a stimulant drug
OPRM1,Rs2281617,C;C genotype
OPRM1,Rs2281617,stimulant drug
OPRM1,Rs2281617,ess euphoria and energy
OPRM1,Rs1799971,HIV infection
OPRM1,Rs540825,trafficking 
OPRM1,Rs1799971,amphetamine-induced euphoria
OPRM1,Rs1799971,pain
OPRM1,Rs1799971,endogenous opioid blockade
OPRM1,Rs1799971,nucleotide polymorphisms
OPRM1,Rs1799971,nicotine dependence
OPRM1,Rs1799971,depression and anxiety.
OPRM1,Rs1799971,less nausea and vomiting
OPRM1,Rs1799971,analgesia
OPRM1,Rs1799971,influence the response to opioids
OPRM1,Rs1799971,higher risk for alcoholism
OPRM1,Rs1799971,cravings for alcohol
OPRM1,Rs2281617,T;T and C;T genotypes
OR10A2,Rs7107418,OR=.8
OR10A2,Rs7107418,rs72921001
OR10A2,Rs7107418,rs72921001
ORMDL3,Rs4795400,asthma
ORMDL3,Rs4795400,French patients with asthma
ORMDL3,Rs4795400,later onset asthma
ORMDL3,Rs4795400,early-onset asthma
ORMDL3,Rs4795400,children exposed to tobacco smoke.
ORMDL3,Rs8069176,rs8069176
ORMDL3,Rs8069176,(17q21)
OTC,Rs191615506,biocurators
OTC,Rs5963409,independent of age and ApoE status.
OTC,Rs5963409,Alzheimer's disease
OTC,Rs191615506,Mendelian disease
OTC,Rs191615506,Table S6
OTC,Rs191615506,Mendelian Disease
OTC,Rs191615506,Pathogenic Regulatory Variants
OTC,Rs191615506,Whole-Genome
OTC,Rs191615506,Mendelian disease
OTC,Rs191615506,SNP
OTOF,Rs397515595,deafness
OXT,Rs17339677,oxytocin/neurophysin I
OXTR,Rs4564970,Alcohol and aggressive behavior in men
OXTR,Rs1042778,development of psychopathy
OXTR,Rs1042778,high levels of callous-unemotional (CU) traits
PADI3,Rs144080386,Ala
PADI3,Rs144080386,Val
PADI3,Rs144080386,Uncombable hair syndrome
PADI3,Rs144080386,PADI3 gene
PADI4,Rs2301888,C allele
PADI4,Rs2301888,Rheumatoid Arthritis
PADI4,Rs2240338,G allele
PADI4,Rs2240338,Rheumatoid Arthritis
PADI4,Rs2240338,Rheumatoid Arthritis
PAH,Rs5030860,non-phenylketonuria hyperphenylalaninemia
PAH,Rs5030860,phenylketonuria
PAH,I4000481,Phenylketonuria
PAH,I4000479,Phenylketonuria
PAH,I3003401,Phenylketonuriars
PAH,I3003400,Phenylketo
PAH,I4000467,Phenylketonuria
PAH,I3003400,on
PAH,I3003400,Phenyl
PAH,I3003399,Phenylketonuria
PAH,I3003397,Phenylketonuriars5030843
PAH,I3003397,Phenylketonuria
PAH,I3003400,iars
PALB2,Rs515726065,pathogenic
PALB2,Rs515726117,Breast-Cancer
PALB2,Rs515726099,Mutations in PALB2
PALB2,Rs515726117,Mutations in PALB2
PALB2,Rs515726065,Breast-Cancer Risk
PALB2,Rs515726065,PALB2see
PALB2,Rs515726065,Mutations
PALB2,Rs515726099,Breast-Cancer
PALB2,Rs180177132,breast cancer
PALB2,Rs180177132,hance of developing the disease by age 70
PALB2,Rs180177132,carriers had an odds ratio
PALB2,Rs180177132,breast cancer cases concluded
PALB2,Rs180177132,publication study involving
PALB2,Rs180177132,gene on chromosome
PALB2,Rs180177132,represents a very rare mutation
PALB2,Rs515726065,Breast-Cancer
PARK2,Rs992037,metabolite range or with a ratio of metabolites
PARK2,Rs992037, males from Southern Germany
PARK2,Rs992037,"Parkinson disease (autosomal recessive, juvenile)"
PARK2,Rs992037,increased lysine values
PARK2,Rs992037,ncreased lysine values
PARK2,Rs137853055,i5007828
PARK2,Rs137853055,c.931C>T
PARK2,Rs137853055,p.Gln311Ter)
PARK2,Rs992037,Parkinson disease
PARK7,I5047038,rs74315354
PARK7,I5047042,Parkinson's disease
PARK7,I5047042,rs28938172Parkinson
PARK7,I5047042,disease
PARK7,Rs28938172,"autosomal recessive, early-onset Parkinson disease (type 7)"
PAX2,Rs768607170,pathogenic variant
PAX5,Rs398123063,has been associated with
PAX5,Rs398123063,acute lymphoblastic leukemia
PAX5,Rs398123063,B cell precursor
PAX5,Rs6476606,(A>G)=-0.027
PCDH15,Rs10825264,cisplatin-induced cytotoxicity
PCSK1,Rs6232,Obesity
PCSK1,Rs6232,increased risk of obesity
PCSK9,Rs778796405,Whole-Genome
PCSK9,Rs778796405,Pathogenic Regulatory Variants
PCSK9,Rs778796405,Mendelian Disease
PCSK9,Rs778796405,Mendelian disease
PCSK9,Rs778796405,Table S6
PCSK9,Rs778796405,biocurators
PCSK9,Rs778796405,Mendelian disease
PCSK9,Rs778796405,SNP
PCSK9,Rs369067856,mutation
PCSK9,Rs28942112,inherited familial
PCSK9,Rs369067856,diabetes
PCSK9,Rs28942112,autosomal dominantly
PCSK9,Rs28362286,low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults
PCSK9,Rs28362286,decreased LDL levels
PCSK9,Rs28362286,lowered risk for coronary events
PCSK9,Rs28362286,owered LDL-C level
PCSK9,Rs28362286,plasma LDL-C levels being up to 40% lower than average
PCSK9,Rs28362286,"2% frequency in Africans, 0.1% in Europeans"
PCSK9,Rs28362286,rs28362286
PDE4B,Rs1321172,multiple sclerosis
PDE4D,Rs966221,stroke
PDE4D,Rs966221,atherothrombotic strokes
PDHA1,Rs3810710,neurological problems
PDHA1,Rs3810710,lactic acidosis
PDHA1,Rs3810710,pyruvate dehydrogenase E1 alpha deficiency 
PDZD7,Rs148695069,pathogenic variant
PDZD7,Rs397516633,pathogenic variant
PDZD7,Rs753034799,pathogenic variant
PEMT,Rs7946,Hispanic and African-American descent
PEMT,Rs7946,breast cancer
PEMT,Rs7946,breast cancer 
PEMT,Rs7946,fatty liver
PER1,Rs2585408,rs722141
PER1,Rs2585408,SNP
PER1,Rs2585408,haplotype block
PER1,Rs2585408,rs991407
PER1,Rs2585408,rs2585408
PEX1,Rs28939678,peroxisome biogenesis disorders
PEX10,Rs62636524,Zellweger syndrome spectrum
PEX10,Rs62636524,PEX Gene
PEX7,I5006212,Rhizomelic chondrodysplasia punctata type 1
PEX7,I5006215,Rhizomelic chondrodysplasia punctata type 1
PGAM2,Rs10250779,African-American
PGAM2,Rs10250779,intense muscle pain and cramps upon exercising
PGAM2,Rs10250779,polymorphisms in human genes
PGR,Rs529359,colorectal cancer
PGR,Rs529359,women
PGR,Rs529359,colorectal cance
PGR,Rs529359,women
PGR,Rs529359,colorectal cancer
PGR,Rs529359,ndometrial cancer
PGR,Rs529359,Breast Cancer
PGR,Rs529359,women
PGR,Rs529359,colorectal cancer
PGR,Rs529359,European subjects
PGR,Rs500760,breast cancer
PGR,Rs529359,endometrial cancer
PGR,Rs529359,Breast Cancer
PGR,Rs481775,women
PGR,Rs481775,colorectal cancer
PGR,Rs481775,European subjects
PGR,Rs481775,women
PGR,Rs481775,colorectal cancer
PGR,Rs481775,ethnic heterogenity
PGR,Rs481775,endometrial cancer
PGR,Rs529359,women
PHIP,Rs768324201,Arg
PHIP,Rs768324201,Ser
PHIP,Rs200788163,pathogenic variant
PHKG2,Rs572115942,high blood sugar
PHKG2,Rs572115942,hepatomegaly
PHKG2,Rs572115942,Mauriac syndrome
PIEZO1,Rs202103485,xerocytosis
PIEZO1,Rs202103485,xerocytosis
PIEZO1,Rs202103485,affected patients
PIEZO1,Rs202103485,xerocystosis
PIEZO1,Rs202103485,associated with xerocytosis
PIEZO1,Rs202103485,causative for xerocystosis
PINK1,Rs74315356,definitely pathogenic
PINK1,Rs28940285,c.1040T>C (p.Leu347Pro or L347P)
PINK1,Rs28940285,608309.000523and
PINK1,Rs28940285,i3003043
PINK1,Rs74315356,autosomal recessive
PINK1,Rs74315356,early-onset Parkinson disease
PINK1,Rs74315356,early-onset Parkinson disease
PITX1,Rs6596189,autism
PITX1,Rs11959298,autism
PKD1,Rs199476102,Polycystic Kidney disease
PKD1,Rs199476102,PKD
PKD1,Rs199476102,polycystic kidney disease
PKD1,Rs199476102,SNP
PKD1,Rs199476099,Polycystic Kidney disease
PKD1,Rs200520583,kidney diseas
PKD1,Rs1060499718,polycystic kidney disease
PKD1,Rs1057518604,the variant allele is pathogenic for autosomal dominant polycystic kidney disease
PKD1,Rs1057518604,autosomal dominant polycystic kidney disease
PKD1,Rs1057516206,Tyr1181Ter
PKD1,Rs1057516206,3543T
PKD1,Rs1060499718,autosomal dominant polycystic kidney disease
PKD2,Rs145877597,highly likely to be pathogenic
PKD2,Rs145877597,Autosomal Polycystic Kidney Disease
PKD2,Rs121918042,i5002464
PKD2,Rs121918041,aka c.1213C
PKD2,Rs121918042,c.1390C>T
PKD2,Rs121918041,T (p.Gln405Ter)
PKD2,Rs121918042,(p.Arg464Ter)23
PKHD1,I6016737,HD
PKHD1,I6016737,see
PKHD1,I6016654,autosomal recessive polycystic kidney diseasers
PKHD1,I6016642,PKHD1
PKHD1,I6016785,see
PKHD1,I5900581,PKHD1
PKHD1,I5012610,Polycystic Kidney disease
PKHD1,I5007344,PKHD1
PKHD1,I6016629,Polycystic kidney disease
PKNOX2,Rs750338,alcohol dependence
PKNOX2,Rs750338,substance dependence in European-origin women
PKNOX2,Rs750338,alcohol dependence
PKNOX2,Rs750338,European-origin women
PLD3,Rs145999145,SNP
PLD3,Rs145999145,Alzheimer's disease
PLD3,Rs145999145,disease
PLD3,Rs537053537,pathogenic variant
PMEL,Rs17118154,pigmentary glaucoma (PG)
PMEL,Rs17118154,pigment dispersion syndrome (PDS) in the iris
PMEL,Rs17118154,blindness in young adults
PMS1,Rs143265397,Bipolar Disorder
PMS1,Rs143265397,bipolar disorder
PMS1,Rs143265397,bipolar disorde
PMS1,Rs143265397,Familial Bipolar Disorder
PMS1,Rs143265397,variants speculated
PMS2,Rs17420802,Lynch syndrome
PMS2,Rs17420802,sporadic endometrial cancers
PMS2,Rs17420802,non-polyposis colorectal cancer
PNMT,Rs3764351,reward dependence temperament
PNPLA3,Rs6006460,lower hepatic fat content
POLE,Rs5744760,rs5744760(G)
POLE,Rs5744760,c.1007A>G
POLE,Rs5744760,p.Asn336SerClinVar
POLE,Rs116162724,Heterozygotes
POLE,Rs116162724,colorectal cancer
POLE,Rs143690372,colorectal cancer
POLR3B,Rs138249161,hypomyelinating leukodystrophy
POMC,Rs753856820,biocurators
POMC,Rs753856820,Table S6
POMC,Rs753856820,SNP
POMC,Rs753856820,Mendelian disease
POMC,Rs753856820,Pathogenic Regulatory Variants
POMC,Rs753856820,Whole-Genome
POMC,Rs753856820,Mendelian disease
POMC,Rs753856820,Mendelian Disease
PON1,Rs705379,aryesterase activity
PON1,Rs705379,rs705379
PON1,Rs705379,paraoxonase 
PON1,Rs705379,gene
PON1,Rs705379,PON1
PON1,Rs705379,activity 
PON1,Rs705379,involve 
PON1,Rs705379,SNP
PON1,Rs705381,trait-anxiety
PON1,Rs705381,weight profiles
PON2,Rs12026,(glycine replacing alanine)
PON2,Rs12026,xacerbates glycemia in non-insulin dependent diabetes mellitus
POT1,Rs758673417,represents a rare mutation in the POT1 gene on chromosome 7
POT1,Rs758673417,the minor allele is reported to increase risk for colorectal cancer
PPARA,Rs135551,myocardial infarction
PPARA,Rs135551,rs135551
PPARG,Rs3856806,polymorphism is associated with non-traumatic hip fracture risk
PPARG,Rs3856806,Variations in the peroxisome proliferator-activated receptor-gamma gene and melanoma risk
PPARG,Rs3856806,PPAR-gamma gene polymorphisms and psoriatic arthritis
PPARG,Rs3856806,The association of Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma gene with serum osteoprotegerin levels in healthy Korean women
PPARG,Rs3856806,Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia
PPARG,Rs3856806,genes related to insulin sensitivity
PPARG,Rs3856806,the risk of biliary tract cancer and biliary stone
PPARG,Rs3856806,Polycystic ovary syndrome and ovarian response
PPARG,Rs3856806,Variants in inflammation genes and the risk of biliary tract cancers and stones
PPARG,Rs3856806,dietary fat interaction influences bone mass in mice and humans
PPARG,Rs3856806,Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis
PPARG,Rs3856806,Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies
PPARG,Rs3856806,related to gestational diabetes mellitus in the Korean population
PPARG,Rs3856806,Genetic-epidemiological evidence on genes associated with HDL cholesterol levels
PPARG,Rs3856806,Genetic variation in the ADIPOR2 gene is associated with liver fat content
PPARG,Rs3856806,Association and interaction of PPAR-complex gene variants with latent traits of left ventricular diastolic function
PPARG,Rs3856806,estrogen-related risk factors on breast cancer risk
PPARG,Rs3856806,susceptibility to chronic periodontitis
PPARG,Rs3856806,PPARG gene promoter polymorphism is associated with non-traumatic hip fracture risk in the elderly Slovenian population
PPARG,Rs3856806,retinoid X receptor-alpha genes and type 2 diabetes risk in a Chinese Han population
PPARG,Rs3856806,PPAR-gamma gene polymorphisms with obesity and obesity-associated phenotypes in north indian population
PPARG,Rs3856806,Low-penetrance alleles predisposing to sporadic colorectal cancers
PPARG,Rs3856806,chronic periodontitis
PPARG,Rs3856806,obesity-related traits
PPARG,Rs3856806,traits of left ventricular diastolic function
PPARG,Rs3856806,breast cancer risk
PPARG,Rs10865710,Joint effect of peroxisome proliferator-activated receptor gamma genetic polymorphisms and estrogen-related risk factors on breast cancer risk:
PPARG,Rs1175543,baseline cholesterol levels
PPARG,Rs121909244,Pro495Leu
PPARG,Rs121909244,P495L
PPARG,Rs371713160,Mendelian disease
PPARG,Rs371713160,Whole-Genome
PPARG,Rs371713160,Pathogenic Regulatory Variants
PPARG,Rs371713160,Mendelian Disease
PPARG,Rs371713160,Table S6
PPARG,Rs371713160,biocurators
PPARG,Rs371713160,SNP
PPARG,Rs3856806,melanoma risk
PPARG,Rs3856806,Granulomatosis
PPARG,Rs3856806,liver fat
PPARG,Rs3856806,Type 2 diabetes
PPARG,Rs371713160,Mendelian disease
PPARG,Rs3856806,endometriosis
PPARG,Rs3856806,sporadic colorectal cancers
PPARG,Rs3856806,risk of biliary tract cancer and biliary stone
PPARG,Rs3856806,insulin sensitivity
PPARG,Rs3856806,PPAR-gamma gene polymorphisms and psoriatic arthritis
PPARG,Rs3856806,Polycystic ovary syndrome
PPARGC1A,Rs8192678,between five candidate genes and type 2 diabetes in Chinese Han population
PPARGC1A,Rs8192678,Part I: Polycystic ovary syndrome and ovarian response
PPARGC1A,Rs8192678,nfluence their modifying effect in Huntington disease
PPARGC1A,Rs8192678,due to Intensive Diabetes Therapy
PPARGC1A,Rs8192678,GC-1alpha as modifier of onset age in Huntington disease
PPARGC1A,Rs8192678,patients with sarcoidosis
PPARGC1A,Rs8192678,female reproductive disorders
PPARGC1A,Rs8192678,PGC-1alpha modifies age at onset in Huntington's Disease
PPARGC1A,Rs8192678,polymorphisms and type 2 diabetes
PPARGC1A,Rs8192678,"PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases"
PPARGC1A,Rs8192678,not with hypertension hypertrophy
PPARGC1A,Rs8192678,hypertrophic cardiomyopathy
PPARGC1A,Rs8192678,individuals over 50yrs
PPARGC1A,Rs8192678,risk for hypertension and systolic blood pressure (SBP)
PPARGC1A,Rs8192678,gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients
PPP2R5D,Rs863225080,"ntellectual disability, macrocephaly, hypotonia, and autism"
PRDM16,Rs2651899,rs2651899
PRDM16,Rs2651899,PRDM16 gene
PRDM16,Rs2651899,polymorphisms on migraine susceptibility in the Northern Indian population
PRDM9,Rs6889665,people of West African ancestry
PRF1,Rs786205093,(p.Asp70Thrfs)
PRF1,Rs35947132,systemic-onset juvenile idiopathic arthritis
PRF1,Rs28933376,c.1304C>T (p.Thr435Met)
PRF1,Rs35947132,Macrophage activation syndrome
PRF1,Rs104894176,i5000837
PRF1,Rs104894176,p.Trp374Ter
PRF1,Rs104894176,c.1122G>A
PRF1,Rs28933376,c.1304C>T (p.Thr435Met)
PRKAG2,Rs121908987,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
PRKAG2,Rs121908991,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
PRKAG2,Rs267606978,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
PRKCG,Rs121918517,gene on chromosome
PRKCG,Rs121918517,Based on one publication
PRKCG,Rs121918517,allele is reported to lead in a dominant manner to spinocerebellar ataxia
PRKCH,Rs2230500,Association of PRKCH gene with lacunar infarction in a local Chinese Han population.
PRKCH,Rs2230500,were significantly associated with stroke Genetic association
PRKCH,Rs2230500,have been associated with higher risk for subcortical silent brain infarction
PRKCH,Rs2230500,subcortical silent brain infarction
PRKCH,Rs2230500,stroke
PRKCH,Rs2230500,ischemic stroke
PRKG1,Rs10824310,genome-wide homozygosity
PRKG1,Rs10824310,genome-wide homozygosity
PRNP,Rs74315403,homozygotes being more likely to develop Fatal Familial Insomnia
PRNP,Rs74315403,families indicated strong likelihood of developing Creuzfeldt-Jakob disease given the D178N mutation
PRNP,Rs74315403,symptoms lay on a spectrum from typical Creutzfeldt-Jakob disease to Fatal Familial Insomnia
PRNP,Rs74315403,"Normally Aspartate, a polymorphism can create the D178N mutation which is linked to inherited Creutzfeldt-Jakob disease or Fatal Familial Insomnia"
PRNP,Rs267606980,G127V
PRNP,Rs267606980,appears to protect against kuru
PRNP,Rs267606980,"rs267606980,"
PRNP,Rs74315403,Prion protein gene
PROC,Rs121918153,(p.Arg220Gln
PROC,Rs121918156,c.793C>T
PROC,Rs121918156,p.Leu265Phe
PROC,Rs121918156,i5003618
PROC,Rs757583846,Arg57Trp
PROC,Rs757583846,c.169C>T
PROC,Rs757583846,C>G variant
PROC,Rs757583846,pathogenic C>T variant
PROC,Rs757583846,C>G variant
PROC,Rs757583846,dbSNP
PROC,Rs757583846,Arg>Gly
PRODH,Rs4819756,schizophrenia
PRODH,Rs4819756,rs2870983
PRODH,Rs4819756,rs4819756
PRODH,Rs2870983,schizophrenia
PRODH,Rs2870983,The minor alleles of rs4819756 and rs2870983
PROS1,Rs387906675,Tyr
PROS1,Rs387906675,Cys
PROS1,Rs6122,Thr
PROS1,Rs6122,Met
PSEN1,Rs63749967,considered pathogenic
PSEN1,Rs63749967,autosomal dominant
PSEN1,Rs63749824,age of onsets
PSEN1,Rs63749891,"rs63749891(C), also known as c.833G>C, p.Arg278Thr or R278T "
PSEN1,Rs63749891,Alzheimer's disease
PSEN1,Rs63749891, rs63749891(T)
PSEN1,Rs63749967,potentially early-onset
PSEN1,Rs63749891,c.833G>T (p.Arg278Ile)
PSEN1,Rs63749891,rs63749891
PSEN1,Rs63749891,"c.833G>T, p.Arg278Ile or R278I (ClinVar) "
PSEN1,Rs63750299,"c.518T>G, L173W or Leu173Trp"
PSEN1,Rs63750325,pathogenic mutation
PSEN1,Rs63750299,rs63750299(G)
PSEN1,Rs63750301,Alzheimer's
PSEN1,Rs63750301,Alzheimer's
PSEN1,Rs63750306,single nucleotide mutations are known and considered pathogenic
PSEN1,Rs63750306,Alzheimer's disease
PSEN1,Rs63750306,Alzheimer's disease
PSEN1,Rs63750325,Alzheimer's disease
PSEN1,Rs63750325,pathogenic mutation
PSEN1,Rs63750325,early-onset Alzheimer's disease
PSEN1,Rs63749824,later onset
PSEN1,Rs63750391,Alzheimer's disease
PSEN1,Rs63750299,PSEN
PSEN1,Rs63749824,late-onset Alzheimer's disease.
PSEN1,Rs63749891," rs63749891(A), also known as c.833G>A, p.Arg278Lys or R278K"
PSEN1,Rs63749824,mutation spans a large range of age of onsets (53–78 y)
PSEN1,Rs63749824,"""could lead to underestimation of its frequency and is of importance for genetic counseling""."
PSEN1,I3002721,Alzheimer's diseasers
PSEN1,Rs121917807,Gly266Ser
PSEN1,Rs121917808,spastic spastic paraparesis (paraplegia)
PSEN1,Rs121917808,arly-onset Alzheimer's disease
PSEN1,Rs121917808,Alzheimer's disease
PSEN1,Rs121917808,spastic spastic paraparesis
PSEN1,Rs17125721,Alzheimer
PSEN1,Rs17125721,Alzheimer's disease
PSEN1,Rs17125721,homozygotes for APO E4 do not get the disease
PSEN1,Rs533487738,Mendelian disease
PSEN1,Rs533487738,Whole-Genome
PSEN1,Rs17125721,gene variation
PSEN1,Rs533487738,Mendelian Disease
PSEN1,Rs533487738,SNP
PSEN1,Rs533487738,Table S6
PSEN1,Rs533487738,biocurators
PSEN1,Rs533487738,Mendelian disease
PSEN1,Rs63749805,Alzheimer's disease
PSEN1,Rs63749824,gene
PSEN1,Rs63749824,utosomal dominant
PSEN1,Rs63749824,allele is considered pathogenic for late-onset Alzheimer's disease
PSEN1,Rs63749824,pathogenic mutation
PSEN1,Rs533487738,Pathogenic Regulatory Variants
PSEN1,Rs63749824,has been found in several families with late-onset AD
PSEN2,Rs63750812,autosomal dominant
PSEN2,Rs63750812,rs63750812(A) allele
PSEN2,Rs63750812,Alzheimer's disease
PSEN2,Rs63750812,PSEN2-CTF
PSEN2,Rs775145486,as pathogenic for Alzheimer's disease
PSEN2,Rs63750812,Aβ42
PSEN2,Rs63750812,Aβ42/Aβ40 ratio
PSEN2,Rs63750812,allele
PSEN2,Rs63750812,mutation
PSEN2,Rs63750812,presenilin PSEN2 gene
PSEN2,Rs63750812,PSEN2-NTF
PSEN2,Rs63750812,SNP
PSEN2,Rs63750812,Inherited as an autosomal dominant
PSEN2,Rs63750812,V148I
PSEN2,Rs63750812,Val148Ile
PSEN2,Rs28936380,"autosomal dominant,"
PSEN2,Rs28936380,causative for early-onset Alzheimer's disease
PSEN2,Rs574125890,pathogenic for Alzheimer's disease
PSEN2,Rs200670135,Alzheimer's disease
PSEN2,Rs63749851,"Alzheimer's disease,"
PSEN2,Rs63750048,atypical early-onset Alzheimer's disease
PSEN2,Rs63750812,early-onset Alzheimer's disease
PSEN2,Rs63750812,rs63750812
PSEN2,Rs61757781,Alzheimer's disease
PTGS1,Rs3842787,coronary angiographies (CAGs)
PTGS1,Rs3842787,experienced bleeding
PTGS1,Rs3842787,higher risk for bleeding in otherwise low risk patients who (i) did undergo percutaneous coronary intervention and (ii) did not take clopidogrel
PTGS2,Rs689466,Crohn's diseas
PTGS2,Rs689466,ulcerative colitis
PTGS2,Rs689466,inflammatory bowel diseas
PTGS2,Rs689466,ulcerative colitis
PTGS2,Rs689466,ulcerative colitis
PTGS2,Rs689466,Danish
PTGS2,Rs689466,infection and risk of gastric cancer
PTGS2,Rs689466,histopathological features
PTGS2,Rs689466,breast cancer prognosis
PTGS2,Rs689466,oesophageal squamous cell carcinoma
PTGS2,Rs689466,acute myeloid leukemia
PTGS2,Rs689466,Helicobacter pylori acquisition and gastric cancer
PTGS2,Rs689469,COX-2 (PTGS2) 
PTGS2,Rs689466,Scottis
PTGS2,Rs689466,Diabetes
PTGS2,Rs689466,esophageal cancer
PTGS2,Rs689466,prostate cancer
PTGS2,Rs689466,breast cance
PTGS2,Rs689466,South Africa
PTGS2,Rs689466,oesophageal squamous cell carcinoma
PTGS2,Rs689466,Chinese population
PTGS2,Rs689466,myeloid leukemia
PTGS2,Rs689466,gastric cancer
PTGS2,Rs689466,Hodgkin lymphoma
PTGS2,Rs689466,gastric cancer
PTGS2,Rs689466,esophageal cancer
PTGS2,Rs689466,depression
PTGS2,Rs689466,hepatocellular carcinoma
PTGS2,Rs689466,Danish
PTGS2,Rs689466,colorectal cancer
PTGS2,Rs689466,colon cancer
PTGS2,Rs689466,Helicobacter pylori infection
PTGS2,Rs689466,response and remission to antidepressants in major depression
PTGS2,Rs689466,Parkinson's disease
PTGS2,Rs689466,meat intake in relation to risk of colorectal cancer
PTGS2,Rs5277,cervical cancer
PTGS2,Rs5277,Parkinson's disease
PTGS2,Rs5277,breast cancer
PTGS2,Rs5277,ridine diphosphate glucuronosyltransferase
PTGS2,Rs5277,prostate cancer
PTGS2,Rs5277,cervical cancer
PTGS2,Rs5277,Korean
PTGS2,Rs5277,Parkinson's disease
PTGS2,Rs5270,prostate cancer
PTGS2,Rs2745557,"PTGS2,"
PTGS2,Rs2745557,rs2745557 
PTGS2,Rs20415,polymorphisms in the COX-2 gene
PTGS2,Rs20415,prostate cancer
PTGS2,Rs689466,risk for hepatocellular carcinoma
PTGS2,Rs5277, breast canc
PTGS2,Rs5277,prostate cancer
PTGS2,Rs5270,polymorphisms in the COX-2 gene
PTGS2,Rs5277,sporadic colorectal cancers
PTGS2,Rs689466,colon cancer risk
PTGS2,Rs689466,aggressive prostate cancer risk
PTGS2,Rs689466,coronary and carotid calcium
PTGS2,Rs689466,Parkinson's disease
PTGS2,Rs689466,younger age at diagnosis and with extensive ulcerative coliti
PTGS2,Rs689466,Multidrug Resistance
PTGS2,Rs689466,those who never smoked
PTGS2,Rs689466,1157 healthy controls
PTGS2,Rs689466,732 Crohn's disease (CD) cases
PTGS2,Rs689466,973 ulcerative colitis (UC) cases
PTGS2,Rs5277,stomach cancer in China
PTGS2,Rs5277,colon cancer
PTGS2,Rs5277,aggressive prostate cancer risk
PTGS2,Rs689466,higher risk for ulcerative colitis and inflammatory bowel disease
PTGS2,Rs5277,coronary and carotid calcium
PTPN11,Rs11066320,LDL cholestero
PTPN11,Rs11066320,apoB
PTPN11,Rs11066320,SHP-2
PTPN11,Rs11066320,PI3-kinase
PTPN2,Rs2542151,Crohn's disease
PTPN2,Rs2542151,type-1 diabetes
PTPN2,Rs2542151,Crohn's disease
PTPN2,Rs2542151,heterozygotes
PTPN2,Rs2542151,homozygotes
PTPN2,Rs2542151,type-1 diabetes
PTPN2,Rs514000,Crohn's disease
PTPN22,Rs2488457,chromosome 1
PTPN22,Rs2488457,slightly increased risk
PTPN22,Rs2488457,"Crohn's disease, type-1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, and celiac disease"
PTPN22,Rs2488457,type 1 diabetes and juvenile idiopathic arthritis
PTPN22,Rs3765598,Rheumatoid Arthritis
PTPN22,Rs2488457,(PTPN22) gene polymorphisms
PTPN22,Rs2488457,susceptibility to Graves' disease in a Japanese population
PTPN22,Rs2488457,Behcet's disease
PTPN22,Rs2488457,PTPN22 620W variant with type 1 diabetes
PTPN22,Rs2488457,Diabetes
PTPN22,Rs2488457,juvenile idiopathic arthritis
PTPN22,Rs2488457,rheumatoid arthritis
PTPN22,Rs2488457,Crohn's disease
PTPN22,Rs2488457,diabetes
PTPN22,Rs2488457,sclerosis
PTPN22,Rs2488457,rheumatoid arthritis
PTPN22,Rs2488457,lupus
PTPN22,Rs2488457,diabetes
PTPN22,Rs2488457,diabetes
PTPN22,Rs2488457,juvenile idiopathic arthritis
PTPN22,Rs2488457,Graves' disease
PTPN22,Rs2488457,celiac disease
PTPRQ,Rs749210663,deafness
PTPRQ,Rs61729287,rare (T) allele
PTPRQ,Rs61729287,recessive form of deafness
PTPRQ,Rs61729287,PTPRQ gene variant
PTS,Rs3819331,tetrahydrobiopterin pathway genes
PTS,Rs3819331,autism
PTS,Rs3819331,autism
PTS,Rs3819331,autism
PTS,Rs3819331,related to dopamine
PXK,Rs6445975,lupus erythematosus
PXK,Rs6445975,"tissues including brain, heart, skeletal muscle, and peripheral blood lymphocytes"
PXK,Rs6445975,breast cancer
PXK,Rs6445975,breast cancer
PYGM,Rs119103255,Arg576Ter 
PYGM,Rs119103257,gene
PYGM,Rs119103255,i5005804
PYGM,Rs119103255,R576X23andMe 
PYGM,Rs119103255,1726C
PYGM,Rs119103253,PYGM 
PYGM,Rs119103252,K543T23
PYGM,Rs119103252,Lys543Thr
PYGM,Rs119103252,PYGM gene
PYGM,Rs119103253,gene
RAD50,Rs2240032,breast cancer
RAD50,Rs2240032,familial breast cancer
RAD50,Rs2240032,single nucleotide polymorphisms
RAD50,Rs2706347,FCER1A
RAD51C,Rs587781410,cancer
RAD51D,Rs753862052,cancer
RAF1,Rs80338797,c.1837C>G (p.Leu613Val)
RAF1,Rs397516826,p.Arg256Ser
RAF1,Rs397516826,c.768G>C
RAF1,Rs397516826,p.Arg256Ser
RAF1,Rs397516826,c.768G>T
RAF1,Rs121434594,T (p.Pro261Ser) 23
RAF1,Rs121434594,aka c.781C
RAF1,Rs121434594,i5008105
RAPSN,Rs45547231,congenital myasthenic syndrome
RARRES2,Rs17173608,ype-2 diabetes
RARRES2,Rs17173608,wer visceral adipose tissue mass
RARRES2,Rs17173608,lower waist-to-hip ratio
RB1,Rs387906521,Whole-Genome
RB1,Rs387906521,Mendelian disease
RB1,Rs387906521,Table S6
RB1,Rs387906521,SNP
RB1,Rs387906521,Mendelian Disease
RB1,Rs387906521,Pathogenic Regulatory Variants
RB1,Rs387906521,Mendelian disease
RB1,Rs387906521,biocurators
RB1,Rs387906520,biocurators
RB1,Rs387906520,Table S6
RB1,Rs387906520,SNP
RB1,Rs387906520,Mendelian Disease
RB1,Rs387906520,Pathogenic Regulatory Variants
RB1,Rs387906520,Whole-Genome
RB1,Rs387906520,Mendelian disease
RB1,Rs387906520,Mendelian disease
RBFOX1,Rs3785234,15
RET,Rs2506030,Medullary Thyroid Carcinoma
RET,Rs2506030,congenital aganglionosis
RET,Rs2506030,homozygotes
RET,Rs2506030,Hirschsprung disease
RET,Rs3026785,Hirschsprung disease
RET,Rs2506030,Medullary Thyroid Carcinoma
RET,Rs2506030,congenital aganglionosis
RET,Rs2506030,"short segment, long segment, or total colonic aganglionosis (TCA)"
RET,Rs2506030,Multiple Endocrine Neoplasia
RET,Rs2506030,Multiple Endocrine Neoplasia
RET,Rs2506030,neural crest
RET,Rs2506030,Hirschsprung disease
RET,Rs1799939,primary vesicoureteric reflux (pVUR) patients in Quebec
RET,Rs2506030,tyrosine kinases.
RET,Rs1799939,full siblings
RET,Rs1799939,index cases
RET,Rs201740483,Familial Bipolar Disorder
RET,Rs1799939,pVUR from the Irish population
RET,Rs201740483,bipolar disorder
RET,Rs201740483,Bipolar Disorder
RET,Rs201740483,bipolar disorde
RET,Rs2506030,Nucleotide Polymorphism
RET,Rs201740483,variants speculated
RGS2,Rs2746073,schizophrenia symptom severity
RGS2,Rs2746071,schizophrenia symptom severity
RGS2,Rs2746073,RGS2
RGS2,Rs2746073,RGS5
RGS2,Rs2746073,schizophrenia
RGS2,Rs2746073,malaria
RGS2,Rs2746073,severe malaria pathogenesis
RGS4,Rs2661319,schizophrenia
RGS4,Rs2661319,schizophrenia
RGS4,Rs2661319,schizophrenia in Japanese
RHD,Rs121912763,transfusion reactions
RHD,Rs1053360,Polymorphisms of RhD(Va)
RHD,Rs1053360,a new RhD(Va)-like variant
RMRP,Rs772443941,Pathogenic Regulatory Variants
RMRP,Rs772443941,Whole-Genome
RMRP,Rs772443941,Mendelian disease
RMRP,Rs761398394,Mendelian disease
RMRP,Rs761398394,biocurators
RMRP,Rs761398394,Table S6
RMRP,Rs761398394,SNP
RMRP,Rs761398394,Mendelian Disease
RMRP,Rs753874439,Whole-Genome
RMRP,Rs761398394,Whole-Genome
RMRP,Rs761398394,Mendelian disease
RMRP,Rs753874439,Mendelian disease
RMRP,Rs753874439,biocurators
RMRP,Rs753874439,Table S6
RMRP,Rs753874439,SNP
RMRP,Rs753874439,Mendelian Disease
RMRP,Rs753874439,Pathogenic Regulatory Variants
RMRP,Rs772443941,Mendelian Disease
RMRP,Rs761398394,Pathogenic Regulatory Variants
RMRP,Rs786204684,Mendelian disease
RMRP,Rs772443941,Table S6
RMRP,Rs786204684,biocurators
RMRP,Rs786204684,Table S6
RMRP,Rs786204684,SNP
RMRP,Rs786204684,Mendelian Disease
RMRP,Rs786204684,Pathogenic Regulatory Variants
RMRP,Rs786204684,Whole-Genome
RMRP,Rs786204684,Mendelian disease
RMRP,Rs772665785,Mendelian disease
RMRP,Rs772665785,biocurators
RMRP,Rs772665785,Table S6
RMRP,Rs772665785,SNP
RMRP,Rs772665785,Mendelian Disease
RMRP,Rs772665785,Pathogenic Regulatory Variants
RMRP,Rs772665785,Whole-Genome
RMRP,Rs772665785,Mendelian disease
RMRP,Rs772443941,Mendelian disease
RMRP,Rs772443941,biocurators
RMRP,Rs772443941,SNP
RMRP,Rs753874439,Mendelian disease
RMRP,Rs551450545,Mendelian Disease
RMRP,Rs748623920,biocurators
RMRP,Rs533294975,Mendelian disease
RMRP,Rs533294975,biocurators
RMRP,Rs533294975,Table S6
RMRP,Rs533294975,SNP
RMRP,Rs533294975,Mendelian Disease
RMRP,Rs533294975,Pathogenic Regulatory Variants
RMRP,Rs533294975,Whole-Genome
RMRP,Rs748623920,Mendelian disease
RMRP,Rs533294975,Mendelian disease
RMRP,Rs199476103,biocurators
RMRP,Rs199476103,Table S6
RMRP,Rs199476103,SNP
RMRP,Rs199476103,Mendelian Disease
RMRP,Rs199476103,Pathogenic Regulatory Variants
RMRP,Rs199476103,Whole-Genome
RMRP,Rs199476103,Mendelian disease
RMRP,Rs199476103,Mendelian disease
RMRP,Rs551450545,Whole-Genome
RMRP,Rs551450545,Mendelian disease
RMRP,Rs551450545,SNP
RMRP,Rs748623920,Table S6
RMRP,Rs748623920,SNP
RMRP,Rs748623920,Mendelian Disease
RMRP,Rs748623920,Pathogenic Regulatory Variants
RMRP,Rs748623920,Whole-Genome
RMRP,Rs748623920,Mendelian disease
RMRP,Rs551450545,Pathogenic Regulatory Variants
RMRP,Rs74810894,biocurators
RMRP,Rs74810894,Mendelian disease
RMRP,Rs74810894,SNP
RMRP,Rs74810894,Mendelian Disease
RMRP,Rs74810894,Pathogenic Regulatory Variants
RMRP,Rs74810894,Whole-Genome
RMRP,Rs74810894,Mendelian disease
RMRP,Rs551450545,Mendelian disease
RMRP,Rs551450545,biocurators
RMRP,Rs551450545,Table S6
RMRP,Rs74810894,Table S6
RNASEH2CP1,I3000043,lacks a dbSNP identifier
RNLS,Rs2576178,essential hypertension
RNLS,Rs2576178,essential hypertension
RORA,Rs754499,rs4458717
RORA,Rs754499,rs4660646
RORA,Rs754499,rs11149566 
RTEL1,Rs201540674,a founder mutation in Ashkenazi Jews
RTEL1,Rs2297441,20q13
RTEL1,Rs2297441,21q22
RUNX1,Rs2268277,Japanese population with rheumatoid arthritis
RUNX1,Rs2268277,ailed to showed a statistically significant association with rheumatoid arthritisrs
RYR1,Rs63749869,central core disease
RYR1,Rs193922753,RYR1 gene
RYR1,Rs193922753,causative for malignant hyperthermia
RYR1,Rs193922764,p.Arg401Cys
RYR1,Rs193922764,R401C
RYR1,Rs193922803,aka c.7063C
RYR1,Rs193922809,gene considered causative for malignant hyperthermia
RYR1,Rs193922878,p.L4838V
RYR1,Rs193922878,p.Leu4838Val
RYR1,Rs1801086,both are pathogenic
RYR1,Rs193922878,malignant hyperthermia
RYR1,Rs28933396,central core disease
RYR1,Rs63749869,congenital neuromuscular disease
RYR1,Rs193922878,rs193922878
RYR1,Rs121918595,heterozygous
RYR1,Rs193922803,(p.Arg2355Trp lub R2355W)
RYR1,Rs121918595,RYR1 gene
RYR1,Rs118192162,increased susceptibility
RYR1,Rs118192162,malignant hyperthermia
RYR1,Rs118192163,hyperthermia
RYR1,Rs118192167,c.14387A>G (p.Tyr4796Cys or Y4796C)23
RYR1,Rs118192167,i5000022
RYR1,Rs121918592,rs121918592
RYR1,Rs121918592,in the RYR1 gene
RYR1,Rs121918592,heterozygous
RYR1,Rs121918595,rs121918595
RYR1,Rs121918595,Thr4826Ile
RYR1,Rs121918595,T4826
RYR1,Rs121918595,SNP
RYR1,Rs121918592,increased susceptibility to malignant hyperthermia
RYR1,Rs121918595,increased susceptibility to malignant hyperthermia
RYR2,Rs2056387,brachial artery endothelial function
RYR2,Rs2056387,treadmill exercise responses
RYR2,Rs2056387,echocardiographic dimensions
RYR2,Rs2056387,brachial artery endothelial function
RYR2,Rs2056387,Framingham Heart Study
SACS,I5012578,Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS)
SACS,I5012578,neurodegenerative disorder
SACS,I5012578,Charlevoix
SACS,I5012578,Saguenay-Lac-St-Jean
SARDH,Rs149481147,sarcosinemia
SARDH,Rs149391396,cause sarcosinemia
SARDH,Rs140559739,the variant (rare) allele
SARDH,Rs140559739,gene that has been reported to cause sarcosinemia
SARDH,Rs140559739,condition brought about through autosomal recessive inheritance
SCARB1,Rs4238001,in-depth review
SCARB1,Rs4238001,hyperalphalipoproteinemia
SCARB1,Rs4238001,hyperalphalipoproteinemia.
SCARB1,Rs4238001,high-density lipoprotein
SCARB1,Rs4238001,independent predictor
SCARB1,Rs4238001,Scavenger receptor class B
SCARB1,Rs1672879,European Americans
SCARB1,Rs1672879,Hispanic Americans
SCARB1,Rs1672879,American
SCARB1,Rs1672879,European
SCARB1,Rs1672879,African
SCARB1,Rs1672879,Hispanic
SCARB1,Rs1672879,African Americans
SCARB1,Rs1672879,postmenopausal women
SCG3,Rs16964465,obesity
SCG3,Rs16964476,obesity
SCN2A,Rs121917750,"benign familial neonatal-infantile seizures (BFNIS), type 3."
SCN3A,Rs758906955,NM_006922.3(SCN3A):c.4114A>G
SCN3A,Rs758906955,p.Met1372Val)OMIM
SCN4A,Rs774453167,Sudden Infant Death Syndrome
SCN4A,Rs751368967,exome analysis
SCN4A,Rs751368967,minor allele
SCN4A,Rs751368967,SCN4A gene variant
SCN4A,Rs751368967,Sudden Infant Death Syndrome
SCN5A,Rs137854604,T allele of rs137854604 was seen in a 39-year-old Japanese patient who was admitted to the hospital for recurrent syncope
SCN5A,Rs137854604,suffered an episode of spontaneous ventricular fibrillation
SCN5A,Rs137854604,did not have typical ECG findings of Brugada syndrome
SCN8A,Rs1601012,Chinese
SCN8A,Rs1601012,Genetic polymorphisms
SCN8A,Rs1601012,suicidal behavior in psychiatric disorders
SCN8A,Rs1601012,psychiatric disorders
SCN8A,Rs1601012,suicidal behavior
SCN8A,Rs1601012,Chinese population
SCN9A,Rs6746030,increased pain
SCN9A,Rs4369876,It is unclear how this can be reconciled with the reports of decreased pain
SCN9A,Rs4369876,had a small fiber neuropathy and increased pain
SCN9A,Rs4369876,and/or lower post-operative pain following surgery
SCN9A,Rs4369876,associated with congenital insensitivity to pain
SCN9A,Rs4369876,increased pain
SCN9A,Rs4369876,lower post-operative pain following surgery
SCN9A,Rs4369876,fiber neuropathy
SCN9A,Rs121908916,SNP
SCN9A,Rs121908916,insensitivity to pain
SCN9A,Rs121908909,insensitivity to pain
SCN9A,Rs121908908,S459X
SCN9A,Rs121908908, p.Ser459Ter
SCN9A,Rs121908908,c.1376C>
SCN9A,Rs121908908,rs121908908
SCN9A,Rs4369876,congenital insensitivity to pain 
SDHB,Rs398123690,a hereditary cancer predisposing syndrome
SDHB,Rs398123690,pheochromocytomas
SDHD,Rs11214077,cancers
SERPINA1,Rs709932,pulmonary emphysema
SERPINA1,Rs709932,pulmonary emphysema
SERPINA1,Rs267606950,"c.552delC (p.Tyr184Terfs, Y160X, p.Tyr160Ter)"
SERPINA1,Rs17751769,pulmonary emphysema
SERPINA1,Rs1303, rs1303
SERPINA1,Rs17580,"rs17580 PiS variant is most associated with risk of developing COPD, especially in smokers, but it's association with emphysema is variable"
SERPINA1,Rs17580,but there is no known association with liver disease or cystic fibrosis
SERPINA1,Rs17580,cystic fibrosis
SERPINA1,Rs17580,found no association between rs17580 and risk for cholangiocarcinomaAlpha-1 Antitrypsin Deficiency
SERPINC1,Rs121909567,dominantly inherited
SERPINC1,Rs121909567,rs121909567(T)
SERPINC1,Rs121909567,antithrombin III deficiency
SERPINC1,Rs121909567,recessively inherited mutation
SERPINC1,Rs121909567,Mutations
SERPINC1,Rs121909567,rare mutation
SERPINC1,Rs121909567,antithrombin III deficiency
SERPINC1,Rs121909567,SERPINC1
SERPINE1,Rs1799889,coronary artery disease
SERPINE1,Rs1799889,abdominal aortic aneurysm
SERPINE1,Rs1799889,myocardial infarction
SERPINE1,Rs1799889,Finnish
SERPINE1,Rs1799889,coronary heart disease
SERPINE1,Rs1799889,pneumonia
SERPINE1,Rs1799889,female
SERPINE1,Rs1799889,Polycystic ovary syndrome
SERPINE1,Rs1799889,female
SERPINE1,Rs1799889,endometriosis
SERPINE1,Rs1799889,Alzheimer's disease
SERPINE1,Rs1799889,Chinese Han population
SERPINE1,Rs1799889,adolescent girls
SERPINE1,Rs1799889,polycystic ovary syndrome
SERPINE1,Rs1799889,ovarian cancer
SERPINE1,Rs1799889,atherosclerosis
SERPINE1,Rs1799889,rheumatoid arthritis
SERPINE1,Rs1799889,colorectal cancer
SERPINE1,Rs1799889,depression
SERPINE1,Rs1799889,Alzheimer's disease
SERPINE1,Rs1799889,United States of selected candidate gene variants
SERPINE1,Rs1799889,depression
SERPINE1,Rs1799889,abdominal aortic aneurysm
SERPINE1,Rs1799889,rheumatoid arthritis
SERPINE1,Rs1799889,colorectal cancer
SERPINE1,Rs1799889,plasminogen activator inhibitor
SERPINE1,Rs1799889,atherosclerosis
SERPINE1,Rs1799889,coronary artery disease
SERPINE1,Rs1799889,myocardial infarction
SERPINE1,Rs1799889,Plasminogen activator inhibitor-1
SERPINE1,Rs1799889,nucleotide polymorphisms
SERPINE1,Rs1799889,coronary heart disease.
SERPINE1,Rs1799889,Polycystic ovary syndrome
SERPINE1,Rs1799889,female reproductive disorders
SERPINE1,Rs1799889,pneumonia
SERPINE1,Rs1799889,endometriosis
SERPINE1,Rs1799889,polymorphisms
SERPINE1,Rs1799889,Alzheimer's
SERPINE1,Rs1799889,disease
SERPINE1,Rs1799889,Genetic polymorphisms
SERPINE1,Rs1799889,polycystic ovary syndrome
SERPINE1,Rs1799889,fibrinolytic
SERPINE1,Rs1799889,ovarian cancer
SERPINE1,Rs1799889,Polymorphisms
SERPINE1,Rs1799889,genetic polymorphism
SERPING1,Rs121907950,M_000062.2 (SERPING1): c.1394C> T (p.Ala465Val) 23 andMe name: i5000466
SERPING1,Rs2511989,odds ratio of 0.44 (CI: 0.31 to 0.64)
SERPING1,Rs2511989,odds ratio of 0.63 (CI: 0.47 to 0.84) for age-related macular degeneration
SERPING1,Rs2511989,protective effect against age related macular degeneration
SERPING1,Rs1085307611,936delC (
SERPING1,Rs1085307611,NM_000062
SERPING1,Rs1085307611,.2
SERPING1,Rs1085307611,SERPING1):
SERPING1,Rs1064793350,c.512C>A: i6018350
SERPING1,Rs1064793350,(p.Pro171Leu)23
SERPING1,Rs1064793350,NM_000062.2(SERPING1):c.512C>T
SETD1A,Rs869312832,schizophrenia
SETD1A,Rs869312832,Rare loss-of-function variants in SETD1A
SETD1A,Rs869312832,schizophrenia and developmental disorders
SETD1A,Rs869312832,developmental disorders
SETD1A,Rs869312830,developmental disorders
SETD1A,Rs869312830,schizophrenia
SETD1A,Rs869312830,schizophrenia and developmental disorders
SEZ6L,Rs663048,rs663048
SEZ6L,Rs663048,lung cancer
SGSH,Rs1459579613,c.1093C>T
SH2D1A,Rs111033625,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033625,type 1
SH2D1A,Rs111033628,X-linked Lymphoproliferative syndrome
SH2D1A,Rs111033629,"Lymphoproliferative syndrome, type 1"
SH2D1A,Rs587777612,Lymphoproliferative syndrome
SH2D2A,Rs926103,Swedish
SH2D2A,Rs926103,genetic susceptibility of multiple sclerosis
SH2D2A,Rs926103,Danish
SH2D2A,Rs926103,Promethease
SH2D2A,Rs926103,multiple sclerosis 
SH2D2A,Rs926103,Multiple sclerosis
SH2D2A,Rs926103,associated with multiple sclerosis in Norwegian
SH3TC2,Rs80338918,Charcot-Marie-Tooth type 4C neuropathy
SH3TC2,Rs80338920,Charcot-Marie-Tooth type 4C neuropathy
SH3TC2,Rs80338923,Charcot-Marie-Tooth type 4C neuropathy
SH3TC2,Rs80338925,Charcot-Marie-Tooth type 4C neuropathy
SHANK3,Rs397514705,Phelan-McDermid syndrome
SHANK3,Rs397514705,"seizures, mild facial dysmorphism, and an autism-like disorder"
SHANK3,Rs397514705,African-American woman with developmental delay
SHANK3,Rs397514705,autism
SHANK3,Rs397514705,Phelan-McDermid syndrome
SHANK3,Rs397514705,autism-like disorder
SHANK3,Rs397514705,mild facial dysmorphism
SHANK3,Rs397514705,seizures
SHANK3,Rs397514705,evelopmental delay
SHANK3,Rs397514705,25-year-old African-American woman
SHANK3,Rs397514705,autism
SHANK3,Rs397514705,chromosome 22
SHANK3,Rs397514705,rare variant
SHBG,Rs727428,obesity
SHBG,Rs727428,insulin resistance
SHBG,Rs727428,type 2 diabetes mellitus
SHBG,Rs727428,globulin hormone
SHBG,Rs727428,estradiol
SHBG,Rs727428,testosterone
SHBG,Rs727428,steroid hormones
SHBG,Rs6258,risk of gastric cancer
SHBG,Rs727428,This SNP was previously associated with risk of type 2 diabetes mellitus.
SHBG,Rs727428,independent of the effects of insulin resistance and obesity
SHBG,Rs727428,rendering them biologically unavailable
SHBG,Rs727428,SHBG binds steroid hormones
SHBG,Rs12150660,gastric cancer
SHBG,Rs12150660,testosterone levels
SHBG,Rs727428,sex-hormone
SHMT1,Rs9909104,epithelial ovarian cancer
SHMT1,Rs9909104,primary epithelial ovarian cancer
SHMT1,Rs9909104,epithelial ovarian cancer
SHMT1,Rs9909104,SHMT1 intron 5 A>G (rs9909104)
SHMT1,Rs9909104,Caucasian cases 
SIPA1,Rs2448490,"This study also found that rs2448490 can be combined with an independent predictor of metastasis free survival, rs9306160, to yield an even stronger prognostic."
SIPA1,Rs3741378,rs746429
SIPA1,Rs3741378,rs931127
SIPA1,Rs3741378, breast cancer rs3741378(C)
SIPA1,Rs2448490,homozygotes showed a reduced metastasis risk compared to rs2448490(G) allele carriers.
SIPA1,Rs3741378,lymph node metastasis
SIPA1,Rs2448490,rs2448490 
SIPA1,Rs2448490,breast cancer
SIPA1,Rs2448490,breast cancer
SIPA1,Rs2448490,breast cancer
SIPA1,Rs2448490,breast cancer
SIPA1,Rs2448490,1 SIPA1 gene
SIX5,Rs55938914,pathogenic variant
SLC12A3,Rs1529927,high blood pressure
SLC12A6,I5012575,Agenesis of the Corpus Callosum with Peripheral Neuropathy
SLC12A6,Rs121908428,rs121908428
SLC12A6,Rs121908428,R675X
SLC12A6,Rs121908428,SNP
SLC12A6,Rs121908428,SLC12A6 gene
SLC12A6,Rs121908428,risk allele
SLC12A6,Rs121908428,rs121908428(T)
SLC12A6,Rs121908428,ACCPN mutations
SLC12A6,Rs121908428,SNP
SLC12A6,Rs121908428,dbSNP
SLC12A6,Rs121908428,SNP
SLC12A6,Rs121908428,i5012575
SLC12A6,Rs121908428,risk allele
SLC15A2,Rs138745887,bipolar disorde
SLC15A2,Rs138745887,bipolar disorder
SLC15A2,Rs138745887,Bipolar Disorder
SLC15A2,Rs138745887,Familial Bipolar Disorder
SLC15A2,Rs138745887,variants speculated
SLC17A5,Rs80338794,Salla disease
SLC17A5,Rs80338794,neurodegenerative disease
SLC18A1,Rs56575139,genomic location
SLC19A1,Rs12483377,spina bifida and conotruncal heart defects
SLC19A1,Rs12483377,aka c.4309G>A 
SLC19A1,Rs12483377,female reproductive disorders
SLC19A1,Rs12483377,endometriosis
SLC1A2,Rs4755404,polymorphisms
SLC1A2,Rs4755404,schizophrenia.
SLC1A2,Rs4756224,polymorphisms
SLC1A2,Rs4534557,schizophrenia.
SLC1A2,Rs752949,polymorphisms
SLC1A2,Rs752949,schizophrenia.
SLC1A2,Rs781379291,pathogenic variant
SLC1A2,Rs4756224,schizophrenia.
SLC1A2,Rs4534557,polymorphisms
SLC1A2,Rs1923295,schizophrenia.
SLC1A2,Rs3838796,polymorphisms
SLC1A2,Rs1923298,schizophrenia.
SLC1A2,Rs1923298,polymorphisms
SLC1A2,Rs1923295,polymorphisms
SLC1A2,Rs1885343,schizophrenia.
SLC1A2,Rs1885343,polymorphisms
SLC1A2,Rs1570216,schizophrenia.
SLC1A2,Rs1570216,polymorphisms
SLC1A2,Rs3838796,schizophrenia.
SLC22A4,Rs3792876,rs1050152(T)
SLC22A4,Rs3792876,Crohn's disease
SLC22A4,Rs3792876,rs1051052
SLC22A4,Rs3792876,"information for rs1050152 was accidentally entered for this SNP, rs3792876"
SLC22A4,Rs3792876,rheumatoid arthritis
SLC22A4,Rs272893,Crohn's disease
SLC22A4,Rs272893,Crohn's
SLC22A4,Rs272879,susceptibility to severe malaria
SLC22A4,Rs1050152,Crohn's disease
SLC22A4,Rs1050152,rs1050152
SLC22A4,Rs3792876,autoimmune disease
SLC22A5,Rs2631372,Crohn's disease
SLC22A5,Rs2631372,Crohn's disease
SLC22A5,Rs28383481,minor allele
SLC26A2,Rs386833492,Table S6
SLC26A2,Rs386833492,Mendelian disease
SLC26A2,Rs386833492,SNP
SLC26A2,Rs386833492,biocurators
SLC26A2,Rs386833492,Pathogenic Regulatory Variants
SLC26A2,Rs386833492,Whole-Genome
SLC26A2,Rs386833492,Mendelian disease
SLC26A2,Rs386833492,Mendelian Disease
SLC26A4,Rs111033244,Pendred Syndrome
SLC26A4,Rs111033244,hearing loss
SLC26A4,Rs111033244,hearing loss condition known as Pendred Syndrome
SLC26A4,Rs111033220,hearing loss
SLC26A4,Rs111033220,Pendred Syndrome
SLC26A4,Rs111033220,Inherited recessively
SLC26A4,Rs111033220,p.Thr410Met 
SLC26A4,Rs111033220,c.1229C>T
SLC26A4,Rs111033220,enlarged vestibular aqueduct syndrome
SLC26A4,Rs111033212,with enlarged vestibular aqueduct.
SLC26A4,Rs111033212,to be pathogenic for Pendred Syndrome or a form of deafness
SLC26A4,Rs111033212,pathogenic for Pendred Syndrome or a form of deafness
SLC26A4,I5000002,Pendred Syndrom
SLC26A4,I5000002,Hearing loss
SLC26A4,I5000002,Pendred Syndrome
SLC26A4,I5000002,Hearing loss
SLC26A4,Rs111033220,rs111033220
SLC28A3,Rs56350726,ribavirin therapy
SLC28A3,Rs56350726,protection against anemia in patients with chronic hepatitis C.
SLC28A3,Rs56350726,nucleoside transporters
SLC2A9,Rs13129697,lower uric acid levels
SLC2A9,Rs13129697,variation in serum uric acid levels
SLC2A9,Rs16890979,Atherosclerosis Risk
SLC2A9,Rs3775948,gout association
SLC2A9,Rs3775948,ambiguous flipping
SLC2A9,Rs3775948,C/G alleles
SLC2A9,Rs3775948,SNP
SLC2A9,Rs3775948,interpreting alleles
SLC34A3,Rs121918237,hypophosphatemic bone disease
SLC37A4,Rs80356491,people of European ancestry
SLC37A4,Rs80356491,glycogen storage disease
SLC37A4,Rs121908980,Glycogen storage disease type Ib
SLC37A4,Rs121908980,neutropenia
SLC37A4,Rs121908980,Glycogen storage disease type Ib without neutropenia.
SLC39A4,Rs121434288,p.Gly526Arg
SLC45A2,Rs183671,associated with hair graying in these mixed Latin American populations.
SLC45A2,Rs183671,facial and scalp hair features
SLC45A2,Rs183671,hair graying
SLC45A2,Rs183671,rs183671(C) allele 
SLC45A2,Rs183671,"nfluencing facial and scalp hair features,"
SLC45A2,Rs16891982,Squamous Cell Carcinoma
SLC45A2,Rs16891982,oculocutaneous and ocular albinism
SLC45A2,Rs16891982,cutaneous malignant melanoma (CMM)
SLC45A2,Rs16891982,having black hair color
SLC45A2,Rs16891982,malignant melanoma
SLC45A2,Rs16891982,skin pigmentation
SLC45A2,Rs16891982,skin cancer
SLC4A1,Rs121912749,bipolar disorde
SLC4A1,Rs121912749,Bipolar Disorder
SLC4A1,Rs121912749,Familial Bipolar Disorder
SLC4A1,Rs121912749,variants speculated
SLC4A1,Rs121912749,bipolar disorder
SLC5A2,Rs61742739,familial form of renal glycosuria
SLC5A2,Rs61742739,glycosuria
SLC5A2,Rs61742739,glycosuria
SLC5A2,Rs61742739,familial form of renal glycosuria
SLC5A2,Rs61742739,heterozygous for rs61742739(G)
SLC6A2,Rs734980,better response
SLC6A2,Rs998424,attention deficit hyperactivity disorder symptoms from age 2 to 3
SLC6A2,Rs998424,ADHD
SLC6A2,Rs998424,attention-deficit/hyperactivity disorder symptoms in adults.
SLC6A2,Rs734980,ADHD
SLC6A2,Rs3785152,better response to treatment of ADHD with atomoxetine
SLC6A2,Rs1532701,depression
SLC6A2,Rs3785143,with Attention deficit hyperactivity disorder
SLC6A2,Rs3785143,T allele
SLC6A2,Rs1566652,ADHD
SLC6A2,Rs1566652,better response
SLC6A2,Rs1532701,antidepressants
SLC6A2,Rs3785152,T allele
SLC6A3,Rs27072,Canadian population-based sample of same-age twins
SLC6A3,Rs27072,polymorphism of the dopamine transporter gene
SLC6A3,Rs27072,early smoking
SLC6A3,Rs27072,nicotine dependence
SLC6A3,Rs27072,dopamine and serotonin transporter genes
SLC6A3,Rs27072,antisocial personality disorder
SLC6A3,Rs27072,alcoholics
SLC6A3,Rs27072,dopamine transporter gene polymorphisms
SLC6A3,Rs27072,chlorpromazine and clozapine and on extrapyramidal syndrome in schizophrenia
SLC6A3,Rs464049,pediatric bipolar disorder
SLC6A3,Rs464049,schizophrenia
SLC6A3,Rs27072,ADHD
SLC6A3,Rs464049,tuberculosis
SLC6A3,Rs464049,schizophrenia
SLC6A3,Rs464049,Croatians
SLC6A3,Rs464049,increased risk of schizophrenia
SLC6A3,Rs464049,pediatric bipolar disorder
SLC6A3,Rs464049,cigarette smoking behaviors
SLC6A3,Rs27072,Alcohol Dependence
SLC6A3,Rs27072,dopamine transporter gene 
SLC6A3,Rs27072,attention-deficit hyperactivity disorder
SLC6A3,Rs27072,dopamine transporter gene
SLC6A3,Rs27048,"associated with more severe symptoms upon alcohol withdrawal,"
SLC6A3,Rs27048,such as seizures
SLC6A3,Rs27072,dopamine transporter
SLC6A3,Rs27072,severe symptoms
SLC6A3,Rs27072,alcohol withdrawal
SLC6A3,Rs27072,seizures
SLC6A3,Rs27072,polymorphism
SLC6A3,Rs27072,ADHD
SLC6A3,Rs27072,Caucasian alcohol-dependent patients
SLC6A3,Rs27072,dopamine transporter gene
SLC6A3,Rs27072,tobacco and alcohol use
SLC6A3,Rs27072,19-year-olds
SLC6A3,Rs27072,dopamine transporter gene
SLC6A3,Rs27072,schizophrenia
SLC6A3,Rs27072,Dopamine Transporter Gene
SLC6A3,Rs27072,Expression in Human Brain
SLC6A3,Rs27072,Bipolar Disorder
SLC6A3,Rs27072,Canadian children aged 6 to 16
SLC6A4,Rs140701,SNPs
SLC6A4,Rs25528,rigid-compulsive behaviors.
SLC6A4,Rs140701,rs4583306
SLC6A4,Rs140701, rs140701
SLC6A4,Rs140701,rs3794808
SLC6A4,Rs140701,SNP 
SLC6A4,Rs25528,susceptibility to autism
SLC6A4,Rs140701,increased risk for panic disorder
SLC6A4,Rs140701,A-A-G
SLC6A4,Rs140701,rs140701(A)
SLC6A4,Rs140701,social anxiety disorder
SLC6A4,Rs11080122,Neuroticism
SLC6A4,Rs11080122,Neuroticism
SLC6A4,Rs140701,rs140701(A)
SLC6A8,Rs80338740,novel mutation
SLC6A8,Rs80338740,creatine deficiency syndrome
SLC9A9,Rs9828519,multiple sclerosis
SLC9A9,Rs9828519,sclerosis disease
SLC9A9,Rs1995356,genomewide association
SLC9A9,Rs1995356,depression
SLC9A9,Rs1995356,depression
SLCO1B1,Rs2306283,neonatal hyperbilirubinemia
SLCO1B1,Rs2306283,atorvastatin-induced myalgia
SLCO1B1,Rs2306283,colorectal cancer
SLCO1B1,Rs2306283,irinotecan-associated gastrointestinal toxicity
SLCO1B1,Rs2306283,type 2 diabetes
SLCO1B1,Rs2306283,statin intolerance
SLCO1B1,Rs2306283,Gilbert's syndrome
SLCO1B1,Rs2306283,Pazopanib-induced hyperbilirubinemia
SLCO1B1,Rs2306283,unconjugated hyperbilirubinemia
SLCO1B1,Rs2306283,familial hypercholesterolemia
SLCO1B1,Rs2306283,cancer
SLCO1B1,Rs2306283,bilirubin levels
SLCO1B1,Rs2306283,hyperbilirubinemia
SLCO1B1,Rs2306283,statin intolerance
SLCO1B1,Rs2306283,colorectal cancer
SLCO1B1,Rs2306283,rs2306283
SLCO1B1,Rs2306283,reduced plasma concentrations of repaglinide
SLCO1B1,Rs2306283,increased hepatic uptake
SLCO1B1,Rs2306283,statin-related myopathy
SLCO1B1,Rs2306283,hypercholesterolemia
SMN1,Rs104893933,mutation
SMN1,Rs104893933,recessively inherited type 1 spinal muscular atrophy
SMN1,Rs104893933,mutation in the SMN1 gene on chromosome 5
SMN1,Rs104893933,mutation associated with the recessively inherited type 1 spinal muscular atrophy
SMOC2,Rs13208776,vitiligo
SMPD1,Rs120074118,Niemann-Pick Disease Type A
SMPD1,Rs120074124,Disease Type A
SMPD1,Rs120074118,Arg610del
SMPD1,Rs120074118,Niemann-Pick Disease Type A
SMPD1,Rs120074117,Niemann-Pick Disease type B
SMPD1,Rs120074117,Niemann-Pick Disease type A
SMPD1,Rs120074117,Niemann-Pick Disease Type A
SNAP25,Rs353016,higher intelligence in children
SNAP25,Rs353016,higher intelligence in children
SNAP25,Rs362988,variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder
SNAP25,Rs362988,eastern Indian attention deficit hyperactivity disorder probands
SNAP25,Rs363043,SNAP25 
SNAP25,Rs363043,higher intelligence
SNCA,Rs356168,slight increase in risk for Parkinson's
SNCA,Rs356168,slightly reduced risk for Parkinson's disease
SNX10,Rs587777490,osteopetrosis
SNX10,Rs772724819,osteopetrosis
SNX10,Rs772724819,mutation pathogenic for osteopetrosis
SNX19,Rs2298566,heart disease
SNX19,Rs2298566,coronary heart disease
SOCS3,Rs4969168,atopic dermatitis
SOCS3,Rs4969168,glucose homeostasis traits
SOCS3,Rs4969168,obesity
SOCS3,Rs4969168,type 2 diabetes mellitus
SOCS3,Rs4969168,chronic hepatitis C
SOCS3,Rs4969168,Hispanic Americans
SOCS3,Rs4969168,obesity
SOCS3,Rs4969168,glucose homeostasis traits
SOCS3,Rs4969168,hepatitis C virus infection
SOCS3,Rs4969168,type 2 diabetes mellitus
SOCS3,Rs4969168,influence patient response to antiviral therapy in chronic hepatitis C
SOCS3,Rs4969168,atopic dermatitis
SOD1,Rs7277748,ALS
SOD1,Rs121912438,polymorphism
SOD1,Rs121912441,amyotrophic lateral sclerosis
SOD1,Rs1041740,cardiovascular mortality
SOD1,Rs121912438,polymorphism of the SOD1 gene
SOD2,Rs4880,increased risk of acoustic neuroma
SOD2,Rs5746136,A=
SOD2,Rs4880,association with Alzheimer's disease
SOD2,Rs4880,slightly worse disease-free survival rates
SOD2,Rs4880,slightly less side effects
SOD2,Rs4880,worse survival rates
SOD2,Rs4880,carriers with breast cancer
SOD2,Rs4880,various types of brain tumors
SOD2,Rs4880,slightly associated with Alzheimer's disease
SOD2,Rs4880,"risk for aggressive forms of the cancer (OR=2.3, CI: 1.0-4.9). rs4880(C;T) prostate cancer patients"
SOD2,Rs4880,higher iron intake level
SOD2,Rs4880,prostate cancer
SOD2,Rs4880,mesothelioma were even higher for patients lacking obvious exposure to asbestos fibers
SOD2,Rs4880,increased risk of malignant pleural mesothelioma
SOD2,Rs4880,10 fold higher risk for heart disease
SOD2,Rs4880,reduce enzyme activity
SOD2,Rs4880,significant increase in grade 2 late rectal bleeding
SORCS2,Rs10937823,the minor allele (T) was found to be associated with bipolar disease
SORCS2,Rs10937823,s10937823 was again found to be significantly associated with bipolar disorder 
SORCS2,Rs10937823,replicated the association between rs10937823 and bipolar disorder
SORCS2,Rs10937823,the highest risk of bipolar disorder was associated with presence of both rs10937823 and rs1170191
SORCS2,Rs10937823,alterations to the SORCS2 gene can lead to neuronal dysfunction.
SORCS2,Rs10937823,gene on chromosome 4p16.1 is found to be highly expressed in the mature human brain and kidney.
SORCS2,Rs10937823,SORCS2
SORCS2,Rs10937823,rs10937823
SORCS2,Rs10937823,neuronal dysfunction.
SORCS2,Rs10937823,neuronal apoptosis
SORCS2,Rs10937823,dbSNPThe SORCS2
SORCS2,Rs10937823,play a role in bipolar disorder
SORL1,Rs11218343,Alzheimer’s disease
SORL1,Rs11218350,increased (or decreased) risk for Alzheimer's disease
SORL1,Rs11218350,Caucasians
SORL1,Rs11218350,Alzheimer's disease
SORL1,Rs1784931,increased (or decreased) risk for Alzheimer's disease
SORL1,Rs1784931,Caucasians
SORL1,Rs726601,Alzheimer's disease
SORL1,Rs726601,with increased (or decreased) risk for Alzheimer's disease
SOS1,Rs397517164,Glu108Lys
SOS1,Rs397517164,322G
SOS1,Rs397517164,aka 
SOS1,Rs397517164,Glu
SOS1,Rs397517164,Lys
SOX5,Rs11047102,systemic sclerosis
SOX5,Rs11047102,systemic sclerosis
SOX5,Rs1464500,schizophrenics
SOX5,Rs869025321,Lamb-shaffer syndrome
SOX5,Rs869025321,autosomal dominant mutation
SPR,Rs750423023,Pathogenic Regulatory Variants
SPR,Rs750423023,Mendelian disease
SPR,Rs750423023,biocurators
SPR,Rs750423023,Table S6
SPR,Rs750423023,SNP
SPR,Rs750423023,Mendelian Disease
SPR,Rs750423023,Whole-Genome
SPR,Rs387907200,p.Gly102Cys
SPR,Rs587776777,AGAAC
SPR,Rs398122922,596
SPR,Rs750423023,Mendelian disease
SPR,Rs1876487,brain tissue
SPR,Rs1876487,Parkinson's disease
SPR,Rs1876487,Parkinson's disease
SPTA1,Rs35948326,"rs35948326,"
SPTA1,Rs35948326, c.2909C>
SRD5A2,Rs12470143,Polycystic ovary syndrome
SRD5A2,Rs9282858,prostate cancer
SREBF1,Rs1889018,type-2 diabetes
SREBF1,Rs1889018,insulin sensitivity
SREBF1,Rs1889018,type-2 diabetes
SREBF1,Rs1889018,Caucasian patients
SRRM2,Rs149019598,mutation
SRRM2,Rs149019598,co-segregated with the disease
SRRM2,Rs149019598,Papillary thyroid carcinoma
SSUH2,Rs116840802,A CAV3 microdeletion
SSUH2,Rs116840802,A CAV3 microdeletion
SSUH2,Rs116840802,A CAV3 microdeletion
SSUH2,Rs28936685,rippling muscle disease
STAG3,Rs587777267,Gln188Argfs
STAT3,Rs4796793,kidney cancer
STAT3,Rs4796793,interferon-alpha immunotherapy for metastatic kidney cancer
STAT3,Rs4796793,he most significant predictor of IFN-alpha response
STAT4,Rs7582694,SLE
STAT4,Rs7582694,primary Sjogren's syndrome
STAT4,Rs7582694,systemic lupus erythematosus
STAT4,Rs7582694,systemic lupus erythematosus (SLE)
STAT4,Rs7582694,colonic Crohn's disease
STAT4,Rs7582694,systemic lupus erythematosus
STAT4,Rs7582694,single-nucleotide polymorphism
STAT4,Rs7582694,SLE
STAT4,Rs7582694,SLE
STAT4,Rs7582694,systemic lupus erythematosus
STAT4,Rs7582694,systemic lupus erythematosus (SLE)
STAT4,Rs7582694,systemic lupus erythematosus
STAT4,Rs7582694,systemic lupus erythematosus
STAT4,Rs7582694,Crohn's disease
STAT4,Rs7582694,systemic lupus erythematosus
STAT4,Rs7582694,Sjogren's syndrome
STAT4,Rs7582694,systemic lupus erythematosus (SLE)
STAT4,Rs3821236,risk of Systemic lupus erythematosus.
STAT4,Rs7582694,SLE
STAT5B,Rs9900213,interferon alpha
STAT5B,Rs9900213,chronic myeloid leukemia
STAT5B,Rs9900213,STAT3 expression
STAT5B,Rs9900213,polymorphism
STK11,Rs1131690925,p.Gln123Ter
SULT1A1,Rs9282861,defines the SULT1A1 2 allele
SURF1,Rs782316919,Associated with Leigh syndrome
SURF1,Rs28933402,Leigh syndrome
SURF1,Rs28933402,more common in some French-Canadian populations
SURF1,Rs28933402,Leigh syndrome
SURF1,Rs28933402,French-Canadian populations
SURF1,Rs782316919,Leigh syndrome
TAF1,Rs864321627,Ile
TAF1,Rs864321627,Thr
TAP2,Rs241448,Alzheimer's disease
TAP2,Rs241448,susceptibility to the disease
TAP2,Rs241448,viral infections such as herpes
TAP2,Rs241448,HIV and HSV-1 viruses
TAP2,Rs241448,Alzheimer patients
TARDBP,Rs387906334,SNP
TARDBP,Rs387906334,Mendelian disease
TARDBP,Rs387906334,biocurators
TARDBP,Rs387906334,Table S6
TARDBP,Rs387906334,Pathogenic Regulatory Variants
TARDBP,Rs387906334,Whole-Genome
TARDBP,Rs387906334,Mendelian disease
TARDBP,Rs387906334,Mendelian Disease
TAS2R38,Rs10246939,rs10246939
TAS2R38,Rs10246939,"the ""tasting"" allele"
TAZ,Rs387907218,"Barth syndrome,"
TAZ,Rs387907218,3-Methylglutaconic aciduria type 2
TAZ,Rs104894942,"Barth syndrome,"
TAZ,Rs587776741,3-Methylglutaconic aciduria type 2
TAZ,Rs587776741,"Barth syndrome,"
TAZ,Rs132630277,3-Methylglutaconic aciduria type 2
TAZ,Rs104894937,3-Methylglutaconic aciduria type 2
TAZ,Rs104894942,3-Methylglutaconic aciduria type 2
TAZ,Rs104894941,3-Methylglutaconic aciduria type 2
TAZ,Rs104894941,"Barth syndrome,"
TAZ,Rs104894937,"Barth syndrome,"
TAZ,Rs132630277,"Barth syndrome,"
TBC1D4,Rs61736969,higher 2 hour plasma glucose
TBC1D4,Rs61736969,and serum insulin
TBC1D4,Rs61736969,and subset of diabetes that features deterioration of postprandial glucose homeostasis
TBX15,Rs984225,excessive hairiness
TBX21,Rs9910408,asthma
TBX21,Rs9910408,airway hyperresponsiveness
TBX21,Rs2240017,hese heterozgotes are reported to improve better over time in response to corticosteroid treatment for asthma than the rs2240017(G;G) homozygotes
TBX21,Rs2074190,predictive accuracy of 92%.
TBX21,Rs2074190,Japanese population
TBX21,Rs2074190,homozygotes
TBX21,Rs2074190,aspirin-induced asthma
TCF7L2,Rs12255372,Breast cancer.
TCF7L2,Rs12255372,aggressive prostate cancer
TCF7L2,Rs12255372,type-2 diabetes
TCF7L2,Rs12255372,"type-2 diabetes,"
TCF7L2,Rs10885406,type-2 diabetes
TCF7L2,Rs12255372,breast cancer 
TCN2,Rs1801198,cancer
TCN2,Rs1801198,Polish
TCOF1,Rs2255796,excess maternal transmission
TCOF1,Rs2255796,cleft palate
TCOF1,Rs2255796,excess maternal transmission
TCOF1,Rs2255796,cleft palate
TCOF1,Rs15251,cleft palate
TCOF1,Rs15251,excess maternal transmission
TCOF1,Rs15251,cleft palate
TCOF1,Rs15251,excess maternal transmission
TEK,Rs387906745,cause Multiple cutaneous and mucosal venous malformations
TERC,Rs199422279,Mendelian Disease
TERC,Rs199422277,Mendelian disease
TERC,Rs199422279,Mendelian disease
TERC,Rs199422279,Whole-Genome
TERC,Rs199422279,Pathogenic Regulatory Variants
TERC,Rs199422279,SNP
TERC,Rs199422280,Mendelian Disease
TERC,Rs199422279,biocurators
TERC,Rs199422279,Mendelian disease
TERC,Rs199422280,Mendelian disease
TERC,Rs199422280,Whole-Genome
TERC,Rs199422280,Pathogenic Regulatory Variants
TERC,Rs199422277,biocurators
TERC,Rs199422279,Table S6
TERC,Rs199422277,Table S6
TERC,Rs199422280,SNP
TERC,Rs199422277,Mendelian Disease
TERC,Rs199422277,Pathogenic Regulatory Variants
TERC,Rs199422277,Whole-Genome
TERC,Rs199422277,Mendelian disease
TERC,Rs199422276,Mendelian disease
TERC,Rs199422276,biocurators
TERC,Rs199422276,Table S6
TERC,Rs199422276,SNP
TERC,Rs199422276,Mendelian Disease
TERC,Rs199422276,Pathogenic Regulatory Variants
TERC,Rs199422276,Whole-Genome
TERC,Rs199422276,Mendelian disease
TERC,Rs199422275,Mendelian disease
TERC,Rs199422275,biocurators
TERC,Rs199422277,SNP
TERC,Rs199422280,Table S6
TERC,Rs199422275,Table S6
TERC,Rs199422280,Mendelian disease
TERC,Rs540289812,biocurators
TERC,Rs540289812,Table S6
TERC,Rs540289812,SNP
TERC,Rs540289812,Mendelian Disease
TERC,Rs540289812,Pathogenic Regulatory Variants
TERC,Rs540289812,Whole-Genome
TERC,Rs540289812,Mendelian disease
TERC,Rs199422287,Mendelian disease
TERC,Rs199422287,biocurators
TERC,Rs199422287,Table S6
TERC,Rs199422287,SNP
TERC,Rs199422287,Mendelian Disease
TERC,Rs199422287,Pathogenic Regulatory Variants
TERC,Rs199422287,Whole-Genome
TERC,Rs199422287,Mendelian disease
TERC,Rs199422284,Mendelian disease
TERC,Rs199422284,biocurators
TERC,Rs199422281,Mendelian disease
TERC,Rs199422281,Whole-Genome
TERC,Rs199422281,Pathogenic Regulatory Variants
TERC,Rs199422281,Mendelian Disease
TERC,Rs199422281,SNP
TERC,Rs540289812,Mendelian disease
TERC,Rs199422280,biocurators
TERC,Rs199422281,biocurators
TERC,Rs199422284,Mendelian disease
TERC,Rs199422284,Whole-Genome
TERC,Rs199422284,Pathogenic Regulatory Variants
TERC,Rs199422284,Mendelian Disease
TERC,Rs199422284,SNP
TERC,Rs199422284,Table S6
TERC,Rs199422281,Mendelian disease
TERC,Rs199422275,SNP
TERC,Rs199422281,Table S6
TERC,Rs199422275,Pathogenic Regulatory Variants
TERC,Rs199422268,biocurators
TERC,Rs199422268,Table S6
TERC,Rs199422268,SNP
TERC,Rs199422268,Mendelian Disease
TERC,Rs199422268,Pathogenic Regulatory Variants
TERC,Rs199422268,Whole-Genome
TERC,Rs199422268,Mendelian disease
TERC,Rs199422265,Mendelian disease
TERC,Rs199422265,biocurators
TERC,Rs199422265,Table S6
TERC,Rs199422265,SNP
TERC,Rs199422265,Mendelian Disease
TERC,Rs199422265,Pathogenic Regulatory Variants
TERC,Rs199422265,Whole-Genome
TERC,Rs199422265,Mendelian disease
TERC,Rs199422261,Mendelian disease
TERC,Rs199422261,biocurators
TERC,Rs199422260,Mendelian disease
TERC,Rs199422260,Whole-Genome
TERC,Rs199422260,Pathogenic Regulatory Variants
TERC,Rs199422260,Mendelian Disease
TERC,Rs199422260,SNP
TERC,Rs199422260,Table S6
TERC,Rs199422268,Mendelian disease
TERC,Rs199422260,biocurators
TERC,Rs199422261,Mendelian disease
TERC,Rs199422261,Whole-Genome
TERC,Rs199422261,Pathogenic Regulatory Variants
TERC,Rs199422261,Mendelian Disease
TERC,Rs199422261,SNP
TERC,Rs199422261,Table S6
TERC,Rs199422260,Mendelian disease
TERC,Rs199422269,Mendelian disease
TERC,Rs199422275,Mendelian Disease
TERC,Rs199422269,Pathogenic Regulatory Variants
TERC,Rs199422275,Whole-Genome
TERC,Rs199422275,Mendelian disease
TERC,Rs199422274,Mendelian disease
TERC,Rs199422274,biocurators
TERC,Rs199422274,Table S6
TERC,Rs199422274,SNP
TERC,Rs199422274,Mendelian Disease
TERC,Rs199422274,Pathogenic Regulatory Variants
TERC,Rs199422274,Whole-Genome
TERC,Rs199422274,Mendelian disease
TERC,Rs199422273,Mendelian disease
TERC,Rs199422273,biocurators
TERC,Rs199422273,Table S6
TERC,Rs199422273,SNP
TERC,Rs199422273,Mendelian Disease
TERC,Rs199422269,Whole-Genome
TERC,Rs199422273,Whole-Genome
TERC,Rs199422269,Mendelian Disease
TERC,Rs199422269,SNP
TERC,Rs199422269,Table S6
TERC,Rs199422269,Mendelian disease
TERC,Rs199422272,Mendelian disease
TERC,Rs199422272,Whole-Genome
TERC,Rs199422269,biocurators
TERC,Rs199422272,Mendelian Disease
TERC,Rs199422272,SNP
TERC,Rs199422272,Table S6
TERC,Rs199422272,biocurators
TERC,Rs199422272,Mendelian disease
TERC,Rs199422273,Mendelian disease
TERC,Rs199422272,Pathogenic Regulatory Variants
TERC,Rs199422273,Pathogenic Regulatory Variants
TERT,Rs2242652,skin cancer risk.
TERT,Rs2242652,telomere-maintaining
TF,Rs1799852,serum transferrin levels
TF,Rs1799852,H63D
TF,Rs1799852,C282Y 
TF,Rs1799852,transferrin saturation
TF,Rs1799852,rs1799852
TF,Rs1799852,transferrin saturation
TF,Rs1799852,"HFE gene (C282Y, H63D"
TF,Rs1799852,"transferrin gene TF (rs3811647, rs1799852)"
TF,Rs1799852,iron deficiency anaemia
TF,Rs1799852,endophenotypes
TF,Rs1799852,hepatic protein secretion
TF,Rs1799852,HFE
TF,Rs1799852,serum transferrin
TF,Rs1799852,serum transferrin levels
TF,Rs1799852,rs2280673
TF,Rs1799852,SNPs
TF,Rs1799852,TF 
TF,Rs1799852,rs1799852
TF,Rs1799852,MAF 0.09
TF,Rs1799852,rs2280673 
TF,Rs1799852,MAF 0.34
TF,Rs1799852,serum transferrin
TF,Rs1799852,rs1799852
TF,Rs1799852,serum ferritin
TF,Rs1799852,serum iron or transferrin saturation
TF,Rs1799852,iron metabolism
TF,Rs1799852,hepatic protein secretion
TF,Rs1799852,endophenotypes 
TF,Rs1799852,serum ferritin
TF,Rs1799852,serum transferrin
TF,Rs1799852,rs2280673
TF,Rs1799852,SNPs 
TF,Rs1799852,serum transferrin
TF,Rs1799852,oxidative stress
TF,Rs1799852,HFE hereditary haemochromatosis
TF,Rs1799852,iron deficiency anaemia
TF,Rs1799852,menstruating women
TF,Rs1799852,rs1799852
TF,Rs1799852,menstruating women
TF,Rs1799852,allelic expression using EST mining
TF,Rs1799852,cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition
TF,Rs1799852,SNP
TF,Rs1799852,CYBRD1
TF,Rs1799852,serum ferritin levels
TF,Rs1799852,ohort study of HFE hereditary haemochromatosis
TF,Rs1799852,iron deficiency anaemia
TF,Rs1799852,"transferrin gene TF (rs3811647, rs1799852)"
TF,Rs1799852,"HFE gene (C282Y, H63D)"
TF,Rs1799852,iron deficiency anaemia risk
TF,Rs1799852,rs3811647
TF,Rs1799852,MAF 0.34
TF,Rs1799852,rs2280673
TF,Rs1799852,MAF 0.09
TF,Rs1799852, rs1799852
TF,Rs1799852,TF gene
TF,Rs1799852,serum transferrin levels
TF,Rs1799852,heritability of serum transferrin
TF,Rs1799852,H63D
TF,Rs1799852,C282Y
TF,Rs1799852,rs1799852
TF,Rs1799852,transferrin saturation
TF,Rs1799852,serum transferrin
TF,Rs1799852,HFE
TFAM,Rs2306604,Alzheimer's disease case-control associations using family-based methods
TFAM,Rs2306604,identify divergent pathways to Alzheimer's disease
TFAM,Rs2306604,Polish Parkinson's disease patients
TFAM,Rs2306604,Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta
TFAM,Rs2306604,sporadic Alzheimer disease
TFAM,Rs1937,late-onset Alzheimer's disease
TFAM,Rs2306604,Alzheimer's and Parkinson's disease
TFR2,Rs80338890,hemochromatosis
TFR2,Rs80338885,Taiwanese
TFR2,Rs80338890,young Italian patients
TFR2,Rs80338876,hemochromatosis
TFR2,Rs7385804,iron-deficiency anemia
TFR2,Rs80338876,young Italian patients
TG,Rs2076740,Graves' disease
TG,Rs2076740,autoimmune hypothyroidism
TG,Rs2076740,Autoimmune Hypothyroidism
TG,Rs2076740,Hashimoto's (HT)
TG,Rs2076740,Graves(GD)
TG,Rs2076740,Hypothyroidism (HY)
TG,Rs2076740,AITD
TG,Rs2076740,autoimmune thyroid disease
TG,Rs2076740,GD
TG,Rs2076740,AITD
TG,Rs2076740,AITD
TG,Rs2076740,human and murine autoimmune thyroid disease
TG,Rs2076740,285 Caucasian AITD (autoimmune thyroid disease) patients and 150 Caucasian controls
TG,Rs2076740,Hashimoto's thyroiditis)
TG,Rs2076740,Graves' disease
TG,Rs2076740,Hashimoto's thyroiditis
TG,Rs2076740,autoimmune thyroid disease
TG,Rs2076740,AITD
TG,Rs2076740,human and murine autoimmune thyroid disease
TGFB1,Rs11466345,a reduced risk of adenocarcinoma
TGFB1,Rs2241712,increased risk for chronic obstructive pulmonary disease (COPD)
TGFB1,Rs2241712,asthma
TGFB1,Rs2241712,chronic obstructive pulmonary disease
TGFB1,Rs1800471,intestinal resection
TGFB1,Rs1800471,stricturing Crohn's disease
TGFB1,Rs1800471,Crohn's disease
TGFB1,Rs1800471,fibrosis
TGFB1,Rs11466345,adenocarcinoma
TGFB1,Rs11466345,adenocarcinoma cases
TGFB1,Rs11466345,adenoma cases
TGFB1,Rs11466345,adenocarcinoma
TGFB1,Rs11466345,colorectal adenocarcinoma
TGFB1,Rs11466345,colorectal neoplasia
TGFB1,Rs11466314,multiple sclerosis pathogenesis
TGFB1,Rs11466314,multiple sclerosis pathogenesis
TGFB1,Rs2241712,asthma
TGFB1,Rs2241712,increased airway responsiveness
TGFB2,Rs863223797,died suddenly
TGFB2,Rs863223797,healthy young adult
TGFB2,Rs863223797,'suspicious' mutation
TGFB2,Rs863223797,genome
TGFB3,Rs770828281,Mendelian Disease
TGFB3,Rs770828281,Mendelian disease
TGFB3,Rs770828281,biocurators
TGFB3,Rs770828281,Table S6
TGFB3,Rs770828281,SNP
TGFB3,Rs770828281,Pathogenic Regulatory Variants
TGFB3,Rs770828281,Whole-Genome
TGFB3,Rs770828281,Mendelian disease
TGFB3,Rs387906514,biocurators
TGFB3,Rs387906514,Table S6
TGFB3,Rs387906514,SNP
TGFB3,Rs387906514,Mendelian Disease
TGFB3,Rs387906514,Pathogenic Regulatory Variants
TGFB3,Rs387906514,Whole-Genome
TGFB3,Rs387906514,Mendelian disease
TGFB3,Rs387906514,Mendelian disease
TGFBR1,Rs868,TGFBR1 SNP
TGFBR1,Rs868,TGFBR1 gene
TGFBR1,Rs868,urothelial cell carcinoma of the bladder
TGFBR1,Rs868,muscle-invasive bladder cancer tumors
TGFBR1,Rs334349,colon cancer
TGFBR1,Rs334348,colon cancer
TGFBR1,Rs1590,colon cancer
TGFBR1,Rs7871490,colon cancer
TGFBR2,Rs1078985,do not appear to affect risk of abdominal aortic aneurysm (AAA).
TGFBR2,Rs1078985,TGFBR2
TH,Rs3842727,suicidal behavior
TH,Rs3842727,tyrosine hydroxylase
TH,Rs3842727,Dopa decarboxylase
TH,Rs3842727,gene variants
TH,Rs3842727,suicidal behavior
TH,Rs6578993,Genetic determinants of target
TH,Rs6578993,potentials
TIMP2,Rs9900972,spine bone mineral density
TIMP2,Rs9900972,Non-vertebral fracture risk
TLR2,Rs5743708,rs4696480 (T-16934A i Arg753Gln)
TLR2,Rs1898830,associated with an increased risk for shedding and lesion frequency of genital herpes simplex virus type 2 HSV-2 outbreaks.
TLR2,Rs1898830,increased risk for shedding
TLR2,Rs1898830,lesion frequency of genital herpes simplex virus type 2 HSV-2 outbreaks
TLR3,Rs3775291,age-related macular degeneration
TLR3,Rs3775291,development of immune responses in the 1st year of life
TLR3,Rs3775291,oll-like receptor polymorphisms
TLR3,Rs3775291,age-related macular degeneration
TLR3,Rs3775291,subacute sclerosing panencephalitis
TLR3,Rs3775291,prostate cancer mortality
TLR3,Rs3775291,cancer risk.
TLR3,Rs3775291,polypoidal choroidal vasculopathy
TLR3,Rs3775291,Chinese
TLR3,Rs3775291,ick-borne encephalitis virus
TLR3,Rs3775291,ge-related macular degeneration-susceptibility single nucleotide
TLR3,Rs3775291,chinese
TLR3,Rs3775291,dry ARMD
TLR3,Rs3775291,choroidal neovascularization
TLR3,Rs3775291,dry ARMD
TLR3,Rs3775291,Americans of European descent
TLR3,Rs3775291,geographic atrophy
TLR3,Rs1879026,immune responses to measles vaccine
TLR3,Rs3775291,ARMD
TLR3,Rs3775291,"""dry"" ARMD"
TLR3,Rs3775291,geographic atrophy
TLR3,Rs3775291,reduces the odds of having dry ARMD
TLR3,Rs3775291,cuts your odds by more than half
TLR3,Rs3775291,age related macular degeneration
TLR3,Rs3775291,TBEV
TLR3,Rs3775291,tick-borne encephalitis
TLR3,Rs3775291,cancer
TLR3,Rs3775291,"age related macular degeneration (ARMD),"
TLR3,Rs3775291,"""dry"" ARMD"
TLR3,Rs3775291,subacute sclerosing panencephalitis
TLR4,Rs5030728,prostate cancer
TLR4,Rs5030728,Genetic variants and prostate cancer risk
TLR4,Rs5030728, viral restriction genes.
TLR4,Rs5030728,candidate replication
TMC1,Rs121908073,100C
TMC1,Rs121908073,Arg34Ter 
TMC1,Rs121908073,R34X
TMC1,Rs121908073,i5003572
TMEM43,Rs63750743,arrhythmogenic right ventricular dysplasia type 5 (ARVD5)
TMEM43,Rs63750743,arrhythmic disorder
TMEM43,Rs63750743,rs63750743(T)
TMPRSS6,Rs855791,iron-deficiency anemia
TMPRSS6,Rs855791,rs855791
TMPRSS6,Rs855791,type 2 diabetes
TNF,Rs361525,breast cancer
TNF,Rs361525,1.64x increase in the subtype known as diffuse large B cell lymphoma
TNF,Rs361525,affect inflammatory and innate immune responses
TNF,Rs361525,rs361525 
TNF,Rs361525,TNF-238 SNP
TNF,Rs361525,238.2
TNF,Rs361525,(G) allele
TNF,Rs361525,238.1
TNF,Rs361525,SNP 
TNF,Rs361525,umor necrosis factor-alpha gene
TNF,Rs361525,Breast cancer
TNF,Rs361525,Caucasian 
TNF,Rs361525,rs361525(A) allele
TNF,Rs361525,(G;G) genotype
TNF,Rs361525,breast cancer
TNF,Rs361525,invasive breast cancer risk
TNF,Rs361525,SNP
TNF,Rs361525,Graft versus host disease (GVHD)
TNF,Rs361525,allogeneic
TNF,Rs361525,associated with a 1.31x increase in non-Hodgkin lymphoma
TNF,Rs361525,Lymphoma
TNF,Rs361525,unlikely to be a major risk factor for XFG in Caucasians
TNF,Rs361525,exfoliation glaucoma (XFG)
TNF,Rs1800750,recurrent acute otitis
TNF,Rs361525,Breast cancer
TNF,Rs361525,somewhat elevated risk for breast cancer
TNF,Rs361525,breast cancer
TNF,Rs361525,persuasive evidence against an overall association between invasive breast cancer risk and (this SNP)
TNF,Rs361525,Graft versus host disease (GVHD)
TNF,Rs361525,graft versus host disease (GVHD) is about twice as frequent if either the donor or the recipient is a carrier of the rs361525(A) allele
TNF,Rs361525,Otitis or ear infections
TNF,Rs361525,more prone to ear infections
TNF,Rs361525,haematopoietic
TNF,Rs361525,Nasal polyps
TNF,Rs361525,Psoriasis
TNF,Rs361525,Polish psoriasis patients
TNF,Rs361525,onset age was lower in rs361525(A) carriers
TNF,Rs361525,Diabetes and verbal memory
TNF,Rs361525,slower decline of verbal memory over a period of 48 weeks in a study of elderly patients with type-2 diabetes
TNF,Rs361525,Sudden infant death syndrome (SIDS)
TNF,Rs361525,babies may be at higher risk for sudden infant death syndrome (SIDS)
TNF,Rs361525,Exfoliation glaucoma A
TNF,Rs361525,Exfoliation glaucoma
TNF,Rs361525,increased risk for nasal polyps
TNF,Rs361525,stem cell transplant recipients 
TNF,Rs361525,graft versus host disease (GVHD)
TNF,Rs361525,rs361525(A) allele
TNF,Rs361525,exfoliation glaucoma (XFG)
TNF,Rs361525,rs361525
TNF,Rs361525,XFG
TNF,Rs361525,Caucasians
TNF,Rs361525,Lymphoma
TNF,Rs361525,lymphoma 
TNF,Rs361525,SNPs 
TNF,Rs361525,immune function genes
TNF,Rs361525,SNPs 
TNF,Rs361525,Exfoliation glaucoma
TNF,Rs361525,cytokine genes
TNF,Rs361525,non-Hodgkin lymphoma
TNF,Rs361525,diffuse large B cell lymphoma
TNF,Rs361525,SNPS 
TNF,Rs361525,cytokine genes
TNF,Rs361525,inflammatory and innate immune responses
TNF,Rs361525,rs1800629 
TNF,Rs361525,rs1799724 
TNF,Rs361525,rs909253
TNF,Rs361525,rs2239704
TNF,Rs361525,tumor necrosis factor-alpha and lymphotoxin-alpha
TNF,Rs1800629,"in European populations, the rs1800629(A) allele is associated with increased risk for systemic lupus erythematosus (SLE). In Europeans, the oodds ratio for the (A;A) genotype was 4.0, CI: 2.5-6.4, p<0.001. No association was detected in Asian-derived populations."
TNF,Rs361525,infants
TNF,Rs361525,sudden infant death syndrome (SIDS)
TNF,Rs361525,Otitis
TNF,Rs361525,ear infections
TNF,Rs361525,rs361525(G;G)
TNF,Rs361525,homozygotes 
TNF,Rs361525,ear infections
TNF,Rs361525,Nasal polyps
TNF,Rs361525,rs361525(A;A) genotype
TNF,Rs361525,nasal polyps
TNF,Rs361525,Turkish 
TNF,Rs361525,Norwegian 
TNF,Rs361525,Psoriasis
TNF,Rs361525,psoriasis
TNF,Rs361525,rs361525(A) allele
TNF,Rs361525,Sudden infant death syndrome (SIDS)
TNF,Rs361525,type-2 diabetes
TNF,Rs361525,rs361525(G;G)
TNF,Rs361525,Diabetes 
TNF,Rs361525,verbal memory
TNF,Rs361525,rs361525(A)
TNF,Rs361525,verbal memory
TNF,Rs361525,Polish 
TNF,Rs1800629, A study of 120 Columbian patients with SLE found an increased risk for rs1800629(A) carriers
TNF,Rs1800629,This SNP in the tumor necrosis factor-alpha gene
TNF,Rs1800629,"while rs1800629 status is significantly associated with risk for sepsis, especially among Asians, it was not associated with mortality from sepsis."
TNF,Rs1800629,Crohn's disease In a study of 235 Portuguese patients
TNF,Rs1800629,genotype was associated with higher susceptibility to Crohn's disease
TNF,Rs1800629,Exfoliation glaucoma (XFG) A study of 204 patients with exfoliation glaucoma (XFG) concluded that rs1800629 is unlikely to be a major risk factor for XFG in Caucasians
TNF,Rs1800629,Graves' disease A meta-analysis of 10 case-control studies
TNF,Rs1800629,"Graves' disease cases, concluded that rs1800629(A) carriers were associated with this type of hyperthyroidism"
TNF,Rs1800629,Heart disease A study of 600 Italian patients concluded that rs1800629(A) carriers are at increased risk for acute heart attack and have other markers of heart disease
TNF,Rs1800629,A study of 50 Egyptian children with rheumatic heart disease
TNF,Rs1800629,association between rs1800629 and risk for myocardial infarction
TNF,Rs1800629,"Ischemic stroke A meta-analysis of 18 studies with 8075 patients found no significant association between ischemic stroke and the TNFα-308G/A, except potentially in a subgroup of East Asians"
TNF,Rs1800629,Leprosy A study of 37 Thai patients with leprosy found that the rs1800629(A) allele was more common
TNF,Rs1800629,Liver disease A study of 108 Chinese patients
TNF,Rs1800629,increased risk for liver cancer and are also at higher risk for hepatic fibrosis and more severe liver damage
TNF,Rs1800629,Lymphoma A study of 194 Tunisian patients indicated an increased risk for non-Hodgkin lymphoma among rs1800629(A;A) genotypes
TNF,Rs1800629,incident non-Hodgkin lymphoma (NHL)
TNF,Rs1800629,follicular lymphoma and diffuse large B-cell lymphoma
TNF,Rs1800629,lymphoma patients and 982 controls looked at 57 SNPs in 36 immune function genes
TNF,Rs1800629,"tumor necrosis factor-alpha and lymphotoxin-alpha, were associated with a 1.31x increase in non-Hodgkin lymphoma"
TNF,Rs1800629,diffuse large B cell lymphoma
TNF,Rs1800629,Susceptibility to Mediterranean spotted fever
TNF,Rs1800629, but not for Caucasians
TNF,Rs1800629,he risk of COPD was statistically significant for Asians
TNF,Rs1800629,"Chronic obstructive pulmonary disease A meta-analysis of 36 publications totaling ~5,000 patients"
TNF,Rs1800629,"In a study of Norwegian children, nonallergic asthma was associated with rs1800629(A)"
TNF,Rs1799724,Caucasians
TNF,Rs1799724,Alzheimer's disease
TNF,Rs1799724,post-menopausal women
TNF,Rs1799724,low bone mineral density
TNF,Rs1799724,gastric cancer risk
TNF,Rs1799724,Caucasians
TNF,Rs1800629,may be an increased risk for fatal outcomes among Asians
TNF,Rs1799724,post-menopausal women
TNF,Rs1799724,low bone mineral density
TNF,Rs1800629,in a Sicilian population the rs1800629 polymorphism did not affect susceptibility to Mediterranean spotted fever
TNF,Rs1799724,cigarette smoking
TNF,Rs1800610,rs1800610
TNF,Rs1800610,Type II Diabetes
TNF,Rs1800610,T allele
TNF,Rs1800629,"Allograft rejection Among 72 Polish patients receiving a kidney transplant, the risk of acute kidney allograft rejection"
TNF,Rs1800629,"Asthma A meta-analysis of ~2,500 patients"
TNF,Rs1800629,increased risk for asthma
TNF,Rs1800629,Mexican families and their asthmatic children
TNF,Rs1800629,carriers had an increased risk of asthma
TNF,Rs1800629,especially among children of non-smoking parents
TNF,Rs1799724,gastric cancer
TNF,Rs1800629,igraine Polymorphisms in the tumor necrosis factor (TNF) gene may be associated with migraine and cardiovascular disease
TNF,Rs1799724,Alzheimer's disease
TNF,Rs1800629,Nasal polyps The rs1800629(A;G) genotype was associated with increased risk for nasal polyps in a study of 82 Turkish patients
TNF,Rs1800629,"Egyptian children with rheumatic heart disease found increased risk associated with the rs1800629(A;A) homozygotes, with odds ratio = 5.7, p<0.001. However, there was a significantly lower frequency of heterozygous genotypes."
TNF,Rs1800629,12 publications consisting of 6000+ cases found no significant association between rs1800629 and risk for myocardial infarction.
TNF,Rs1800629,"found no significant association between ischemic stroke and the TNFα-308G/A, except potentially in a subgroup of East Asians."
TNF,Rs1800629,A study of 37 Thai patients with leprosy found that the rs1800629(A) allele was more common
TNF,Rs1800629,"A study of 194 Tunisian patients indicated an increased risk for non-Hodgkin lymphoma among rs1800629(A;A) genotypes,"
TNF,Rs1800629,"non-Hodgkin lymphoma (NHL) cases indicated that, compared with the wild-type rs1800629(G;G), the (A;A) genotype was associated with increased risk (odds ratio 2.14, CI: 0.94-4.85), whereas the (A;G) genotype was not. This association was similar for follicular lymphoma and diffuse large B-cell lymphoma."
TNF,Rs1800629,"Five SNPs in two cytokine genes, tumor necrosis factor-alpha and lymphotoxin-alpha, were associated with a 1.31x increase in non-Hodgkin lymphoma"
TNF,Rs1800629,with a 1.64x increase in the subtype known as diffuse large B cell lymphoma
TNF,Rs1800629,The cytokine genes affect inflammatory and innate immune responses
TNF,Rs1800629,in a Sicilian population the rs1800629 polymorphism did not affect susceptibility to Mediterranean spotted fever.
TNF,Rs1800629,Migraine Polymorphisms in the tumor necrosis factor (TNF) gene may be associated with migraine and cardiovascular disease.
TNF,Rs1800629,indicated that rs1800629(A) carriers might be at lower risk for multiple sclerosis
TNF,Rs1800629,The rs1800629(A;G) genotype was associated with increased risk for nasal polyps in a study of 82 Turkish patients. Another study found a nearly doubled risk for rs1800629(A)
TNF,Rs1800629,A study of 160 Polish patients indicated that the rs1800629(A) allele frequency was significantly decreased among patients with early-onset psoriasis
TNF,Rs1800629,147 Irish patients with psoriasis were studied and the results indicated that the rs1800629(A;A) genotype was associated with increased risk as well as earlier onset of psoriasis.
TNF,Rs1800629,s1800629(A) allele carriers respond less well to TNF-alpha inhibitors when being treated for rheumatoid arthritis.
TNF,Rs1800629,"In a pooled analysis of seven case-control studies, the odds ratio for sarcoidosis for carriers of the rs1800629(A) allele was either 1.47 (CI 1.03-2.08 under a dominant model) or 1.39 (CI: 0.67-2.90; under a recessive model)."
TNF,Rs1800629,A study of 159 patients with severe trauma indicated that the rs1800629(A) allele was associated with higher risk of developing sepsis and of dying
TNF,Rs1800629,Multiple sclerosis (MS) A study of 300 Croatian and Slovenian patients indicated that rs1800629(A) carriers might be at lower risk for multiple sclerosis
TNF,Rs1800629,concluded that rs1800629(A) carriers are at increased risk for acute heart attack and have other markers of heart disease.
TNF,Rs1800629,concluded that rs1800629(A) carriers were associated with this type of hyperthyroidism
TNF,Rs1800629,A study of 108 Chinese patients concludes that rs1800629(A) carriers are at 3.23x (CI: 1.10-9.44) increased risk for liver cancer and are also at higher risk for hepatic fibrosis and more severe liver damage.
TNF,Rs1800629,"the rs1800629(A;A) genotype was associated with higher susceptibility to Crohn's disease,"
TNF,Rs1800629,Psoriasis A study of 160 Polish patients indicated that the rs1800629(A) allele frequency was significantly decreased among patients with early-onset psoriasis
TNF,Rs1800629,Irish patients with psoriasis were studied
TNF,Rs1800629,as well as earlier onset of psoriasis
TNF,Rs1800629,Rheumatoid arthritis - response to TNF-alpha inhibitors 2009 meta-analysis of 9 studies concludes rs1800629(A) allele carriers respond less well to TNF-alpha inhibitors when being treated for rheumatoid arthritis
TNF,Rs1800629,"Sarcoidosis In a pooled analysis of seven case-control studies, the odds ratio for sarcoidosis for carrier"
TNF,Rs1800629,A study of 204 patients with exfoliation glaucoma (XFG) concluded that rs1800629 is unlikely to be a major risk factor for XFG in Caucasians
TNF,Rs1800629,Susceptibility to sepsis A study of 159 patients with severe trauma indicated that the rs1800629(A) allele was associated with higher risk of developing sepsis and of dying
TNF,Rs1800629,anti-inflammatory interventions should be developed for use in carriers of this SNP should they suffer severe injuries
TNF,Rs1800629,"risk for sepsis, especially among Asians"
TNF,Rs1800629,mortality from sepsis
TNF,Rs1800629,fatal outcomes among Asians
TNF,Rs1800629,"Sarcoidosis In a pooled analysis of seven case-control studies, the odds ratio for sarcoidosis for carriers"
TNF,Rs1800629,"in European populations, the rs1800629(A) allele is associated with increased risk for systemic lupus erythematosus"
TNF,Rs1800629,"In Europeans, the oodds ratio for the (A;A) genotype was 4.0, CI: 2.5-6.4, p<0.001. No association was detected in Asian-derived populations"
TNF,Rs1800629,The (A) allele is associated with higher levels of TNF expression
TNF,Rs1800629,"concluded that the association between the rs1800629(A) allele and the risk of COPD was statistically significant for Asians (odds ratio 2.36, CI: 1.84 - 3.02, p < 0.0001) but not for Caucasians."
TNF,Rs1800629,"Allograft rejection Among 72 Polish patients receiving a kidney transplant, the risk of acute kidney allograft rejection was 2.5x higher among rs1800629(A) carriers"
TNF,Rs1800629,rs1800629(A) allele was associated with a 1.46x increased risk for asthma
TNF,Rs1800629,"In a study of ~600 Mexican families and their asthmatic children, rs1800629(A) carriers had an increased risk of asthma"
TNF,Rs1800629,"In a study of Norwegian children, nonallergic asthma was associated with rs1800629(A) carriers"
TNF,Rs1800629,ystemic lupus erythematosus (SLE) A study of 120 Columbian patients with SLE found an increased risk for rs1800629(A) carriers
TNFRSF10A,Rs20576,subsequent metastasis
TNFRSF10A,Rs20576,prostate cancer
TNFRSF10A,Rs20576,are treated by radiation therapy
TNFRSF10A,Rs20576,prostate cancer
TNFRSF10A,Rs20576,subsequent metastasis
TNFRSF1A,Rs104895225,TNFRSF1A
TNFRSF1A,Rs767455,Crohn's disease
TNFRSF1A,Rs767455,Japanese patients
TNFRSF1A,Rs767455,responses to infliximab
TNFRSF1A,Rs767455,multiple sclerosis
TNFRSF1A,Rs767455,Crohn's
TNFRSF1A,Rs767455,polymorphisms of tumour necrosis
TNFRSF1A,Rs767455,multiple sclerosis
TNFRSF1A,Rs104895225,mutations 
TNFRSF1A,Rs104895228,lupus erythematosus
TNFRSF1A,Rs104895225,associated 
TNFRSF1A,Rs104895225,factor 
TNFRSF1A,Rs104895225,necrosis
TNFRSF1A,Rs104895225,tumor
TNFRSF1A,Rs104895225, receptor-associated periodic syndrome:
TNFRSF1A,Rs104895225,tumor-necrosis-factor
TNFRSF1A,Rs104895217,55 kDa
TNFRSF1A,Rs104895217,TNF
TNFRSF1A,Rs104895225,syndrome
TNFSF15,Rs7848647,increased risk for Crohn's disease
TNFSF15,Rs3810936,increased risk for Crohn's disease
TNNI3,Rs104894725,"c.616A> C, p.Lys206Gln"
TNNI3,Rs397516354,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs397516353,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs397516357,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs397516349,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNI3,Rs267607130,copy of the rare rs267607130(C) allele is reported to lead to dilated cardiomyopathy
TNNI3,Rs267607128,familial hypertrophic cardiomyopathy
TNNI3,Rs267607128,rare mutation in the TNNI3 gene on chromosome 19
TNNI3,Rs267607128,familial hypertrophic cardiomyopathy
TNNI3,Rs104894725,i5007728
TNNI3,Rs104894725,"rs104894725,"
TNNI3,Rs397516351,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNI3,I5048707,familial hypertrophic cardiomyopathy
TNNI3,I5048707,hypertrophic
TNNI3,I5048707,cardiomyopathy
TNNI3,I5007735,"familial restrictive cardiomyopathy, type 1"
TNNI3,I5007732,familial restrictive cardiomyopathy
TNNI3,I5007731,"familial hypertrophic cardiomyopathy, type 7"
TNNI3,I5007731,familial hypertrophic cardiomyopathy
TNNI3,I5007730,"hypertrophic cardiomyopathy, type 7"
TNNI3,I5007730,hypertrophic cardiomyopathy
TNNI3,I3002796,"cardiomyopathy, type 1"
TNNI3,I3002796,familial restrictive cardiomyopathy
TNNI3,I5048716,familial restrictive cardiomyopathy
TNNT2,Rs3729547,thickening of the ventricular wall
TNNT2,Rs3729547,heart failure or sudden cardiac death. The molecular mechanisms whereby mutations in the same gene (T
TNNT2,Rs3729547,overall weakening of the heart muscle and can lead to heart failure or sudden cardiac death
TNNT2,Rs376923877,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs727504246,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs397516456,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs397516457,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs397516463,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs397516470,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs3729547,hypertrophic cardiomyopathy in the Indian
TNNT2,Rs397516455,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs3729547,thinning of the ventricular wall
TNNT2,Rs3729547,hypertrophic cardiomyopathy
TNNT2,Rs3729547,dilated cardiomyopathy (DCM) in the Han Chinese
TNNT2,Rs3729547,dilated cardiomyopathy (DCM) in the H
TNNT2,Rs3729547,rs3729547
TNNT2,Rs3729547,cardiac death
TNNT2,Rs3729547,weakening of the heart muscle and can lead to heart failure
TNNT2,Rs3729547,hypertrophic cardiomyopathy 
TNNT2,Rs3729547,dilated cardiomyopathy
TNNT2,Rs3729547,hypertrophic cardiomyopathy
TNNT2,Rs3729547,dilated cardiomyopathy
TNNT2,Rs121964856,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs121964855,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TNNT2,Rs3729547, population. . This SNP is loc
TOR1A,Rs1182,primary blepharospasm
TOR1A,Rs1182,rs1182
TOR1A,Rs1182,TOR1A polymorphism
TOR1A,Rs1182,rs1182
TOR1A,Rs1182,rs13283584
TOR1A,Rs1182,dystonia
TOR1A,Rs1182,sex
TOR1A,Rs1182,age
TOR1A,Rs1182,dystonia
TOR1A,Rs1182,SNP
TP53,Rs1042522,African-Americans
TP53,Rs1042522,Asian children and adults
TP53,Rs1042522,type-2 diabetes
TP53,Rs1042522,Finnish patients
TP53,Rs1042522,endometrial cancer
TP53,Rs1042522,in vitro fertilization (IVF) patients
TP53,Rs1042522,colorectal cancer
TP53,Rs1042522,Caucasians
TP53,Rs1042522,decreased implantation and fertility
TP53,Rs1042522,telangiectasia
TP53,Rs1042522,breast-conserving surgery
TP53,Rs1042522,African Americans
TP53,Rs1042522,cisplatin
TP53,Rs1042522,implantation failure
TP53,Rs1042522,advanced gastric cancer
TP53,Rs1042522,breast cancer
TP53,Rs1042522,"breast cancer,"
TP53,Rs1042522,breast cancer
TP53,Rs1042522,paclitaxel
TP53,Rs1042522,cell lung cancer
TP53,Rs1042522,advanced gastric cancer
TP53,Rs1042522,cancer of certain types
TP53,Rs1042522,breast-conserving surgery
TP53,Rs1042522,increased risk for breast cancer
TP53,Rs1042522,cell lung cancer
TP53,Rs1042522,chemotherapy
TP53,Rs1042522,irinotecan plus cisplatin regimen
TP53,Rs1042522,colorectal cancer
TPCN2,Rs3829241,2116 Icelanders and 1214 Dutch individuals
TPCN2,Rs35264875,blonde hair color
TPCN2,Rs3829241,blonde and brown hair
TPCN2,Rs3829241,5130 Icelanders
TPCN2,Rs3829241,blonde versus brown
TPH1,Rs7933505,schizophrenia
TPH2,Rs7963720,Only for Hispanics
TPH2,Rs4570625,psychiatric and/or behavioural phenomena
TPH2,Rs4570625,early-onset obsessive compulsive disorder
TPH2,Rs4570625,anxiety symptoms
TPH2,Rs4570625,panic disorder
TPH2,Rs4570625,attention-deficit/hyperactivity disorder
TPH2,Rs4570625,personality trait of harm avoidance
TPH2,Rs4570625,personality traits
TPH2,Rs4570625,autistic disorder
TPH2,Rs4570625,functional promoter polymorphism
TPH2,Rs4570625,anxiety during alcohol detoxification outcome
TPH2,Rs4570625,alcohol dependence disorder features
TPH2,Rs4570625,schizophrenia
TPH2,Rs4570625,paranoid schizophrenia
TPH2,Rs7305115,susceptibility to suicide
TPH2,Rs7305115,susceptibility to suicide
TPH2,Rs7963720,individuals who have a genoset composed
TPH2,Rs7963720,higher risk for developing heroin addiction
TPH2,Rs4570625,paranoid schizophrenia
TPH2,Rs4570625,Emotion appraisal
TPH2,Rs4570625,disorders related to emotional dysregulation
TPH2,Rs4570625,autistic disorder
TPH2,Rs4570625,schizophrenia
TPH2,Rs11178997,decreased cortisol and ACTH stimulation
TPH2,Rs11178997,factors for major depression
TPH2,Rs11178997,unipolar and bipolar disorder in a Northern Swedish
TPH2,Rs11178997,susceptibility to paranoid schizophrenia
TPH2,Rs1386496,tryptophan hydroxylase-2 gene
TPH2,Rs1386496,suicide risk in major depression.
TPH2,Rs17110563,bipolar disorder
TPH2,Rs1843809,attention-deficit
TPH2,Rs11178997,increased risk for bipolar disorder in a study of 883 Russian patients
TPH2,Rs1843809,hyperactivity disorder
TPH2,Rs4570625,emotional dysregulation
TPH2,Rs4290270,heroin addiction
TPH2,Rs4570625,psychiatric and/or behavioural phenomena
TPH2,Rs4570625,obsessive compulsive disorder
TPH2,Rs4570625,anxiety symptoms
TPH2,Rs4570625,panic disorder with a possible gender-dependent effect
TPH2,Rs4570625,personality trait of harm avoidance
TPH2,Rs1843809,hyperactivity disorder
TPM1,Rs727503518,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TPM1,Rs28934270,Familial hypertrophic cardiomyopathysee
TPM1,Rs28934270,polymorphism
TPM1,Rs199476315,reported to be pathogenic/likely pathogenic for familial hypertrophic cardiomyopathy (HCM)
TPM1,Rs28934269,hypertrophic cardiomyopathyse
TPMT,Rs1142345,incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs
TPMT,Rs1142345,rs1142345(G)
TPMT,Rs1800584,rs180058
TPMT,Rs1800584,rare SNP
TPMT,Rs1800584,TPMT
TPMT,Rs1800584,incapable of detoxifying byproducts
TPMT,Rs1800584,antineoplastic and immunosuppressant drugs
TPMT,Rs1800584,"rs1800584 is a rare SNP in the TPMT gene, potentially encoding a variant incapable of detoxifying byproducts of certain antineoplastic and immunosuppressant drugs"
TPO,Rs732609,Thyroid cancer
TPO,Rs732609,Spanish
TPO,Rs732609,among Spanish
TPO,Rs732609,Italians
TPO,Rs732609,lower risk of hypothyroidism 
TPO,Rs732609,Thyroid cancer
TPO,Rs732609,hypothyroidism among Italians
TPP1,Rs28940573,Tripeptidyl peptidase 1 deficiency
TPP1,Rs56144125,Batten disease
TPP1,Rs56144125,neuronal ceroid lipofuscinosis
TRA,Rs1154155,narcolepsy
TRA,Rs1154155,Narcolepsy
TRA,Rs1154155,narcolepsy
TRA,Rs1154155,only a 1.5 percent chance of developing narcolepsy
TRA,Rs1154155,a sudden loss of muscle tone that can cause people to collapse
TRA,Rs1154155,cataplexy
TRA,Rs1154155,narcolepsy
TRA,Rs1154155,narcolepsy
TRA,Rs1154155,Narcolepsy
TRA,Rs1154155,narcolepsy
TRA,Rs1154155,autoimmune disorder
TRA,Rs1154155,narcolepsy
TRA,Rs1154155,narcolepsy
TRA,Rs1154155,narcolepsy and cataplexy
TRA,Rs1154155,narcolepsy
TRAF1,Rs3761847,The excess mortality was attributed to deaths due to malignancies and sepsis but not cardiovascular disease
TRAF1,Rs3761847,is associated with increased risk of anti CCP-positive rheumatoid arthritis
TRAF1,Rs3761847,deaths due to malignancies and sepsis but not cardiovascular disease (CVD)
TRAF1,Rs3761847,associated with an increased risk of death
TRAF1,Rs3761847,chronic inflammation
TRAF1,Rs2416804,increases susceptibility to Rheumatoid Arthritis
TRAF1,Rs3761847,anti CCP-positive rheumatoid arthritis
TREM2,Rs104894002,polycystic lipomembranous osteodysplasia
TREM2,Rs104894002,"sclerosing leukoencephalopathy-2 (PLOSL2), "
TREM2,Rs104894002, Alzheimer's disease
TRIM2,Rs879253863,pathogenic variant
TRIP13,Rs376882637,pathogenic variant
TRPC6,I5005219,Focal segmental glomerulosclerosis
TRPC6,I6019084,Focal segmental glomerulosclerosis
TRPC6,Rs121434394,Focal segmental glomerulosclerosis
TRPC6,Rs121434395,Focal segmental glomerulosclerosis
TRPC6,Rs121434395,Focal segmental glomerulosclerosis
TRPM4,Rs387907216,progressive familial heart block type 1B
TRPM4,Rs201907325,heart block
TRPM4,Rs267607142,heart block type 1B
TRPM4,Rs172149856,An additional mention
TRPM4,Rs172151858,progressive familial heart block type 1B
TRPM4,Rs172149856,progressive familial heart block
TRPM6,Rs2274924,type-2 diabetes
TRPM6,Rs2274924,rare alleles at rs3750425 and rs2274924
TRPM6,Rs2274924,magnesium intake was lower than 250 mg per day
TRPM6,Rs3750425,type-2 diabetes
TRPM6,Rs3750425,rare alleles at rs3750425 and rs2274924
TRPM6,Rs3750425,magnesium intake was lower than 250 mg per day
TRPM8,Rs10166942,this SNP
TRPM8,Rs10166942,rs10166942
TRPM8,Rs10166942,ne of three influencing the condition
TRPM8,Rs10166942,migraines
TSC1,Rs118203396,tuberous sclerosis complex
TSC1,Rs118203396,Missense mutations
TSC1,Rs118203396,TSC1 gene
TSHR,Rs225014,frequently detected in patients with depression.
TSHR,Rs225014,"osteoarthritis, psychological disorders, reduced thyroid hormone metabolism, Type 2 diabetes, and various other conditions."
TSHR,Rs225014,Osteoarthritis
TSHR,Rs225014,higher risk of osteoarthritis
TSHR,Rs225014,a new susceptibility locus for symptomatic osteoarthritis
TSHR,Rs225014,additional osteoarthritis studies
TSHR,Rs225014,in female cases with advanced/symptomatic hip osteoarthritis
TSHR,Rs225014,Psychological disorders
TSHR,Rs225014,"patients with depression,"
TSHR,Rs225014,recurrent depressive disorder.
TSHR,Rs225014,Both SNPs were significantly higher in the BPAD (Bipolar disorder) patients
TSHR,Rs2268458,Graves' disease
TSHR,Rs225014,lower brain thyroid levels (not reflected in their serum levels)
TSHR,Rs225014,variants have shown that thyroid hormones contribute to osteoarthritis and these variants influence Intelligence quotient alterations associated with iodine deficiency.
TSHR,Rs225014,risk factor for neurodegenerative disease
TSHR,Rs225014, testing for and treating polymorphisms
TSHR,Rs225014,Type 2 Diabetes
TSHR,Rs225014,Patients carrying D2 Ala/Ala genotype had a higher fasting plasma insulin and HOMA(IR) index as compared to patients carrying Thr/Ala or Thr/Thr genotypes
TSHR,Rs225014,Polymorphisms in this SNP
TSHR,Rs2268458,Graves' disease
TSHR,Rs4704397,gestation
TSHR,Rs4704397,offspring birthweight
TSHR,Rs225014,Thyroid hormone metabolism and treatment for hypothyroidism
TSHR,Rs1991517,TSHR polymorphism of rs1991517 was relevant to bone density and insulin resistance
TSHR,Rs179247,Graves disease
TSHR,Rs1991517,"not associated with T4 hormone levels, nor with BMI, nor with fracture risk"
TSHR,Rs12101255,Graves' disease
TSHR,Rs12101255,"the same under dominant, recessive and co-dominant models"
TSHR,Rs12101255,allele
TSHR,Rs12101255,allele 
TSHR,Rs12101255,exhibited strong association with GD in all three cohorts
TSHR,Rs12101255,allele 
TSHR,Rs12101255,allele
TSHR,Rs12101255,allele
TSHR,Rs12101255,preliminary evidence that the disease-associated genotypes 
TSHR,Rs1991517,presence of TSHR mRNA in human osteoblast cell lines
TSHR,Rs12101255,association
TSHR,Rs12101255," reduced mRNA expression ratios of flTSHR relative to two alternate TSHR mRNA splice variants"" (Abstract)"
TSHR,Rs121908866,congenital hypothyroidism mutations
TSHR,Rs121908866,hypothyroidism
TSHR,Rs179247,Graves disease 
TSHR,Rs179247,Italian Origin
TSHR,Rs179247,Graves' disease
TSHR,Rs179247,rs179247 (A)
TSHR,Rs179247,Three SNPs in the 3q locus
TSHR,Rs179247,rs179247 (AA) and rs12101255 (TT) 
TSHR,Rs179247,reduced mRNA expression ratios
TSHR,Rs1991517,had a 2·3% higher femoral neck BMD (P = 0·03) and a 12·6% lower TSH level (P = 0·04).
TSHR,Rs12101255,with Graves' disease
TTC29,Rs763399136,Asthenozoospermia
TTC29,Rs763399136,Male Infertility
TUB,Rs2272382,obesity
TUB,Rs1528133,increased weight
TUB,Rs2272382,diabetes
TUBB8,Rs869025611,Mutations in TUBB8 and Human Oocyte Meiotic Arrest
TXLNGY,Rs372706460,and
TXLNGY,Rs372706460,Me
TXLNGY,Rs372706460,name
TXNRD2,Rs737865,bupropion treatment
TXNRD2,Rs737865,smoking cessation
TXNRD2,Rs737865,schizophrenia
TXNRD2,Rs737865,non-Hodgkin lymphoma
TXNRD2,Rs737865,nxiety-related personality traits
TYK2,Rs34536443,tuberculosis
TYK2,Rs34536443,he risk of developing tuberculosis
TYR,Rs61754382,c.1037-1G>A
TYR,Rs1799989,schizophrenics
TYR,Rs1126809,albinism
TYR,Rs1126809,basal cell carcinoma
TYR,Rs1126809,increased risk of cutaneous malignant melanoma
TYR,Rs1126809,skin cancer
TYR,Rs1126809,sun sensitivity
TYR,Rs1126809,eye color
TYR,Rs1126809,albinism
TYR,Rs1126809,cell carcinoma
TYR,Rs1126809,cutaneous malignant melanoma
TYR,Rs1126809,skin cancer
TYR,Rs1126809,sun sensitivity
TYR,Rs1126809,eye color
TYR,Rs1126809,amino acid change
TYR,Rs1126809,tyrosinase gene
TYRP1,Rs2733832,skin pigmentation
TYRP1,Rs2733832,Influences appearance
UBA5,Rs540839115,pathogenic
UBA5,Rs540839115,autosomal recessive spinocerebellar
UCP1,Rs3811787,obesity abdominal fat area
UCP1,Rs3811787,Korean women
UCP1,Rs3811787,obesity abdominal fat area in Korean women
UGT1A10,Rs11892031,bladder cancer risk
UGT1A10,Rs11892031,intronic region
UGT1A8,Rs11892031,bladder cancer risk
UGT1A8,Rs11892031,intronic region
UGT2B7,Rs7439366,interindividual variability
UGT2B7,Rs7439366,tamoxifen metabolism
UGT2B7,Rs7439366,breast cancer 
UNC13D,Rs959968589,hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs796065025,hemophagocytic lymphohistiocytosis
UNC13D,Rs777759523,HLH
UNC13D,Rs777759523,aka c.1389 + 1G
UNC13D,Rs754882266,ClinVar
UNC13D,Rs754882266,hemophagocytic lymphohistiocytosis
UNC13D,Rs754882266,Aconsidered pathogenic
UNC13D,Rs754621494,hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs747169857,familial hemophagocytic lymphohistiocytosis
UNC13D,Rs202020396,familial hemophagocytic lymphohistiocytosis (HLH)
UNC13D,Rs121434353,pathogenic for familial hemophagocytic lymphohistiocytosis (HLH)
UROD,Rs74349352,Mendelian disease
UROD,Rs74349352,biocurators
UROD,Rs74349352,Table S6
UROD,Rs74349352,SNP
UROD,Rs74349352,Pathogenic Regulatory Variants
UROD,Rs74349352,Whole-Genome
UROD,Rs74349352,Mendelian disease
UROD,Rs74349352,Mendelian Disease
UROS,Rs397515350,Table S6
UROS,Rs397515351,Mendelian disease
UROS,Rs397515351,biocurators
UROS,Rs397515351,Table S6
UROS,Rs397515351,SNP
UROS,Rs397515351,Mendelian Disease
UROS,Rs397515351,Pathogenic Regulatory Variants
UROS,Rs397515351,Whole-Genome
UROS,Rs397515351,Mendelian disease
UROS,Rs397515350,Mendelian disease
UROS,Rs397515350,biocurators
UROS,Rs397515350,SNP
UROS,Rs397515348,Mendelian disease
UROS,Rs397515350,Pathogenic Regulatory Variants
UROS,Rs397515350,Whole-Genome
UROS,Rs397515350,Mendelian disease
UROS,Rs397515348,Mendelian disease
UROS,Rs397515348,biocurators
UROS,Rs397515348,Table S6
UROS,Rs397515348,SNP
UROS,Rs397515348,Mendelian Disease
UROS,Rs397515348,Pathogenic Regulatory Variants
UROS,Rs397515348,Whole-Genome
UROS,Rs397515350,Mendelian Disease
USH1C,Rs55843567,syndromic and non-syndromic deafness
USP9Y,Rs3212292, black men
USP9Y,Rs3212292,protective lipid profile
USP9Y,Rs2032602,Asian
USP9Y,Rs2032602,Y haplogroup D
USP9Y,Rs2032602,mutation 
USP9Y,Rs2032602,Asian haplogroup D
UTY,Rs796827870,23andMe nazwa: i4000146
VARS,Rs1060499734,p.Leu885Phe
VARS,Rs1060499734,L885F
VARS,Rs769369302,3173G
VARS,Rs769369302,Arg1058Gln 
VARS,Rs769369302,R1058Q
VDR,Rs3782905,prostate cancer prognosis
VDR,Rs3782905,Chinese Han population
VDR,Rs3782905,adiposity phenotypes
VDR,Rs3782905,Asthma
VDR,Rs3782905,asthma
VDR,Rs3782905,Hispanic and African Americans
VEGFA,Rs2146323,smaller hippocampal volumes than T-allele and A-allele carriers
VEGFA,Rs3025030,bladder cancer risk
VEGFA,Rs3025030,age-related macular degeneration
VEGFA,Rs3025030,neovascular age-related macular degeneration
VEGFA,Rs3025030,rheumatoid arthritis
VHL,Rs104893829,somatic mutations in patients
VKORC1,Rs1799853,Moroccan patients
VKORC1,Rs1799853,children
VKORC1,Rs1799853,very preterm infants
VKORC1,Rs1799853,capsaicin metabolism
VKORC1,Rs9923231,thromboembolism
VKORC1,Rs1799853,gallbladder cancer 
VKORC1,Rs1799853,rs1799853 is a SNP in the CYP2C9 gene and is linked to poor warfarin metabolism and risk of GI bleeding with some NSAID drugs.
VKORC1,Rs1799853,gallstone 
VKORC1,Rs1799853,ode-positive breast cancer
VKORC1,Rs1799853,The CYP2C9 2 allele is also associated with higher sensitivity to the anti-epileptic drug phenytoin
VKORC1,Rs1799853,the study discovered that carriers of CYP2C8 3 (a minor allele of both rs10509681 and rs11572080) had a GI bleeding event risk OR=1.81 (95% CI=0.95–3.46; P=0.071) and risk increased if carriers drank more than 20g alcohol/day
VKORC1,Rs1799853,"Individuals carrying minor alleles of this both CYP2C9 2 rs1799853 AND CYP2C8 3 (a minor allele of both rs10509681 and rs11572080) have increased risk of developing acute gastrointestinal bleeding during the use of NSAIDs that are CYP2C8 or CYP2C9 substrates, such as aceclofenac, celecoxib, diclofenac, ibuprofen, indomethazine, lornoxicam, meloxicam, naproxen, piroxicam, tenoxicam and valdecoxib."
VKORC1,Rs1799853,"In addition, carriers of the risk allele for CYP2C9 2 rs1799853 have decreased metabolism of Ibuprofen, Flurbiprofen, Piroxicam, and Tenoxicam."
VKORC1,Rs1799853,"""Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding,"""
VKORC1,Rs1799853,"Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans."
VKORC1,Rs1799853,"Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Low-penetrance alleles predisposing to sporadic colorectal cancers:"
VKORC1,Rs28940303,warfarin dose
VKORC1,Rs28940304,warfarin dose
VKORC1,Rs28940305,warfarin dose
VKORC1,Rs9923231,hypercoagulability
VKORC1,Rs1799853,Sao Miguel's healthy population
VKORC1,Rs1799853,The effect of CYP2C9 variants on drug metabolism should not be predicted without also considering CYP2C9 3
VKORC1,Rs1799853,Hodgkin lymphoma
VKORC1,Rs1799853,Chilean women
VKORC1,Rs1799853,French
VKORC1,Rs1799853,poor warfarin metabolism
VKORC1,Rs1799853,GI bleeding
VKORC1,Rs1799853,poor metabolism of warfarin
VKORC1,Rs1799853,Stevens-Johnson syndrome
VKORC1,Rs1799853,gastrointestinal bleeding
VKORC1,Rs1799853,Individuals carrying minor alleles of this both CYP2C9 2 rs1799853 AND CYP2C8 3
VKORC1,Rs1799853,increased risk of developing acute gastrointestinal bleeding
VKORC1,Rs1799853,decreased metabolism
VKORC1,Rs1799853,gastrointestinal bleeding
VKORC1,Rs1799853,GI bleeding
VKORC1,Rs1799853,NSAID-induced gastrointestinal bleeding
VKORC1,Rs1799853,European-Americans
VKORC1,Rs1799853,African-Americans
VKORC1,Rs1799853,cancer
VKORC1,Rs1799853,orthopedic patients
VKORC1,Rs1799853,Caucasians
VKORC1,Rs1799853,African Americans
VKORC1,Rs1799853,Genetic factors
VKORC1,Rs1799853,Han Chinese
VKORC1,Rs1799853,colorectal cancer
VKORC1,Rs1799853,sporadic colorectal cancers
VKORC1,Rs1799853,Colon tumor
VPS35,Rs188286943,D620N 
VPS35,Rs188286943,aka c.1858G
VPS35,Rs188286943,"p.Asp620Asn,"
VPS41,Rs11984145,errors 
VPS41,Rs11984145,8 
VPS41,Rs11984145,CANTAB 
VPS41,Rs11984145,Neuropsychological 
VPS41,Rs11984145,Automated 
VWF,Rs33978901,p.Arg924Gln
VWF,Rs33978901,"R924Q,"
VWF,Rs33978901,SNP
VWF,Rs33978901,chromosome 12
VWF,Rs33978901,rs33978901(T)
VWF,Rs33978901,dbSNP
VWF,Rs33978901,SNPedia
VWF,Rs33978901,VWF level reduction
VWF,Rs33978901,Von Willebrand disease
VWF,Rs33978901,VWF mutation
VWF,Rs33978901,i5049145
VWF,Rs33978901,VWF
VWF,Rs33978901, FVIII
VWF,Rs33978901,SNP
VWF,Rs33978901,FVIII
VWF,Rs33978901,rs33978901
VWF,I5049258,Von Willebrand
VWF,Rs33978901,blood group O
VWF,I3002455,Willebrand disease
VWF,I5049159,Von Willebrand disease
VWF,I5049258,Willebrand disease
VWF,Rs33978901,c.2771G>A
VWF,I5049284,Von Willebrand disease
VWF,I5049343,Willebrand disease
VWF,I5049284,Willebrand disease
VWF,Rs1063856,hepatopulmonary syndrome 
VWF,Rs1063856,coronary heart disease
VWF,Rs1063856,liver disease
VWF,Rs121964894,"allele is considered pathogenic for Von Willebrand disease, type 2N"
VWF,Rs267607353,Von Willebrand disease
VWF,Rs33978901,Von Willebrand disease
VWF,I5049343,Von Willebrand disease
WDPCP,Rs11683229,(IL6)
WFS1,Rs10012946,The effect of multiple genetic variants in predicting the risk of type 2 diabetes.
WFS1,Rs10012946,Novel association of HK1 with glycated hemoglobin in a non-diabetic population
WFS1,Rs10012946,rs10012946 is in linkage disequilibrium with a polymorphism that increases susceptibility to Type II Diabetes
WFS1,Rs10012946,type 1 diabetes.
WFS1,Rs10012946,Type II Diabetes
WFS1,Rs10010131,diabetes
WFS1,Rs10010131,obesity-susceptibility
WFS1,Rs10010131,genetics of type 2 diabetes
WFS1,Rs10010131,polymorphisms
WFS1,Rs10010131,polymorphisms
WFS1,Rs10010131,2 diabetes
WFS1,Rs10010131,Obesity
WISP3,Rs1230345,schizophrenia
WRN,Rs2553268,systolic blood pressure
WRN,Rs2553268,systolic blood pressure
WRN,OMIM604611.0004,Werner Syndrome
WRN,OMIM604611.0004,Japanese Werner Syndrome cases
WT1,Rs28942089,Denys-Drash syndrome
WT1,Rs28942089, is considered causal for Denys-Drash syndrome
WT1,Rs587776574,aka 
WT1,Rs587776574,443delG 
WT1,Rs587776574,Gly148Valfs
XPNPEP2,Rs138365897,bipolar disorde
XPNPEP2,Rs3788853,cause susceptibility to angioedema|skin swelling when taking medicines called ACE Inhibitors
XPNPEP2,Rs138365897,Bipolar Disorder
XPNPEP2,Rs138365897,variants speculated
XPNPEP2,Rs138365897,Familial Bipolar Disorder
XPNPEP2,Rs138365897,bipolar disorder
XRCC1,Rs25486,African-Americans
XRCC1,Rs25486,lung cancer
XRCC1,Rs25486,Latinos
XRCC1,Rs761564262,NM_006297
XRCC1,Rs761564262,1293G
XRCC1,Rs761564262,Lys431Asn
XRCC1,Rs761564262,OMIM
XRCC1,Rs761564262,NM_006297.2(XRCC1):c.1293G>C
XRCC1,Rs761564262,p.Lys431Asn
YARS2,Rs11539445,considered pathogenic
ZBED9,Rs13194504,The most strongly associating HLA loci were HLA-B
ZBED9,Rs13194504,associated with schizophrenia as strongly as rs13194504 
ZBED9,Rs13194504,Schizophrenia risk from complex variation of complement component 4 Supplementary Figure 6b Associations to HLA alleles and coding-sequence polymorphisms 
ZBED9,Rs13194504,genetically predicted C4A expression and rs13194505 
ZBED9,Rs13194504,Schizophrenia risk from complex variation of complement component 4
ZBED9,Rs13194504,associate strongly with schizophrenia
ZMAT4,Rs2722425,Framingham
ZNF644,Rs769065721,Mendelian disease
ZNF644,Rs769065721,Table S6
ZNF644,Rs769065721,SNP
ZNF644,Rs769065721,Mendelian Disease
ZNF644,Rs769065721,Pathogenic Regulatory Variants
ZNF644,Rs769065721,Whole-Genome
ZNF644,Rs769065721,Mendelian disease
ZNF644,Rs769065721,biocurators
ZNF644,Rs587776903,biocurators
ZNF644,Rs587776903,Table S6
ZNF644,Rs587776903,SNP
ZNF644,Rs587776903,Mendelian Disease
ZNF644,Rs587776903,Pathogenic Regulatory Variants
ZNF644,Rs587776903,Whole-Genome
ZNF644,Rs587776903,Mendelian disease
ZNF644,Rs587776903,Mendelian disease
ZNF80,Rs905568,Tardive dyskinesia
ZNF80,Rs7620754,Tardive dyskinesia
ZNF80,Rs905568,Tardive dyskinesia
ZNF80,Rs3732782,Tardive dyskinesia
ZNF80,Rs3732782,Tardive dyskinesia
ZNF80,Rs7620754,Tardive dyskinesia
ZNF804A,Rs1344706,bipolar disorders
ZNF804A,Rs7597593,association
ZNF804A,Rs7597593,schizophrenia
ZNF804A,Rs7597593,sex-modulated
ZNF804A,Rs7597593,sex-modulated association of ZNF804A with schizophrenia.
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,antipsychotic response
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,psychosis subphenotype
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,Apoptotic engulfment pathway
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,psychosis
ZNF804A,Rs1344706,Dopamine Hypothesis 
ZNF804A,Rs1344706,Schizophrenia
ZNF804A,Rs1344706,Schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNF804A,Rs1344706,schizophrenia
ZNRF3,Rs2269577,Vitiligo
ZSCAN25,Rs776746,testicular germ cell cancer
ZSCAN25,Rs45593941,SNP
ZSCAN25,Rs45593941,rs28365085
ZSCAN25,Rs776746,testicular germ cell cancer
ZSCAN25,Rs776746,prostate cancer
ZSCAN25,Rs776746,Caucasians
ZSCAN25,Rs776746,African descent
ZSCAN25,Rs776746,colorectal cancer
ZSCAN25,Rs776746,myeloid leukemia
ZSCAN25,Rs776746,cancer
ZSCAN25,Rs776746,prostate cancer
ZSCAN25,Rs776746,HIV
ZSCAN25,Rs776746,African Americans
ZSCAN25,Rs45593941,CYP3A5 3F variant
ZSCAN25,Rs776746,hyperbilirubinemia
ZSCAN25,Rs776746,Gilbert's syndrome
ZSCAN25,Rs776746,breast cancer
ZSCAN25,Rs776746,Asian Indians
ZSCAN25,Rs45593941,rs45593941(T) allele
ZSCAN25,Rs45446698,CYP3A7 1C
ZSCAN25,Rs45593941,SNP
ZSCAN25,Rs776746,genomic ancestry of individuals from different geographical regions of Brazil
ZSCAN25,Rs10264272,rs10264272
ZSCAN25,Rs10264272,14690G>A
ZSCAN25,Rs10264272,SNP 
ZSCAN25,Rs10264272,CYP3A5
ZSCAN25,Rs10264272,CYP3A5
ZSCAN25,Rs10264272,CYP3A5 6
ZSCAN25,Rs10264272,14690G>A
ZSCAN25,Rs10264272,dbSNP
ZSCAN25,Rs10264272,624G-A
ZSCAN25,Rs10264272,AAG (Lysine)
ZSCAN25,Rs10264272,AAA (Lysine)
ZSCAN25,Rs28383479,nonfunctional
ZSCAN25,Rs41303343,those of African descent
ZSCAN25,Rs45446698,"increased risk of breast cancer, lung cancer, and CLL"
ZSCAN25,Rs45593941,rs45593941
ZSCAN25,Rs45593941,L82R
ZSCAN25,Rs45593941,CYP3A5 gene
ZSCAN25,Rs776746,nephrotoxicity
